
<html lang="en"     class="pb-page"  data-request-id="c497f029-95ac-4240-9585-68896dbc1a3a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b00911"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases" /></meta><meta name="dc.Creator" content="Alen  Krajnc" /></meta><meta name="dc.Creator" content="Jürgen  Brem" /></meta><meta name="dc.Creator" content="Philip  Hinchliffe" /></meta><meta name="dc.Creator" content="Karina  Calvopiña" /></meta><meta name="dc.Creator" content="Tharindi D.  Panduwawala" /></meta><meta name="dc.Creator" content="Pauline A.  Lang" /></meta><meta name="dc.Creator" content="Jos J. A. G.  Kamps" /></meta><meta name="dc.Creator" content="Jonathan M.  Tyrrell" /></meta><meta name="dc.Creator" content="Emma  Widlake" /></meta><meta name="dc.Creator" content="Benjamin G.  Saward" /></meta><meta name="dc.Creator" content="Timothy R.  Walsh" /></meta><meta name="dc.Creator" content="James  Spencer" /></meta><meta name="dc.Creator" content="Christopher J.  Schofield" /></meta><meta name="dc.Description" content="The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clinical development. We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clinically impo..." /></meta><meta name="Description" content="The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clinical development. We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clinically impo..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 27, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00911" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00911" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00911" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00911" /></link>
        
    
    

<title>Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00911" /></meta><meta property="og:title" content="Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0005.jpeg" /></meta><meta property="og:description" content="The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clinical development. We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clinically important metallo-β-lactamases (MBLs), including NDM-1 and VIM-1/2. VNRX-5133 activity against IMP-1 and tested B2/B3 MBLs was lower/not observed. Crystallography reveals how VNRX-5133 binds to the class D SBL OXA-10 and MBL NDM-1. The crystallographic results highlight the ability of bicyclic boronates to inhibit SBLs and MBLs via binding of a tetrahedral (sp3) boron species. The structures imply conserved binding of the bicyclic core with SBLs/MBLs. With NDM-1, by crystallography, we observed an unanticipated VNRX-5133 binding mode involving cyclization of its acylamino oxygen onto the boron of the bicyclic core. Different side-chain binding modes for bicyclic boronates for SBLs and MBLs imply scope for side-chain optimization. The results further support the “high-energy-intermediate” analogue approach for broad-spectrum β-lactamase inhibitor development and highlight the ability of boron inhibitors to interchange between different hybridization states/binding modes." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00911"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00911">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00911&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00911&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00911&amp;href=/doi/10.1021/acs.jmedchem.9b00911" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8544-8556</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00847" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00946" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Alen Krajnc</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alen Krajnc</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alen++Krajnc">Alen Krajnc</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7822-1944" title="Orcid link">http://orcid.org/0000-0001-7822-1944</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jürgen Brem</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jürgen Brem</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%BCrgen++Brem">Jürgen Brem</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0137-3226" title="Orcid link">http://orcid.org/0000-0002-0137-3226</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philip Hinchliffe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philip Hinchliffe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Cellular and Molecular Medicine, Biomedical Sciences Building, University Walk, University of Bristol, Bristol BS8 1TD, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Hinchliffe">Philip Hinchliffe</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8611-4743" title="Orcid link">http://orcid.org/0000-0001-8611-4743</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karina Calvopiña</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karina Calvopiña</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karina++Calvopi%C3%B1a">Karina Calvopiña</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tharindi D. Panduwawala</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tharindi D. Panduwawala</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tharindi+D.++Panduwawala">Tharindi D. Panduwawala</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pauline A. Lang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pauline A. Lang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pauline+A.++Lang">Pauline A. Lang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3187-1469" title="Orcid link">http://orcid.org/0000-0003-3187-1469</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jos J. A. G. Kamps</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jos J. A. G. Kamps</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jos+J.+A.+G.++Kamps">Jos J. A. G. Kamps</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan M. Tyrrell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan M. Tyrrell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Microbiology & Infectious Disease, Institute of Infection & Immunity, UHW Main Building, Heath Park, Cardiff CF14 4XN, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+M.++Tyrrell">Jonathan M. Tyrrell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emma Widlake</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emma Widlake</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Microbiology & Infectious Disease, Institute of Infection & Immunity, UHW Main Building, Heath Park, Cardiff CF14 4XN, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emma++Widlake">Emma Widlake</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin G. Saward</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin G. Saward</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+G.++Saward">Benjamin G. Saward</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Timothy R. Walsh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timothy R. Walsh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Microbiology & Infectious Disease, Institute of Infection & Immunity, UHW Main Building, Heath Park, Cardiff CF14 4XN, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+R.++Walsh">Timothy R. Walsh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James Spencer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James Spencer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Cellular and Molecular Medicine, Biomedical Sciences Building, University Walk, University of Bristol, Bristol BS8 1TD, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James++Spencer">James Spencer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4602-0571" title="Orcid link">http://orcid.org/0000-0002-4602-0571</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Christopher J. Schofield</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher J. Schofield</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#a1c2c9d3c8d2d5ced1c9c4d38fd2c2c9cec7c8c4cdc5e1c2c9c4cc8fced98fc0c28fd4ca"><span class="__cf_email__" data-cfemail="4c2f243e253f38233c24293e623f2f24232a252920280c2f242921622334622d2f623927">[email protected]</span></a>. Tel: +44 (0)1865 275625. Fax: +44 (0)1865 285002.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Schofield">Christopher J. Schofield</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0290-6565" title="Orcid link">http://orcid.org/0000-0002-0290-6565</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00911&amp;href=/doi/10.1021%2Facs.jmedchem.9b00911" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8544–8556</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 27, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 June 2019</li><li><span class="item_label"><b>Published</b> online</span>27 August 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 September 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00911" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00911</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00911"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4776</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">62</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00911" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alen&quot;,&quot;last_name&quot;:&quot;Krajnc&quot;},{&quot;first_name&quot;:&quot;Jürgen&quot;,&quot;last_name&quot;:&quot;Brem&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Hinchliffe&quot;},{&quot;first_name&quot;:&quot;Karina&quot;,&quot;last_name&quot;:&quot;Calvopiña&quot;},{&quot;first_name&quot;:&quot;Tharindi&quot;,&quot;last_name&quot;:&quot;D. Panduwawala&quot;},{&quot;first_name&quot;:&quot;Pauline&quot;,&quot;last_name&quot;:&quot;A. Lang&quot;},{&quot;first_name&quot;:&quot;Jos&quot;,&quot;last_name&quot;:&quot;J. A. G. Kamps&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;M. Tyrrell&quot;},{&quot;first_name&quot;:&quot;Emma&quot;,&quot;last_name&quot;:&quot;Widlake&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;G. Saward&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;R. Walsh&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Spencer&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Schofield&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8544-8556&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00911&quot;},&quot;abstract&quot;:&quot;The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clinical development. We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clinically important metallo-β-lactamases (MBLs), including NDM-1 and VIM-1/2. VNRX-5133 activity against IMP-1 and tested B2/B3 MBLs was lower/not observed. Crystallography reveals how VNRX-5133 binds to the class D SBL OXA-10 and MBL NDM-1. The crystallographic results highlight the ability of bicyclic boronates to inhibit SBLs and MBLs via binding of a tetrahedral (sp3) boron species. The structures imply conserved binding of the bicyclic core with SBLs/MBLs. With NDM-1, by crystallography, we observed an unanticipated VNRX-5133 binding mode involving cyclization of its acylamino oxygen onto the boron of the bicyclic core. Different side-chain binding modes for bicyclic boronates for SBLs and MBLs imply scope for side-chain optimization. The results further support the “high-energy-intermediate” analogue approach for broad-spec&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00911&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00911" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00911&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00911" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00911&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00911" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00911&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00911&amp;href=/doi/10.1021/acs.jmedchem.9b00911" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00911" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00911" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00911%26sid%3Dliteratum%253Aachs%26pmid%3D31454231%26genre%3Darticle%26aulast%3DKrajnc%26date%3D2019%26atitle%3DBicyclic%2BBoronate%2BVNRX-5133%2BInhibits%2BMetallo-%2Band%2BSerine-%25CE%25B2-Lactamases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D18%26spage%3D8544%26epage%3D8556%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292580" title="Binding modes">Binding modes</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/jmcmar.2019.62.issue-18/20190926/jmcmar.2019.62.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clinical development. We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clinically important metallo-β-lactamases (MBLs), including NDM-1 and VIM-1/2. VNRX-5133 activity against IMP-1 and tested B2/B3 MBLs was lower/not observed. Crystallography reveals how VNRX-5133 binds to the class D SBL OXA-10 and MBL NDM-1. The crystallographic results highlight the ability of bicyclic boronates to inhibit SBLs and MBLs via binding of a tetrahedral (sp<sup>3</sup>) boron species. The structures imply conserved binding of the bicyclic core with SBLs/MBLs. With NDM-1, by crystallography, we observed an unanticipated VNRX-5133 binding mode involving cyclization of its acylamino oxygen onto the boron of the bicyclic core. Different side-chain binding modes for bicyclic boronates for SBLs and MBLs imply scope for side-chain optimization. The results further support the “high-energy-intermediate” analogue approach for broad-spectrum β-lactamase inhibitor development and highlight the ability of boron inhibitors to interchange between different hybridization states/binding modes.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">β-Lactamase-catalyzed hydrolysis is the most important resistance mechanism for β-lactams, which comprise the most important class of antibacterials (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, top).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Inhibitors of one of the two mechanistic classes of β-lactamases, the nucleophilic serine-β-lactamases (SBLs),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> are established drugs for use in combination with an appropriate β-lactam antibiotic partner (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B, bottom). The well-established SBL inhibitors (clavulanic acid,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> sulbactam,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> tazobactam<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a>) only inhibit a subset of SBLs (Ambler class A and some class C enzymes, but not typically class D enzymes) and are increasingly susceptible to evolved resistance, including via bacterial production of extended-spectrum serine-β-lactamases (ESBLs). The same issues are compromising the use of carbapenems, which manifest both antibacterial and β-lactamase inhibition properties.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. β-Lactam antibacterials, β-lactamase inhibitors in clinical use, outline mechanisms for serine- and metallo-β-lactamase (SBL and MBL) catalysis, and bicyclic boronates in research and development. (A) Major classes of β-lactam antibiotics and SBL inhibitors currently in clinical use, including the clinically approved “monocyclic” boron-containing inhibitor vaborbactam (which has little MBL activity<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>); mode of action of (B) SBLs and (C) MBLs, exemplified by hydrolysis of a carbapenem. Note that the hydrolyzed carbapenem products can be produced in different tautomeric forms. (D) Note that the ability of boronate inhibitors (e.g., VNRX-5133) to interchange between sp<sup>2</sup> and sp<sup>3</sup> forms can enable them to mimic both substrates (sp<sup>2</sup> carbonyl) and the first tetrahedral intermediate (sp<sup>3</sup>). Selected examples of bicyclic boronates from research and development are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The clinical importance of the second mechanistic class of β-lactamases, i.e., the zinc-ion-dependent metallo-β-lactamases (MBLs), which have a different fold/evolutionary origin to the SBLs, is growing.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This is of particular concern because MBLs catalyze the efficient hydrolysis of nearly all β-lactam classes, with the exception of the monobactams, which are not currently hydrolyzed by MBLs at a clinically relevant rate.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The vulnerability of the β-lactams to β-lactamases has long stimulated interest in developing non-β-lactam inhibitors of penicillin-binding proteins (PBPs) and β-lactamases. These studies resulted in the development of avibactam,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> which, unlike (at least most) “traditional” β-lactam inhibitors that act irreversibly to form acyl-enzyme complexes, inhibits class A, C, and some class D SBLs by reversible formation of an acyl-enzyme-type complex via reaction of its diazabicyclooctane core. However, avibactam does not inhibit MBLs;<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> moreover, there is evidence that SBLs and MBLs have potential to evolve to hydrolyze it.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">There is thus interest in the development of non-acylating inhibitors of β-lactamases and PBPs. With this objective in mind, multiple approaches and compounds have been explored, most with relatively little success. In pioneering work, acyclic boronic acids have been developed as multiple myeloma drugs, targeting human proteasomes, which employ nucleophilic threonine catalysis.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> After a long gestation period, boronic acids/boronate esters have emerged as β-lactamase inhibitors with considerable clinical potential.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17−20)</a> Boronate-based inhibitors are of mechanistic interest as, in their tetrahedral (sp<sup>3</sup>-hybridized) forms, they are proposed to be analogues of the high-energy “tetrahedral” intermediates present in the catalytic cycle of the nucleophilic serine enzymes, such as SBLs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) and PBPs, as well as MBLs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> It has also been proposed that boron in its sp<sup>2</sup>-hybridized form can mimic the β-lactam carbonyl group of substrates, which β-lactamases bind highly efficiently.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Recent work has led to the first clinical introduction of a boronic acid-based SBL inhibitor, vaborbactam (formerly RPX7009), for use in combination with the carbapenem meropenem.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Whilst the early boronic acid SBL inhibitors are apparently predominantly acyclic in solution, vaborbactam adopts a monocyclic boronate structure, as observed at the active site of an SBL (CTX-M-15).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Vaborbactam, however, has limited SBL coverage and only moderately inhibits MBLs.<a onclick="showRef(event, 'ref15 ref26'); return false;" href="javascript:void(0);" class="ref ref15 ref26">(15,26)</a> By contrast, recent studies have indicated that bicyclic boronates can inhibit a broader range of SBLs and, importantly, some B1 subfamily MBLs.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a></div><div class="NLM_p last">The potential of bicyclic boronates to act as dual action inhibitors of SBLs and MBLs is reported in the academic<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a> and patent literature.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Taniborbactam (VNRX-5133) is now in phase 3 clinical trials as a relatively broad-spectrum β-lactamase inhibitor. However, while its ability to extend the activity of β-lactam antibiotics against SBL- and MBL-harboring bacteria is reported,<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> the breadth of its activity versus isolated β-lactamases has been unclear. There are no reported structures of VNRX-5133 complexed with SBLs or MBLs in the PDB database. To address these issues, we synthesized VNRX-5133 and tested it for inhibition against a panel of SBLs and MBLs. The results support the potential of bicyclic boronates for broad-spectrum β-lactamase inhibition. Together with previous studies, they also illustrate how the ability of boron to readily interchange between different hybridization states and binding modes in water can help to enable potent inhibition.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">VNRX-5133 was synthesized via a modified version of the reported<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> stereocontrolled route in 11 steps from 2-methoxy-3-methylbenzoic acid <b>1</b> via Matteson homologation<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthesis and NMR analysis of VNRX-5133. (A) Reagents and conditions: (a) oxalyl chloride, cat. DMF, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt), 90 min and then 2-methylpropan-2-ol, 40 °C, 18 h; (b) <i>N</i>-bromosuccinimide, benzoyl peroxide, CCl<sub>4</sub>, reflux, UV, 5 h; (c) bis[(+)-pinanediolato]diboron, Pd(dppf)Cl<sub>2</sub>, KOAc, 1,4-dioxane, 95 °C, 16 h; (d) CH<sub>2</sub>Cl<sub>2</sub>, tetrahydrofuran (THF), <i>n</i>-BuLi, −100 °C, 45 min and then 4 in THF, ZnCl<sub>2</sub>, −95 °C to rt, overnight; (e) lithium bis(trimethylsilyl)amide, THF, −100 °C to −78 °C, 2 h; (f) MeOH, THF, −10 °C to rt, 1 h; (g) K<sub>2</sub>CO<sub>3</sub>, 1:1 CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, rt, 1 h and then 2-(boc-amino)ethyl bromide, benzyltriethylammonium chloride, reflux, 18 h; (h) di-<i>tert</i>-butyl dicarbonate, <i>N</i>,<i>N</i>-diisopropylethylamine, reflux, 16 h; (i) LiOH·H<sub>2</sub>O, 1:2:1 THF/EtOH/H<sub>2</sub>O, rt, 5 h; (j) 11, triethylamine, PyBOP and then crude 7, rt, 75 min; (k) BCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 1 h. (B) <sup>1</sup>H NMR (600 MHz) of high-performance liquid chromatography (HPLC)-purified VNRX-5133 in D<sub>2</sub>O.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The requisite (+)-pinanediol boronate precursor <b>4</b> (87%) was prepared according to reported procedures.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Stereoselective one-carbon homologation of <b>4</b> using in situ generated dichloromethyllithium<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> gave (<i>S</i>)-chloride <b>5</b>. Initial yields after chromatographic purification were low. Following optimization, <b>5</b> was routinely obtained in improved yield (55–61%) in high diastereomeric purity (d.r., <98%, <sup>1</sup>H NMR).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Reaction of <b>5</b> with lithium bis(trimethylsilyl)amide at −90 °C gave bis(trimethylsilyl)-protected amine <b>6</b> with inversion of configuration. To avoid decomposition, crude <i>N</i>-<b>6</b> was not separated and immediately treated with stoichiometric anhydrous methanol (−10 °C to room temperature, THF) to give amine <b>7</b>.</div><div class="NLM_p">The desired side chain carboxylic acid with the <i>trans</i> stereochemistry <b>11</b> was prepared from commercial ethyl 2-(<i>trans</i>-4-aminocyclohexyl) acetate hydrochloride <b>8</b> in three steps. Initial attempts to install the desired ethane-1,2-diamine moiety via <i>N</i>-alkylation were unproductive, possibly due to the low solubility of <b>8</b> in the tested organic solvents. Biphasic conditions (1:1, CH<sub>2</sub>Cl<sub>2</sub>:H<sub>2</sub>O) employing 5 mol% benzyltriethylammonium chloride as a phase-transfer catalyst gave <b>9</b> (49%) following chromatography, which was Boc-protected to give ethyl ester <b>10</b> (82%). Saponification followed by ion-exchange chromatography (Amberlite H-120) gave <b>11</b> (67%).</div><div class="NLM_p last">The formation of the amide linking <b>7</b> and <b>11</b> was achieved using (benzotriazole-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> to give <b>12</b> in moderate yield (34%). One-pot cleavage of the Boc, <i>tert</i>-butyl, methyl ether protecting groups, and the chiral auxiliary using BCl<sub>3</sub> (−78 °C, CH<sub>2</sub>Cl<sub>2</sub>) followed by acidic workup (likely aiding the spontaneous bicyclization) gave VNRX-5133 (<b>13</b>) (42%) following HPLC purification. VNRX-5133 (<b>13</b>) was thus prepared in 3% overall yield over 6 linear steps (excluding steps e and f, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, where intermediates were not isolated). The route described here represents an improvement for the asymmetric synthesis of VNRX-5133 compared to that reported,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> with the number of steps being cut from 16 to 11. There is, however, clear scope for further optimization.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Biochemical Evaluation</h3><div class="NLM_p">We screened VNRX-5133 for activity against a panel of clinically relevant SBLs and MBLs (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) using an established method involving hydrolysis of the “fluorogenic” cephalosporin probe FC5<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> or meropenem for CphA.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In conference reports, VNRX-5133 has been reported to inhibit both SBLs and MBLs.<a onclick="showRef(event, 'ref31 ref33 ref39'); return false;" href="javascript:void(0);" class="ref ref31 ref33 ref39">(31,33,39)</a> Consistent with this and our previously reported results on the inhibition of all classes of β-lactamases by structurally related (bi)cyclic boronates,<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a> VNRX-5133 manifests submicromolar half-maximal inhibitory concentration (IC<sub>50</sub>) values (0.53–0.008 μM) against all major classes of clinically relevant β-lactamases tested, with particularly potent activity, i.e., in the subnanomolar range (IC<sub>50</sub> ∼ 0.5 nM), against the Verona-integron-encoded MBL-2, VIM-2. Notably, VNRX-5133 was less active against the clinically important imipenemase (IMP)-1 B1 MBL (IC<sub>50</sub> ∼ 2.51 μM) and the B2 MBL from <i>Aeromonas hydrophila</i> CphA (CphA, IC<sub>50</sub> ∼ 2.51 μM), nor did it inhibit subclass B3 MBL L1 from <i>Stenotrophomonas maltophilia</i>. The comparison of IC<sub>50</sub> values reveals that VNRX-5133 (taniborbactam) is 50 to >50 000-fold more potent against the clinically relevant MBLs compared to vaborbactam<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (VNRX-5133 is, in general, more potent than the structurally related bicyclic boronate CB2<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> against the same enzymes). Variation in the pre-incubation times of VNRX-5133 with subclass B1 MBL NDM-1 did not result in different IC<sub>50</sub> values (Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Table S2 and Figure S33</a>), thus supporting the case for the reversible inhibition by VNRX-5133, as observed for related bicyclic boronate inhibitors.<a onclick="showRef(event, 'ref29 ref40'); return false;" href="javascript:void(0);" class="ref ref29 ref40">(29,40)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activities of VNRX-5133 versus representative serine- and metallo-β-lactamases<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center">VNRX-5133 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">vaborbactam<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">CB2<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SBL</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">TEM-116</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">0.003<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left">MBLs</td><td class="colsep0 rowsep0" align="left">B1</td><td class="colsep0 rowsep0" align="left">IMP-1</td><td class="colsep0 rowsep0" align="left">2.51</td><td class="colsep0 rowsep0" align="left">126</td><td class="colsep0 rowsep0" align="left">1<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B1</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">631</td><td class="colsep0 rowsep0" align="left">0.029<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B1</td><td class="colsep0 rowsep0" align="left">VIM-1</td><td class="colsep0 rowsep0" align="left">0.0079</td><td class="colsep0 rowsep0" align="left">398</td><td class="colsep0 rowsep0" align="left">0.085<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B1</td><td class="colsep0 rowsep0" align="left">VIM-2</td><td class="colsep0 rowsep0" align="left">0.0005</td><td class="colsep0 rowsep0" align="left">316</td><td class="colsep0 rowsep0" align="left">0.003<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B2</td><td class="colsep0 rowsep0" align="left">CphA</td><td class="colsep0 rowsep0" align="left">2.51</td><td class="colsep0 rowsep0" align="left">631</td><td class="colsep0 rowsep0" align="left">>100<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B3</td><td class="colsep0 rowsep0" align="left">L1</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">336</td><td class="colsep0 rowsep0" align="left">not inhibited<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SBL</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">AmpC (<i>P. aeruginosa</i>)</td><td class="colsep0 rowsep0" align="left">0.301</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.12<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">SBLs</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">OXA-10</td><td class="colsep0 rowsep0" align="left">0.234</td><td class="colsep0 rowsep0" align="left">>400</td><td class="colsep0 rowsep0" align="left">not available</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">OXA-10<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.645</td><td class="colsep0 rowsep0" align="left">>400</td><td class="colsep0 rowsep0" align="left">5.1<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">OXA-48</td><td class="colsep0 rowsep0" align="left">0.537</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">not available</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">OXA-48<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.39</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">2.6<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values of VNRX-5133 against a panel of SBLs and MBLs (see Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_002.pdf" class="ext-link">Table S1</a> for error analysis). SBL, serine-β-lactamase; MBL, metallo-β-lactamase.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">These assays were run in the presence of 100 mM aqueous sodium bicarbonate.</p></div></div></div><div class="NLM_p last">Notably, improved inhibition with respect to vaborbactam is also observed for VNRX-5133 against the class A narrow-spectrum β-lactamase TEM-116 (500-fold increase) and for the tested class D SBLs (a 10- to 2000-fold increase, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In particular, VNRX-5133 manifests moderate inhibition of the narrow-spectrum oxacillinase OXA-10 (IC<sub>50</sub> ∼ 0.234 μM), which is not inhibited by vaborbactam (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Only moderate inhibition of the OXA-48 carbapenemase was observed (IC<sub>50</sub> ∼ 0.537 μM). Overall, these results support the proposal that VNRX-5133 possesses an unusually broad-spectrum inhibitory activity against Ambler Class A (ESBLs), B (NDM and VIM), C (AmpC from <i>P. aeruginosa</i>) and, to a somewhat lesser extent, D (OXA) β-lactamases. Nonetheless, the lower activity of VNRX-5133, in particular, against the subclass B1 MBL IMP-1, as well as the tested B2/B3 MBLs implies that there is scope for further optimization of this new inhibitor class.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Crystallography</h3><div class="NLM_p">To investigate the binding mode of VNRX-5133 to β-lactamases, we initiated crystallographic analyses and obtained structures of it in complex with the class D SBL OXA-10 and the B1 subclass MBL NDM-1, at resolutions of 2.17 Å (space group: <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>) and 1.51 Å (space group: <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>), respectively. In each structure, there are two chains (A/B) in the asymmetric unit.</div><div class="NLM_p">After soaking of an NDM-1 crystal with VNRX-5133, there was clear <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> density corresponding to bound VNRX-5133 in the active site in both chains A and B. Unexpectedly, the electron density (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) indicated the presence of a tricyclic form of VNRX-5133 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, and Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Figure S2A</a>), which was refined at full occupancy in chain B (with an average B-factor of 18.02 Å<sup>2</sup>). In chain A, a mixture of both the bicyclic (as solely observed with OXA-10) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) and tricyclic forms was modeled (at occupancies of 0.6 and 0.4, respectively). The ethylamino atoms of the VNRX-5133 side chain in both chains A and B lacked observable electron density and were removed in the final model. The tricyclic structure is probably formed by cyclization of the side chain amide oxygen onto the boron. Although there is no obvious basic amino acid residue close enough to the side chain amide to catalyze this reaction manifested in the crystal structure, this type of reaction has precedent in synthetic chemistry.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural basis of serine- and metallo-β-lactamase inhibition by VNRX-5133. (A) View from a crystal structure of VNRX-5133 complexed with NDM-1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RMF">6RMF</a>) in chain A showing the major observed bicyclic form (yellow). (B) View from a crystal structure of VNRX-5133 complexed with NDM-1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RMF">6RMF</a>) in chain B showing the tricyclic form (magenta). (C) An overlay of bicyclic (60%, yellow) and tricyclic (40%, magenta) forms of VNRX-5133 in chains A or B of NDM-1 and 2mFo-DFc electron density for the tricyclic inhibitor form in chain B (contoured to 3σ, gray mesh). (D) Proposed mechanism for formation of the unexpected tricyclic VNRX-5133 complex. Enz-Nu = Enz-(ZnII)<sub>n</sub>-OH (MBL) or Enz-Ser-OH (SBL). (E) Binding mode of VNRX-5133 to the OXA-10 SBL (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RTN">6RTN</a>). (F) Comparison of the binding modes of VNRX-5133 in complex with OXA-10 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RTN">6RTN</a>) in chain A (pale blue) and chain B (pale yellow); omit electron density for the bicyclic form in chain A (contoured at 3σ, gray mesh).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For both bicyclic and tricyclic forms with NDM-1, the bicyclic “boronate core”, including the aryl carboxylate, adopts nearly identical binding modes (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Notably, binding of VNRX-5133 to NDM-1 increases the Zn1–Zn2 distance from ∼3.6 Å (e.g., PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZGZ">5ZGZ</a><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>) to 4.3 Å (in both chains A and B); a similar increase has been observed on binding/reaction of the antibiotic ampicillin with NDM-1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZGE">5ZGE</a><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>) and on binding of CB2 to VIM-2.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Such changes in the positioning of metal ions induced by inhibitor–substrate interactions in β-lactamase catalysis have also been observed with extended X-ray absorption fine structure (EXFAS) spectroscopy studies, as shown in the case of the subclass B3 MBL L1 from <i>S. maltophilia</i><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and with other metallo-enzymes (see e.g.,<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45−47)</a>); it may also be that the extent of such metal ion translocations is not fully reflected in crystallographic compared to solution studies. It should also be noted that the precipitants used in crystallography experiments for NDM-1:<b>VNRX-5133</b> and OXA-10:<b>VNRX-5133</b> structures were at pH 5.8 and pH 8.0, respectively.</div><div class="NLM_p">One boron-bound oxygen effectively bridges the two active site zinc ions in NDM-1 but is closer to Zn1 (1.9 Å) than Zn2 (3 Å). The boron-bound oxygen that “becomes” part of the 5-membered ring of the tricyclic VNRX-5133 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) is positioned to make a significantly weaker interaction with Zn2 (2.8 Å) than Zn1 and is positioned almost identically to the same boron-bound oxygen in the bicyclic VNRX-5133 structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). For comparison, CB2 binding to VIM-2 results in interactions of the boron-bound oxygens of 2.6 and 1.9 Å to Zn2.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> A number of other interactions of VNRX-5133 are conserved with respect to other bicyclic boronates (i.e., CB2 and others<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a>), including that of the aryl carboxylate with Zn2 and Lys<sub>224</sub> and the “endocyclic” boronate ester oxygen with Zn2. The L3 loop, which is proposed to be involved in binding inhibitors/substrates,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> is partly disordered in the case of the VNRX-5133 complex (residues 67–70 and 68–70 could not be modeled in chains A and B, respectively) and has high B-factors compared to the rest of the main chain, indicating flexibility. These observations suggest that the L3 loop may not have an important role in stabilizing VNRX-5133 NDM-1 binding (Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Figure S4</a>).</div><div class="NLM_p">The tricyclic form observed in NDM-1 is probably generated by the reaction of the acylamino side-chain carbonyl group with the VNRX-5133 boron, together with associated loss of water/hydroxide (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Given that we observed evidence for both the bicyclic and tricyclic forms in the crystal structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B), it seems likely that tricyclization occurs at the active site, though we cannot rule out the presence of the tricyclic form at low concentrations in the solution phase.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Further studies will be necessary to exclude the possibility that the observed tricyclic inhibitor form is not a crystallization artifact; it has been proposed that at least one MBL–inhibitor complex crystal structure, i.e. the mono-zinc carbapenemase MBL CphA in complex with biapenem, does not necessarily reflect the catalytic pathway in solution.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> Nevertheless, the observation of a tricycle is a striking example of the ability of boron-based inhibitors to interchange between different forms, potentially giving a tightly bound enzyme–inhibitor complex.</div><div class="NLM_p">In the case of the OXA-10:<b>VNRX-5133</b> complex structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E), the inhibitor is observed to bind similarly in chains A and B (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F), with the boron atom covalently linked to the nucleophilic serine (Ser<sub>67</sub>), likely mimicking the tetrahedral intermediate in SBL/MBL catalysis (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B,C).<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> The essential conserved lysine (Lys<sub>70</sub>),<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> which acts as a general acid/base, is, at least predominantly, in its carbamylated (KCX<sub>70</sub>) form in both chains A and B (Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Figure S3</a>). Comparison of this structure with that of OXA-10 complexed with the structurally related bicyclic boronate inhibitor CB1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQ9">5FQ9</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) reveals that, while the bicyclic cores of both inhibitors manifest similar binding modes, there are substantial variations in the conformations adopted by their acylamino side chains, which have implications for the side chain optimization (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The boron-containing bicyclic cores and the acylamino side chains of both VNRX-5133 and CB1 are positioned to make hydrophobic/aromatic interactions with Tyr<sub>102</sub> and Met<sub>99</sub>. Although there is some variation in their precise conformations, the VNRX-5133 and CB1 aryl carboxylates are both positioned to make polar interactions with Gly<sub>207</sub> and Arg<sub>250</sub> that bind the analogous carboxylates in β-lactams (Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Figure S1</a>). Note that some variations of the aryl carboxylate binding modes are anticipated, given the differences in the precise modes of carboxylate binding employed by different classes of SBL/MBL/PBP.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlays of reported bicyclic boronate structures and VNRX-5133 in MBLs, SBLs, and a PBP reveal different side-chain orientations. Views from NDM-1:VNRX-5133 (yellow, bicyclic form, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RFM">6RFM</a>), VIM-2:CB2 (teal, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQC">5FQC</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), BcII:CB2 (pale green, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQB">5FQB</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), AmpC:CB1 (orange, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6I30">6I30</a><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>), PBP-2:CB2 (gray, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J8X">5J8X</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), OXA-10:VNRX-5133 (pale blue, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RTN">6RTN</a>), OXA-10:CB1 (brown, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQ9">5FQ9</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), and CTX-M-15:CB1 (wheat, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T66">5T66</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>). Note that although the crystallographically observed orientations of the acylamino side chains vary, the binding modes of cyclic ring systems and their carboxylate are conserved, including for VNRX-5133. The acylamino side chains adopt two broad orientations, reflecting binding to SBLs (U-shaped). The VNRX-5133 acylamino side chain adopts clearly different conformations in the bicyclic inhibitor forms in both OXA-10 and NDM-1 structures (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Although care should be taken in assuming that the crystallographically observed binding modes accurately reflect the solution behavior, the structural observations imply that the optimized VNRX-5133 side chain can enable potent inhibition of different β-lactamase classes, by adopting different binding modes. Structural analyses of the cyclic boronates bound to MBLs and SBLs reveal that the acylamino side chain adopts two types of orientations (at least in the crystalline state), reflecting binding to SBLs or MBLs. These observations imply that there is likely further scope for side chain optimization, including with respect to extending the scope and potency of MBL inhibition and obtaining more potent (bi/tri)cyclic boronate-based PBP inhibitors. Importantly, comparison of the OXA-10 and NDM-1 structures with those observed for other structurally related compounds, i.e., CB1/CB2 (which differ from VNRX-5133 only in their C-3 acylamino side chains) when complexed with SBLs (OXA-10,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> CTX-M-15,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> AmpC<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>), MBLs (NDM-1,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> VIM-2,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> BcII<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), and a PBP (PBP-5<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), reveal conservation in the binding mode of the bicyclic boronate core (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Even allowing for the observed tricycle formation with NDM-1, similar conformations are observed across all Ambler classes of β-lactamases as well as with a PBP (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Superimposition of structures of OXA-10:<b>VNRX-5133</b> and NDM-1:<b>VNRX-5133</b> with analogous structures of the respective enzymes with “intermediate” complexes derived from substrates (e.g., hydrolyzed benzylpenicillin) reveals the binding modes adopted by VNRX-5133/related inhibitors overlap with those adopted by hydrolyzed β-lactams (Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Figures S1 and S2B</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Microbiology</h3><div class="NLM_p">Antimicrobial susceptibility testing of VNRX-5133 in combination with meropenem (carbapenem) or cefepime (cephalosporin) was performed in minimal inhibitory concentration (MIC) antimicrobial assay format utilizing six clinical isolates of NDM-1-producing clinically relevant strains of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In all cases, the MIC values of cefepime/meropenem were significantly reduced in the presence of VNRX-5133 compared to those in its absence (MIC > 64 μg mL<sup>–1</sup>). Both cefepime/VNRX-5133 and meropenem/VNRX-5133 combinations were highly active against all six of the NDM-1-producing clinical isolates tested, with MIC ranges of 16–0.25 and 1–0.125 μg mL<sup>–1</sup>, respectively. These results reveal the potential of VNRX-5133 to act against clinically relevant MBLs (i.e., NDM-1) in bacteria, consistent with the results from clinical trials with VNRX-5133.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of VNRX-5133 on Cefepime/Meropenem MICs for Selected NDM-1 MBL-expressing <i>Enterobacteriaceae</i><a class="ref internalNav" href="#t2fn2" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">genotype</th><th class="colsep0 rowsep0" align="center">Cef/MEM MIC (μg mL<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">Cef/MEM + VNRX-5133 (10 μg mL<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S117</td><td class="colsep0 rowsep0" align="left">Ec</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">16/1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IR57</td><td class="colsep0 rowsep0" align="left">Ec</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">8/0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B64</td><td class="colsep0 rowsep0" align="left">Kp</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.25/0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B68-1</td><td class="colsep0 rowsep0" align="left">Kp</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.5/0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IR43</td><td class="colsep0 rowsep0" align="left">Kp</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.5/0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">91N</td><td class="colsep0 rowsep0" align="left">Ec</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">4/0.125</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn2"><div class="footnote" id="t2fn2"><sup><sup>a</sup></sup><p class="last">Ec, <i>Escherichia coli</i>; Kp, <i>Klebsiella pneumoniae</i>; MEM, meropenem; Cef, cefepime.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The overall results clearly support the clinical potential<a onclick="showRef(event, 'ref39 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref39 ref52 ref53 ref54">(39,52−54)</a> of VNRX-5133 (taniborbactam) for inhibition of MBLs as well as SBLs, thus potentially extending the current utility of current β-lactam antibiotics. In this regard, VNRX-5133 is different to the clinically approved boron-containing β-lactamase inhibitor vaborbactam, which has little activity versus clinically relevant MBLs.<a onclick="showRef(event, 'ref15 ref26'); return false;" href="javascript:void(0);" class="ref ref15 ref26">(15,26)</a> The coverage of clinically relevant MBLs (and SBLs) by VNRX-5133, however, is imperfect, with significantly lower or no inhibition being observed for clinically relevant IMP-1, L1, or OXA-48 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). There is thus scope for further optimization of this promising new class of β-lactamase inhibitors.</div><div class="NLM_p">The crystallographic results also further imply the potentially unique properties of boron-containing small molecules to interchange between different binding modes/hybridization states, thus potentially enabling (more) potent inhibition. It is possible that bicyclic boronates can bind to SBLs and MBLs in their sp<sup>2</sup> hybridization state, which mimics that of the β-lactam.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Once bound at the active site, they can then react with the SBL nucleophilic serine or MBL-Zn(II)-bridged water/hydroxide to give a tightly bound sp<sup>3</sup> complex, mimicking the tetrahedral intermediate in catalysis. Note that with the MBLs, in principle, the sp<sup>3</sup> boronate form could bind to the active site, with a displacement of the “hydrolytic” water/hydroxide from the active site Zn(II) ions.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a></div><div class="NLM_p last">The potential of boron to enable further reaction when an inhibitor is bound to a protein is strikingly evidenced by the crystallographic observation of the tricyclic form in the case of NDM-1 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Further biophysical analyses are required to demonstrate relevance of the tricyclic inhibitor form in solution and thus rule out the possibility that the tricyclic inhibitor form is an artifact arising from the crystallization conditions. This ability has been exploited in the case of boron compounds in dynamic combinatorial chemistry<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and is manifested in the reaction of amidomethylboronic acid inhibitors with two active site serines in the case of penicillin-binding protein from <i>Actinomadura</i> sp. R39.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> We propose that the ability of boron compounds to “morph” between states can be further exploited in inhibitor/modulator design, especially where conformational changes during ligand binding are desirable. Such applications will likely require a combination of precise activity/binding assays coupled with detailed biophysical studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedures</h3><div class="NLM_p">Unless otherwise stated, reactions were performed under argon using dried glassware and solvents. All commercially available chemicals, reagents, and solvents were used as commercially supplied or purified using appropriate standard procedures. Petroleum ether (PetEt) refers to distilled light petroleum of fraction 30–40 °C. A cold bath at −100 °C was prepared by addition of liquid nitrogen to a mixture of 1:1 ethanol/methanol. Reactions were monitored by thin layer chromatography (TLC) using Merck silica gel 60 F<sub>254</sub> aluminum sheets, 5 × 7.5 cm, and using an liquid chromatography–mass spectrometry (LC–MS) system (Agilent Technologies 1260 Infinity Series) fitted with a 6120 Quadrupole mass spectrometer and a Merck Chromolith Performance C18 (100 × 4.2 mm) HPLC column. TLC analyses were visualized by exposure to UV irradiation (λ<sub>max</sub> = 254 or 365 nm) and by dipping the plates in phosphomolybdic acid, potassium permanganate, or ninhydrin followed by heating with a heat gun. Chromatographic purifications were performed using a Biotage Isolera flash purification system with Biotage prepacked SNAP KP-Sil or SNAP-ULTRA columns and analytical-grade solvents. <sup>1</sup>H, <sup>13</sup>C, and <sup>11</sup>B NMR spectra were recorded using Bruker AVIII HD 400, AVIII HD 500, or AVIII 600 instruments in the solvents indicated. Deuterated solvents were used as supplied. Chemical shifts (δ), referenced using residual solvent peaks, are reported in parts per million downfield from tetramethylsilane or residual solvent peak as internal standard. Multiplicity is given as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), app (apparent), or a combination of these. Coupling constants, <i>J</i>, are reported in hertz (Hz) to the nearest 0.5 Hz. COSY, HSQC, and/or HMBC spectra were utilized to aid the chemical shift assignments where appropriate. Infrared (IR) spectra were recorded using a Bruker Tensor 27 FT-IR spectrometer; wavenumbers (ν<sub>max</sub>) are quoted in cm<sup>–1</sup>. Analytical-grade solvents and a PerkinElmer 341 polarimeter were used for measurement of optical rotations; [α]<sub class="stack">D</sub><sup class="stack">T</sup> values are reported in 10<sup>–1</sup> deg cm<sup>2</sup> g<sup>–1</sup>, and concentrations (<i>c</i>) are quoted in g per 100 mL; D refers to the D-line of sodium (589 nm), and temperatures (<i>T</i>) are given in degrees Celsius (°C). Preparative HPLC was run using a Shimadzu prep-LC system equipped with an ACE 5 μm C18 column (100 mm × 21.2 mm id). HPLC preparatory method A refers to [binary gradient: 10 mM HCl in water (solvent A), acetonitrile + 25% MeOH (solvent B), 15 mL min<sup>–1</sup>] 0–5 min gradient 1% B; 5–30 min gradient 10% B; 31–36 min gradient 90% B, 37–45 min gradient 1% B; UV detection at 254 nm. Low-resolution mass spectra were recorded using an Agilent 6120 Quadrupole MS instrument. High-resolution mass spectra (HRMS) were recorded using a Bruker MicroTOF instrument with an ESI source and time-of-flight (TOF) analyzer. The LC–MS system (Agilent Technologies 1260 Infinity Series) was fitted with a 6120 Quadrupole mass spectrometer and a Merck Chromolith Performance C18 (100 × 4.2 mm) HPLC column. All compounds synthesized were ≥95% pure as judged by <sup>1</sup>H and <sup>13</sup>C NMR, LC–MS, or qHNMR analyses.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> <i>tert</i>-Butyl 2-Methoxy-3-methylbenzoate (<b>2</b>)</h4><div class="NLM_p last">To a solution of 2-methoxy-3-methylbenzoic acid <b>1</b> (2 g, 12.0 mmol, 1 equiv) and anhydrous <i>N</i>,<i>N</i>-dimethylformamide (5 drops) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added oxalyl chloride (1.54 mL, 17.9 mmol, 1.5 equiv) dropwise under Shlenk conditions. The resultant mixture was stirred at room temperature (rt) for 90 min, before volatiles were removed in vacuo. The resulting oil was dissolved in anhydrous 2-methylpropan-2-ol (30 mL) and stirred at 40 °C for 18 h before the volatiles were removed in vacuo. H<sub>2</sub>O (30 mL) and CH<sub>2</sub>Cl<sub>2</sub> (60 mL) were added, and the layers were separated. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 60 mL). The combined organic layers were washed with brine (30 mL), dried (MgSO<sub>4</sub>), and then concentrated in vacuo. The crude material was purified by flash chromatography (0–30% EtOAc in cyclohexane) to afford the desired product <b>2</b> as a colorless oil (1.70 g, 63%). <i>R</i><sub>f</sub> 0.50 (19:1 CH<sub>2</sub>Cl<sub>2</sub>–MeOH); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.52–7.42 (m, 1H, H-4), 7.25–7.20 (m, 1H, H-2), 6.95 (app t, <i>J</i> = 7.5 Hz, 1H, H-3), 3.75 (s, 3H, H-16), 2.24 (s, 3H, H-9), 1.53 (s, 9H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.1 (C-8), 158.0 (C-6), 134.5 (C-2), 132.6 (C-1), 129.0 (C-4), 126.9 (C-5), 123.5 (C-3), 81.4 (C-12), 61.5 (C-16), 28.4 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 16.2 (C-9); ν<sub>max</sub>/cm (neat): 2978, 2360, 1720, 1593, 1468, 1416, 1367, 1169; HRMS (ESI-TOF) calcd for C<sub>13</sub>H<sub>18</sub>O<sub>3</sub><sup>23</sup>Na [M + Na]<sup>+</sup>: 245.11482, found: 245.11487.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> <i>tert</i>-Butyl 3-(bromomethyl)-2-methoxybenzoate (<b>3</b>)</h4><div class="NLM_p last">A mixture of <i>tert</i>-butyl 2-methoxy-3-methylbenzoate <b>2</b> (1.69 g, 7.60 mmol, 1 equiv), <i>N</i>-bromosuccinimide (NBS; 1555 mg, 8.74 mmol, 1.15 equiv), and benzoyl peroxide (368 mg, 1.52 mmol, 0.2 equiv) in CCl<sub>4</sub> (20 mL) was refluxed in the presence of a Philips HB175 (75 W, UV type 3) lamp for 5 h. The reaction mixture was then cooled to rt, the precipitate was removed by filtration, and the filtrate was concentrated in vacuo. The crude material was purified by flash chromatography (0–25% petroleum ether (PetEt) in cyclohexane) to afford the desired product <b>3</b> as a colorless oil (1.33 g, 58%). <i>R</i><sub>f</sub> 0.50 (19:1 CH<sub>2</sub>Cl<sub>2</sub>–MeOH); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.66–7.60 (m, 1H, H-4), 7.48–7.41 (m, 1H, H-2), 7.04 (app t, <i>J</i> = 8.0 Hz, 1H, H-3), 4.52 (s, 2H, H-9), 3.90 (s, 3H, H-16), 1.54 (s, 9H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 165.3 (<u class="uu">C</u>=O), 158.2 (C-6), 134.6 (C-2), 132.7 (C-1), 132.3 (C-4), 127.0 (C-5), 123.9 (C-3), 81.9 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 62.9 (C-16), 28.3 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 27.8 (C-9); ν<sub>max</sub>/cm (neat): 2979, 2360, 1718, 1591, 1469, 1423, 1080; HRMS (ESI-TOF) calcd for C<sub>13</sub>H<sub>17</sub>O<sub>3</sub><sup>79</sup>Br<sup>23</sup>Na [M + Na]<sup>+</sup>: 323.02533, found: 323.02542.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>tert</i>-Butyl 2-Methoxy-3-(((3a<i>R</i>,4<i>R</i>,6<i>R</i>,7a<i>S</i>)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)methyl)benzoate (<b>4</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl 3-(bromomethyl)-2-methoxybenzoate <b>3</b> (1.7 g, 5.64 mmol, 1 equiv), bis[(+)-pinanediolato] diboron (2.43 g, 6.80 mmol, 1.2 equiv), and potassium acetate (1108 mg, 98.1 mmol, 2 equiv) were suspended in anhydrous 1,4-dioxane (22.5 mL). The vessel was degassed for 20 min, and then Pd(dppf)Cl<sub>2</sub> (228 mg, 0.28 mmol, 5 mol%) was added. The reaction mixture was refluxed at 95 °C for 16 h and then concentrated in vacuo. The residue was redissolved in EtOAc (20 mL) and filtered through a Celite pad. The filtrate was concentrated to dryness under reduced pressure, and the crude material was purified by flash chromatography (0–20% EtOAc in cyclohexane) to afford the desired product as a colorless oil (1.79 g, 87%). <i>R</i><sub>f</sub> 0.70 (15:1 PetEt–EtOAc); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48–7.42 (m, 1H, H-4), 7.28–7.22 (m, 1H, H-6), 6.94 (app t, <i>J</i> = 7.5 Hz, 1H, H-5), 4.20 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, H-13), 3.74 (s, 3H, H-29), 2.25 (s, 2H, H-24), 2.24–2.17 (m, 1H, H-15″), 2.13–2.10 (m, 1H, H-12), 1.96 (t, <i>J</i> = 5.5 Hz, 1H, H-16), 1.84–1.80 (m, 1H, H-15′), 1.77–1.74 (m, 1H, H-11″), 1.52 (s, 9H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.32 (s, 3H, H-23), 1.21 (s, 3H, H-18), 1.12 (d, <i>J</i> = 10.0 Hz, 1H, H-11′), 0.76 (s, 3H, H-19); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.2 (C-8), 157.5 (C-2), 134.4 (C-6), 134.1 (C-3), 128.6 (C-4), 126.5 (C-1), 123.5 (C-5), 86.0 (C-13), 81.2 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 78.0 (C-14), 61.6 (C-29), 51.4 (C-15), 39.7 (C-12), 39.6 (C-16), 38.3 (C-17), 35.6 (C-24), 28.7 (C-19), 28.4 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 27.2 (C-23), 26.5 (C-11), 24.2 (C-18); <sup>11</sup>B NMR (128 MHz, CDCl<sub>3</sub>) δ 32.8; ν<sub>max</sub>/cm (neat): 2977, 2918, 2360, 2341, 1721, 1466, 1425. 1367, 1338, 1305, 1279, 1230, 1077, 1028; HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>33</sub>O<sub>5</sub><sup>10</sup>B <sup>23</sup>Na [M + Na]<sup>+</sup>: 422.23496, found: 422.23471; [α]<sub class="stack">D</sub><sup class="stack">25</sup> = +15.0° (<i>c</i> 0.8, CHCl<sub>3</sub>).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> <i>tert</i>-Butyl 3-((<i>S</i>)-2-chloro-2-((3a<i>R</i>,4<i>R</i>,6<i>R</i>,7a<i>S</i>)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)ethyl)-2-methoxybenzoate (<b>5</b>)</h4><div class="NLM_p last">In an oven-dried three-necked round-bottom flask under an argon flow, a solution of anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.29 mL, 4.56 mmol, 2.5 equiv) in anhydrous THF (5.5 mL) was cooled to −100 °C. While maintaining a low temperature, <i>n</i>-butyllithium (2.5 M in hexanes, 1.16 mL, 1.6 equiv) was added slowly dropwise down the inside wall of the flask (maintaining the temperature below −90 °C at all times). The resulting turbid white suspension obtained by the formation of microcrystalline dichloromethyllithium was stirred at −100 °C for 45 min. Batches that turned black in the above process (signaling the decomposition of dichloromethyllithium) were immediately quenched with isopropanol and water and discarded. A precooled (−90 °C) solution of boronic ester <b>4</b> (730 mg, 1.82 mmol, 1 equiv) in anhydrous THF (1.2 mL) was then added dropwise at −95 °C. The resulting bright yellow solution was stirred for 20 min at −95 °C, before the freshly prepared anhydrous ZnCl<sub>2</sub> solution (0.7 M in THF, 1.48 mL, 0.8 equiv) was added in one portion. The reaction mixture was then allowed to warm up slowly to rt overnight without removal of the cooling bath. The resultant solution was cooled using an ice bath, quenched with sat. aq NH<sub>4</sub>Cl solution (20 mL), extracted with EtOAc (3 × 20 mL), washed with brine (15 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and then concentrated in vacuo. The crude material was purified by flash chromatography (5–50% PetEt in pentane) to afford the desired product <b>5</b> as a pale yellow oil (500 mg, 61%). <i>R</i><sub>f</sub> 0.55 (20:1 PetEt–EtOAc); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.62 (dd, <i>J</i> = 7.5, 2.0 Hz, 1H, H-4), 7.39 (dd, <i>J</i> = 7.5, 2.0 Hz, 1H, H-6), 7.05 (app t, <i>J</i> = 7.5 Hz, 1H, H-5), 4.35 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, H-13), 3.85 (s, 3H, H-29), 3.75–3.70 (m, 1H, H-22), 2.26 (dd, <i>J</i> = 14.0, 7.5 Hz, 2H, H-24), 2.25–2.17 (m, 1H, H-15″), 2.10 (m, 1H, H-12), 1.94–1.90 (m, 1H, H-16), 1.84-1.80 (m, 1H, H-15′), 1.78–1.74 (m, 1H, H-11″), 1.45 (s, 9H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.27 (s, 3H, H-23), 1.22 (s, 3H, H-18) 1.19 (d, <i>J</i> = 10.0 Hz, 1H, H-11′), 0.83 (s, 3H, H-19); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 166.2 (C-8), 157.8 (C-2), 137.0 (C-6), 134.4 (C-3), 128.6 (C-4), 125.5 (C-1), 123.5 (C-5), 86.0 (C-13), 81.2 (C-25), 78.0 (C-14), 61.6 (C-29), 51.3 (C-15), 39.6 (C-16), 39.2 (C-17), 35.6 (C-24), 28.7 (C-19), 28.3 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 27.2 (C-23), 26.5 (C-11), 24.1 (C-18), C-22 not observed due to peak broadening; ν<sub>max</sub>/cm (neat): 2979, 2929, 2359, 2341, 1719, 1466, 1421, 1369, 1303, 1254, 1172, 1135, 767; HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>34</sub>O<sub>5</sub><sup>10</sup>B<sup>35</sup>Cl<sup>23</sup>Na [M + Na]<sup>+</sup>: 470.21164, found: 470.21167; [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −10.0 ° (<i>c</i> 7.6, CHCl<sub>3</sub>).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>tert</i>-Butyl 3-((<i>R</i>)-2-amino-2-((3a<i>R</i>,4<i>R</i>,6<i>R</i>,7a<i>S</i>)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)ethyl)-2-methoxybenzoate (<b>7</b>)</h4><div class="NLM_p last">To a stirred solution of (<i>S</i>)-chloride <b>5</b> (400 mg, 0.89 mmol, 1 equiv) in anhydrous THF (4 mL) under an argon flow was added a solution of lithium bis(trimethylsilyl)amide (LiHDMS, 1 M in THF, 0.94 mL, 0.94 mmol, 1.05 equiv) dropwise over 30 min at −100 °C. The resultant mixture was stirred at −78 °C for 2 h before the volatiles were removed in vacuo. The resultant thick brown oil was immediately used in the next step without further purification. To a solution of crude bis-TMS-protected amine <b>6</b> (500 mg, 0.87 mmol, 1 equiv) in THF (4 mL) was added anhydrous MeOH (2 mL) dropwise at −10 °C. The resultant cloudy solution was stirred at rt for 60 min before the volatiles were removed in vacuo. The crude amine <b>7</b> thus obtained as a pale yellow oil was immediately used in the next step without further purification.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Ethyl 2-(<i>trans</i>-4-((2-((<i>tert</i>-butoxycarbonyl)amino)ethyl)-amino)cyclohexyl)acetate (<b>9</b>)</h4><div class="NLM_p last">Ethyl-2-(<i>trans</i>-4-aminocyclohexyl)acetate hydrochloride <b>8</b> (2 g, 9.04 mmol, 1 equiv) was dissolved in 1:1 CH<sub>2</sub>Cl<sub>2</sub>-H<sub>2</sub>O (70 mL), and K<sub>2</sub>CO<sub>3</sub> (2740 mg, 20.7 mmoL, 2.3 equiv) was added. The resultant biphasic suspension was vigorously stirred at rt for 60 min, before benzyltriethylammonium chloride (103 mg, 0.45 mmol, 5 mol%) and 2-(Boc-amino)ethyl bromide (2100 mg, 9.37 mmol, 1.04 equiv) were added in one portion. The reaction mixture was refluxed for 18 h, before it was poured into sat. aq NH<sub>4</sub>Cl (70 mL). The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 70 mL). The combined organic layers were washed with brine (70 mL), dried (MgSO<sub>4</sub>), then concentrated in vacuo. The crude material was purified by flash chromatography (0–20% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford the desired product <b>9</b> as a white solid (1.45 g, 49%). <i>R</i><sub>f</sub> 0.80 (1:1 EtOAc–pentane); mp 118–120 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 5.00 (br s, 1H, Boc-N<u class="uu">H</u>), 4.05 (q, <i>J</i> = 7.0 Hz, 2H, -OC<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 3.18−3.04 (m, 2H, C<u class="uu">H</u><sub>2</sub>), 2.74−2.61 (m, 2H, C<u class="uu">H</u><sub>2</sub>), 2.39−2.24 (m, 1H, C<u class="uu">H</u>), 2.11 (d, <i>J</i> = 7.0 Hz, 2H, C<u class="uu">H</u><sub>2</sub>), 1.90−1.82 (m, 2H, C<u class="uu">H</u><sub>2</sub>), 1.80−1.59 (m, 3H, C<u class="uu">H</u><sub>2</sub> + C<u class="uu">H</u>), 1.37 (s, 9H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.18 (t, <u class="uu">J</u> = 7.0 Hz, 3H, -OCH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.11−1.03 (m, 2H, C<u class="uu">H</u><sub>2</sub>), 0.99−0.92 (m, 2H, C<u class="uu">H</u><sub>2</sub>); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 173.1 (-NH-<u class="uu">C</u>=O), 156.3 (<u class="uu">C</u>=O), 79.3 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 60.3 (-CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>CH<sub>3</sub>), 56.6 (<u class="uu">C</u>H), 46.4 (<u class="uu">C</u>H<sub>2</sub>), 41.8 (<u class="uu">C</u>H<sub>2</sub>), 34.7 (<u class="uu">C</u>H), 33.3 (<u class="uu">C</u>H<sub>2</sub>), 31.7 (<u class="uu">C</u>H<sub>2</sub>), 28.6 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 14.4 (-CO<sub>2</sub>CH<sub>2</sub><u class="uu">C</u>H<sub>3</sub>);  ν<sub>max</sub>/cm (neat): 3348, 2953, 2851, 1731, 1711, 1520, 1450, 1391, 1282, 1249, 1172, 1032; HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>33</sub>O<sub>4</sub>N<sub>2</sub> [M + H]<sup>+</sup>: 329.24348, found: 329.24289.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Ethyl 2-(<i>trans</i>-4-((<i>tert</i>-butoxycarbonyl)(2-((<i>tert</i>-butoxycarbonyl)amino)ethyl)amino)cyclohexyl)acetate (<b>10</b>)</h4><div class="NLM_p last">Ethyl 2-(<i>trans</i>-4-((2-((<i>tert</i>-butoxycarbonyl)amino)ethyl)amino)cyclohexyl)acetate <b>9</b> (1.4 g, 4.26 mmol, 1 equiv) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (37 mL) before di-<i>tert</i>-butyl dicarbonate (2326 mg, 10.7 mmol, 2.5 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (1.11 mL, 6.39 mmol, 1.5 equiv) were added. The reaction mixture was refluxed for 16 h, before the volatiles were removed in vacuo. The residue thus obtained was resuspended in CH<sub>2</sub>Cl<sub>2</sub> (30 mL), and sat. aq NH<sub>4</sub>Cl (50 mL) was added. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 70 mL). The combined organic layers were dried (MgSO<sub>4</sub>), then concentrated in vacuo. The crude material was purified by flash chromatography (0–20% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford the desired product <b>10</b> as a yellow oil (1.50 g, 82%). <i>R</i><sub>f</sub> 0.90 (1:1 EtOAc–pentane); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.11 (q, <i>J</i> = 7.0 Hz, 2H, -OC<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 3.31–3.10 (m, 4H, C<u class="uu">H</u><sub>2</sub>), 2.17 (d, <i>J</i> = 7.0 Hz, 2H, C<u class="uu">H</u><sub>2</sub>), 1.86−1.58 (m, 5H, C<u class="uu">H</u><sub>2</sub> + C<u class="uu">H</u>), 1.65−1.32 (m, 19H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>) + C<u class="uu">H</u>), 1.25 (t, <i>J</i> = 7.0, 3.0 Hz, 3H, -OCH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.17−0.99 (m, 2H, C<u class="uu">H</u><sub>2</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8 (-NH-<u class="uu">C</u>=O), 156.4 (<u class="uu">C</u>=O), 156.1 (<u class="uu">C</u>=O), 79.9 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 60.2 (-CO<sub>2</sub>C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 42.5 (<u class="uu">C</u>H<sub>2</sub>), 41.6 (<u class="uu">C</u>H), 41.0 (<u class="uu">C</u>H<sub>2</sub>), 34.0 (<u class="uu">C</u>H), 32.2 (<u class="uu">C</u>H<sub>2</sub>), 30.3 (<u class="uu">C</u>H<sub>2</sub>), 28.5 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 28.4 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 14.3 (-CO<sub>2</sub>CH<sub>2</sub><u class="uu">C</u>H<sub>3</sub>); ν<sub>max</sub>/cm (neat): 3367, 2978, 2931, 1715, 1689, 1516, 1453, 1408, 1391, 1248, 1170; HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>41</sub>O<sub>6</sub>N<sub>2</sub> [M + H]<sup>+</sup>: 429.29591, found: 429.29582.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-(<i>trans</i>-4-((<i>tert</i>-Butoxycarbonyl)(2-((<i>tert</i>-butoxycarbonyl)amino)ethyl)amino)cyclohexyl)acetic  Acid (<b>11</b>)</h4><div class="NLM_p last">Ethyl ester <b>10</b> (1604 mg, 3.74 mmol, 1 equiv) was dissolved in 1:2:1 mixture of THF/EtOH/H<sub>2</sub>O (10 mL), and LiOH·H<sub>2</sub>O (224 mg, 9.36 mmol, 2.5 equiv) was added. The resultant cloudy solution was stirred at rt for 5 h before the volatiles were removed in vacuo. The residue thus obtained was dissolved in minimum amount of water and filtered through a short column of <i>Amberlite</i> IR-120 (H<sup>+</sup> form). To the obtained aqueous filtrate was added EtOAc (50 mL), and the layers were separated. The aqueous layer was extracted with EtOAc (3 × 50 mL), washed with brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and then concentrated in vacuo to afford the desired product <b>11</b> as a shiny white solid (1 g, 67%). <i>R</i><sub>f</sub> 0.45 (1:1 EtOAc–pentane); mp 97–98 °C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.36–3.12 (m, 4H, C<u class="uu">H</u><sub>2</sub>), 2.25 (d, <i>J</i> = 7.0 Hz, 2H, C<u class="uu">H</u><sub>2</sub>), 1.93–1.86 (m, 2H, C<u class="uu">H</u><sub>2</sub>), 1.80–1.70 (m, 3H, C<u class="uu">H</u><sub>2</sub> + C<u class="uu">H</u>), 1.68–1.33 (m, 21H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub> + C<u class="uu">H</u><sub>2</sub> + C<u class="uu">H</u>), 1.20–1.06 (m, 2H, C<u class="uu">H</u><sub>2</sub>); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 178.5 (<u class="uu">C</u>=O), 177.0 (<u class="uu">C</u>=O), 80.1 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 80.0 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 41.1 (<u class="uu">C</u>H<sub>2</sub>), 33.7 (<u class="uu">C</u>H), 32.1 (<u class="uu">C</u>H<sub>2</sub>), 30.3 (<u class="uu">C</u>H<sub>2</sub>), 28.5 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 28.4 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 20.7; ν<sub>max</sub>/cm (neat): 3055, 3009, 2974, 2930, 1706, 1686, 1672, 1518, 1477, 1409, 1365, 1247, 1023; HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>37</sub>O<sub>6</sub>N<sub>2</sub> [M + H]<sup>+</sup>: 401.26461, found: 401.26401.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>tert</i>-Butyl 3-((<i>R</i>)-2-(2-(<i>trans</i>-4-((<i>tert</i>-butoxycarbonyl)(2-((tert-butoxycarbonyl)amino)ethyl)amino)cyclohexyl)acetamido)-2-((3a<i>R</i>,4<i>R</i>,6<i>R</i>,7a<i>S</i>)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)ethyl)-2-methoxybenzoate (<b>12</b>)</h4><div class="NLM_p last">To a solution of carboxylic acid <b>11</b> (416 mg, 1.04 mmol, 1.2 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (2.60 mL) were added triethylamine (0.36 mL, 2.61 mmol, 3 equiv), benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP; 541 mg, 1.04 mmol, 1.2 equiv), and crude amine <b>7</b> (325 mg, 0.87 mmol, 1 equiv). The resultant solution was stirred at rt for 75 min before water (10 mL) was added, and the layers were separated. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL). The combined organic layers were washed with brine (10 mL), dried (MgSO<sub>4</sub>), then concentrated in vacuo. The crude material was purified by flash chromatography (0–20% MeOH in CH<sub>2</sub>Cl<sub>2</sub>). Although several impurities were still present after this step (as judged by <sup>1</sup>H NMR and LC–MS), the amide <b>12</b> thus obtained as a yellow foam (224 mg, 34%) was used in the next step without further purification. <i>R</i><sub>f</sub> 0.55 (1:2 EtOAc–pentane); <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.61–7.49 (m, 1H, Ar), 7.46–7.35 (m, 1H, Ar), 7.13–7.09 (m, 1H, Ar), 4.22–4.14 (m, 1H, C<u class="uu">H</u>OB), 3.80 (s, 3H, −OC<u class="uu">H</u><sub>3</sub>), 3.21–3.10 (m, 4H, −NC<u class="uu">H</u><sub>2</sub>C<u class="uu">H</u><sub>2</sub>NHBoc), 2.94–2.85 (m, 2H, C<u class="uu">H</u>B + Ar-C<u class="uu">H</u><sub>2</sub>), 2.75–2.67 (m, 1H, Ar-C<u class="uu">H</u><sub>2</sub>), 2.38–2.30 (m, 1H, pinanediol-C<u class="uu">H</u><sub>2</sub>), 2.26 (d, <i>J</i> = 7.0 Hz, 2H, -CHC<u class="uu">H</u><sub>2</sub>CO), 2.12–2.06 (m, 1H, pinanediol-C<u class="uu">H</u><sub>2</sub>), 2.01 (s, 1H, cyclohexyl-C<u class="uu">H</u>), 1.94 (app t, <i>J</i> = 5.5 Hz, 1H, pinanediol-C<u class="uu">H</u>), 1.90–1.79 (m, 5H, cyclohexyl-C<u class="uu">H</u><sub>2</sub> + pinanediol-C<u class="uu">H</u>), 1.76–1.66 (m, 3H, cyclohexyl-C<u class="uu">H</u><sub>2</sub> + cyclohexyl-C<u class="uu">H</u>), 1.64–1.58 (m, 11H, -CO<sub>2</sub>C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub> + cyclohexyl-C<u class="uu">H</u><sub>2</sub>), 1.40–1.36 (s, 10H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub> + pinanediol-C<u class="uu">H</u><sub>2</sub>), 1.43 (s, 9H, C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.37 (s, 3H, C<u class="uu">H</u><sub>3</sub>), 1.28 (s, 3H, C<u class="uu">H</u><sub>3</sub>), 1.18–1.08 (m, 2H, cyclohexyl-C<u class="uu">H</u><sub>2</sub>), 0.89 (s, 3H, C<u class="uu">H</u><sub>3</sub>); <sup>13</sup>C NMR (126 MHz, MeOD) δ 174.9, 173.0, 170.3, 158.4, 157.3, 144.1, 141.5, 133.2, 131.1, 130.3, 126.5, 125.6, 124.7, 81.2, 80.0, 78.4, 69.9, 61.5, 59.8, 55.3, 52.9, 51.9, 42.0, 41.8, 40.8, 38.7, 36.8, 35.2, 33.2, 30.1, 29.1, 29.0, 28.8, 28.7, 28.4, 28.4, 27.5, 27.2, 24.6, 24.3, 20.9, 14.5; ν<sub>max</sub>/cm (neat): 3627, 3599, 2987, 2864, 2360, 1701, 1692, 1592, 1466, 1454, 1305, 1277, 1136; HRMS (ESI-TOF) calcd for C<sub>44</sub>H<sub>71</sub>O<sub>10</sub>N<sub>3</sub><sup>10</sup>B [M + H]<sup>+</sup>: 811.52633, found: 811.52667.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-3-(2-(<i>trans</i>-4-((2-Aminoethyl)amino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[<i>e</i>][1,2]oxaborinine-8-carboxylic Acid (<b>13</b>)</h4><div class="NLM_p last">To a precooled (−78 °C) solution of boronate <b>12</b> (50 mg, 0.06 mmol, 1 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added BCl<sub>3</sub> (1 M in CH<sub>2</sub>Cl<sub>2</sub>, 0.31 mL, 5 equiv) dropwise over 20 min. The reaction mixture was stirred for 60 min, then water (5 mL) was added, and the layers were separated. The organic layer was extracted with water (3 × 5 mL). The combined aqueous layers were lyophilized to afford the crude product as a brown solid. Following challenging purification via HPLC preparatory method A, the desired product <b>13</b> was obtained as a white solid (10 mg, 42%). The relatively low yield may reflect deborylation during purification as suggested by LC–MS analyses of the collected fractions. Purity: ≥96% by qHNMR. <i>R</i><sub>f</sub> baseline (1:1 CH<sub>2</sub>Cl<sub>2</sub>–MeOH); <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ 7.84–7.75 (m, 1H, H-4), 7.47–7.37 (m, 1H, H-6), 7.06 (app t, <i>J</i> = 8.0 Hz, 1H, H-5), 3.34–3.29 (m, 4H, H-33, H-34), 3.28–3.22 (m, 1H, H-9), 3.00–2.88 (m, 2H, H-8), 2.82–2.71 (m, 1H, H-23), 2.34–2.27 (m, 1H, H-19′), 2.14–2.04 (m, 1H, H-19″), 1.88–1.73 (m, 2H, C<u class="uu">H</u><sub>2</sub>-27/C<u class="uu">H</u><sub>2</sub>-29), 1.43–1.37 (m, 1H, C<u class="uu">H</u><sub>2</sub>-26/C<u class="uu">H</u><sub>2</sub>-30), 1.35–1.26 (m, 1H, H-25), 1.20–0.90 (m, 2H, C<u class="uu">H</u><sub>2</sub>-27/C<u class="uu">H</u><sub>2</sub>-29), 0.86–0.75 (m, 1H, C<u class="uu">H</u><sub>2</sub>-26/C<u class="uu">H</u><sub>2</sub>-30), 0.68–0.38 (m, 2H, C<u class="uu">H</u><sub>2</sub>-26/C<u class="uu">H</u><sub>2</sub>-30); <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ 179.3 (C-10), 169.93 (C-3), 156.4 (C-1), 136.6 (C-6), 129.7 (C-4), 128.7 (Ar-<u class="uu">C</u>), 121.9 (C-5), 116.7 (Ar-<u class="uu">C</u>), 56.9 (C-23), 41.1 (C-33/C-34), 35.6 (C-33/C-34), 35.5 (C-19), 33.6 (C-25), 30.5 (C-8), 28.9 (C-26/C-30), 28.4 (C-26/C-30), 28.1 (C-27/C-39), 28.0 (C-27/C-39), C-9 not observed due to peak broadening; HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>29</sub>O<sub>5</sub>N<sub>3</sub><sup>10</sup>B [M + H]<sup>+</sup>: 389.22311, found: 389.22333.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Inhibition Assays</h3><div class="NLM_p last">Inhibitory activity of VNRX-5133 against representative SBLs and MBLs was determined using a fluorogenic assay monitoring the enzymatic breakdown of the cephalosporin probe FC5,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> with the exception of the subclass B2 MBL CphA, for which the hydrolysis of meropenem substrate was used.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The FC5/meropenem assays were conducted at room temperature in clear-bottomed Greiner 384 black well microplates (FC5) or Greiner 96 well UV star microplates (meropenem), using a ClarioStar or PHERAstar FS microplate reader (BMG LabTech). Representative β-lactamases were tested at the following concentrations: AmpC, 500 pM; OXA-10, 250 pM; OXA-48, 12.5 nM; TEM, 1 nM; VIM-1, 100 pM; NDM-1, 20 pM; IMP-1, 20 pM; VIM-2, 500 pM; and L1, 50 pM. The concentration of FC5 employed was 10 μM for TEM-1 and 5 μM for all other enzymes. The concentration of meropenem used was 12.5 μM for CphA. TEM-116, AmpC, OXA-10, and OXA-48 inhibition assays were run in “SBL buffer” (phosphate buffer, pH 7.4, 0.01% (v/v) Triton X-100), while IMP-1, VIM-1, VIM-2, NDM-1, NDM-2, L1, and CphA were screened in “MBL buffer” (50 mM HEPES, pH 7.2, 1 μM ZnSO<sub>4</sub>, 1 μg mL<sup>–1</sup> BSA, 0.01% v/v Triton X-100). OXA-10 and OXA-48 assays were also run in “SBL buffer” supplemented with 100 mM NaHCO<sub>3</sub>. The initial rates of reaction (measured after 10 min pre-incubation of VNRX-5133 with the enzyme) were assessed by monitoring the fluorescence intensity at λ<sub>ex</sub> = 380 nm and λ<sub>em</sub> = 460 nm, except for B2 MBL CphA, where UV absorbance was monitored at λ = 300 nm. Following the determination of initial rates of reaction, the data were fitted using a four-parameter function: log (inhibitor) vs. response, variable slope in GraphPad Prism 6 (Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Table S1</a>) to obtain IC<sub>50</sub> values.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Antimicrobial Susceptibility Testing</h3><div class="NLM_p last">Meropenem (MEM) and cefepime (Cef) were tested alone (0.06–64 μg mL<sup>–1</sup>) and in combination with bicyclic boronate VNRX-5133 (10 μg mL<sup>–1</sup>) against a small set of NDM-1-producing <i>Enterobacteriaceae</i> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), in triplicate. Minimal inhibitory concentration (MIC) values were determined by the agar dilution method and interpreted using published guidelines described by EUCAST/CLSI.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> All reported MIC values are within ±1 log<sub>2</sub> dilution of the reference MIC values.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Crystallization Experiments, X-ray Data Collection, and Processing</h3><div class="NLM_p">NDM-1 was cloned and purified as previously described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Crystallization experiments were set up using a solution of OXA-10 (8.5 mg mL<sup>–1</sup>) in 50 mM MES, pH 6.0; 100 mM NaCl; and NDM-1 (30 mg mL<sup>–1</sup>) in 20 mM Tris, pH 8.0; 150 mM NaCl; and 2 mM DTT. OXA-10 crystals were supplemented with 10 mM VNRX-5133. OXA-10 crystallization was performed at room temperature using the sitting drop vapor diffusion method. Crystals were obtained using 100 μL of reservoir solution, i.e. 200 mM Zn(OAc)<sub>2</sub>·2H<sub>2</sub>O, 100 mM imidazole, 20% PEG 3000, pH 8.0, and a 1:1 mixture (0.2 μL:0.2 μL) of protein/reservoir solution in the crystallization drop. Crystals were cryoprotected using well solution diluted to 25% (v/v) aqueous glycerol and harvested with nylon loops and subsequent flash-cooling in liquid nitrogen.</div><div class="NLM_p">NDM-1 was crystallized by sitting drop vapor diffusion in CrysChem 24-well plates (Hampton Research) at 19 °C, with micro seeding. Protein (2 μL) was mixed with 1.5 μL of the reservoir solution (32% PEG3350, 0.1 M Bis-Tris, pH 5.8, 0.15 M NH<sub>4</sub>SO<sub>4</sub>) and 0.5 μL of crystal seed. Crystals were then soaked by addition of 2 mM VNRX-5133 directly to the drop for 4 h. Crystals were then cryoprotected by brief exposure to 20% (v/v) aqueous glycerol (in well solution) and subsequently flash-cooled in liquid nitrogen.</div><div class="NLM_p last">Diffraction data for OXA-10 and NDM-1 were collected at 100 K at beamlines I04 and I24, respectively, of the Diamond Light Source, Didcot. OXA-10 diffraction data were integrated and scaled using autoPROC. NDM-1 data were integrated in DIALS and scaled in Aimless. The structures were solved by isomorphous molecular replacement using reported NDM-1 (PDB accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SPU">3SPU</a><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a>) and OXA-10 (PDB accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQ9">5FQ9</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) as search models. Both structures were then iteratively fitted and refined using PHENIX<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and Coot.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Processing and refinement statistics for NDM-1 and OXA-10 with VNRX-5133 can be found in Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Table S3</a>. Molprobity validation reports for OXA-10 and NDM-1 structures are available in Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Tables S4 and S5</a>, respectively.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00911" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00911" class="ext-link">10.1021/acs.jmedchem.9b00911</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings for VNRX-5133 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS spectra of all synthesized compounds; LC–MS spectrum of VNRX-5133; data from time dependence experiments; error analysis for reported inhibition values and processing and refinement statistics (including Molprobity validation reports) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv">jm9b00911_si_001.csv (0.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_002.pdf">jm9b00911_si_002.pdf (2.26 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 6RMF (NDM-1:<b>VNRX-5133</b>) and 6RTN (OXA-10:<b>VNRX-5133</b>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b00911" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Schofield</span> - <span class="hlFld-Affiliation affiliation">Chemistry
Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0290-6565" title="Orcid link">http://orcid.org/0000-0002-0290-6565</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5b38332932282f342b333e2975283833343d323e373f1b38333e36753423753a38752e30"><span class="__cf_email__" data-cfemail="24474c564d57504b544c41560a57474c4b424d41484064474c41490a4b5c0a45470a514f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alen Krajnc</span> - <span class="hlFld-Affiliation affiliation">Chemistry
Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7822-1944" title="Orcid link">http://orcid.org/0000-0001-7822-1944</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jürgen Brem</span> - <span class="hlFld-Affiliation affiliation">Chemistry
Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0137-3226" title="Orcid link">http://orcid.org/0000-0002-0137-3226</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Hinchliffe</span> - <span class="hlFld-Affiliation affiliation">School
of Cellular and Molecular Medicine, Biomedical Sciences Building,
University Walk, University of Bristol, Bristol BS8 1TD, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8611-4743" title="Orcid link">http://orcid.org/0000-0001-8611-4743</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karina Calvopiña</span> - <span class="hlFld-Affiliation affiliation">Chemistry
Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tharindi D. Panduwawala</span> - <span class="hlFld-Affiliation affiliation">Chemistry
Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pauline A. Lang</span> - <span class="hlFld-Affiliation affiliation">Chemistry
Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3187-1469" title="Orcid link">http://orcid.org/0000-0003-3187-1469</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jos J. A. G. Kamps</span> - <span class="hlFld-Affiliation affiliation">Chemistry
Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan M. Tyrrell</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Microbiology & Infectious Disease, Institute of Infection & Immunity, UHW Main Building, Heath Park, Cardiff CF14 4XN, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emma Widlake</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Microbiology & Infectious Disease, Institute of Infection & Immunity, UHW Main Building, Heath Park, Cardiff CF14 4XN, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin G. Saward</span> - <span class="hlFld-Affiliation affiliation">Chemistry
Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy R. Walsh</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Microbiology & Infectious Disease, Institute of Infection & Immunity, UHW Main Building, Heath Park, Cardiff CF14 4XN, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Spencer</span> - <span class="hlFld-Affiliation affiliation">School
of Cellular and Molecular Medicine, Biomedical Sciences Building,
University Walk, University of Bristol, Bristol BS8 1TD, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4602-0571" title="Orcid link">http://orcid.org/0000-0002-4602-0571</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.J.S. and J.B. conceived the research. A.K. with the help of TDP synthesized and characterized compounds used for the study. J.B., K.C., P.A.L., and J.A.G.K. purified the enzymes used in biochemical studies (except NDM-1 used for crystallography), crystallized VNRX-5133 with OXA-10, collected X-ray data, and solved the structure. P.H. and J.S. crystallized VNRX-5133 with NDM-1 and carried out the crystallographic analysis. J.M.T., E.W., and T.R.W. performed the MIC experiments. B.G.S. assisted A.K. with the HPLC purification. A.K. and C.J.S. wrote the initial drafts of the manuscript. A.K., J.B., P.H., and C.J.S. discussed the results and wrote the final manuscript. All authors provided feedback and helped shape the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>We thank our co-workers and collaborators, apologize for incomplete citations, and thank the Wellcome Trust, Cancer Research U.K., the Medical Research Council, the Biotechnology and Biological Research Council (BB/S50676X/1), the Innovative Medicines Initiative (European Lead factory and ENABLE components), for funding our work on antibiotics, MBL fold enzymes, and β-lactamase inhibitors. The work was also supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health Grant R01AI100560 (J.S). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work has been facilitated by the BrisSynBio Biosuite (U.K. Biotechnology and Biological Sciences (BBSRC) and Engineering and Physical Sciences (EPSRC) Research Councils, BB/L01386X/1) and the BBSRC ALERT14 equipment initiative (BB/M012107/1).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">SBL</td><td class="NLM_def"><p class="first last">serine-β-lactamase</p></td></tr><tr><td class="NLM_term">MBL</td><td class="NLM_def"><p class="first last">metallo-β-lactamase</p></td></tr><tr><td class="NLM_term">ESBL</td><td class="NLM_def"><p class="first last">extended-spectrum β-lactamase</p></td></tr><tr><td class="NLM_term">PBP</td><td class="NLM_def"><p class="first last">penicillin-binding protein</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">PyBOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">Ec</td><td class="NLM_def"><p class="first last">Escherichia coli</p></td></tr><tr><td class="NLM_term">Kp</td><td class="NLM_def"><p class="first last">Klebsiella pneumoniae</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimal inhibitory concentration</p></td></tr><tr><td class="NLM_term">MEM</td><td class="NLM_def"><p class="first last">meropenem</p></td></tr><tr><td class="NLM_term">Cef</td><td class="NLM_def"><p class="first last">cefepime</p></td></tr><tr><td class="NLM_term">MES</td><td class="NLM_def"><p class="first last">2-(<i>N</i>-morpholino)ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">Tris</td><td class="NLM_def"><p class="first last">tris(hydroxymethyl)aminomethane</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">poly(ethylene glycol)</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munita, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, C. A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Antibiotic Resistance</span>. <i>Microbiol. Spectr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">42</span> <span class="refDoi"> DOI: 10.1128/microbiolspec.VMBF-0016-2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2Fmicrobiolspec.VMBF-0016-2015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&author=J.+M.+Munitaauthor=C.+A.+Arias&title=Mechanisms+of+Antibiotic+Resistance&doi=10.1128%2Fmicrobiolspec.VMBF-0016-2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2Fmicrobiolspec.VMBF-0016-2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fmicrobiolspec.VMBF-0016-2015%26sid%3Dliteratum%253Aachs%26aulast%3DMunita%26aufirst%3DJ.%2BM.%26aulast%3DArias%26aufirst%3DC.%2BA.%26atitle%3DMechanisms%2520of%2520Antibiotic%2520Resistance%26jtitle%3DMicrobiol.%2520Spectr.%26date%3D2016%26volume%3D4%26doi%3D10.1128%2Fmicrobiolspec.VMBF-0016-2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majiduddin, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Materon, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T. G.</span></span> <span> </span><span class="NLM_article-title">Molecular analysis of beta-lactamase structure and function</span>. <i>Int. J. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1078/1438-4221-00198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1078%2F1438-4221-00198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=12195735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVCqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2002&pages=127-137&author=F.+K.+Majiduddinauthor=I.+C.+Materonauthor=T.+G.+Palzkill&title=Molecular+analysis+of+beta-lactamase+structure+and+function&doi=10.1078%2F1438-4221-00198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular analysis of beta-lactamase structure and function</span></div><div class="casAuthors">Majiduddin, Fahd K.; Materon, Isabel C.; Palzkill, Timothy G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-137</span>CODEN:
                <span class="NLM_cas:coden">IMEMFV</span>;
        ISSN:<span class="NLM_cas:issn">1438-4221</span>.
    
            (<span class="NLM_cas:orgname">Urban & Fischer Verlag GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review with 83 refs.  The extensive and sometimes irresponsible use of β-lactam antibiotics in clin. and agricultural settings has contributed to the emergence and widespread dissemination of antibiotic-resistant bacteria.  Bacteria have evolved 3 strategies to escape the activity of β-lactam antibiotics: (1) alteration of the target site (e.g., penicillin-binding proteins), (2) redn. of drug permeation across the bacterial membrane (e.g., efflux pumps) and (3) prodn. of β-lactamases.  The β-lactamases inactivate β-lactam antibiotics by hydrolyzing the peptide bond of the characteristic 4-membered β-lactam ring, thus rendering the antibiotic ineffective.  The inactivation of the antibiotic provides resistance to the bacterium.  Currently, there are >300 β-lactamases described for which numerous kinetic, structural, computational, and mutagenesis studies have been performed.  Here, the authors discuss recent work performed on the 4 different classes (A, B, C, and D) of β-lactamases.  These investigative advances further expand the knowledge of these complex enzymes, and hopefully, will provide addnl. tools to develop new inhibitors and antibiotics based on structural and rational designs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Pw6I_rH_V7Vg90H21EOLACvtfcHk0ljU-5Cj5bNMJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVCqurw%253D&md5=f8e4bd8e364a6924de9be9f4bdf49895</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1078%2F1438-4221-00198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1078%252F1438-4221-00198%26sid%3Dliteratum%253Aachs%26aulast%3DMajiduddin%26aufirst%3DF.%2BK.%26aulast%3DMateron%26aufirst%3DI.%2BC.%26aulast%3DPalzkill%26aufirst%3DT.%2BG.%26atitle%3DMolecular%2520analysis%2520of%2520beta-lactamase%2520structure%2520and%2520function%26jtitle%3DInt.%2520J.%2520Med.%2520Microbiol.%26date%3D2002%26volume%3D292%26spage%3D127%26epage%3D137%26doi%3D10.1078%2F1438-4221-00198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leigh, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradnock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marriner, J. M.</span></span> <span> </span><span class="NLM_article-title">Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1093/jac/7.3.229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fjac%2F7.3.229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=6974165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A280%3ADyaL38%252FgslGktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1981&pages=229-236&author=D.+A.+Leighauthor=K.+Bradnockauthor=J.+M.+Marriner&title=Augmentin+%28amoxycillin+and+clavulanic+acid%29+therapy+in+complicated+infections+due+to+beta-lactamase+producing+bacteria&doi=10.1093%2Fjac%2F7.3.229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria</span></div><div class="casAuthors">Leigh D A; Bradnock K; Marriner J M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of antimicrobial chemotherapy</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-36</span>
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSq6_Rz7rzPpPlX7E30qdzfW6udTcc2eYcXIGT9zT6t7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL38%252FgslGktw%253D%253D&md5=e1fd25853e4509fbc4859b5fbe33b96d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F7.3.229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F7.3.229%26sid%3Dliteratum%253Aachs%26aulast%3DLeigh%26aufirst%3DD.%2BA.%26aulast%3DBradnock%26aufirst%3DK.%26aulast%3DMarriner%26aufirst%3DJ.%2BM.%26atitle%3DAugmentin%2520%2528amoxycillin%2520and%2520clavulanic%2520acid%2529%2520therapy%2520in%2520complicated%2520infections%2520due%2520to%2520beta-lactamase%2520producing%2520bacteria%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1981%26volume%3D7%26spage%3D229%26epage%3D236%26doi%3D10.1093%2Fjac%2F7.3.229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reading, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, M.</span></span> <span> </span><span class="NLM_article-title">Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">852</span>– <span class="NLM_lpage">857</span>, <span class="refDoi"> DOI: 10.1128/AAC.11.5.852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.11.5.852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=879738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaE2sXks1GjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1977&pages=852-857&author=C.+Readingauthor=M.+Cole&title=Clavulanic+acid%3A+a+beta-lactamase-inhiting+beta-lactam+from+Streptomyces+clavuligerus&doi=10.1128%2FAAC.11.5.852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Clavulanic acid:  a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus</span></div><div class="casAuthors">Reading, C.; Cole, M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">852-7</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">A novel β-lactamase inhibitor has been isolated from S. clavuligerus ATCC 27064 and given the name clavulanic acid (I).  Conditions for the cultivation of the organism and detection and isolation of I are described.  This compd. resembles the nucleus of a penicillin but differs in having no acylamino side chain, having O instead of S, and contg. a β-hydroxyethylidine substituent in the oxazolidine ring.  I is a potent inhibitor of many β-lactamases, including those found in Escherichia coli (plasmid mediated), Klebsiella aerogenes, Proteus mirabilis, and Staphylococcus aureus, the inhibition being of a progressive type.  The cephalosporinase type of β-lactamase found in Pseudomonas aeruginosa and Enterobacter cloacae P99 and the chromosomally mediated β-lactamase of E. coli are less well inhibited.  The min. inhibitory concns. of ampicillin and cephaloridine against β-lactamase-producing, penicillin-resistant strains of S. aureus, K. aerogenes, P. mirabilis, and E. coli are considerably reduced by the addn. of low concns. of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ573qlu2SG7Vg90H21EOLACvtfcHk0ljU-5Cj5bNMJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXks1GjtLw%253D&md5=f418af59b52360c0ffe187922c0ef99d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1128%2FAAC.11.5.852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.11.5.852%26sid%3Dliteratum%253Aachs%26aulast%3DReading%26aufirst%3DC.%26aulast%3DCole%26aufirst%3DM.%26atitle%3DClavulanic%2520acid%253A%2520a%2520beta-lactamase-inhiting%2520beta-lactam%2520from%2520Streptomyces%2520clavuligerus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1977%26volume%3D11%26spage%3D852%26epage%3D857%26doi%3D10.1128%2FAAC.11.5.852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nahata, M. C.</span></span> <span> </span><span class="NLM_article-title">Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination</span>. <i>Drug Intell. Clin. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1177/106002808802200702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1177%2F106002808802200702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=3046887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaL1cXltVeqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1988&pages=534-541&author=J.+M.+Bensonauthor=M.+C.+Nahata&title=Sulbactam%2Fampicillin%2C+a+new+beta-lactamase+inhibitor%2Fbeta-lactam+antibiotic+combination&doi=10.1177%2F106002808802200702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination</span></div><div class="casAuthors">Benson, John M.; Nahata, Milap C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Intelligence & Clinical Pharmacy</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">534-41</span>CODEN:
                <span class="NLM_cas:coden">DICPBB</span>;
        ISSN:<span class="NLM_cas:issn">0012-6578</span>.
    </div><div class="casAbstract">A review with 62 refs.  Chem. and stability, mechanism of action, antibacterial spectrum, pharmacokinetics, clin. trials, and cost are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jCNXJQcIELVg90H21EOLACvtfcHk0lhBNUc1e4ejAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVeqsbo%253D&md5=c9783303eb3b65ac887db0cec13f5831</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1177%2F106002808802200702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F106002808802200702%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DJ.%2BM.%26aulast%3DNahata%26aufirst%3DM.%2BC.%26atitle%3DSulbactam%252Fampicillin%252C%2520a%2520new%2520beta-lactamase%2520inhibitor%252Fbeta-lactam%2520antibiotic%2520combination%26jtitle%3DDrug%2520Intell.%2520Clin.%2520Pharm.%26date%3D1988%26volume%3D22%26spage%3D534%26epage%3D541%26doi%3D10.1177%2F106002808802200702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitzis, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acar, J. F.</span></span> <span> </span><span class="NLM_article-title">Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">955</span>– <span class="NLM_lpage">957</span>, <span class="refDoi"> DOI: 10.1128/AAC.29.5.955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.29.5.955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=3015011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaL28XktVensL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=955-957&author=L.+Gutmannauthor=M.+D.+Kitzisauthor=S.+Yamabeauthor=J.+F.+Acar&title=Comparative+evaluation+of+a+new+beta-lactamase+inhibitor%2C+YTR+830%2C+combined+with+different+beta-lactam+antibiotics+against+bacteria+harboring+known+beta-lactamases&doi=10.1128%2FAAC.29.5.955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative evaluation of a new β-lactamase inhibitor, YTR 830, combined with different β-lactam antibiotics against bacteria harboring known β-lactamases</span></div><div class="casAuthors">Gutmann, L.; Kitzis, M. D.; Yamabe, S.; Acar, J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">955-7</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">YTR 830, a new β-lactamase inhibitor, combined with amoxicillin or carbenicillin, showed a synergistic effect similar to that obsd. with clavulanic acid, and generally better than that with sulbactam, against strains harboring chromosome-encoded penicillinases and broad-spectrum β-lactamases or plasmid-detd. β-lactamases.  With ampicillin, YTR 830 showed the best synergistic activity of the inhibitors against Proteus morganii, Citrobacter freundii, and Enterobacter cloacae and their mutants with a depressed chromosome-encoded cephalosporinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogTChUBoARS7Vg90H21EOLACvtfcHk0lhBNUc1e4ejAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktVensL8%253D&md5=82dd2faab2a9f4c5eec1c500f09e9c66</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2FAAC.29.5.955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.29.5.955%26sid%3Dliteratum%253Aachs%26aulast%3DGutmann%26aufirst%3DL.%26aulast%3DKitzis%26aufirst%3DM.%2BD.%26aulast%3DYamabe%26aufirst%3DS.%26aulast%3DAcar%26aufirst%3DJ.%2BF.%26atitle%3DComparative%2520evaluation%2520of%2520a%2520new%2520beta-lactamase%2520inhibitor%252C%2520YTR%2520830%252C%2520combined%2520with%2520different%2520beta-lactam%2520antibiotics%2520against%2520bacteria%2520harboring%2520known%2520beta-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1986%26volume%3D29%26spage%3D955%26epage%3D957%26doi%3D10.1128%2FAAC.29.5.955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endimiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Carbapenems: past, present, and future</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4943</span>– <span class="NLM_lpage">4960</span>, <span class="refDoi"> DOI: 10.1128/AAC.00296-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.00296-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=21859938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSru7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=4943-4960&author=K.+M.+Papp-Wallaceauthor=A.+Endimianiauthor=M.+A.+Taracilaauthor=R.+A.+Bonomo&title=Carbapenems%3A+past%2C+present%2C+and+future&doi=10.1128%2FAAC.00296-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenems: past, present, and future</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.; Endimiani, Andrea; Taracila, Magdalena A.; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4943-4960</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  In this review, we summarize the current "state of the art" of carbapenem antibiotics and their role in our antimicrobial armamentarium.  Among the β-lactams currently available, carbapenems are unique because they are relatively resistant to hydrolysis by most β-lactamases, in some cases act as "slow substrates" or inhibitors of β-lactamases, and still target penicillin binding proteins.  This "value-added feature" of inhibiting β-lactamases serves as a major rationale for expansion of this class of β-lactams.  We describe the initial discovery and development of the carbapenem family of β-lactams.  Of the early carbapenems evaluated, thienamycin demonstrated the greatest antimicrobial activity and became the parent compd. for all subsequent carbapenems.  To date, more than 80 compds. with mostly improved antimicrobial properties, compared to those of thienamycin, are described in the literature.  We also highlight important features of the carbapenems that are presently in clin. use: imipenem-cilastatin, meropenem, ertapenem, doripenem, panipenem-betamipron, and biapenem.  In closing, we emphasize some major challenges and urge the medicinal chemist to continue development of these versatile and potent compds., as they have served us well for more than 3 decades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Y-IuobRax7Vg90H21EOLACvtfcHk0lhBNUc1e4ejAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSru7rJ&md5=5104ffe81fe097b4ae11a5c6a8fc7fb0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FAAC.00296-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00296-11%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DEndimiani%26aufirst%3DA.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DCarbapenems%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D4943%26epage%3D4960%26doi%3D10.1128%2FAAC.00296-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, P. A.</span></span> <span> </span><span class="NLM_article-title">Interplay between beta-lactamases and new beta-lactamase inhibitors</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1038/s41579-019-0159-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1038%2Fs41579-019-0159-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=30837684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmsV2it78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=295-306&author=K.+Bushauthor=P.+A.+Bradford&title=Interplay+between+beta-lactamases+and+new+beta-lactamase+inhibitors&doi=10.1038%2Fs41579-019-0159-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Interplay between β-lactamases and new β-lactamase inhibitors</span></div><div class="casAuthors">Bush, Karen; Bradford, Patricia A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">295-306</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Resistance to β-lactam antibiotics in Gram-neg. bacteria is commonly assocd. with prodn. of β-lactamases, including extended-spectrum β-lactamases (ESBLs) and carbapenemases belonging to different mol. classes: those with a catalytically active serine and those with at least one active-site Zn2+ to facilitate hydrolysis.  To counteract the hydrolytic activity of these enzymes, combinations of a β-lactam with a β-lactamase inhibitor (BLI) have been clin. successful.  However, some β-lactam-BLI combinations have lost their effectiveness against prevalent Gram-neg. pathogens that produce ESBLs, carbapenemases or multiple β-lactamases in the same organism.  In this Review, descriptions are provided for medically relevant β-lactamase families and various BLI combinations that have been developed or are under development.  Recently approved inhibitor combinations include the inhibitors avibactam and vaborbactam of the diazabicyclooctanone and boronic acid inhibitor classes, resp., as new scaffolds for future inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXtftw0FH0DbVg90H21EOLACvtfcHk0lhBNUc1e4ejAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmsV2it78%253D&md5=a34fa17f62c7e7ff86b3c82960d7b465</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41579-019-0159-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41579-019-0159-8%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DK.%26aulast%3DBradford%26aufirst%3DP.%2BA.%26atitle%3DInterplay%2520between%2520beta-lactamases%2520and%2520new%2520beta-lactamase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2019%26volume%3D17%26spage%3D295%26epage%3D306%26doi%3D10.1038%2Fs41579-019-0159-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span> <span> </span><span class="NLM_article-title">Metallo-beta-lactamase structure and function</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1277</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2012.06796.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1111%2Fj.1749-6632.2012.06796.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=23163348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1277&publication_year=2013&pages=91-104&author=T.+Palzkill&title=Metallo-beta-lactamase+structure+and+function&doi=10.1111%2Fj.1749-6632.2012.06796.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Metallo-β-lactamase structure and function</span></div><div class="casAuthors">Palzkill, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1277</span>
        (<span class="NLM_cas:issue">Antimicrobial Therapeutics Reviews</span>),
    <span class="NLM_cas:pages">91-104</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Lactam antibiotics are the most commonly used antibacterial agents and growing resistance to these drugs is a concern.  Metallo-β-lactamases are a diverse set of enzymes that catalyze the hydrolysis of a broad range of β-lactam drugs including carbapenems.  This diversity is reflected in the observation that the enzyme mechanisms differ based on whether one or two zincs are bound in the active site that, in turn, is dependent on the subclass of β-lactamase.  The dissemination of the genes encoding these enzymes among Gram-neg. bacteria has made them an important cause of resistance.  In addn., there are currently no clin. available inhibitors to block metallo-β-lactamase action.  This review summarizes the numerous studies that have yielded insights into the structure, function, and mechanism of action of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKW_XazIQODLVg90H21EOLACvtfcHk0lhihWfJYY-Qkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCgtb4%253D&md5=ceb4276f35d73e361e2c2fe27015ab8e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2012.06796.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2012.06796.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalzkill%26aufirst%3DT.%26atitle%3DMetallo-beta-lactamase%2520structure%2520and%2520function%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2013%26volume%3D1277%26spage%3D91%26epage%3D104%26doi%3D10.1111%2Fj.1749-6632.2012.06796.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span> <span> </span><span class="NLM_article-title">Emerging carbapenemases: a global perspective</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">S8</span>– <span class="NLM_lpage">S14</span>, <span class="refDoi"> DOI: 10.1016/S0924-8579(10)70004-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2FS0924-8579%2810%2970004-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=21129630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFant7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=S8-S14&author=T.+R.+Walsh&title=Emerging+carbapenemases%3A+a+global+perspective&doi=10.1016%2FS0924-8579%2810%2970004-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging carbapenemases: a global perspective</span></div><div class="casAuthors">Walsh, Timothy R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S8-S14</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The celestial rise in antibiotic resistance among Gram-neg. bacteria has challenged both the scientific and pharmaceutical sectors.  The hallmark of this general increase is the unbridled dissemination of carbapenem resistance genes, namely KPC, OXA and metallo-β-lactamase variants.  In particular, the media attention given to the NDM-1 metallo-β-lactamase has highlighted the global consequences of human behavior on spreading antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppOj-JqmWB2rVg90H21EOLACvtfcHk0lhihWfJYY-Qkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFant7%252FL&md5=82ca57681fcb369b0d30868e2c15fa41</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0924-8579%2810%2970004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-8579%252810%252970004-2%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26atitle%3DEmerging%2520carbapenemases%253A%2520a%2520global%2520perspective%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2010%26volume%3D36%26spage%3DS8%26epage%3DS14%26doi%3D10.1016%2FS0924-8579%2810%2970004-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenitsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagace-Wiens, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denisuik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. P.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlowsky, J. A.</span></span> <span> </span><span class="NLM_article-title">Ceftazidime-avibactam: a novel cephalosporin/beta-lactamase inhibitor combination</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1007/s40265-013-0013-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1007%2Fs40265-013-0013-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=23371303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWms7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=159-177&author=G.+G.+Zhanelauthor=C.+D.+Lawsonauthor=H.+Adamauthor=F.+Schweizerauthor=S.+Zelenitskyauthor=P.+R.+Lagace-Wiensauthor=A.+Denisuikauthor=E.+Rubinsteinauthor=A.+S.+Ginauthor=D.+J.+Hobanauthor=J.+P.+Lynchauthor=J.+A.+Karlowsky&title=Ceftazidime-avibactam%3A+a+novel+cephalosporin%2Fbeta-lactamase+inhibitor+combination&doi=10.1007%2Fs40265-013-0013-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination</span></div><div class="casAuthors">Zhanel, George G.; Lawson, Christopher D.; Adam, Heather; Schweizer, Frank; Zelenitsky, Sheryl; Lagace-Wiens, Philippe R. S.; Denisuik, Andrew; Rubinstein, Ethan; Gin, Alfred S.; Hoban, Daryl J.; Lynch, Joseph P., 3rd; Karlowsky, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-177</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and some Ambler class D enzymes.  This review summarizes the existing data published for ceftazidime-avibactam, including relevant chem., mechanisms of action and resistance, microbiol., pharmacokinetics, pharmacodynamics, and efficacy and safety data from animal and human trials.  Although not a β-lactam, the chem. structure of avibactam closely resembles portions of the cephem bicyclic ring system, and avibactam has been shown to bond covalently to β-lactamases.  Very little is known about the potential for avibactam to select for resistance.  The addn. of avibactam greatly (4-1024-fold min. inhibitory concn. [MIC] redn.) improves the activity of ceftazidime vs. most species of Enterobacteriaceae depending on the presence or absence of β-lactamase enzyme(s).  Against Pseudomonas aeruginosa, the addn. of avibactam also improves the activity of ceftazidime (∼fourfold MIC redn.).  Limited data suggest that the addn. of avibactam does not improve the activity of ceftazidime vs. Acinetobacter species or most anaerobic bacteria (exceptions: Bacteroides fragilis, Clostridium perfringens, Prevotella spp. and Porphyromonas spp.).  The pharmacokinetics of avibactam follow a two-compartment model and do not appear to be altered by the co-administration of ceftazidime.  The max. plasma drug concn. (Cmax) and area under the plasma concn.-time curve (AUC) of avibactam increase linearly with doses ranging from 50 mg to 2,000 mg.  The mean vol. of distribution and half-life of 22 L (∼0.3 L/kg) and ∼2 h, resp., are similar to ceftazidime.  Like ceftazidime, avibactam is primarily renally excreted, and clearance correlates with creatinine clearance.  Pharmacodynamic data suggest that ceftazidime-avibactam is rapidly bactericidal vs. β-lactamase-producing Gram-neg. bacilli that are not inhibited by ceftazidime alone.  Clin. trials to date have reported that ceftazidime-avibactam is as effective as std. carbapenem therapy in complicated intra-abdominal infection and complicated urinary tract infection, including infection caused by cephalosporin-resistant Gram-neg. isolates.  The safety and tolerability of ceftazidime-avibactam has been reported in three phase I pharmacokinetic studies and two phase II clin. studies.  Ceftazidime-avibactam appears to be well tolerated in healthy subjects and hospitalized patients, with few serious drug-related treatment-emergent adverse events reported to date.  In conclusion, avibactam serves to broaden the spectrum of ceftazidime vs. ss-lactamase-producing Gram-neg. bacilli.  The exact roles for ceftazidime-avibactam will be defined by efficacy and safety data from further clin. trials.  Potential future roles for ceftazidime-avibactam include the treatment of suspected or documented infections caused by resistant Gram-neg.-bacilli producing extended-spectrum ss-lactamase (ESBL), Klebsiella pneumoniae carbapenemases (KPCs) and/or AmpC ss-lactamases.  In addn., ceftazidime-avibactam may be used in combination (with metronidazole) for suspected polymicrobial infections.  Finally, the increased activity of ceftazidime-avibactam vs. P. aeruginosa may be of clin. benefit in patients with suspected or documented P. aeruginosa infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe6FoMOMncBbVg90H21EOLACvtfcHk0lhihWfJYY-Qkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWms7zO&md5=29776a4dd902a5e75f1971270fa545a5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs40265-013-0013-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-013-0013-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DLawson%26aufirst%3DC.%2BD.%26aulast%3DAdam%26aufirst%3DH.%26aulast%3DSchweizer%26aufirst%3DF.%26aulast%3DZelenitsky%26aufirst%3DS.%26aulast%3DLagace-Wiens%26aufirst%3DP.%2BR.%26aulast%3DDenisuik%26aufirst%3DA.%26aulast%3DRubinstein%26aufirst%3DE.%26aulast%3DGin%26aufirst%3DA.%2BS.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BP.%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26atitle%3DCeftazidime-avibactam%253A%2520a%2520novel%2520cephalosporin%252Fbeta-lactamase%2520inhibitor%2520combination%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26spage%3D159%26epage%3D177%26doi%3D10.1007%2Fs40265-013-0013-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehmann, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkup, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S. L.</span></span> <span> </span><span class="NLM_article-title">Avibactam is a covalent, reversible, non-beta-lactam beta-lactamase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">11663</span>– <span class="NLM_lpage">11668</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205073109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1073%2Fpnas.1205073109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=22753474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ciu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=11663-11668&author=D.+E.+Ehmannauthor=H.+Jahicauthor=P.+L.+Rossauthor=R.+F.+Guauthor=J.+Huauthor=G.+Kernauthor=G.+K.+Walkupauthor=S.+L.+Fisher&title=Avibactam+is+a+covalent%2C+reversible%2C+non-beta-lactam+beta-lactamase+inhibitor&doi=10.1073%2Fpnas.1205073109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor</span></div><div class="casAuthors">Ehmann, David E.; Jahic, Haris; Ross, Philip L.; Gu, Rong-Fang; Hu, Jun; Kern, Gunther; Walkup, Grant K.; Fisher, Stewart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">11663-11668, S11663/1-S11663/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Avibactam is a β-lactamase inhibitor that is in clin. development, combined with P-lactam partners, for the treatment of bacterial infections comprising Gram-neg. organisms.  Avibactam is a structural class of inhibitor that does not contain a β-lactam core but maintains the capacity to covalently acylate its β-lactamase targets.  Using the TEM-1 enzyme, we characterized avibactam inhibition by measuring the on-rate for acylation and the off-rate for deacylation.  The deacylation off-rate was 0.045 min-1, which allowed investigation of the deacylation route from TEM-1.  Using NMR and MS, we showed that deacylation proceeds through regeneration of intact avibactam and not hydrolysis.  Other than TEM-1, four addnl. clin. relevant β-lactamases were shown to release intact avibactam after being acylated.  We showed that avibactam is a covalent, slowly reversible inhibitor, which is a unique mechanism of inhibition among β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDBeJlngFA5LVg90H21EOLACvtfcHk0limpkmWFiadIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ciu73K&md5=4da3c333df0a1eeb6ab84cabd65ab8ec</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205073109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205073109%26sid%3Dliteratum%253Aachs%26aulast%3DEhmann%26aufirst%3DD.%2BE.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DRoss%26aufirst%3DP.%2BL.%26aulast%3DGu%26aufirst%3DR.%2BF.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DKern%26aufirst%3DG.%26aulast%3DWalkup%26aufirst%3DG.%2BK.%26aulast%3DFisher%26aufirst%3DS.%2BL.%26atitle%3DAvibactam%2520is%2520a%2520covalent%252C%2520reversible%252C%2520non-beta-lactam%2520beta-lactamase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D11663%26epage%3D11668%26doi%3D10.1073%2Fpnas.1205073109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damblon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smargiasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercuri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frère, J.-M.</span></span> <span> </span><span class="NLM_article-title">Interaction of Avibactam with Class B Metallo-β-Lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5655</span>– <span class="NLM_lpage">5662</span>, <span class="refDoi"> DOI: 10.1128/AAC.00897-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.00897-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=27401561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=5655-5662&author=M.+I.+Abboudauthor=C.+Damblonauthor=J.+Bremauthor=N.+Smargiassoauthor=P.+Mercuriauthor=B.+Gilbertauthor=A.+M.+Rydzikauthor=T.+D.+W.+Claridgeauthor=C.+J.+Schofieldauthor=J.-M.+Fr%C3%A8re&title=Interaction+of+Avibactam+with+Class+B+Metallo-%CE%B2-Lactamases&doi=10.1128%2FAAC.00897-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of Avibactam with class B metallo-β-lactamases</span></div><div class="casAuthors">Abboud, Martine I.; Damblon, Christian; Brem, Jurgen; Smargiasso, Nicolas; Mercuri, Paola; Gilbert, Bernard; Rydzik, Anna M.; Claridge, Timothy D. W.; Schofield, Christopher J.; Frere, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5655-5662</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-Lactamases are the most important mechanisms of resistance to the β-lactam antibacterials.  There are two mechanistic classes of β-lactamases: the serine β-lactamases (SBLs) and the zinc-dependent metallo-β-lactamases (MBLs).  Avibactam, the first clin. useful non-β-lactam β-lactamase inhibitor, is a broad-spectrum SBL inhibitor, which is used in combination with a cephalosporin antibiotic (ceftazidime).  There are multiple reports on the interaction of avibactam with SBLs but few such studies with MBLs.  We report biochem. and biophys. studies on the binding and reactivity of avibactam with representatives from all 3 MBL subfamilies (B1, B2, and B3).  Avibactam has only limited or no activity vs. MBL-mediated resistance in pathogens.  Avibactam does not inhibit MBLs and binds only weakly to most of the MBLs tested; in some cases, avibactam undergoes slow hydrolysis of one of its urea N-CO bonds followed by loss of CO2, in a process different from that obsd. with the SBLs studied.  The results suggest that while the evolution of MBLs that more efficiently catalyze avibactam hydrolysis should be anticipated, pursuing the development of dual-action SBL and MBL inhibitors based on the diazabicyclooctane core of avibactam may be productive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSoutDc696brVg90H21EOLACvtfcHk0limpkmWFiadIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKkt74%253D&md5=e789376f6e1f32c28b2b26f3ed89e926</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FAAC.00897-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00897-16%26sid%3Dliteratum%253Aachs%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DDamblon%26aufirst%3DC.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSmargiasso%26aufirst%3DN.%26aulast%3DMercuri%26aufirst%3DP.%26aulast%3DGilbert%26aufirst%3DB.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DFr%25C3%25A8re%26aufirst%3DJ.-M.%26atitle%3DInteraction%2520of%2520Avibactam%2520with%2520Class%2520B%2520Metallo-%25CE%25B2-Lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D5655%26epage%3D5662%26doi%3D10.1128%2FAAC.00897-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e01224</span>– <span class="NLM_lpage">e01217</span>, <span class="refDoi"> DOI: 10.1128/AAC.01224-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.01224-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28971873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1CrtbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01224-e01217&author=C.+T.+Lohansauthor=J.+Bremauthor=C.+J.+Schofield&title=New+Delhi+Metallo-%CE%B2-Lactamase+1+Catalyzes+Avibactam+and+Aztreonam+Hydrolysis&doi=10.1128%2FAAC.01224-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis</span></div><div class="casAuthors">Lohans, Christopher T.; Brem, Juergen; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e01224-17/1-e01224-17/3</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpxK2A1fuBLVg90H21EOLACvtfcHk0limpkmWFiadIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1CrtbnO&md5=9ea98051adda394c81a86a8ee6851c99</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.01224-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01224-17%26sid%3Dliteratum%253Aachs%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DNew%2520Delhi%2520Metallo-%25CE%25B2-Lactamase%25201%2520Catalyzes%2520Avibactam%2520and%2520Aztreonam%2520Hydrolysis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01224%26epage%3De01217%26doi%3D10.1128%2FAAC.01224-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gareth, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvopiña, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widlake, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowson, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Profiling Interactions of Vaborbactam with Metallo-β-Lactamases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1981</span>– <span class="NLM_lpage">1984</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.05.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.bmcl.2019.05.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=31171422" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1981-1984&author=W.+Garethauthor=R.+C.+Langleyauthor=J.+M.+Tyrrellauthor=P.+Hinchliffeauthor=K.+Calvopi%C3%B1aauthor=C.+Tookeauthor=E.+Widlakeauthor=C.+G.+Dowsonauthor=J.+Spencerauthor=T.+R.+Walshauthor=C.+J.+Schofieldauthor=J.+Brem&title=Profiling+Interactions+of+Vaborbactam+with+Metallo-%CE%B2-Lactamases&doi=10.1016%2Fj.bmcl.2019.05.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.05.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.05.031%26sid%3Dliteratum%253Aachs%26aulast%3DGareth%26aufirst%3DW.%26aulast%3DLangley%26aufirst%3DR.%2BC.%26aulast%3DTyrrell%26aufirst%3DJ.%2BM.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DCalvopi%25C3%25B1a%26aufirst%3DK.%26aulast%3DTooke%26aufirst%3DC.%26aulast%3DWidlake%26aufirst%3DE.%26aulast%3DDowson%26aufirst%3DC.%2BG.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DProfiling%2520Interactions%2520of%2520Vaborbactam%2520with%2520Metallo-%25CE%25B2-Lactamases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D1981%26epage%3D1984%26doi%3D10.1016%2Fj.bmcl.2019.05.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Field-Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, F. E.</span></span> <span> </span><span class="NLM_article-title">Bortezomib (Velcade trade mark) in the Treatment of Multiple Myeloma</span>. <i>Ther. Clin. Risk Manage.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.2147/tcrm.2006.2.3.271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.2147%2Ftcrm.2006.2.3.271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=18360602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWltb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=271-279&author=A.+Field-Smithauthor=G.+J.+Morganauthor=F.+E.+Davies&title=Bortezomib+%28Velcade+trade+mark%29+in+the+Treatment+of+Multiple+Myeloma&doi=10.2147%2Ftcrm.2006.2.3.271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bortezomib (Velcade) in the treatment of multiple myeloma</span></div><div class="casAuthors">Field-Smith, Antonia; Morgan, Gareth J.; Davies, Faith E.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-279</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1176-6336</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  The introduction of bortezomib, a novel first-in-class proteasome inhibitor, has been a major break through in the treatment of multiple myeloma.  It is currently approved for the treatment of myeloma in the relapsed setting post transplant or as a second line treatment in patients unsuitable for transplantation.  In pre-clin. studies bortezomib showed a no. of different anti-myeloma effects including disruption of the cell cycle and induction of apoptosis, alteration of the bone marrow microenvironment and inhibition of nuclear factor kappa B (NFκB).  Due to its novel mechanism of action, bortezomib has been shown to induce responses in previously refractory patients (including those with poor risk cytogenetics), and results in an increased progression free and overall survival in relapsed patients when compared with dexamethasone treatment alone.  It is well tolerated and can be administered in the outpatient setting with manageable toxicities.  Peripheral neuropathy is the most common dose limiting toxicity and thrombocytopenia can generally be managed with platelet transfusions without reducing or omitting doses.  Bortezomib shows a synergistic effect in combination with dexamethasone and also sensitizes myeloma cells to the effects of other chemotherapeutic agents with major response rates of over 50% being shown in the relapsed setting.  Initial data from ongoing trials in front line therapy are encouraging with response rates of 80%-90% when bortezomib is given in combination with other agents and importantly, the ability to mobilize peripheral blood stem cells is not impaired.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-VhbO5d60LVg90H21EOLACvtfcHk0lg8OmmZG-DoJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWltb7L&md5=a146395a750aaa853913d3014f03979a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2147%2Ftcrm.2006.2.3.271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Ftcrm.2006.2.3.271%26sid%3Dliteratum%253Aachs%26aulast%3DField-Smith%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DG.%2BJ.%26aulast%3DDavies%26aufirst%3DF.%2BE.%26atitle%3DBortezomib%2520%2528Velcade%2520trade%2520mark%2529%2520in%2520the%2520Treatment%2520of%2520Multiple%2520Myeloma%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manage.%26date%3D2006%26volume%3D2%26spage%3D271%26epage%3D279%26doi%3D10.2147%2Ftcrm.2006.2.3.271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focia, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span> <span> </span><span class="NLM_article-title">Nanomolar inhibitors of AmpC beta-lactamase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1021/ja0288338</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0288338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslOntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=685-695&author=F.+Morandiauthor=E.+Caselliauthor=S.+Morandiauthor=P.+J.+Fociaauthor=J.+Blazquezauthor=B.+K.+Shoichetauthor=F.+Prati&title=Nanomolar+inhibitors+of+AmpC+beta-lactamase&doi=10.1021%2Fja0288338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomolar Inhibitors of AmpC β-Lactamase</span></div><div class="casAuthors">Morandi, Federica; Caselli, Emilia; Morandi, Stefania; Focia, Pamela J.; Blazquez, Jesus; Shoichet, Brian K.; Prati, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">685-695</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and the cephalosporins.  In an effort to combat these enzymes, a combination of stereoselective org. synthesis, enzymol., microbiol., and X-ray crystallog. was used to design and evaluate new carboxyphenyl-glycylboronic acid transition-state analog inhibitors of the class C β-lactamase AmpC.  The new compds. improve inhibition by over 2 orders of magnitude compared to analogous glycylboronic acids, with Ki values as low as 1 nM.  On the basis of the differential binding of different analogs, the introduced carboxylate alone contributes about 2.1 kcal/mol in affinity.  This carboxylate corresponds to the ubiquitous C3(4)' carboxylate of β-lactams, and this energy represents the first thermodn. measurement of the importance of this group in mol. recognition by class C β-lactamases.  The structures of AmpC in complex with two of these inhibitors were detd. by X-ray crystallog. at 1.72 and 1.83 Å resoln.  These structures suggest a structural basis for the high affinity of the new compds. and provide templates for further design.  The highest affinity inhibitor was 5 orders of magnitude more selective for AmpC than for characteristic serine proteases, such as chymotrypsin.  This inhibitor reversed the resistance of clin. pathogens to the third generation cephalosporin ceftazidime; it may serve as a lead compd. for drug discovery to combat bacterial resistance to β-lactam antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR7LDmSNwdM7Vg90H21EOLACvtfcHk0lg8OmmZG-DoJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslOntL4%253D&md5=308c88cbf5e16934025866276a6ae8e7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja0288338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0288338%26sid%3Dliteratum%253Aachs%26aulast%3DMorandi%26aufirst%3DF.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DMorandi%26aufirst%3DS.%26aulast%3DFocia%26aufirst%3DP.%2BJ.%26aulast%3DBlazquez%26aufirst%3DJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DPrati%26aufirst%3DF.%26atitle%3DNanomolar%2520inhibitors%2520of%2520AmpC%2520beta-lactamase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D685%26epage%3D695%26doi%3D10.1021%2Fja0288338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, R. A.</span></span> <span> </span><span class="NLM_article-title">Exploring the potential of boronic acids as inhibitors of OXA-24/40 beta-lactamase</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1002/pro.3100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1002%2Fpro.3100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=27997706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=515-526&author=J.+P.+Wernerauthor=J.+M.+Mitchellauthor=M.+A.+Taracilaauthor=R.+A.+Bonomoauthor=R.+A.+Powers&title=Exploring+the+potential+of+boronic+acids+as+inhibitors+of+OXA-24%2F40+beta-lactamase&doi=10.1002%2Fpro.3100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase</span></div><div class="casAuthors">Werner, Josephine P.; Mitchell, Joshua M.; Taracila, Magdalena A.; Bonomo, Robert A.; Powers, Rachel A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-526</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">β-Lactam antibiotics are crucial to the management of bacterial infections in the medical community.  Due to overuse and misuse, clin. significant bacteria are now resistant to many com. available antibiotics.  The most widespread resistance mechanism to β-lactams is the expression of β-lactamase enzymes.  To overcome β-lactamase mediated resistance, inhibitors were designed to inactivate these enzymes.  However, current inhibitors (clavulanic acid, tazobactam, and sulbactam) for β-lactamases also contain the characteristic β-lactam ring, making them susceptible to resistance mechanisms employed by bacteria.  This presents a crit. need for novel, non-β-lactam inhibitors that can circumvent these resistance mechanisms.  The carbapenem-hydrolyzing class D β-lactamases (CHDLs) are of particular concern, given that they efficiently hydrolyze potent carbapenem antibiotics.  Unfortunately, these enzymes are not inhibited by clin. available β-lactamase inhibitors, nor are they effectively inhibited by the newest, non-β-lactam inhibitor, avibactam.  Boronic acids are known transition state analog inhibitors of class A and C β-lactamases, and are not extensively characterized as inhibitors of class D β-lactamases.  Importantly, boronic acids provide a novel way to potentially inhibit class D β-lactamases.  Sixteen boronic acids were selected and tested for inhibition of the CHDL OXA-24/40.  Several compds. were identified as effective inhibitors of OXA-24/40, with Ki values as low as 5 μM.  The X-ray crystal structures of OXA-24/40 in complex with BA3, BA4, BA8, and BA16 were detd. and revealed the importance of interactions with hydrophobic residues Tyr112 and Trp115.  These boronic acids serve as progenitors in optimization efforts of a novel series of inhibitors for class D β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphGKFNJYCrO7Vg90H21EOLACvtfcHk0lg8OmmZG-DoJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kisrg%253D&md5=73c4063f4a06e5cf8bd8262e17b6e611</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fpro.3100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3100%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DJ.%2BP.%26aulast%3DMitchell%26aufirst%3DJ.%2BM.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DPowers%26aufirst%3DR.%2BA.%26atitle%3DExploring%2520the%2520potential%2520of%2520boronic%2520acids%2520as%2520inhibitors%2520of%2520OXA-24%252F40%2520beta-lactamase%26jtitle%3DProtein%2520Sci.%26date%3D2017%26volume%3D26%26spage%3D515%26epage%3D526%26doi%3D10.1002%2Fpro.3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spellberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Boronic Acid Transition State Inhibitors Active against KPC and Other Class A beta-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1128/AAC.02641-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.02641-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=26729496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2mtL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1751-1759&author=L.+J.+Rojasauthor=M.+A.+Taracilaauthor=K.+M.+Papp-Wallaceauthor=C.+R.+Bethelauthor=E.+Caselliauthor=C.+Romagnoliauthor=M.+L.+Winklerauthor=B.+Spellbergauthor=F.+Pratiauthor=R.+A.+Bonomo&title=Boronic+Acid+Transition+State+Inhibitors+Active+against+KPC+and+Other+Class+A+beta-Lactamases%3A+Structure-Activity+Relationships+as+a+Guide+to+Inhibitor+Design&doi=10.1128%2FAAC.02641-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic acid transition state inhibitors active against KPC and other class A β-lactamases: structure-activity relationships as a guide to inhibitor design</span></div><div class="casAuthors">Rojas, Laura J.; Taracila, Magdalena A.; Papp-Wallace, Krisztina M.; Bethel, Christopher R.; Caselli, Emilia; Romagnoli, Chiara; Winkler, Marisa L.; Spellberg, Brad; Prati, Fabio; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1751-1759</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Boronic acid transition state inhibitors (BATSIs) are competitive, reversible β-lactamase inhibitors (BLIs).  In this study, a series of BATSIs with selectively modified regions (R1, R2, and amide group) were strategically designed and tested against representative class A β-lactamases of Klebsiella pneumoniae, KPC-2 and SHV-1.  Firstly, the R1 group of compds. 1a to 1c and 2a to 2e mimicked the side chain of cephalothin, whereas for compds. 3a to 3c, 4a, and 4b, the thiophene ring was replaced by a Ph, typical of benzylpenicillin.  Secondly, variations in the R2 groups which included substituted aryl side chains (compds. 1a, 1b, 1c, 3a, 3b, and 3c) and triazole groups (compds. 2a to 2e) were chosen to mimic the thiazolidine and dihydrothiazine ring of penicillins and cephalosporins, resp.  Thirdly, the amide backbone of the BATSI, which corresponds to the amide at C-6 or C-7 of β-lactams, was also changed to the following bioisosteric groups: urea (compd. 3b), thiourea (compd. 3c), and sulfonamide (compds. 4a and 4b).  Among the compds. that inhibited KPC-2 and SHV-1 β-lactamases, nine possessed 50% inhibitory concns. (IC50s) of ≤ 600 nM.  The most active compds. contained the thiopheneacetyl group at R1 and for the chiral BATSIs, a carboxy- or hydroxy-substituted aryl group at R2.  The most active sulfonamido deriv., compd. 4b, lacked an R2 group.  Compd. 2b (S02030) was the most active, with acylation rates (k2/K) of 1.2 ± 0.2 ± 104 M-1 s-1 for KPC-2 and 4.7 ± 0.6 × 103 M-1 s-1 for SHV-1, and demonstrated antimicrobial activity against Escherichia coli DH10B carrying blaSHV variants and blaKPC-2 or blaKPC-2 and against clin. strains of Klebsiella pneumoniae and E. coli producing different class A β-lactamase genes.  At most, MICs decreased from 16 to 0.5 mg/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHumxGp1lHkrVg90H21EOLACvtfcHk0ljkwm7duleqwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2mtL3O&md5=490342c29e85e45e3bd1875eff15c583</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.02641-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02641-15%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DL.%2BJ.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DWinkler%26aufirst%3DM.%2BL.%26aulast%3DSpellberg%26aufirst%3DB.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DBoronic%2520Acid%2520Transition%2520State%2520Inhibitors%2520Active%2520against%2520KPC%2520and%2520Other%2520Class%2520A%2520beta-Lactamases%253A%2520Structure-Activity%2520Relationships%2520as%2520a%2520Guide%2520to%2520Inhibitor%2520Design%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D1751%26epage%3D1759%26doi%3D10.1128%2FAAC.02641-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. B.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1038/nsb0896-688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1038%2Fnsb0896-688" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=688-695&author=N.+C.+Strynadkaauthor=R.+Martinauthor=S.+E.+Jensenauthor=M.+Goldauthor=J.+B.+Jones&title=Structure-based+design+of+a+potent+transition+state+analogue+for+TEM-1+beta-lactamase&doi=10.1038%2Fnsb0896-688"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnsb0896-688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb0896-688%26sid%3Dliteratum%253Aachs%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DS.%2BE.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DJ.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520a%2520potent%2520transition%2520state%2520analogue%2520for%2520TEM-1%2520beta-lactamase%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D3%26spage%3D688%26epage%3D695%26doi%3D10.1038%2Fnsb0896-688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ness, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paetzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span> <span> </span><span class="NLM_article-title">Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">5312</span>– <span class="NLM_lpage">5321</span>, <span class="refDoi"> DOI: 10.1021/bi992505b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi992505b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVelsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=5312-5321&author=S.+Nessauthor=R.+Martinauthor=A.+M.+Kindlerauthor=M.+Paetzelauthor=M.+Goldauthor=S.+E.+Jensenauthor=J.+B.+Jonesauthor=N.+C.+Strynadka&title=Structure-based+design+guides+the+improved+efficacy+of+deacylation+transition+state+analogue+inhibitors+of+TEM-1+beta-Lactamase&doi=10.1021%2Fbi992505b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design Guides the Improved Efficacy of Deacylation Transition State Analogue Inhibitors of TEM-1 β-Lactamase</span></div><div class="casAuthors">Ness, Steven; Martin, Richard; Kindler, Alois M.; Paetzel, Mark; Gold, Marvin; Jensen, Susan E.; Jones, J. Bryan; Strynadka, Natalie C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5312-5321</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition state analog boronic acid inhibitors mimicking the structures and interactions of good penicillin substrates for the TEM-1 β-lactamase of Escherichia coli were designed using graphic analyses based on the enzyme's 1.7 Å crystallog. structure.  The synthesis of two of these transition state analogs, (1R)-1-phenylacetamido-2-(3-carboxyphenyl)ethylboronic acid (1) and (1R)-1-acetamido-2-(3-carboxy-2-hydroxyphenyl)ethylboronic acid (2), is reported.  Kinetic measurements show that, as designed, compds. 1 and 2 are highly effective deacylation transition state analog inhibitors of TEM-1 β-lactamase, with inhibition consts. of 5.9 and 13 nM, resp.  These values identify them as among the most potent competitive inhibitors yet reported for a β-lactamase.  The best inhibitor of the current series was (1R)-1-phenylacetamido-2-(3-carboxyphenyl)ethylboronic acid (1, KI = 5.9 nM), which resembles most closely the best known substrate of TEM-1, benzylpenicillin (penicillin G).  The high-resoln. crystallog. structures of these two inhibitors covalently bound to TEM-1 are also described.  In addn. to verifying the design features, these two structures show interesting and unanticipated changes in the active site area, including strong hydrogen bond formation, water displacement, and rearrangement of side chains.  The structures provide new insights into the further design of this potent class of β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-aQSFfZl_R7Vg90H21EOLACvtfcHk0ljkwm7duleqwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVelsr8%253D&md5=441c78891c1860f80e29660283299961</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi992505b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi992505b%26sid%3Dliteratum%253Aachs%26aulast%3DNess%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DKindler%26aufirst%3DA.%2BM.%26aulast%3DPaetzel%26aufirst%3DM.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DS.%2BE.%26aulast%3DJones%26aufirst%3DJ.%2BB.%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26atitle%3DStructure-based%2520design%2520guides%2520the%2520improved%2520efficacy%2520of%2520deacylation%2520transition%2520state%2520analogue%2520inhibitors%2520of%2520TEM-1%2520beta-Lactamase%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26spage%3D5312%26epage%3D5321%26doi%3D10.1021%2Fbi992505b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudin, A. K.</span></span> <span> </span><span class="NLM_article-title">The versatility of boron in biological target engagement</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1038/nchem.2814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1038%2Fnchem.2814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28754930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Gku7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=731-742&author=D.+B.+Diazauthor=A.+K.+Yudin&title=The+versatility+of+boron+in+biological+target+engagement&doi=10.1038%2Fnchem.2814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The versatility of boron in biological target engagement</span></div><div class="casAuthors">Diaz, Diego B.; Yudin, Andrei K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">731-742</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Boron-contg. mols. have been extensively used for the purposes of chem. sensing, biol. probe development, and drug discovery.  Due to boron's empty p orbital, it can coordinate to heteroatoms such as oxygen and nitrogen.  This reversible covalent mode of interaction has led to the use of boron as bait for nucleophilic residues in disease-assocd. proteins, culminating in the approval of new therapeutics that work by covalent mechanisms.  Our anal. of a wide range of covalent inhibitors with electrophilic groups suggests that boron is a unique electrophile in its chameleonic ability to engage protein targets.  Here, we review boron's interactions with a range of protein side-chain residues and reveal that boron's properties are nuanced and arise from its uncommon coordination preferences.  These mechanistic and structural insights should serve as a guide for the development of selective boron-based bioactive mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYy4b-paw5prVg90H21EOLACvtfcHk0ljkwm7duleqwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Gku7bF&md5=cf5669d184a5badc7101aa2e3d1f2500</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2814%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DD.%2BB.%26aulast%3DYudin%26aufirst%3DA.%2BK.%26atitle%3DThe%2520versatility%2520of%2520boron%2520in%2520biological%2520target%2520engagement%26jtitle%3DNat.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D731%26epage%3D742%26doi%3D10.1038%2Fnchem.2814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krajnc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduwawala, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Will morphing boron-based inhibitors beat the beta-lactamases?</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2019.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.cbpa.2019.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=31004962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXns1yrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2019&pages=101-110&author=A.+Krajncauthor=P.+A.+Langauthor=T.+D.+Panduwawalaauthor=J.+Bremauthor=C.+J.+Schofield&title=Will+morphing+boron-based+inhibitors+beat+the+beta-lactamases%3F&doi=10.1016%2Fj.cbpa.2019.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Will morphing boron-based inhibitors beat the β-lactamases?</span></div><div class="casAuthors">Krajnc, Alen; Lang, Pauline A.; Panduwawala, Tharindi D.; Brem, Jurgen; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The β-lactams remain the most important antibacterials, but their use is increasingly compromised by resistance, importantly by β-lactamases.  Although β-lactam and non-β-lactam inhibitors forming stable acyl-enzyme complexes with nucleophilic serine β-lactamases (SBLs) are widely used, these are increasingly susceptible to evolved SBLs and do not inhibit metallo-β-lactamases (MBLs).  Boronic acids and boronate esters, esp. cyclic ones, can potently inhibit both SBLs and MBLs.  Vaborbactam, a monocyclic boronate, is approved for clin. use, but its β-lactamase coverage is limited.  Bicyclic boronates rapidly react with SBLs and MBLs forming stable enzyme-inhibitor complexes that mimic the common anionic high-energy tetrahedral intermediates in SBL/MBL catalysis, as revealed by crystallog.  The ability of boronic acids to 'morph' between sp2 and sp3 hybridization states may help enable potent inhibition.  There is limited structure-activity relationship information on the (bi)cyclic boronate inhibitors compared to β-lactams, hence scope for creativity towards new boron-based β-lactamase inhibitors/antibacterials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYQIvXncI3a7Vg90H21EOLACvtfcHk0ljW-SMRiOfsOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXns1yrt7k%253D&md5=7e703c747a254766bda580563fb42a7f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2019.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2019.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DKrajnc%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DP.%2BA.%26aulast%3DPanduwawala%26aufirst%3DT.%2BD.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DWill%2520morphing%2520boron-based%2520inhibitors%2520beat%2520the%2520beta-lactamases%253F%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D50%26spage%3D101%26epage%3D110%26doi%3D10.1016%2Fj.cbpa.2019.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsivkovski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potts, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abendroth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loutit, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, M. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Cyclic Boronic Acid beta-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3682</span>– <span class="NLM_lpage">3692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3682-3692&author=S.+J.+Heckerauthor=K.+R.+Reddyauthor=M.+Totrovauthor=G.+C.+Hirstauthor=O.+Lomovskayaauthor=D.+C.+Griffithauthor=P.+Kingauthor=R.+Tsivkovskiauthor=D.+Sunauthor=M.+Sabetauthor=Z.+Taraziauthor=M.+C.+Cliftonauthor=K.+Atkinsauthor=A.+Raymondauthor=K.+T.+Pottsauthor=J.+Abendrothauthor=S.+H.+Boyerauthor=J.+S.+Loutitauthor=E.+E.+Morganauthor=S.+Dursoauthor=M.+N.+Dudley&title=Discovery+of+a+Cyclic+Boronic+Acid+beta-Lactamase+Inhibitor+%28RPX7009%29+with+Utility+vs+Class+A+Serine+Carbapenemases&doi=10.1021%2Facs.jmedchem.5b00127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases</span></div><div class="casAuthors">Hecker, Scott J.; Reddy, K. Raja; Totrov, Maxim; Hirst, Gavin C.; Lomovskaya, Olga; Griffith, David C.; King, Paula; Tsivkovski, Ruslan; Sun, Dongxu; Sabet, Mojgan; Tarazi, Ziad; Clifton, Matthew C.; Atkins, Kateri; Raymond, Amy; Potts, Kristy T.; Abendroth, Jan; Boyer, Serge H.; Loutit, Jeffrey S.; Morgan, Elizabeth E.; Durso, Stephanie; Dudley, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3682-3692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The increasing dissemination of carbapenemases in Gram-neg. bacteria has threatened the clin. usefulness of the β-lactam class of antimicrobials.  A program was initiated to discover a new series of serine β-lactamase inhibitors contg. a boronic acid pharmacophore, with the goal of finding a potent inhibitor of serine carbapenemase enzymes that are currently compromising the utility of the carbapenem class of antibacterials.  Potential lead structures were screened in silico by modeling into the active sites of key serine β-lactamases.  Promising candidate mols. were synthesized and evaluated in biochem. and whole-cell assays.  Inhibitors were identified with potent inhibition of serine carbapenemases, particularly the Klebsiella pneumoniae carbapenemase (KPC), with no inhibition of mammalian serine proteases.  Studies in vitro and in vivo show that RPX7009 (9f) is a broad-spectrum inhibitor, notably restoring the activity of carbapenems against KPC-producing strains.  Combined with a carbapenem, 9f is a promising product for the treatment of multidrug resistant Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpE5YX_dRNLVg90H21EOLACvtfcHk0ljW-SMRiOfsOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2gs7g%253D&md5=965fbf2b42f2e1b38eccc3b23dfa374f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00127%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DGriffith%26aufirst%3DD.%2BC.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DTsivkovski%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DSabet%26aufirst%3DM.%26aulast%3DTarazi%26aufirst%3DZ.%26aulast%3DClifton%26aufirst%3DM.%2BC.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DRaymond%26aufirst%3DA.%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DBoyer%26aufirst%3DS.%2BH.%26aulast%3DLoutit%26aufirst%3DJ.%2BS.%26aulast%3DMorgan%26aufirst%3DE.%2BE.%26aulast%3DDurso%26aufirst%3DS.%26aulast%3DDudley%26aufirst%3DM.%2BN.%26atitle%3DDiscovery%2520of%2520a%2520Cyclic%2520Boronic%2520Acid%2520beta-Lactamase%2520Inhibitor%2520%2528RPX7009%2529%2520with%2520Utility%2520vs%2520Class%2520A%2520Serine%2520Carbapenemases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3682%26epage%3D3692%26doi%3D10.1021%2Facs.jmedchem.5b00127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhillon, S.</span></span> <span> </span><span class="NLM_article-title">Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1270</span>, <span class="refDoi"> DOI: 10.1007/s40265-018-0966-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1007%2Fs40265-018-0966-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=30128699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGjt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=1259-1270&author=S.+Dhillon&title=Meropenem%2FVaborbactam%3A+A+Review+in+Complicated+Urinary+Tract+Infections&doi=10.1007%2Fs40265-018-0966-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections</span></div><div class="casAuthors">Dhillon, Sohita</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1259-1270</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  The global threat of the spread of carbapenem resistance in Enterobacteriaceae has led to the search for new antibacterials.  I.v. meropenem/vaborbactam (Vabomere) is the first carbapenem/β-lactamase inhibitor combination approved in the USA for use in patients with complicated urinary tract infections (cUTIs), including pyelonephritis.  Vaborbactam is a potent inhibitor of class A serine carbapenemases, which, when combined with the antibacterial meropenem, restores the activity of meropenem against β-lactamase producing Enterobacteriaceae, particularly Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae.  In the phase 3, noninferiority TANGO I trial in patients with cUTIs, i.v. meropenem/vaborbactam was noninferior to i.v. piperacillin/tazobactam for overall success (composite of clin. cure and microbial eradication; FDA primary endpoint) and microbial eradication (EMA primary endpoint).  Meropenem/vaborbactam was generally well tolerated, with a tolerability profile generally similar to that of piperacillin/tazobactam.  TANGO I did not assess the efficacy of meropenem/vaborbactam for the treatment of infections caused by carbapenem-resistant Enterobacteriaceae and meropenem/vaborbactam is currently not indicated for these patients.  Available evidence indicates that meropenem/vaborbactam is a useful treatment option for patients with cUTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfbl_iY8DrWrVg90H21EOLACvtfcHk0ljW-SMRiOfsOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGjt7vE&md5=61025d2c50c93af20f96fc70cbf60a32</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs40265-018-0966-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-018-0966-7%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26atitle%3DMeropenem%252FVaborbactam%253A%2520A%2520Review%2520in%2520Complicated%2520Urinary%2520Tract%2520Infections%26jtitle%3DDrugs%26date%3D2018%26volume%3D78%26spage%3D1259%26epage%3D1270%26doi%3D10.1007%2Fs40265-018-0966-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio-Aparicio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsivkovski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, M. N.</span></span> <span> </span><span class="NLM_article-title">Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e01443</span>– <span class="NLM_lpage">e01417</span>, <span class="refDoi"> DOI: 10.1128/AAC.01443-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.01443-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28848018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsl2jur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01443-e01417&author=O.+Lomovskayaauthor=D.+Sunauthor=D.+Rubio-Aparicioauthor=K.+Nelsonauthor=R.+Tsivkovskiauthor=D.+C.+Griffithauthor=M.+N.+Dudley&title=Vaborbactam%3A+Spectrum+of+Beta-Lactamase+Inhibition+and+Impact+of+Resistance+Mechanisms+on+Activity+in+Enterobacteriaceae&doi=10.1128%2FAAC.01443-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Vaborbactam: spectrum of beta- lactamase inhibition and impact of resistance mechanisms on activity in Enterobacteriaceae</span></div><div class="casAuthors">Lomovskaya, Olga; Sun, Dongxu; Rubio-Aparicio, Debora; Nelson, Kirk; Tsivkovski, Ruslan; Griffith, David C.; Dudley, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e01443-17/1-e01443-17/15</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Vaborbactam (formerly RPX7009) is a new beta-lactamase inhibitor based on a cyclic boronic acid pharmacophore.  The spectrum of beta-lactamase inhibition by vaborbactam and the impact of bacterial efflux and permeability on its activity were detd. using a panel of strains with beta-lactamases cloned from various classes and a panel of Klebsiella pneumoniae carbapenemase 3 (KPC-3)-producing isogenic strains with various combinations of efflux and porin mutations.  Vaborbactam is a potent inhibitor of class A carbapenemases, such as KPC, as well as an inhibitor of other class A (CTX-M, SHV, TEM) and class C (P99, MIR, FOX) beta-lactamases.  Vaborbactam does not inhibit class D or class B carbapenemases.  When combined with meropenem, vaborbactam had the highest potency compared to the potencies of vaborbactam in combination with other antibiotics against strains producing the KPC beta-lactamase.  Consistent with broad-spectrum beta-lactamase inhibition, vaborbactam reduced the meropenem MICs for engineered isogenic strains of K. pneumoniae with increased meropenem MICs due to a combination of extended-spectrum beta-lactamase prodn., class C betalactamase prodn., and reduced permeability due to porin mutations.  Vaborbactam crosses the outer membrane of K. pneumoniae using both OmpK35 and OmpK36, but OmpK36 is the preferred porin.  Efflux by the multidrug resistance efflux pump AcrAB-TolC had a minimal impact on vaborbactam activity.  Investigation of the vaborbactam concn. necessary for restoration of meropenem potency showed that vaborbactam at 8 g/mL results in meropenem MICs of ≤ 2 g/mL in the most resistant engineered strains contg. multiple mutations.  Vaborbactam is a highly active betalactamase inhibitor that restores the activity of meropenem and other beta-lactam antibiotics in beta-lactamase-producing bacteria, particularly KPC-producing carbapenemresistant Enterobacteriaceae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxqM5yJaqrZ7Vg90H21EOLACvtfcHk0ljI3I6OFURqng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsl2jur4%253D&md5=657d37b1378a7d2d9ba9f829e73e8221</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.01443-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01443-17%26sid%3Dliteratum%253Aachs%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DRubio-Aparicio%26aufirst%3DD.%26aulast%3DNelson%26aufirst%3DK.%26aulast%3DTsivkovski%26aufirst%3DR.%26aulast%3DGriffith%26aufirst%3DD.%2BC.%26aulast%3DDudley%26aufirst%3DM.%2BN.%26atitle%3DVaborbactam%253A%2520Spectrum%2520of%2520Beta-Lactamase%2520Inhibition%2520and%2520Impact%2520of%2520Resistance%2520Mechanisms%2520on%2520Activity%2520in%2520Enterobacteriaceae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01443%26epage%3De01417%26doi%3D10.1128%2FAAC.01443-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Castellanos, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">12406</span> <span class="refDoi"> DOI: 10.1038/ncomms12406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1038%2Fncomms12406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=27499424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaks7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=J.+Bremauthor=R.+Cainauthor=S.+Cahillauthor=M.+A.+McDonoughauthor=I.+J.+Cliftonauthor=J.-C.+Jim%C3%A9nez-Castellanosauthor=M.+B.+Avisonauthor=J.+Spencerauthor=C.+W.+G.+Fishwickauthor=C.+J.+Schofield&title=Structural+basis+of+metallo-%CE%B2-lactamase%2C+serine-%CE%B2-lactamase+and+penicillin-binding+protein+inhibition+by+cyclic+boronates&doi=10.1038%2Fncomms12406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates</span></div><div class="casAuthors">Brem, Jurgen; Cain, Ricky; Cahill, Samuel; McDonough, Michael A.; Clifton, Ian J.; Jimenez-Castellanos, Juan-Carlos; Avison, Matthew B.; Spencer, James; Fishwick, Colin W. G.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12406</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Lactamases enable resistance to almost all β-lactam antibiotics.  Pioneering work revealed that acyclic boronic acids can act as 'transition state analog' inhibitors of nucleophilic serine enzymes, including serine-β-lactamases.  Here we report biochem. and biophys. analyses revealing that cyclic boronates potently inhibit both nucleophilic serine and zinc-dependent β-lactamases by a mechanism involving mimicking of the common tetrahedral intermediate.  Cyclic boronates also potently inhibit the non-essential penicillin-binding protein PBP 5 by the same mechanism of action.  The results open the way for development of dual action inhibitors effective against both serine- and metallo-β-lactamases, and which could also have antimicrobial activity through inhibition of PBPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod70NVhmwa-7Vg90H21EOLACvtfcHk0ljI3I6OFURqng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaks7fM&md5=ec35f6a2ffbfe52b9046821526658492</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fncomms12406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12406%26sid%3Dliteratum%253Aachs%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DCahill%26aufirst%3DS.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DJim%25C3%25A9nez-Castellanos%26aufirst%3DJ.-C.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520metallo-%25CE%25B2-lactamase%252C%2520serine-%25CE%25B2-lactamase%2520and%2520penicillin-binding%2520protein%2520inhibition%2520by%2520cyclic%2520boronates%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fncomms12406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oswin, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Cyclic Boronates Inhibit All Classes of β-Lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e02260</span>– <span class="NLM_lpage">e02216</span>, <span class="refDoi"> DOI: 10.1128/AAC.02260-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.02260-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28115348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFeksbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e02260-e02216&author=S.+T.+Cahillauthor=R.+Cainauthor=D.+Y.+Wangauthor=C.+T.+Lohansauthor=D.+W.+Warehamauthor=H.+P.+Oswinauthor=J.+Mohammedauthor=J.+Spencerauthor=C.+W.+G.+Fishwickauthor=M.+A.+McDonoughauthor=C.+J.+Schofieldauthor=J.+Brem&title=Cyclic+Boronates+Inhibit+All+Classes+of+%CE%B2-Lactamases&doi=10.1128%2FAAC.02260-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic boronates inhibit all classes of β-lactamases</span></div><div class="casAuthors">Cahill, Samuel T.; Cain, Ricky; Wang, David Y.; Lohans, Christopher T.; Wareham, David W.; Oswin, Henry P.; Mohammed, Jabril; Spencer, James; Fishwick, Colin W. G.; McDonough, Michael A.; Schofield, Christopher J.; Brem, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e02260-16/1-e02260-16/13</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-Lactamase-mediated resistance is a growing threat to the continued use of β-lactam antibiotics.  The use of the β-lactam-based serine-β-lactamase (SBL) inhibitors clavulanic acid, sulbactam, and tazobactam and, more recently, the non-β-lactam inhibitor avibactam has extended the utility of β-lactams against bacterial infections demonstrating resistance via these enzymes.  These mols. are, however, ineffective against the metallo-β-lactamases (MBLs), which catalyze their hydrolysis.  To date, there are no clin. available metallo-β-lactamase inhibitors.  Coprodn. of MBLs and SBLs in resistant infections is thus of major clin. concern.  The development of "dual-action" inhibitors, targeting both SBLs and MBLs, is of interest, but this is considered difficult to achieve due to the structural and mechanistic differences between the two enzyme classes.  We recently reported evidence that cyclic boronates can inhibit both serine- and metallo-β-lactamases.  Here we report that cyclic boronates are able to inhibit all four classes of β-lactamase, including the class A extended spectrum β-lactamase CTX-M-15, the class C enzyme AmpC from Pseudomonas aeruginosa, and class D OXA enzymes with carbapenem-hydrolyzing capabilities.  We demonstrate that cyclic boronates can potentiate the use of β-lactams against Gram-neg. clin. isolates expressing a variety of β-lactamases.  Comparison of a crystal structure of a CTX-M-15:cyclic boronate complex with structures of cyclic boronates complexed with other β-lactamases reveals remarkable conservation of the small-mol. binding mode, supporting our proposal that these mols. work by mimicking the common tetrahedral anionic intermediate present in both serine- and metallo-β-lactamase catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUZbpAmThEjrVg90H21EOLACvtfcHk0ljI3I6OFURqng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFeksbnE&md5=829de86b71e9f23c0b131f3b95b7869c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FAAC.02260-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02260-16%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DS.%2BT.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DD.%2BY.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DOswin%26aufirst%3DH.%2BP.%26aulast%3DMohammed%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DCyclic%2520Boronates%2520Inhibit%2520All%2520Classes%2520of%2520%25CE%25B2-Lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De02260%26epage%3De02216%26doi%3D10.1128%2FAAC.02260-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navratilova, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvopina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Studies on the inhibition of AmpC and other beta-lactamases by cyclic boronates</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2019.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.bbagen.2019.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=30738906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivFSqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2019&pages=742-748&author=S.+T.+Cahillauthor=J.+M.+Tyrrellauthor=I.+H.+Navratilovaauthor=K.+Calvopinaauthor=S.+W.+Robinsonauthor=C.+T.+Lohansauthor=M.+A.+McDonoughauthor=R.+Cainauthor=C.+W.+G.+Fishwickauthor=M.+B.+Avisonauthor=T.+R.+Walshauthor=C.+J.+Schofieldauthor=J.+Brem&title=Studies+on+the+inhibition+of+AmpC+and+other+beta-lactamases+by+cyclic+boronates&doi=10.1016%2Fj.bbagen.2019.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates</span></div><div class="casAuthors">Cahill, Samuel T.; Tyrrell, Jonathan M.; Navratilova, Iva Hopkins; Calvopina, Karina; Robinson, Sean W.; Lohans, Christopher T.; McDonough, Michael A.; Cain, Ricky; Fishwick, Colin W. G.; Avison, Matthew B.; Walsh, Timothy R.; Schofield, Christopher J.; Brem, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">742-748</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The β-lactam antibiotics represent the most successful drug class for treatment of bacterial infections.  Resistance to them, importantly via prodn. of β-lactamases, which collectively are able to hydrolyze all classes of β-lactams, threatens their continued widespread use.  Bicyclic boronates show potential as broad spectrum inhibitors of the mechanistically distinct serine- (SBL) and metallo- (MBL) β-lactamase families.  Using biophys. methods, including crystallog. anal., we have investigated the binding mode of bicyclic boronates to clin. important β-lactamases.  Induction expts. and agar-based MIC screening against MDR-Enterobacteriaceae (n = 132) were used to evaluate induction properties and the in vitro efficacy of a bicyclic boronate in combination with meropenem.  Crystallog. anal. of a bicyclic boronate in complex with AmpC from Pseudomonas aeruginosa reveals it binds to form a tetrahedral boronate species.  Microbiol. studies on the clin. coverage (in combination with meropenem) and induction of β-lactamases by bicyclic boronates further support the promise of such compds. as broad spectrum β-lactamase inhibitors.  Together with reported studies on the structural basis of their inhibition of class A, B and D β-lactamases, biophys. studies, including crystallog. anal., support the proposal that bicyclic boronates mimic tetrahedral intermediates common to SBL and MBL catalysis.  Bicyclic boronates are a new generation of broad spectrum inhibitors of both SBLs and MBLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphrtl6rzz_pbVg90H21EOLACvtfcHk0ljhqpNG5WSE_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivFSqsbo%253D&md5=2437a9feb705e3e7d2390b11a611e611</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2019.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DS.%2BT.%26aulast%3DTyrrell%26aufirst%3DJ.%2BM.%26aulast%3DNavratilova%26aufirst%3DI.%2BH.%26aulast%3DCalvopina%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DStudies%2520on%2520the%2520inhibition%2520of%2520AmpC%2520and%2520other%2520beta-lactamases%2520by%2520cyclic%2520boronates%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2019%26volume%3D1863%26spage%3D742%26epage%3D748%26doi%3D10.1016%2Fj.bbagen.2019.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span></span> <span> </span><span class="NLM_article-title">Beta-Lactamase Inhibitors</span>. WO Patent <span class="NLM_patent">WO 2014/089365 A1</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Burns%2C+C.+J.%3B+Daigle%2C+D.%3B+Liu%2C+B.%3B+McGarry%2C+D.%3B+Pevear%2C+D.+C.%3B+Trout%2C+R.+E.+L.+Beta-Lactamase+Inhibitors.+WO+Patent+WO+2014%2F089365+A1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-Lactamase%2520Inhibitors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mushtaq, S.</span>; <span class="NLM_string-name">Vickers, A.</span>; <span class="NLM_string-name">Woodford, N.</span>; <span class="NLM_string-name">Livermore, D. M.</span></span> <i>Potentiation of cefepime by the boronate VNRX-5133 versus gram-negative bacteria with known β-lactamases</i>; <span class="NLM_publisher-name">European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid</span>: <span class="NLM_publisher-loc">Spain</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Mushtaq&author=A.+Vickers&author=N.+Woodford&author=D.+M.+Livermore&title=Potentiation+of+cefepime+by+the+boronate+VNRX-5133+versus+gram-negative+bacteria+with+known+%CE%B2-lactamases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMushtaq%26aufirst%3DS.%26btitle%3DPotentiation%2520of%2520cefepime%2520by%2520the%2520boronate%2520VNRX-5133%2520versus%2520gram-negative%2520bacteria%2520with%2520known%2520%25CE%25B2-lactamases%26pub%3DEuropean%2520Congress%2520of%2520Clinical%2520Microbiology%2520and%2520Infectious%2520Diseases%2520%2528ECCMID%2529%2520in%2520Madrid%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackel Meredith, D. S.</span></span> <i>Antimicrobial Activity of Cefepime in Combination with VNRX-5133 Against a Global 2018 Surveillance Collection of Clinical Isolates</i>; <span class="NLM_publisher-name">European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam</span>: <span class="NLM_publisher-loc">The Netherlands</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=D.+S.+Hackel+Meredith&title=Antimicrobial+Activity+of+Cefepime+in+Combination+with+VNRX-5133+Against+a+Global+2018+Surveillance+Collection+of+Clinical+Isolates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHackel%2BMeredith%26aufirst%3DD.%2BS.%26btitle%3DAntimicrobial%2520Activity%2520of%2520Cefepime%2520in%2520Combination%2520with%2520VNRX-5133%2520Against%2520a%2520Global%25202018%2520Surveillance%2520Collection%2520of%2520Clinical%2520Isolates%26pub%3DEuropean%2520Congress%2520of%2520Clinical%2520Microbiology%2520and%2520Infectious%2520Diseases%2520%2528ECCMID%2529%2520in%2520Amsterdam%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamrick, J. C.</span>; <span class="NLM_string-name">Chatwin, C. L.</span>; <span class="NLM_string-name">John, K. J.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Xerri, L.</span></span> <i>The Ability of Broad-spectrum β-Lactamase Inhibitor Vnrx-5133 to Restore Bactericidal Activity of Cefepime in Enterobacteriaceae and P. aeruginosa-Expressing Ambler Class A, B, C and D Enzymes is Demonstrated Using Time-Kill Kinetics</i>; <span class="NLM_publisher-name">European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid</span>: <span class="NLM_publisher-loc">Spain</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+C.+Hamrick&author=C.+L.+Chatwin&author=K.+J.+John&author=D.+C.+Pevear&author=C.+J.+Burns&author=L.+Xerri&title=The+Ability+of+Broad-spectrum+%CE%B2-Lactamase+Inhibitor+Vnrx-5133+to+Restore+Bactericidal+Activity+of+Cefepime+in+Enterobacteriaceae+and+P.+aeruginosa-Expressing+Ambler+Class+A%2C+B%2C+C+and+D+Enzymes+is+Demonstrated+Using+Time-Kill+Kinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHamrick%26aufirst%3DJ.%2BC.%26btitle%3DThe%2520Ability%2520of%2520Broad-spectrum%2520%25CE%25B2-Lactamase%2520Inhibitor%2520Vnrx-5133%2520to%2520Restore%2520Bactericidal%2520Activity%2520of%2520Cefepime%2520in%2520Enterobacteriaceae%2520and%2520P.%2520aeruginosa-Expressing%2520Ambler%2520Class%2520A%252C%2520B%252C%2520C%2520and%2520D%2520Enzymes%2520is%2520Demonstrated%2520Using%2520Time-Kill%2520Kinetics%26pub%3DEuropean%2520Congress%2520of%2520Clinical%2520Microbiology%2520and%2520Infectious%2520Diseases%2520%2528ECCMID%2529%2520in%2520Madrid%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, D. S.</span></span> <span> </span><span class="NLM_article-title">Boronic esters in asymmetric synthesis</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">10009</span>– <span class="NLM_lpage">10023</span>, <span class="refDoi"> DOI: 10.1021/jo4013942</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo4013942" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=10009-10023&author=D.+S.+Matteson&title=Boronic+esters+in+asymmetric+synthesis&doi=10.1021%2Fjo4013942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic Esters in Asymmetric Synthesis</span></div><div class="casAuthors">Matteson, Donald S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10009-10023</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review discusses the work of Professor Donald Matteson and his research group in the enantioselective synthesis of α-substituted boronic acid esters and their derivs. using the diastereoselective insertion of lithiated dihalomethanes into nonracemic boronates and subsequent substitution reactions as the key steps; the use of the method in the synthesis of insect pheromones and α-amino boronic acid amino acid analogs are discussed.  The use of nonracemic diol auxiliaries for enantioselective boronate ester synthesis, particularly pinanediols, is discussed and the advantages and limitations of the discussed methods for boronate ester synthesis are delineated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppRJ5y69-SqbVg90H21EOLACvtfcHk0ljhqpNG5WSE_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsr7K&md5=b81acd35a955663e4be806cf65bbbd6c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo4013942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo4013942%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26atitle%3DBoronic%2520esters%2520in%2520asymmetric%2520synthesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26spage%3D10009%26epage%3D10023%26doi%3D10.1021%2Fjo4013942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span> <span> </span><span class="NLM_article-title">Homologation of Boronic Esters to Alpha-Chloro Boronic Esters</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1529</span>– <span class="NLM_lpage">1535</span>, <span class="refDoi"> DOI: 10.1021/om50005a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om50005a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaL3sXlslGrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1983&pages=1529-1535&author=D.+S.+Mattesonauthor=D.+Majumdar&title=Homologation+of+Boronic+Esters+to+Alpha-Chloro+Boronic+Esters&doi=10.1021%2Fom50005a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Homologation of boronic esters to α-chloro boronic esters</span></div><div class="casAuthors">Matteson, Donald S.; Majumdar, Debesh</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1529-35</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    </div><div class="casAbstract">The homologation of boronic esters (I, R = primary, secondary, or tertiary alkyl, cycloalkyl, alkenyl, allyl, aryl, or benzyl, and functional substituents in R may include α-benzyloxy, β or remote carbalkoxy, or a remote ketal substituent; R1 = H or Me) with (dichloromethyl)lithium to form α-chloro boronic esters II has been found to be a highly efficient process.  The homologation failed in the presence of an α-phenylthio or an α-boronic ester substituent.  The α-chloro boronic esters readily undergo nucleophilic replacement of chloride with a variety of reagents, including thiophenolate, benzyl oxide, an ester enolate, or alkyl groups from Grignard or lithium reagents.  Either 100% C-alkylation or a majority of O-alkylation and Cope rearrangement could be obtained when tert-Bu lithioacetate reacted with pinacol 3-chloro-1-propene-3-boronate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAlGjGhBVPhrVg90H21EOLACvtfcHk0ljhqpNG5WSE_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslGrtrw%253D&md5=585036c9e7af21592e9fd9ffaffcf71e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fom50005a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom50005a008%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DMajumdar%26aufirst%3DD.%26atitle%3DHomologation%2520of%2520Boronic%2520Esters%2520to%2520Alpha-Chloro%2520Boronic%2520Esters%26jtitle%3DOrganometallics%26date%3D1983%26volume%3D2%26spage%3D1529%26epage%3D1535%26doi%3D10.1021%2Fom50005a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, R.</span></span> <span> </span><span class="NLM_article-title">Directed Chiral Synthesis with Pinanediol Boronic Esters</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">7590</span>– <span class="NLM_lpage">7591</span>, <span class="refDoi"> DOI: 10.1021/ja00545a046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00545a046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaL3MXjtV2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=7590-7591&author=D.+S.+Mattesonauthor=R.+Ray&title=Directed+Chiral+Synthesis+with+Pinanediol+Boronic+Esters&doi=10.1021%2Fja00545a046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Directed chiral synthesis with pinanediol boronic esters</span></div><div class="casAuthors">Matteson, Donald S.; Ray, Rahul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7590-1</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Homologation of boronic esters of (+)-I with LiCHCl2 gave S-α-chloroalkaneboronic esters with high stereoselectivity.  Thus, homologation of II (R = Ph) to S-II (R = PhCHCl) which was treated with MeMgBr to give S-II (R = PhCHMe) which was oxidized to give 93.7% pure S-PhCHMeOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryK2_djJ6WQLVg90H21EOLACvtfcHk0lgJPLCWjES2yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXjtV2nsg%253D%253D&md5=e91984e6c035eeadec90335d4401426c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja00545a046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00545a046%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DRay%26aufirst%3DR.%26atitle%3DDirected%2520Chiral%2520Synthesis%2520with%2520Pinanediol%2520Boronic%2520Esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26spage%3D7590%26epage%3D7591%26doi%3D10.1021%2Fja00545a046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coste, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le-Nguyen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, B.</span></span> <span> </span><span class="NLM_article-title">PyBOP: A new peptide coupling reagent devoid of toxic by-product</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)94371-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2FS0040-4039%2800%2994371-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaK3cXkslyqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1990&pages=205-208&author=J.+Costeauthor=D.+Le-Nguyenauthor=B.+Castro&title=PyBOP%3A+A+new+peptide+coupling+reagent+devoid+of+toxic+by-product&doi=10.1016%2FS0040-4039%2800%2994371-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">PyBOP:  a new peptide coupling reagent devoid of toxic byproduct</span></div><div class="casAuthors">Coste, J.; Le-Nguyen, D.; Castro, B.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-8</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The title compd., benzotriazolyloxytris(pyrrolidine)phosphonium hexafluorophosphate (I, R = pyrrolidino), an analog of BOP (I, R = NMe2), is the only analog exhibiting equiv. properties in peptide bond formation.  It can be used instead of BOP for the sake of safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq9vtgwdipVLVg90H21EOLACvtfcHk0lgJPLCWjES2yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslyqtro%253D&md5=41bcec259d56a4a598f56cc778fa57ea</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2994371-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252994371-5%26sid%3Dliteratum%253Aachs%26aulast%3DCoste%26aufirst%3DJ.%26aulast%3DLe-Nguyen%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DB.%26atitle%3DPyBOP%253A%2520A%2520new%2520peptide%2520coupling%2520reagent%2520devoid%2520of%2520toxic%2520by-product%26jtitle%3DTetrahedron%2520Lett.%26date%3D1990%26volume%3D31%26spage%3D205%26epage%3D208%26doi%3D10.1016%2FS0040-4039%2800%2994371-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Berkel, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salimraj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Assay platform for clinically relevant metallo-beta-lactamases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6945</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1021/jm400769b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400769b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2qsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6945-6953&author=S.+S.+van%0ABerkelauthor=J.+Bremauthor=A.+M.+Rydzikauthor=R.+Salimrajauthor=R.+Cainauthor=A.+Vermaauthor=R.+J.+Owensauthor=C.+W.+Fishwickauthor=J.+Spencerauthor=C.+J.+Schofield&title=Assay+platform+for+clinically+relevant+metallo-beta-lactamases&doi=10.1021%2Fjm400769b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Assay Platform for Clinically Relevant Metallo-β-lactamases</span></div><div class="casAuthors">van Berkel, Sander S.; Brem, Jurgen; Rydzik, Anna M.; Salimraj, Ramya; Cain, Ricky; Verma, Anil; Owens, Raymond J.; Fishwick, Colin W. G.; Spencer, James; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6945-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metallo-β-lactamases (MBLs) are a growing threat to the use of almost all clin. used β-lactam antibiotics.  The identification of broad-spectrum MBL inhibitors is hampered by the lack of a suitable screening platform, consisting of appropriate substrates and a set of clin. relevant MBLs.  We report procedures for the prepn. of a set of clin. relevant metallo-β-lactamases (i.e., NDM-1 (New Delhi MBL), IMP-1 (Imipenemase), SPM-1 (Sao Paulo MBL), and VIM-2 (Verona integron-encoded MBL)) and the identification of suitable fluorogenic substrates (umbelliferone-derived cephalosporins).  The fluorogenic substrates were compared to chromogenic substrates (CENTA, nitrocefin, and imipenem), showing improved sensitivity and kinetic parameters.  The efficiency of the fluorogenic substrates was exemplified by inhibitor screening, identifying 4-chloroisoquinolinols as potential pan MBL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeR_KCHkVUErVg90H21EOLACvtfcHk0lgJPLCWjES2yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2qsL3M&md5=033f9dbfc850699c9c319a4db0d2046d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm400769b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400769b%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBerkel%26aufirst%3DS.%2BS.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DSalimraj%26aufirst%3DR.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DOwens%26aufirst%3DR.%2BJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DAssay%2520platform%2520for%2520clinically%2520relevant%2520metallo-beta-lactamases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6945%26epage%3D6953%26doi%3D10.1021%2Fjm400769b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamrick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatwin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurepina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiswirth, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clancy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pevear, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xerri, L.</span></span> <span> </span><span class="NLM_article-title">1370. Cefepime/VNRX-5133 Broad-Spectrum Activity Is Maintained Against Emerging KPC- and PDC-Variants in Multidrug-Resistant <i>K. pneumoniae</i> and <i>P. aeruginosa</i></span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S419</span>– <span class="NLM_lpage">S420</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fofid%2Fofy210.1201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S419-S420&author=D.+Daigleauthor=J.+Hamrickauthor=C.+Chatwinauthor=N.+Kurepinaauthor=B.+N.+Kreiswirthauthor=R.+K.+Shieldsauthor=A.+Oliverauthor=C.+J.+Clancyauthor=M.-H.+Nguyenauthor=D.+Pevearauthor=L.+Xerri&title=1370.+Cefepime%2FVNRX-5133+Broad-Spectrum+Activity+Is+Maintained+Against+Emerging+KPC-+and+PDC-Variants+in+Multidrug-Resistant+K.+pneumoniae+and+P.+aeruginosa&doi=10.1093%2Fofid%2Fofy210.1201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1201%26sid%3Dliteratum%253Aachs%26aulast%3DDaigle%26aufirst%3DD.%26aulast%3DHamrick%26aufirst%3DJ.%26aulast%3DChatwin%26aufirst%3DC.%26aulast%3DKurepina%26aufirst%3DN.%26aulast%3DKreiswirth%26aufirst%3DB.%2BN.%26aulast%3DShields%26aufirst%3DR.%2BK.%26aulast%3DOliver%26aufirst%3DA.%26aulast%3DClancy%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DM.-H.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DXerri%26aufirst%3DL.%26atitle%3D1370.%2520Cefepime%252FVNRX-5133%2520Broad-Spectrum%2520Activity%2520Is%2520Maintained%2520Against%2520Emerging%2520KPC-%2520and%2520PDC-Variants%2520in%2520Multidrug-Resistant%2520K.%2520pneumoniae%2520and%2520P.%2520aeruginosa%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3DS419%26epage%3DS420%26doi%3D10.1093%2Fofid%2Fofy210.1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
den Akker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Exploring Additional Dimensions of Complexity in Inhibitor Design for Serine β-Lactamases: Mechanistic and Intra- and Inter-molecular Chemistry Approaches</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.00622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.3389%2Ffmicb.2018.00622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=29403456" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-622&author=F.+van%0Aden+Akkerauthor=R.+A.+Bonomo&title=Exploring+Additional+Dimensions+of+Complexity+in+Inhibitor+Design+for+Serine+%CE%B2-Lactamases%3A+Mechanistic+and+Intra-+and+Inter-molecular+Chemistry+Approaches&doi=10.3389%2Ffmicb.2018.00622"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.00622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.00622%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bden%2BAkker%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DExploring%2520Additional%2520Dimensions%2520of%2520Complexity%2520in%2520Inhibitor%2520Design%2520for%2520Serine%2520%25CE%25B2-Lactamases%253A%2520Mechanistic%2520and%2520Intra-%2520and%2520Inter-molecular%2520Chemistry%2520Approaches%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D1%26epage%3D622%26doi%3D10.3389%2Ffmicb.2018.00622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calvopiña, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heesom, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span> <span> </span><span class="NLM_article-title">Structural/mechanistic insights into the efficacy of nonclassical beta-lactamase inhibitors against extensively drug resistant <i>Stenotrophomonas maltophilia</i> clinical isolates</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1111/mmi.13831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1111%2Fmmi.13831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28876489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFehsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2017&pages=492-504&author=K.+Calvopi%C3%B1aauthor=P.+Hinchliffeauthor=J.+Bremauthor=K.+J.+Heesomauthor=S.+Johnsonauthor=R.+Cainauthor=C.+T.+Lohansauthor=C.+W.+G.+Fishwickauthor=C.+J.+Schofieldauthor=J.+Spencerauthor=M.+B.+Avison&title=Structural%2Fmechanistic+insights+into+the+efficacy+of+nonclassical+beta-lactamase+inhibitors+against+extensively+drug+resistant+Stenotrophomonas+maltophilia+clinical+isolates&doi=10.1111%2Fmmi.13831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates</span></div><div class="casAuthors">Calvopina, Karina; Hinchliffe, Philip; Brem, Juergen; Heesom, Kate J.; Johnson, Samar; Cain, Ricky; Lohans, Christopher T.; Fishwick, Colin W. G.; Schofield, Christopher J.; Spencer, James; Avison, Matthew B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-504</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Clavulanic acid and avibactam are clin. deployed serine β-lactamase inhibitors, important as a defense against antibacterial resistance.  Bicyclic boronates are recently discovered inhibitors of serine and some metallo β-lactamases.  Here, we show that avibactam and a bicyclic boronate inhibit L2 (serine β-lactamase) but not L1 (metallo β-lactamase) from the extensively drug resistant human pathogen Stenotrophomonas maltophilia.  X-ray crystallog. revealed that both inhibitors bind L2 by covalent attachment to the nucleophilic serine.  Both inhibitors reverse ceftazidime resistance in S. maltophilia because, unlike clavulanic acid, they do not induce L1 prodn.  Ceftazidime/inhibitor resistant mutants hyperproduce L1, but retain aztreonam/inhibitor susceptibility because aztreonam is not an L1 substrate.  Importantly, avibactam, but not the bicyclic boronate is deactivated by L1 at a low rate; the utility of avibactam might be compromised by mutations that increase this deactivation rate.  These data rationalize the obsd. clin. efficacy of ceftazidime/avibactam plus aztreonam as combination therapy for S. maltophilia infections and confirm that aztreonam-like β-lactams plus nonclassical β-lactamase inhibitors, particularly avibactam-like and bicyclic boronate compds., have potential for treating infections caused by this most intractable of drug resistant pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWDFZtxpcUELVg90H21EOLACvtfcHk0ljSq6W5cOcERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFehsL%252FP&md5=743df6eec7685626581123465d8d6079</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fmmi.13831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmmi.13831%26sid%3Dliteratum%253Aachs%26aulast%3DCalvopi%25C3%25B1a%26aufirst%3DK.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DHeesom%26aufirst%3DK.%2BJ.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26atitle%3DStructural%252Fmechanistic%2520insights%2520into%2520the%2520efficacy%2520of%2520nonclassical%2520beta-lactamase%2520inhibitors%2520against%2520extensively%2520drug%2520resistant%2520Stenotrophomonas%2520maltophilia%2520clinical%2520isolates%26jtitle%3DMol.%2520Microbiol.%26date%3D2017%26volume%3D106%26spage%3D492%26epage%3D504%26doi%3D10.1111%2Fmmi.13831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Observations on the Deprotection of Pinanediol and Pinacol Boronate Esters via Fluorinated Intermediates</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1021/jo901930v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo901930v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFKgurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=468-471&author=S.+R.+Inglisauthor=E.+C.+Y.+Woonauthor=A.+L.+Thompsonauthor=C.+J.+Schofield&title=Observations+on+the+Deprotection+of+Pinanediol+and+Pinacol+Boronate+Esters+via+Fluorinated+Intermediates&doi=10.1021%2Fjo901930v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Observations on the Deprotection of Pinanediol and Pinacol Boronate Esters via Fluorinated Intermediates</span></div><div class="casAuthors">Inglis, Steven R.; Woon, Esther C. Y.; Thompson, Amber L.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">468-471</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methods for the deprotection of pinanediol and pinacol esters of various boronic acids via fluoroborane intermediates were evaluated.  Treatment of the boronate esters with potassium hydrogen difluoride normally gives trifluoroborate salts; in the case of α-amido alkyl or o-amido Ph boronate esters, aq. workup gives difluoroboranes.  Procedures for transformation of both trifluoroborates and difluoroboranes to free boronic acids are described, involving either aq. ammonia or TMSCl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSWOgebPm18LVg90H21EOLACvtfcHk0ljSq6W5cOcERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFKgurjO&md5=4a294b48b07c81df789591989058be17</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo901930v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901930v%26sid%3Dliteratum%253Aachs%26aulast%3DInglis%26aufirst%3DS.%2BR.%26aulast%3DWoon%26aufirst%3DE.%2BC.%2BY.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DObservations%2520on%2520the%2520Deprotection%2520of%2520Pinanediol%2520and%2520Pinacol%2520Boronate%2520Esters%2520via%2520Fluorinated%2520Intermediates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D468%26epage%3D471%26doi%3D10.1021%2Fjo901930v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Q.</span></span> <span> </span><span class="NLM_article-title">Active-Site Conformational Fluctuations Promote the Enzymatic Activity of NDM-1</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">e01579</span>– <span class="NLM_lpage">e01518</span>, <span class="refDoi"> DOI: 10.1128/AAC.01579-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.01579-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=30150473" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=e01579-e01518&author=H.+Zhangauthor=G.+Maauthor=Y.+Zhuauthor=L.+Zengauthor=A.+Ahmadauthor=C.+Wangauthor=B.+Pangauthor=H.+Fangauthor=L.+Zhaoauthor=Q.+Hao&title=Active-Site+Conformational+Fluctuations+Promote+the+Enzymatic+Activity+of+NDM-1&doi=10.1128%2FAAC.01579-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FAAC.01579-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01579-18%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DPang%26aufirst%3DB.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DQ.%26atitle%3DActive-Site%2520Conformational%2520Fluctuations%2520Promote%2520the%2520Enzymatic%2520Activity%2520of%2520NDM-1%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26spage%3De01579%26epage%3De01518%26doi%3D10.1128%2FAAC.01579-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ullah, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of the L1 metallo-β-lactamase from <i>Stenotrophomonas maltophilia</i> at 1.7 å resolution11 Edited by K. Nagai</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1998.2148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1006%2Fjmbi.1998.2148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=9811546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFOqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1998&pages=125-136&author=J.+H.+Ullahauthor=T.+R.+Walshauthor=I.+A.+Taylorauthor=D.+C.+Emeryauthor=C.+S.+Vermaauthor=S.+J.+Gamblinauthor=J.+Spencer&title=The+crystal+structure+of+the+L1+metallo-%CE%B2-lactamase+from+Stenotrophomonas+maltophilia+at+1.7+%C3%A5+resolution11+Edited+by+K.+Nagai&doi=10.1006%2Fjmbi.1998.2148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 Å resolution</span></div><div class="casAuthors">Ullah, J. H.; Walsh, T. R.; Taylor, I. A.; Emery, D. C.; Verma, C. S.; Gamblin, S. J.; Spencer, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-136</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The structure of metallo-β-lactamase L1 from the opportunistic pathogen, S. maltophilia, was detd. at 1.7 Å resoln. by the multi-wavelength anomalous dispersion (MAD) approach exploiting both the intrinsic binuclear Zn center and incorporated selenomethionine residues.  L1 is unique among all known β-lactamases in that it exists as a tetramer.  The protein was found to exhibit the αβ/βα fold found only in the metallo-β-lactamases and displayed several unique features not previously obsd. in these enzymes.  These included a disulfide bridge and 2 substantially elongated loops connected to the active site of the enzyme.  Two closely spaced Zn2+ ions are bound at the active site with tetrahedral (Zn1) and trigonal bipyramidal (Zn2) coordination, resp.; these were bridged by a water mol. which it was proposed acts as the nucleophile in the hydrolytic reaction.  Ligation of the 2nd Zn2+ ion involved both residues and geometry which had not been previously obsd. in the metallo-β-lactamases.  Simulated binding of the substrates, ampicillin, ceftazidime, and imipenem, suggested that the substrate is able to bind to the enzyme in a variety of different conformations whose common features are direct interactions of the β-lactam carbonyl O and N atoms with the Zn2+ ions and of the β-lactam carboxylate with Ser-187.  Here, the authors describe a catalytic mechanism whose principal features are a nucleophilic attack of the bridging water on the β-lactam carbonyl C atom, electrostatic stabilization of a neg. charged tetrahedral transition state, and protonation of the β-lactam N atom by a 2nd water mol. coordinated by Zn2.  Further, the authors propose that direct metal-substrate interactions provide a substantial contribution to substrate binding and that this may explain the lack of specificity which is a feature of this class of enzyme.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ9BHl5xZ3bbVg90H21EOLACvtfcHk0lhca6mgk-eKAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFOqtLY%253D&md5=d4d86e30cb7f6e8cac5efd46b7d3c7a3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2148%26sid%3Dliteratum%253Aachs%26aulast%3DUllah%26aufirst%3DJ.%2BH.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DTaylor%26aufirst%3DI.%2BA.%26aulast%3DEmery%26aufirst%3DD.%2BC.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26aulast%3DSpencer%26aufirst%3DJ.%26atitle%3DThe%2520crystal%2520structure%2520of%2520the%2520L1%2520metallo-%25CE%25B2-lactamase%2520from%2520Stenotrophomonas%2520maltophilia%2520at%25201.7%2520%25C3%25A5%2520resolution11%2520Edited%2520by%2520K.%2520Nagai%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D284%26spage%3D125%26epage%3D136%26doi%3D10.1006%2Fjmbi.1998.2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yapp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aik, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristensen, J. B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, O. N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walport, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinnes, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagg, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krojer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppermann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klose, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span> <span> </span><span class="NLM_article-title">5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3110</span>– <span class="NLM_lpage">3117</span>, <span class="refDoi"> DOI: 10.1039/c3sc51122g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1039%2Fc3sc51122g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=26682036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVehs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=3110-3117&author=R.+J.+Hopkinsonauthor=A.+Tumberauthor=C.+Yappauthor=R.+Chowdhuryauthor=W.+Aikauthor=K.+H.+Cheauthor=X.+S.+Liauthor=J.+B.+L.+Kristensenauthor=O.+N.+F.+Kingauthor=M.+C.+Chanauthor=K.+K.+Yeohauthor=H.+Choiauthor=L.+J.+Walportauthor=C.+C.+Thinnesauthor=J.+T.+Bushauthor=C.+Lejeuneauthor=A.+M.+Rydzikauthor=N.+R.+Roseauthor=E.+A.+Baggauthor=M.+A.+McDonoughauthor=T.+Krojerauthor=W.+W.+Yueauthor=S.+S.+Ngauthor=L.+Olsenauthor=P.+E.+Brennanauthor=U.+Oppermannauthor=S.+Muller-Knappauthor=R.+J.+Kloseauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofieldauthor=A.+Kawamura&title=5-Carboxy-8-hydroxyquinoline+is+a+Broad+Spectrum+2-Oxoglutarate+Oxygenase+Inhibitor+which+Causes+Iron+Translocation&doi=10.1039%2Fc3sc51122g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation</span></div><div class="casAuthors">Hopkinson, Richard J.; Tumber, Anthony; Yapp, Clarence; Chowdhury, Rasheduzzaman; Aik, WeiShen; Che, Ka Hing; Li, Xuan Shirley; Kristensen, Jan B. L.; King, Oliver N. F.; Chan, Mun Chiang; Yeoh, Kar Kheng; Choi, Hwanho; Walport, Louise J.; Thinnes, Cyrille C.; Bush, Jacob T.; Lejeune, Clarisse; Rydzik, Anna M.; Rose, Nathan R.; Bagg, Eleanor A.; McDonough, Michael A.; Krojer, Tobias J.; Yue, Wyatt W.; Ng, Stanley S.; Olsen, Lars; Brennan, Paul E.; Oppermann, Udo; Mueller, Susanne; Klose, Robert J.; Ratcliffe, Peter J.; Schofield, Christopher J.; Kawamura, Akane</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3110-3117</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">2-Oxoglutarate and iron dependent oxygenases are therapeutic targets for human diseases.  Using a representative 2OG oxygenase panel, the authors compare the inhibitory activities of 5-carboxy-8-hydroxyquinoline (IOX1) and 4-carboxy-8-hydroxyquinoline (4C8HQ) with that of two other commonly used 2OG oxygenase inhibitors, N-oxalylglycine (NOG) and 2,4-pyridinedicarboxylic acid (2,4-PDCA).  IOX1 has a broad spectrum of activity, as demonstrated by the inhibition of transcription factor hydroxylases, representatives of all 2OG dependent histone demethylase subfamilies, nucleic acid demethylases and γ-butyrobetaine hydroxylase.  Cellular assays show that, unlike NOG and 2,4-PDCA, IOX1 is active against both cytosolic and nuclear 2OG oxygenases without ester derivatization.  Unexpectedly, crystallog. studies on these oxygenases demonstrate that IOX1, but not 4C8HQ, can cause translocation of the active site metal, revealing a rare example of protein ligand-induced metal movement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_NBtJvNEBOLVg90H21EOLACvtfcHk0lhca6mgk-eKAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVehs73L&md5=506fb4e75971c57a7a968f4d37805856</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc3sc51122g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc51122g%26sid%3Dliteratum%253Aachs%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DAik%26aufirst%3DW.%26aulast%3DChe%26aufirst%3DK.%2BH.%26aulast%3DLi%26aufirst%3DX.%2BS.%26aulast%3DKristensen%26aufirst%3DJ.%2BB.%2BL.%26aulast%3DKing%26aufirst%3DO.%2BN.%2BF.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DYeoh%26aufirst%3DK.%2BK.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DWalport%26aufirst%3DL.%2BJ.%26aulast%3DThinnes%26aufirst%3DC.%2BC.%26aulast%3DBush%26aufirst%3DJ.%2BT.%26aulast%3DLejeune%26aufirst%3DC.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DRose%26aufirst%3DN.%2BR.%26aulast%3DBagg%26aufirst%3DE.%2BA.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DKrojer%26aufirst%3DT.%26aulast%3DYue%26aufirst%3DW.%2BW.%26aulast%3DNg%26aufirst%3DS.%2BS.%26aulast%3DOlsen%26aufirst%3DL.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DOppermann%26aufirst%3DU.%26aulast%3DMuller-Knapp%26aufirst%3DS.%26aulast%3DKlose%26aufirst%3DR.%2BJ.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DKawamura%26aufirst%3DA.%26atitle%3D5-Carboxy-8-hydroxyquinoline%2520is%2520a%2520Broad%2520Spectrum%25202-Oxoglutarate%2520Oxygenase%2520Inhibitor%2520which%2520Causes%2520Iron%2520Translocation%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D3110%26epage%3D3117%26doi%3D10.1039%2Fc3sc51122g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tierney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, G.</span></span> <span> </span><span class="NLM_article-title">X-ray absorption spectroscopy of dinuclear metallohydrolases</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1263</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2014.07.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.bpj.2014.07.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=25229134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVaktLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2014&pages=1263-1272&author=D.+L.+Tierneyauthor=G.+Schenk&title=X-ray+absorption+spectroscopy+of+dinuclear+metallohydrolases&doi=10.1016%2Fj.bpj.2014.07.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">X-Ray Absorption Spectroscopy of Dinuclear Metallohydrolases</span></div><div class="casAuthors">Tierney, David L.; Schenk, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1263-1272</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  In this mini-review, the authors briefly discuss the phys. origin of x-ray absorption spectroscopy (XAS) before illustrating its application using dinuclear metallohydrolases as exemplary systems.  The systems the authors have selected for illustrative purposes present a challenging problem for XAS, one that is ideal to demonstrate the potential of this methodol. for structure/function studies of metalloenzymes in general.  When the metal ion is redox active, XAS provides a sensitive measure of oxidn.-state-dependent differences.  When the metal ion is zinc, XAS is the only spectroscopic method that will provide easily accessible structural information in soln.  In the case of heterodimetallic sites, XAS has the unique ability to interrogate each metal site independently in the same sample.  One of the strongest advantages of XAS is its ability to examine metal ion site structures with crystallog. precision, without the need for a crystal.  This is key for studying flexible metal ion sites, such as those described in the selected examples, because it allows one to monitor structural changes that occur during substrate turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ8NlOsjmFqbVg90H21EOLACvtfcHk0lhca6mgk-eKAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVaktLzO&md5=1d757c5c02bca7ed786a680489d5d531</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2014.07.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2014.07.066%26sid%3Dliteratum%253Aachs%26aulast%3DTierney%26aufirst%3DD.%2BL.%26aulast%3DSchenk%26aufirst%3DG.%26atitle%3DX-ray%2520absorption%2520spectroscopy%2520of%2520dinuclear%2520metallohydrolases%26jtitle%3DBiophys.%2520J.%26date%3D2014%26volume%3D107%26spage%3D1263%26epage%3D1272%26doi%3D10.1016%2Fj.bpj.2014.07.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aitha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Adbul-Wahid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tierney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowder, M. W.</span></span> <span> </span><span class="NLM_article-title">Probing substrate binding to the metal binding sites in metallo-β-lactamase L1 during catalysis</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1039/C5MD00358J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1039%2FC5MD00358J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=27087914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=194-201&author=M.+Aithaauthor=S.+Al-Adbul-Wahidauthor=D.+L.+Tierneyauthor=M.+W.+Crowder&title=Probing+substrate+binding+to+the+metal+binding+sites+in+metallo-%CE%B2-lactamase+L1+during+catalysis&doi=10.1039%2FC5MD00358J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Probing substrate binding to the metal binding sites in metallo-β-lactamase L1 during catalysis</span></div><div class="casAuthors">Aitha, Mahesh; Al-Adbul-Wahid, Sameer; Tierney, David L.; Crowder, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-201</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Metal ions in metallo-β-lactamases (MBLs) play a major role in catalysis.  In this study we investigated the role of the metal ions in the Zn1 and Zn2 sites of MBL L1 during catalysis.  A ZnCo (with Zn(II) in the invariant Zn1 site and Co(II) in the Zn2 site) analog of MBL L1 was prepd. by using a biol. incorporation method.  Extended X-ray absorption fine structure (EXAFS) spectroscopic studies were used to confirm that the ZnCo analog was prepd.  To study the roles of the Zn(II) and Co(II) ions during catalysis, rapid freeze quench (RFQ)-EXAFS studies were used to probe the reaction of the ZnCo-L1 analog with chromacef when quenched at 10 ms, 50 ms, and 100 ms.  The L1-product complex was also analyzed with EXAFS spectroscopy.  The data show that the Zn-Co distance is 3.49 Å in the resting enzyme and that this distance increases by 0.3 Å in the sample that was quenched at 10 ms.  The av. Zn-Co distance decreases at the other time points until reaching a distance of 3.58 Å in the L1-product complex.  The data also show that a Co-S interaction is present in the 100 ms quenched sample and in the L1-product complex, which suggests that there is a significant rearrangement of product in the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-9sdbFv4vt7Vg90H21EOLACvtfcHk0lgaj58rbW5_gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCrsA%253D%253D&md5=1b8ec3da5f9d539a9db8b5a2784e3963</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1039%2FC5MD00358J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00358J%26sid%3Dliteratum%253Aachs%26aulast%3DAitha%26aufirst%3DM.%26aulast%3DAl-Adbul-Wahid%26aufirst%3DS.%26aulast%3DTierney%26aufirst%3DD.%2BL.%26aulast%3DCrowder%26aufirst%3DM.%2BW.%26atitle%3DProbing%2520substrate%2520binding%2520to%2520the%2520metal%2520binding%2520sites%2520in%2520metallo-%25CE%25B2-lactamase%2520L1%2520during%2520catalysis%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26spage%3D194%26epage%3D201%26doi%3D10.1039%2FC5MD00358J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojica, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinati, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llarrull, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, A. J.</span></span> <span> </span><span class="NLM_article-title">Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=544-554&author=M.+M.+Gonzalezauthor=M.+Kosmopoulouauthor=M.+F.+Mojicaauthor=V.+Castilloauthor=P.+Hinchliffeauthor=I.+Pettinatiauthor=J.+Bremauthor=C.+J.+Schofieldauthor=G.+Mahlerauthor=R.+A.+Bonomoauthor=L.+I.+Llarrullauthor=J.+Spencerauthor=A.+J.+Vila&title=Bisthiazolidines%3A+A+Substrate-Mimicking+Scaffold+as+an+Inhibitor+of+the+NDM-1+Carbapenemase&doi=10.1021%2Facsinfecdis.5b00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase</span></div><div class="casAuthors">Gonzalez, Mariano M.; Kosmopoulou, Magda; Mojica, Maria F.; Castillo, Valerie; Hinchliffe, Philip; Pettinati, Ilaria; Brem, Jurgen; Schofield, Christopher J.; Mahler, Graciela; Bonomo, Robert A.; Llarrull, Leticia I.; Spencer, James; Vila, Alejandro J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">544-554</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pathogenic Gram-neg. bacteria resistant to almost all β-lactam antibiotics are a major public health threat.  Zn(II)-dependent or metallo-β-lactamases (MBLs) produced by these bacteria inactivate most β-lactam antibiotics, including the carbapenems, which are "last line therapies" for life-threatening Gram-neg. infections.  NDM-1 is a carbapenemase belonging to the MBL family that is rapidly spreading worldwide.  Regrettably, inhibitors of MBLs are not yet developed.  Here the authors present the bisthiazolidine (BTZ) scaffold as a structure with some features of β-lactam substrates, which can be modified with metal-binding groups to target the MBL active site.  Inspired by known interactions of MBLs with β-lactams, the authors designed four BTZs that behave as in vitro NDM-1 inhibitors with Ki values in the low micromolar range (from 7±1 to 19±3 μM).  NMR spectroscopy demonstrated that they inhibit hydrolysis of imipenem in NDM-1-producing Escherichia coli.  In vitro time kill cell-based assays against a variety of bacterial strains harboring blaNDM-1 including Acinetobacter baumannii show that the compds. restore the antibacterial activity of imipenem.  A crystal structure of the most potent heterocycle (L-CS319) in complex with NDM-1 at 1.9 Å resoln. identified both structural determinants for inhibitor binding and opportunities for further improvements in potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokg8f_hU7BV7Vg90H21EOLACvtfcHk0lgaj58rbW5_gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLbI&md5=3a13478a79bee2dddfad2137406d54a0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00046%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DM.%2BM.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DMojica%26aufirst%3DM.%2BF.%26aulast%3DCastillo%26aufirst%3DV.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DPettinati%26aufirst%3DI.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DMahler%26aufirst%3DG.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DVila%26aufirst%3DA.%2BJ.%26atitle%3DBisthiazolidines%253A%2520A%2520Substrate-Mimicking%2520Scaffold%2520as%2520an%2520Inhibitor%2520of%2520the%2520NDM-1%2520Carbapenemase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D544%26epage%3D554%26doi%3D10.1021%2Facsinfecdis.5b00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebrone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galleni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frère, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dideberg, O.</span></span> <span> </span><span class="NLM_article-title">A Metallo-β-lactamase Enzyme in Action: Crystal Structures of the Monozinc Carbapenemase CphA and its Complex with Biapenem</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.10.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.jmb.2004.10.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=15588826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A280%3ADC%252BD2cnhvVWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2005&pages=785-795&author=G.+Garauauthor=C.+Bebroneauthor=C.+Anneauthor=M.+Galleniauthor=J.-M.+Fr%C3%A8reauthor=O.+Dideberg&title=A+Metallo-%CE%B2-lactamase+Enzyme+in+Action%3A+Crystal+Structures+of+the+Monozinc+Carbapenemase+CphA+and+its+Complex+with+Biapenem&doi=10.1016%2Fj.jmb.2004.10.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem</span></div><div class="casAuthors">Garau Gianpiero; Bebrone Carine; Anne Christine; Galleni Moreno; Frere Jean-Marie; Dideberg Otto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">785-95</span>
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">One strategy developed by bacteria to resist the action of beta-lactam antibiotics is the expression of metallo-beta-lactamases.  CphA from Aeromonas hydrophila is a member of a clinically important subclass of metallo-beta-lactamases that have only one zinc ion in their active site and for which no structure is available.  The crystal structures of wild-type CphA and its N220G mutant show the structural features of the active site of this enzyme, which is modeled specifically for carbapenem hydrolysis.  The structure of CphA after reaction with a carbapenem substrate, biapenem, reveals that the enzyme traps a reaction intermediate in the active site.  These three X-ray structures have allowed us to propose how the enzyme recognizes carbapenems and suggest a mechanistic pathway for hydrolysis of the beta-lactam.  This will be relevant for the design of metallo-beta-lactamase inhibitors as well as of antibiotics that escape their hydrolytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1dmDxal0dc7BItaL1WaVAfW6udTcc2eYSo66F4sU1I7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnhvVWksA%253D%253D&md5=74925de6f500b9fbbe0c015fda324ff3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.10.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.10.070%26sid%3Dliteratum%253Aachs%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DBebrone%26aufirst%3DC.%26aulast%3DAnne%26aufirst%3DC.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DFr%25C3%25A8re%26aufirst%3DJ.-M.%26aulast%3DDideberg%26aufirst%3DO.%26atitle%3DA%2520Metallo-%25CE%25B2-lactamase%2520Enzyme%2520in%2520Action%253A%2520Crystal%2520Structures%2520of%2520the%2520Monozinc%2520Carbapenemase%2520CphA%2520and%2520its%2520Complex%2520with%2520Biapenem%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D345%26spage%3D785%26epage%3D795%26doi%3D10.1016%2Fj.jmb.2004.10.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span> <span> </span><span class="NLM_article-title">QM/MM Studies of Monozinc β-Lactamase CphA Suggest That the Crystal Structure of an Enzyme–Intermediate Complex Represents a Minor Pathway</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">17986</span>– <span class="NLM_lpage">17988</span>, <span class="refDoi"> DOI: 10.1021/ja104241g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja104241g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFaktrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=17986-17988&author=S.+Wuauthor=D.+Xuauthor=H.+Guo&title=QM%2FMM+Studies+of+Monozinc+%CE%B2-Lactamase+CphA+Suggest+That+the+Crystal+Structure+of+an+Enzyme%E2%80%93Intermediate+Complex+Represents+a+Minor+Pathway&doi=10.1021%2Fja104241g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">QM/MM Studies of Monozinc β-Lactamase CphA Suggest That the Crystal Structure of an Enzyme-Intermediate Complex Represents a Minor Pathway</span></div><div class="casAuthors">Wu, Shanshan; Xu, Dingguo; Guo, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17986-17988</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">QM/MM studies of the hydrolysis of a β-lactam antibiotic mol. (biapenem) catalyzed by a monozinc β-lactamase (CphA) have revealed the complete reaction mechanism and shown that an exptl. detd. enzyme-intermediate complex is a stable intermediate or product in a minor pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-R71w52XjPrVg90H21EOLACvtfcHk0lhu5f77BecxVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFaktrfE&md5=adcdd55e04872574168228abe60d5f4a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fja104241g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja104241g%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DH.%26atitle%3DQM%252FMM%2520Studies%2520of%2520Monozinc%2520%25CE%25B2-Lactamase%2520CphA%2520Suggest%2520That%2520the%2520Crystal%2520Structure%2520of%2520an%2520Enzyme%25E2%2580%2593Intermediate%2520Complex%2520Represents%2520a%2520Minor%2520Pathway%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D17986%26epage%3D17988%26doi%3D10.1021%2Fja104241g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vercheval, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauvois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Paolo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauvage, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matagne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frère, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galleni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerff, F.</span></span> <span> </span><span class="NLM_article-title">Three factors that modulate the activity of class D β-lactamases and interfere with the post-translational carboxylation of Lys70</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>432</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1042/BJ20101122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1042%2FBJ20101122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=21108605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOkt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2010&pages=495-506&author=L.+Verchevalauthor=C.+Bauvoisauthor=A.+di+Paoloauthor=F.+Borelauthor=J.-L.+Ferrerauthor=E.+Sauvageauthor=A.+Matagneauthor=J.-M.+Fr%C3%A8reauthor=P.+Charlierauthor=M.+Galleniauthor=F.+Kerff&title=Three+factors+that+modulate+the+activity+of+class+D+%CE%B2-lactamases+and+interfere+with+the+post-translational+carboxylation+of+Lys70&doi=10.1042%2FBJ20101122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Three factors that modulate the activity of class D β-lactamases and interfere with the post-translational carboxylation of Lys70</span></div><div class="casAuthors">Vercheval, Lionel; Bauvois, Cedric; di Paolo, Alexandre; Borel, Franck; Ferrer, Jean-Luc; Sauvage, Eric; Matagne, Andre; Frere, Jean-Marie; Charlier, Paulette; Galleni, Moreno; Kerff, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-504</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The activity of class D β-lactamases is dependent on Lys70 carboxylation in the active site.  Structural, kinetic and affinity studies show that this post-translational modification can be affected by the presence of a poor substrate such as moxalactam but also by the V117T substitution.  Val117 is a strictly conserved hydrophobic residue located in the active site.  In addn., inhibition of class D β-lactamases by chloride ions is due to a competition between the side chain carboxylate of the modified Lys70 and chloride ions.  Detn. of the individual kinetic consts. shows that the deacylation of the acyl-enzyme is the rate-limiting step for the wild-type OXA-10 β-lactamase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0FjX7OsuI7Vg90H21EOLACvtfcHk0lhu5f77BecxVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOkt73K&md5=9c771536c8e0e7f38427e7736ecfd234</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2FBJ20101122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20101122%26sid%3Dliteratum%253Aachs%26aulast%3DVercheval%26aufirst%3DL.%26aulast%3DBauvois%26aufirst%3DC.%26aulast%3Ddi%2BPaolo%26aufirst%3DA.%26aulast%3DBorel%26aufirst%3DF.%26aulast%3DFerrer%26aufirst%3DJ.-L.%26aulast%3DSauvage%26aufirst%3DE.%26aulast%3DMatagne%26aufirst%3DA.%26aulast%3DFr%25C3%25A8re%26aufirst%3DJ.-M.%26aulast%3DCharlier%26aufirst%3DP.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DKerff%26aufirst%3DF.%26atitle%3DThree%2520factors%2520that%2520modulate%2520the%2520activity%2520of%2520class%2520D%2520%25CE%25B2-lactamases%2520and%2520interfere%2520with%2520the%2520post-translational%2520carboxylation%2520of%2520Lys70%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D432%26spage%3D495%26epage%3D506%26doi%3D10.1042%2FBJ20101122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdelraouf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuhussain, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, D. P.</span></span> <span> </span><span class="NLM_article-title">1405. Efficacy of the Human-Simulated Regimen (HSR) of Cefepime (FEP)/VNRX-5133 Combination Against Serine β-Lactamase-Producing Gram-negative Bacteria in the Neutropenic Murine Thigh Infection Model</span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S432</span>– <span class="NLM_lpage">S433</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fofid%2Fofy210.1236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S432-S433&author=K.+Abdelraoufauthor=S.+A.+Abuhussainauthor=D.+P.+Nicolau&title=1405.+Efficacy+of+the+Human-Simulated+Regimen+%28HSR%29+of+Cefepime+%28FEP%29%2FVNRX-5133+Combination+Against+Serine+%CE%B2-Lactamase-Producing+Gram-negative+Bacteria+in+the+Neutropenic+Murine+Thigh+Infection+Model&doi=10.1093%2Fofid%2Fofy210.1236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1236%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelraouf%26aufirst%3DK.%26aulast%3DAbuhussain%26aufirst%3DS.%2BA.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26atitle%3D1405.%2520Efficacy%2520of%2520the%2520Human-Simulated%2520Regimen%2520%2528HSR%2529%2520of%2520Cefepime%2520%2528FEP%2529%252FVNRX-5133%2520Combination%2520Against%2520Serine%2520%25CE%25B2-Lactamase-Producing%2520Gram-negative%2520Bacteria%2520in%2520the%2520Neutropenic%2520Murine%2520Thigh%2520Infection%2520Model%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3DS432%26epage%3DS433%26doi%3D10.1093%2Fofid%2Fofy210.1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geibel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkel, T.</span></span> <span> </span><span class="NLM_article-title">1401. A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single and Repeat Doses of VNRX-5133 in Healthy Subjects</span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S431</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fofid%2Fofy210.1232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S431&author=B.+Geibelauthor=J.+Dowellauthor=D.+Dickersonauthor=T.+Henkel&title=1401.+A+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Study+of+the+Safety+and+Pharmacokinetics+of+Single+and+Repeat+Doses+of+VNRX-5133+in+Healthy+Subjects&doi=10.1093%2Fofid%2Fofy210.1232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1232%26sid%3Dliteratum%253Aachs%26aulast%3DGeibel%26aufirst%3DB.%26aulast%3DDowell%26aufirst%3DJ.%26aulast%3DDickerson%26aufirst%3DD.%26aulast%3DHenkel%26aufirst%3DT.%26atitle%3D1401.%2520A%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Study%2520of%2520the%2520Safety%2520and%2520Pharmacokinetics%2520of%2520Single%2520and%2520Repeat%2520Doses%2520of%2520VNRX-5133%2520in%2520Healthy%2520Subjects%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3DS431%26doi%3D10.1093%2Fofid%2Fofy210.1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahm, D.</span></span> <span> </span><span class="NLM_article-title">1360. Antimicrobial Activity of Cefepime in Combination with VNRX-5133 Against a Global Collection of Enterobacteriaceae Including Resistant Phenotypes</span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S416</span>– <span class="NLM_lpage">S417</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fofid%2Fofy210.1191" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S416-S417&author=M.+Hackelauthor=D.+Sahm&title=1360.+Antimicrobial+Activity+of+Cefepime+in+Combination+with+VNRX-5133+Against+a+Global+Collection+of+Enterobacteriaceae+Including+Resistant+Phenotypes&doi=10.1093%2Fofid%2Fofy210.1191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1191%26sid%3Dliteratum%253Aachs%26aulast%3DHackel%26aufirst%3DM.%26aulast%3DSahm%26aufirst%3DD.%26atitle%3D1360.%2520Antimicrobial%2520Activity%2520of%2520Cefepime%2520in%2520Combination%2520with%2520VNRX-5133%2520Against%2520a%2520Global%2520Collection%2520of%2520Enterobacteriaceae%2520Including%2520Resistant%2520Phenotypes%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3DS416%26epage%3DS417%26doi%3D10.1093%2Fofid%2Fofy210.1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Dynamic combinatorial chemistry employing boronic acids/boronate esters leads to potent oxygenase inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6672</span>– <span class="NLM_lpage">6675</span>, <span class="refDoi"> DOI: 10.1002/anie.201202000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1002%2Fanie.201202000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1WjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=6672-6675&author=M.+Demetriadesauthor=I.+K.+Leungauthor=R.+Chowdhuryauthor=M.+C.+Chanauthor=M.+A.+McDonoughauthor=K.+K.+Yeohauthor=Y.+M.+Tianauthor=T.+D.+Claridgeauthor=P.+J.+Ratcliffeauthor=E.+C.+Woonauthor=C.+J.+Schofield&title=Dynamic+combinatorial+chemistry+employing+boronic+acids%2Fboronate+esters+leads+to+potent+oxygenase+inhibitors&doi=10.1002%2Fanie.201202000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Combinatorial Chemistry Employing Boronic Acids/Boronate Esters Leads to Potent Oxygenase Inhibitors</span></div><div class="casAuthors">Demetriades, Marina; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Chan, Mun Chiang; McDonough, Michael A.; Yeoh, Kar Kheng; Tian, Ya-Min; Claridge, Timothy D. W.; Ratcliffe, Peter J.; Woon, Esther C. Y.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6672-6675, S6672/1-S6672/53</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The reversible reaction of boronic acids with alcs. to form boronate esters, coupled to protein mass spectrometry analyses, was used to discover potent oxygenase inhibitors.  This dynamic combinatorial mass spectrometry technique could potentially be applied to the identification of other protein inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0EBYJgddCLVg90H21EOLACvtfcHk0liWCw6hr55l9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1WjtL0%253D&md5=1e6b2d573dec343072822882f9cccaef</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fanie.201202000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201202000%26sid%3Dliteratum%253Aachs%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DYeoh%26aufirst%3DK.%2BK.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DWoon%26aufirst%3DE.%2BC.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DDynamic%2520combinatorial%2520chemistry%2520employing%2520boronic%2520acids%252Fboronate%2520esters%2520leads%2520to%2520potent%2520oxygenase%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D6672%26epage%3D6675%26doi%3D10.1002%2Fanie.201202000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zervosen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frere, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joris, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luxen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauvage, E.</span></span> <span> </span><span class="NLM_article-title">Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">10839</span>– <span class="NLM_lpage">10848</span>, <span class="refDoi"> DOI: 10.1021/ja200696y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja200696y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFKhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=10839-10848&author=A.+Zervosenauthor=R.+Hermanauthor=F.+Kerffauthor=A.+Hermanauthor=A.+Bouillezauthor=F.+Pratiauthor=R.+F.+Prattauthor=J.+M.+Frereauthor=B.+Jorisauthor=A.+Luxenauthor=P.+Charlierauthor=E.+Sauvage&title=Unexpected+tricovalent+binding+mode+of+boronic+acids+within+the+active+site+of+a+penicillin-binding+protein&doi=10.1021%2Fja200696y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected Tricovalent Binding Mode of Boronic Acids within the Active Site of a Penicillin-Binding Protein</span></div><div class="casAuthors">Zervosen, Astrid; Herman, Raphael; Kerff, Frederic; Herman, Alexandre; Bouillez, Andre; Prati, Fabio; Pratt, R. F.; Frere, Jean-Marie; Joris, Bernard; Luxen, Andre; Charlier, Paulette; Sauvage, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10839-10848</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Boronic acids bearing appropriate side chains are good inhibitors of serine amidohydrolases.  The boron usually adopts a tetrahedral conformation, bound to the nucleophilic serine of the active site and mimicking the transition state of the enzymic reaction.  We have solved the structures of complexes of a penicillin-binding protein (PBP), the DD-peptidase from Actinomadura sp. R39, with four amidomethylboronic acids (2,6-dimethoxybenzamidomethylboronic acid, phenylacetamidomethylboronic acid, 2-chlorobenzamidomethylboronic acid, and 2-nitrobenzamidomethylboronic acid) and the pinacol ester derived from phenylacetamidomethylboronic acid.  We found that in each case, the boron forms a tricovalent adduct with the Oγ from Ser49 and Ser298, and the terminal amine group of Lys410, three key residues involved in the catalytic mechanism of penicillin-binding proteins.  This represents the first tricovalent enzyme-inhibitor adducts obsd. by crystallog.  In two of the five R39-boronate structures, the boronic acid is found as a tricovalent adduct in two monomers of the asym. unit and as a monocovalent adduct with the active serine in the two remaining monomers of the asym. unit.  Formation of the tricovalent complex from a classical monocovalent complex may involve rotation around the Ser49 Cα-Cβ bond to place the boron in a position to interact with Ser298 and Lys410, and a twisting of the side-chain amide such that its carbonyl oxygen is able to hydrogen bond to the oxyanion hole NH of Thr413.  Biphasic kinetics were obsd. in three of the five cases, and details of the reaction between R39 and 2,6-dimethoxybenzamidomethylboronic acid were studied.  Observation of biphasic kinetics was not, however, thought to be correlated with formation of tricovalent complexes, assuming that the latter do form in soln.  On the basis of the crystallog. and kinetic results, a reaction scheme for this unexpected inhibition by boronic acids is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2ewm48mQ5fLVg90H21EOLACvtfcHk0liWCw6hr55l9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFKhsr0%253D&md5=847cbfcb9458d610240b34d01a99a261</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja200696y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja200696y%26sid%3Dliteratum%253Aachs%26aulast%3DZervosen%26aufirst%3DA.%26aulast%3DHerman%26aufirst%3DR.%26aulast%3DKerff%26aufirst%3DF.%26aulast%3DHerman%26aufirst%3DA.%26aulast%3DBouillez%26aufirst%3DA.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26aulast%3DFrere%26aufirst%3DJ.%2BM.%26aulast%3DJoris%26aufirst%3DB.%26aulast%3DLuxen%26aufirst%3DA.%26aulast%3DCharlier%26aufirst%3DP.%26aulast%3DSauvage%26aufirst%3DE.%26atitle%3DUnexpected%2520tricovalent%2520binding%2520mode%2520of%2520boronic%2520acids%2520within%2520the%2520active%2520site%2520of%2520a%2520penicillin-binding%2520protein%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D10839%26epage%3D10848%26doi%3D10.1021%2Fja200696y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wayne, P. A.</span></span> <i>Performance Standards for Antimicrobial Susceptibility Testing</i>, <span class="NLM_edition">27</span>th ed.; <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+A.+Wayne&title=Performance+Standards+for+Antimicrobial+Susceptibility+Testing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWayne%26aufirst%3DP.%2BA.%26btitle%3DPerformance%2520Standards%2520for%2520Antimicrobial%2520Susceptibility%2520Testing%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of New Delhi metallo-beta-lactamase reveals molecular basis for antibiotic resistance</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1484</span>– <span class="NLM_lpage">1491</span>, <span class="refDoi"> DOI: 10.1002/pro.697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1002%2Fpro.697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=21774017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaksL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1484-1491&author=D.+Kingauthor=N.+Strynadka&title=Crystal+structure+of+New+Delhi+metallo-beta-lactamase+reveals+molecular+basis+for+antibiotic+resistance&doi=10.1002%2Fpro.697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance</span></div><div class="casAuthors">King, Dustin; Strynadka, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1484-1491</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">β-Lactams are the most commonly prescribed class of antibiotics and have had an enormous impact on human health.  Thus, it is disquieting that New Delhi metallo-β-lactamase-1 (NDM-1) can confer Enterobacteriaceae with nearly complete resistance to all β-lactam antibiotics including carbapenams.  Here, the authors detd. the crystal structure of Klebsiella pneumoniae apo-NDM-1 to 2.1-Å resoln.  From the structure, it was revealed that NDM-1 had an expansive active site with a unique electrostatic profile, which the authors propose leads to a broader substrate specificity.  In addn., NDM-1 underwent important conformational changes upon substrate binding.  These changes have not been previously obsd. in metallo-β-lactamases and may have a direct influence on substrate recognition and catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrajfR8I0jnVbVg90H21EOLACvtfcHk0liWCw6hr55l9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaksL3O&md5=0f82182108d813855421d7a651095c8a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fpro.697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.697%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DD.%26aulast%3DStrynadka%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520New%2520Delhi%2520metallo-beta-lactamase%2520reveals%2520molecular%2520basis%2520for%2520antibiotic%2520resistance%26jtitle%3DProtein%2520Sci.%26date%3D2011%26volume%3D20%26spage%3D1484%26epage%3D1491%26doi%3D10.1002%2Fpro.697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span> <span> </span><span class="NLM_article-title">PHENIX: building new software for automated crystallographic structure determination</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1954</span>, <span class="refDoi"> DOI: 10.1107/S0907444902016657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1107%2FS0907444902016657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=12393927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1948-1954&author=P.+D.+Adamsauthor=R.+W.+Grosse-Kunstleveauthor=L.-W.+Hungauthor=T.+R.+Ioergerauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+J.+Readauthor=J.+C.+Sacchettiniauthor=N.+K.+Sauterauthor=T.+C.+Terwilliger&title=PHENIX%3A+building+new+software+for+automated+crystallographic+structure+determination&doi=10.1107%2FS0907444902016657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: building new software for automated crystallographic structure determination</span></div><div class="casAuthors">Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li Wei; Ioerger, Thomas R.; McCoy, Airlie J.; Moriarty, Nigel W.; Read, Randy J.; Sacchettini, James C.; Sauter, Nicholas K.; Terwilliger, Thomas C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">D58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1954</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">Structural genomics seeks to rapidly expand the no. of protein structures to ext. the max. amt. of information from genomic sequence databases.  The advent of several large-scale projects worldwide leads to many new challenges in the field of crystallog. macromol. structure detn.  A novel software package, called PHENIX (Python-based Hierarchical Environment for Integrated Xtallog.), is therefore being developed.  This new software will provide the necessary algorithms to proceed from reduced intensity data to a refined mol. model and to facilitate structure soln. for both the novice and expert crystallographer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtuUfHXPmCbVg90H21EOLACvtfcHk0lgbUkcXK8gOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D&md5=9a3b66e1f7d064183f7a9ce108cb4e5e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1107%2FS0907444902016657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444902016657%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26atitle%3DPHENIX%253A%2520building%2520new%2520software%2520for%2520automated%2520crystallographic%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2002%26volume%3D58%26spage%3D1948%26epage%3D1954%26doi%3D10.1107%2FS0907444902016657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgbUkcXK8gOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 62 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Guillermo Bahr, Lisandro J. González, <span class="NLM_string-name hlFld-ContribAuthor">Alejandro J. Vila</span>. </span><span class="cited-content_cbyCitation_article-title">Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (13)
                                     , 7957-8094. <a href="https://doi.org/10.1021/acs.chemrev.1c00138" title="DOI URL">https://doi.org/10.1021/acs.chemrev.1c00138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.1c00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.1c00138%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DMetallo-%2525CE%2525B2-lactamases%252Bin%252Bthe%252BAge%252Bof%252BMultidrug%252BResistance%25253A%252BFrom%252BStructure%252Band%252BMechanism%252Bto%252BEvolution%25252C%252BDissemination%25252C%252Band%252BInhibitor%252BDesign%26aulast%3DBahr%26aufirst%3DGuillermo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D15062021%26volume%3D121%26issue%3D13%26spage%3D7957%26epage%3D8094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alistair J. M. Farley, Yuri Ermolovich, Karina Calvopiña, Patrick Rabe, Tharindi Panduwawala, Jürgen Brem, Fredrik Björkling, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. Schofield</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Metallo-β-lactamase Inhibition by N-Sulfamoylpyrrole-2-carboxylates. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , 1809-1817. <a href="https://doi.org/10.1021/acsinfecdis.1c00104" title="DOI URL">https://doi.org/10.1021/acsinfecdis.1c00104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.1c00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.1c00104%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DStructural%252BBasis%252Bof%252BMetallo-%2525CE%2525B2-lactamase%252BInhibition%252Bby%252BN-Sulfamoylpyrrole-2-carboxylates%26aulast%3DFarley%26aufirst%3DAlistair%2BJ.%2BM.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D26022021%26date%3D18052021%26volume%3D7%26issue%3D6%26spage%3D1809%26epage%3D1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya, David C. Griffith, Debora Rubio-Aparicio, Kirk Nelson, Ruslan Tsivkovski, Dongxu Sun, Mojgan Sabet, Ziad Tarazi, Jonathan Parkinson, Maxim Totrov, Serge H. Boyer, Tomasz W. Glinka, Orville A. Pemberton, Yu Chen, <span class="NLM_string-name hlFld-ContribAuthor">Michael N. Dudley</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7491-7507. <a href="https://doi.org/10.1021/acs.jmedchem.9b01976" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01976%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BCyclic%252BBoronic%252BAcid%252BQPX7728%25252C%252Ban%252BUltrabroad-Spectrum%252BInhibitor%252Bof%252BSerine%252Band%252BMetallo-%2525CE%2525B2-lactamases%26aulast%3DHecker%26aufirst%3DScott%2BJ.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D27112019%26date%3D02042020%26date%3D09032020%26volume%3D63%26issue%3D14%26spage%3D7491%26epage%3D7507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anete Parkova, Anka Lucic, Alen Krajnc, Jürgen Brem, Karina Calvopiña, Gareth W. Langley, Michael A. McDonough, Peteris Trapencieris, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. Schofield</span>. </span><span class="cited-content_cbyCitation_article-title">Broad Spectrum β-Lactamase Inhibition by a Thioether Substituted Bicyclic Boronate. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (6)
                                     , 1398-1404. <a href="https://doi.org/10.1021/acsinfecdis.9b00330" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00330%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DBroad%252BSpectrum%252B%2525CE%2525B2-Lactamase%252BInhibition%252Bby%252Ba%252BThioether%252BSubstituted%252BBicyclic%252BBoronate%26aulast%3DParkova%26aufirst%3DAnete%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D30082019%26date%3D06012020%26date%3D16122019%26volume%3D6%26issue%3D6%26spage%3D1398%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kamaleddin H. M. E. Tehrani, Nora C. Brüchle, Nicola Wade, Vida Mashayekhi, Diego Pesce, Matthijs J. van Haren, <span class="NLM_string-name hlFld-ContribAuthor">Nathaniel I. Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (6)
                                     , 1366-1371. <a href="https://doi.org/10.1021/acsinfecdis.9b00459" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00459%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DSmall%252BMolecule%252BCarboxylates%252BInhibit%252BMetallo-%2525CE%2525B2-lactamases%252Band%252BResensitize%252BCarbapenem-Resistant%252BBacteria%252Bto%252BMeropenem%26aulast%3DTehrani%26aufirst%3DKamaleddin%2BH.%2BM.%2BE.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D25112019%26date%3D03042020%26date%3D31032020%26volume%3D6%26issue%3D6%26spage%3D1366%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Abigail C. Jackson, Jacqueline M. Zaengle-Barone, Elena A. Puccio, <span class="NLM_string-name hlFld-ContribAuthor">Katherine J. Franz</span>. </span><span class="cited-content_cbyCitation_article-title">A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (5)
                                     , 1264-1272. <a href="https://doi.org/10.1021/acsinfecdis.0c00083" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00083%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DA%252BCephalosporin%252BProchelator%252BInhibits%252BNew%252BDelhi%252BMetallo-%2525CE%2525B2-lactamase%252B1%252Bwithout%252BRemoving%252BZinc%26aulast%3DJackson%26aufirst%3DAbigail%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19022020%26date%3D29042020%26date%3D16042020%26volume%3D6%26issue%3D5%26spage%3D1264%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bin Liu, Robert E. Lee Trout, Guo-Hua Chu, Daniel McGarry, Randy W. Jackson, Jodie C. Hamrick, Denis M. Daigle, Susan M. Cusick, Cecilia Pozzi, Filomena De Luca, Manuela Benvenuti, Stefano Mangani, Jean-Denis Docquier, William J. Weiss, Daniel C. Pevear, Luigi Xerri, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. Burns</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2789-2801. <a href="https://doi.org/10.1021/acs.jmedchem.9b01518" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01518%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BTaniborbactam%252B%252528VNRX-5133%252529%25253A%252BA%252BBroad-Spectrum%252BSerine-%252Band%252BMetallo-%2525CE%2525B2-lactamase%252BInhibitor%252Bfor%252BCarbapenem-Resistant%252BBacterial%252BInfections%26aulast%3DLiu%26aufirst%3DBin%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D12092019%26date%3D16122019%26date%3D25112019%26volume%3D63%26issue%3D6%26spage%3D2789%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Concepción González-Bello, Diana Rodríguez, Marina Pernas, Ángela Rodríguez, <span class="NLM_string-name hlFld-ContribAuthor">Esther Colchón</span>. </span><span class="cited-content_cbyCitation_article-title">β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1859-1881. <a href="https://doi.org/10.1021/acs.jmedchem.9b01279" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01279%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Lactamase%252BInhibitors%252BTo%252BRestore%252Bthe%252BEfficacy%252Bof%252BAntibiotics%252Bagainst%252BSuperbugs%26aulast%3DGonz%25C3%25A1lez-Bello%26aufirst%3DConcepci%25C3%25B3n%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D05082019%26date%3D13112019%26date%3D30102019%26volume%3D63%26issue%3D5%26spage%3D1859%26epage%3D1881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Kaiju  Xu</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Rongsheng  Tong</span>, <span class="hlFld-ContribAuthor ">Liang  Xiong</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent research and development of NDM-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113667. <a href="https://doi.org/10.1016/j.ejmech.2021.113667" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113667%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bresearch%252Band%252Bdevelopment%252Bof%252BNDM-1%252Binhibitors%26aulast%3DWang%26aufirst%3DTing%26date%3D2021%26volume%3D223%26spage%3D113667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangfang  Chen</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Bai</span>, <span class="hlFld-ContribAuthor ">Wentian  Liu</span>, <span class="hlFld-ContribAuthor ">Hongtao  Kong</span>, <span class="hlFld-ContribAuthor ">Tingting  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Yao</span>, <span class="hlFld-ContribAuthor ">En  Zhang</span>, <span class="hlFld-ContribAuthor ">Juan  Du</span>, <span class="hlFld-ContribAuthor ">Shangshang  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">H2dpa derivatives containing pentadentate ligands: An acyclic adjuvant potentiates meropenem activity in vitro and in vivo against metallo-β-lactamase-producing Enterobacterales. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113702. <a href="https://doi.org/10.1016/j.ejmech.2021.113702" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113702%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DH2dpa%252Bderivatives%252Bcontaining%252Bpentadentate%252Bligands%25253A%252BAn%252Bacyclic%252Badjuvant%252Bpotentiates%252Bmeropenem%252Bactivity%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bagainst%252Bmetallo-%2525CE%2525B2-lactamase-producing%252BEnterobacterales%26aulast%3DChen%26aufirst%3DFangfang%26date%3D2021%26volume%3D224%26spage%3D113702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Gao</span>, <span class="hlFld-ContribAuthor ">Jia-Qi  Li</span>, <span class="hlFld-ContribAuthor ">Peng-Wei  Kang</span>, <span class="hlFld-ContribAuthor ">Jia-Zhu  Chigan</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Lu  Liu</span>, <span class="hlFld-ContribAuthor ">Yin-Sui  Xu</span>, <span class="hlFld-ContribAuthor ">Le  Zhai</span>, <span class="hlFld-ContribAuthor ">Ke-Wu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-β-lactamase-1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105138. <a href="https://doi.org/10.1016/j.bioorg.2021.105138" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105138%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DN-acylhydrazones%252Bconfer%252Binhibitory%252Befficacy%252Bagainst%252BNew%252BDelhi%252Bmetallo-%2525CE%2525B2-lactamase-1%26aulast%3DGao%26aufirst%3DHan%26date%3D2021%26volume%3D114%26spage%3D105138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilio  Lence</span>, <span class="hlFld-ContribAuthor ">Concepción  González-Bello</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Basis of Bicyclic Boronate β-Lactamase Inhibitors of Ultrabroad Efficacy – Insights From Molecular Dynamics Simulation Studies. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fmicb.2021.721826" title="DOI URL">https://doi.org/10.3389/fmicb.2021.721826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2021.721826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2021.721826%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DMolecular%252BBasis%252Bof%252BBicyclic%252BBoronate%252B%2525CE%2525B2-Lactamase%252BInhibitors%252Bof%252BUltrabroad%252BEfficacy%252B%2525E2%252580%252593%252BInsights%252BFrom%252BMolecular%252BDynamics%252BSimulation%252BStudies%26aulast%3DLence%26aufirst%3DEmilio%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Gavara</span>, <span class="hlFld-ContribAuthor ">Alice  Legru</span>, <span class="hlFld-ContribAuthor ">Federica  Verdirosa</span>, <span class="hlFld-ContribAuthor ">Laurent  Sevaille</span>, <span class="hlFld-ContribAuthor ">Lionel  Nauton</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Corsica</span>, <span class="hlFld-ContribAuthor ">Paola Sandra  Mercuri</span>, <span class="hlFld-ContribAuthor ">Filomena  Sannio</span>, <span class="hlFld-ContribAuthor ">Georges  Feller</span>, <span class="hlFld-ContribAuthor ">Rémi  Coulon</span>, <span class="hlFld-ContribAuthor ">Filomena  De Luca</span>, <span class="hlFld-ContribAuthor ">Giulia  Cerboni</span>, <span class="hlFld-ContribAuthor ">Silvia  Tanfoni</span>, <span class="hlFld-ContribAuthor ">Giulia  Chelini</span>, <span class="hlFld-ContribAuthor ">Moreno  Galleni</span>, <span class="hlFld-ContribAuthor ">Jean-Denis  Docquier</span>, <span class="hlFld-ContribAuthor ">Jean-François  Hernandez</span>. </span><span class="cited-content_cbyCitation_article-title">4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 105024. <a href="https://doi.org/10.1016/j.bioorg.2021.105024" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D4-Alkyl-1%25252C2%25252C4-triazole-3-thione%252Banalogues%252Bas%252Bmetallo-%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DGavara%26aufirst%3DLaurent%26date%3D2021%26volume%3D113%26spage%3D105024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugénie  Romero</span>, <span class="hlFld-ContribAuthor ">Saoussen  Oueslati</span>, <span class="hlFld-ContribAuthor ">Mohamed  Benchekroun</span>, <span class="hlFld-ContribAuthor ">Agathe C.A.  D’Hollander</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ventre</span>, <span class="hlFld-ContribAuthor ">Kamsana  Vijayakumar</span>, <span class="hlFld-ContribAuthor ">Corinne  Minard</span>, <span class="hlFld-ContribAuthor ">Cynthia  Exilie</span>, <span class="hlFld-ContribAuthor ">Linda  Tlili</span>, <span class="hlFld-ContribAuthor ">Pascal  Retailleau</span>, <span class="hlFld-ContribAuthor ">Agustin  Zavala</span>, <span class="hlFld-ContribAuthor ">Eddy  Elisée</span>, <span class="hlFld-ContribAuthor ">Edithe  Selwa</span>, <span class="hlFld-ContribAuthor ">Laetitia A.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Alain  Pruvost</span>, <span class="hlFld-ContribAuthor ">Thierry  Naas</span>, <span class="hlFld-ContribAuthor ">Bogdan I.  Iorga</span>, <span class="hlFld-ContribAuthor ">Robert H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Kevin  Cariou</span>. </span><span class="cited-content_cbyCitation_article-title">Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113418. <a href="https://doi.org/10.1016/j.ejmech.2021.113418" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113418%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAzetidinimines%252Bas%252Ba%252Bnovel%252Bseries%252Bof%252Bnon-covalent%252Bbroad-spectrum%252Binhibitors%252Bof%252B%2525CE%2525B2-lactamases%252Bwith%252Bsubmicromolar%252Bactivities%252Bagainst%252Bcarbapenemases%252BKPC-2%252B%252528class%252BA%252529%25252C%252BNDM-1%252B%252528class%252BB%252529%252Band%252BOXA-48%252B%252528class%252BD%252529%26aulast%3DRomero%26aufirst%3DEug%25C3%25A9nie%26date%3D2021%26volume%3D219%26spage%3D113418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wieslaw  Swietnicki</span>, <span class="hlFld-ContribAuthor ">Waldemar  Goldeman</span>, <span class="hlFld-ContribAuthor ">Mateusz  Psurski</span>, <span class="hlFld-ContribAuthor ">Anna  Nasulewicz-Goldeman</span>, <span class="hlFld-ContribAuthor ">Anna  Boguszewska-Czubara</span>, <span class="hlFld-ContribAuthor ">Marek  Drab</span>, <span class="hlFld-ContribAuthor ">Jordan  Sycz</span>, <span class="hlFld-ContribAuthor ">Tomasz M.  Goszczyński</span>. </span><span class="cited-content_cbyCitation_article-title">Metallacarborane Derivatives Effective against Pseudomonas aeruginosa and Yersinia enterocolitica. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (13)
                                     , 6762. <a href="https://doi.org/10.3390/ijms22136762" title="DOI URL">https://doi.org/10.3390/ijms22136762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22136762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22136762%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMetallacarborane%252BDerivatives%252BEffective%252Bagainst%252BPseudomonas%252Baeruginosa%252Band%252BYersinia%252Benterocolitica%26aulast%3DSwietnicki%26aufirst%3DWieslaw%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D13%26spage%3D6762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giacomo  Luci</span>, <span class="hlFld-ContribAuthor ">Francesca  Mattioli</span>, <span class="hlFld-ContribAuthor ">Marco  Falcone</span>, <span class="hlFld-ContribAuthor ">Antonello  Di Paolo</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2021,</strong> <em>10 </em>
                                    (7)
                                     , 769. <a href="https://doi.org/10.3390/antibiotics10070769" title="DOI URL">https://doi.org/10.3390/antibiotics10070769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics10070769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics10070769%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3DPharmacokinetics%252Bof%252BNon-%2525CE%2525B2-Lactam%252B%2525CE%2525B2-Lactamase%252BInhibitors%26aulast%3DLuci%26aufirst%3DGiacomo%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D7%26spage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen  Tompkins</span>, <span class="hlFld-ContribAuthor ">David  van Duin</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Clinical Microbiology & Infectious Diseases</span><span> <strong>2021,</strong> <em>55 </em><a href="https://doi.org/10.1007/s10096-021-04296-1" title="DOI URL">https://doi.org/10.1007/s10096-021-04296-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10096-021-04296-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10096-021-04296-1%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Clinical%2520Microbiology%2520%2526%2520Infectious%2520Diseases%26atitle%3DTreatment%252Bfor%252Bcarbapenem-resistant%252BEnterobacterales%252Binfections%25253A%252Brecent%252Badvances%252Band%252Bfuture%252Bdirections%26aulast%3DTompkins%26aufirst%3DKathleen%26date%3D2021%26date%3D2021%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viivi H. A.  Hirvonen</span>, <span class="hlFld-ContribAuthor ">James  Spencer</span>, <span class="hlFld-ContribAuthor ">Marc W.  van der Kamp</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial Resistance Conferred by OXA-48 β-Lactamases: Towards a Detailed Mechanistic Understanding. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2021,</strong> <em>65 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.00184-21" title="DOI URL">https://doi.org/10.1128/AAC.00184-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00184-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00184-21%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DAntimicrobial%252BResistance%252BConferred%252Bby%252BOXA-48%252B%2525CE%2525B2-Lactamases%25253A%252BTowards%252Ba%252BDetailed%252BMechanistic%252BUnderstanding%26aulast%3DHirvonen%26aufirst%3DViivi%2BH.%2BA.%26date%3D2021%26volume%3D65%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Estevez-Fregoso</span>, <span class="hlFld-ContribAuthor ">Eunice D.  Farfán-García</span>, <span class="hlFld-ContribAuthor ">Itzel H.  García-Coronel</span>, <span class="hlFld-ContribAuthor ">Erick  Martínez-Herrera</span>, <span class="hlFld-ContribAuthor ">Alberto  Alatorre</span>, <span class="hlFld-ContribAuthor ">Romulus I.  Scorei</span>, <span class="hlFld-ContribAuthor ">Marvin A.  Soriano-Ursúa</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of boron-containing compounds in the fungal kingdom. </span><span class="cited-content_cbyCitation_journal-name">Journal of Trace Elements in Medicine and Biology</span><span> <strong>2021,</strong> <em>65 </em>, 126714. <a href="https://doi.org/10.1016/j.jtemb.2021.126714" title="DOI URL">https://doi.org/10.1016/j.jtemb.2021.126714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtemb.2021.126714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtemb.2021.126714%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Trace%2520Elements%2520in%2520Medicine%2520and%2520Biology%26atitle%3DEffects%252Bof%252Bboron-containing%252Bcompounds%252Bin%252Bthe%252Bfungal%252Bkingdom%26aulast%3DEstevez-Fregoso%26aufirst%3DElizabeth%26date%3D2021%26volume%3D65%26spage%3D126714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henni-Karoliina  Ropponen</span>, <span class="hlFld-ContribAuthor ">Robert  Richter</span>, <span class="hlFld-ContribAuthor ">Anna K.H.  Hirsch</span>, <span class="hlFld-ContribAuthor ">Claus-Michael  Lehr</span>. </span><span class="cited-content_cbyCitation_article-title">Mastering the Gram-negative bacterial barrier – Chemical approaches to increase bacterial bioavailability of antibiotics. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2021,</strong> <em>172 </em>, 339-360. <a href="https://doi.org/10.1016/j.addr.2021.02.014" title="DOI URL">https://doi.org/10.1016/j.addr.2021.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2021.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2021.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DMastering%252Bthe%252BGram-negative%252Bbacterial%252Bbarrier%252B%2525E2%252580%252593%252BChemical%252Bapproaches%252Bto%252Bincrease%252Bbacterial%252Bbioavailability%252Bof%252Bantibiotics%26aulast%3DRopponen%26aufirst%3DHenni-Karoliina%26date%3D2021%26volume%3D172%26spage%3D339%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilio  Lence</span>, <span class="hlFld-ContribAuthor ">Concepción  González‐Bello</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic Boronate β‐Lactamase Inhibitors: The Present Hope against Deadly Bacterial Pathogens. </span><span class="cited-content_cbyCitation_journal-name">Advanced Therapeutics</span><span> <strong>2021,</strong> <em>4 </em>
                                    (5)
                                     , 2000246. <a href="https://doi.org/10.1002/adtp.202000246" title="DOI URL">https://doi.org/10.1002/adtp.202000246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adtp.202000246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadtp.202000246%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Therapeutics%26atitle%3DBicyclic%252BBoronate%252B%2525CE%2525B2%2525E2%252580%252590Lactamase%252BInhibitors%25253A%252BThe%252BPresent%252BHope%252Bagainst%252BDeadly%252BBacterial%252BPathogens%26aulast%3DLence%26aufirst%3DEmilio%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D5%26spage%3D2000246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastian A.  Testero</span>, <span class="hlFld-ContribAuthor ">Leticia I.  Llarrull</span>, <span class="hlFld-ContribAuthor ">Jed F.  Fisher</span>, <span class="hlFld-ContribAuthor ">Shahriar  Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of β‐Lactam Antibiotics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-188. <a href="https://doi.org/10.1002/0471266949.bmc226.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc226.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc226.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc226.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252Bof%252B%2525CE%2525B2%2525E2%252580%252590Lactam%252BAntibiotics%26aulast%3DTestero%26aufirst%3DSebastian%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D188%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna N.  Tevyashova</span>, <span class="hlFld-ContribAuthor ">Mikhail V.  Chudinov</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the medicinal chemistry of organoboron compounds. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2021,</strong> <em>90 </em>
                                    (4)
                                     , 451-487. <a href="https://doi.org/10.1070/RCR4977" title="DOI URL">https://doi.org/10.1070/RCR4977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4977%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DProgress%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Borganoboron%252Bcompounds%26aulast%3DTevyashova%26aufirst%3DAnna%2BN.%26date%3D2021%26volume%3D90%26issue%3D4%26spage%3D451%26epage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qidi  Kong</span>, <span class="hlFld-ContribAuthor ">Yushe  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>35 </em>, 127799. <a href="https://doi.org/10.1016/j.bmcl.2021.127799" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127799%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Badvances%252Bin%252Bantibacterial%252Bagents%26aulast%3DKong%26aufirst%3DQidi%26date%3D2021%26volume%3D35%26spage%3D127799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shu  Song</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in the medicinal chemistry of single boron atom-containing compounds. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>73 </em><a href="https://doi.org/10.1016/j.apsb.2021.01.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DRecent%252Bdevelopments%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bsingle%252Bboron%252Batom-containing%252Bcompounds%26aulast%3DSong%26aufirst%3DShu%26date%3D2021%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F.  de Sousa Coelho</span>, <span class="hlFld-ContribAuthor ">J.-L.  Mainardi</span>. </span><span class="cited-content_cbyCitation_article-title">The multiple benefits of second-generation β-lactamase inhibitors in treatment of multidrug-resistant bacteria. </span><span class="cited-content_cbyCitation_journal-name">Infectious Diseases Now</span><span> <strong>2021,</strong> <em>32 </em><a href="https://doi.org/10.1016/j.idnow.2020.11.007" title="DOI URL">https://doi.org/10.1016/j.idnow.2020.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.idnow.2020.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.idnow.2020.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DInfectious%2520Diseases%2520Now%26atitle%3DThe%252Bmultiple%252Bbenefits%252Bof%252Bsecond-generation%252B%2525CE%2525B2-lactamase%252Binhibitors%252Bin%252Btreatment%252Bof%252Bmultidrug-resistant%252Bbacteria%26aulast%3Dde%2BSousa%2BCoelho%26aufirst%3DF.%26date%3D2021%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Piccirilli</span>, <span class="hlFld-ContribAuthor ">Bernardetta  Segatore</span>, <span class="hlFld-ContribAuthor ">Fabrizia  Brisdelli</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Amicosante</span>, <span class="hlFld-ContribAuthor ">Mariagrazia  Perilli</span>. </span><span class="cited-content_cbyCitation_article-title">Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Antimicrobial Agents</span><span> <strong>2021,</strong> <em>57 </em>
                                    (1)
                                     , 106228. <a href="https://doi.org/10.1016/j.ijantimicag.2020.106228" title="DOI URL">https://doi.org/10.1016/j.ijantimicag.2020.106228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijantimicag.2020.106228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijantimicag.2020.106228%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Antimicrobial%2520Agents%26atitle%3DPotent%252Binhibitory%252Bactivity%252Bof%252Btaniborbactam%252Btowards%252BNDM-1%252Band%252BNDM-1Q119X%252Bmutants%25252C%252Band%252Bin%252Bvitro%252Bactivity%252Bof%252Bcefepime%25252Ftaniborbactam%252Bagainst%252BMBLs%252Bproducing%252BEnterobacterales%26aulast%3DPiccirilli%26aufirst%3DAlessandra%26date%3D2021%26volume%3D57%26issue%3D1%26spage%3D106228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Boron and covalent inhibition. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 135-201. <a href="https://doi.org/10.1016/bs.armc.2020.10.002" title="DOI URL">https://doi.org/10.1016/bs.armc.2020.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2020.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2020.10.002%26sid%3Dliteratum%253Aachs%26atitle%3DBoron%252Band%252Bcovalent%252Binhibition%26aulast%3DLeach%26aufirst%3DAndrew%2BG.%26date%3D2021%26spage%3D135%26epage%3D201%26pub%3DElsevier%26atitle%3DThe%252BDesign%252Bof%252BCovalent-Based%252BInhibitors%26date%3D2021%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Montserrat  Mora-Ochomogo</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Lohans</span>. </span><span class="cited-content_cbyCitation_article-title">β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>6 </em><a href="https://doi.org/10.1039/D1MD00200G" title="DOI URL">https://doi.org/10.1039/D1MD00200G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00200G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00200G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Lactam%252Bantibiotic%252Btargets%252Band%252Bresistance%252Bmechanisms%25253A%252Bfrom%252Bcovalent%252Binhibitors%252Bto%252Bsubstrates%26aulast%3DMora-Ochomogo%26aufirst%3DMontserrat%26date%3D2021%26date%3D2021%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marwa M.  Shaaban</span>, <span class="hlFld-ContribAuthor ">Hanan M.  Ragab</span>, <span class="hlFld-ContribAuthor ">Kenichi  Akaji</span>, <span class="hlFld-ContribAuthor ">Ross P.  McGeary</span>, <span class="hlFld-ContribAuthor ">Alaa-Eldin A.  Bekhit</span>, <span class="hlFld-ContribAuthor ">Waleed M.  Hussein</span>, <span class="hlFld-ContribAuthor ">Julia L.  Kurz</span>, <span class="hlFld-ContribAuthor ">Bassma H.  Elwakil</span>, <span class="hlFld-ContribAuthor ">Salma A.  Bekhit</span>, <span class="hlFld-ContribAuthor ">Tamer M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Mona A.  Mahran</span>, <span class="hlFld-ContribAuthor ">Adnan A.  Bekhit</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104386. <a href="https://doi.org/10.1016/j.bioorg.2020.104386" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104386%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bin%252Bsilico%252Bstudies%252Bof%252Bcertain%252Baryl%252Bsulfonyl%252Bhydrazones%252Bconjugated%252Bwith%252B1%25252C3-diaryl%252Bpyrazoles%252Bas%252Bpotent%252Bmetallo-%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DShaaban%26aufirst%3DMarwa%2BM.%26date%3D2020%26volume%3D105%26spage%3D104386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan C.  Vázquez-Ucha</span>, <span class="hlFld-ContribAuthor ">Jorge  Arca-Suárez</span>, <span class="hlFld-ContribAuthor ">Germán  Bou</span>, <span class="hlFld-ContribAuthor ">Alejandro  Beceiro</span>. </span><span class="cited-content_cbyCitation_article-title">New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 9308. <a href="https://doi.org/10.3390/ijms21239308" title="DOI URL">https://doi.org/10.3390/ijms21239308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21239308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21239308%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNew%252BCarbapenemase%252BInhibitors%25253A%252BClearing%252Bthe%252BWay%252Bfor%252Bthe%252B%2525CE%2525B2-Lactams%26aulast%3DV%25C3%25A1zquez-Ucha%26aufirst%3DJuan%2BC.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D9308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Gavara</span>, <span class="hlFld-ContribAuthor ">Laurent  Sevaille</span>, <span class="hlFld-ContribAuthor ">Filomena  De Luca</span>, <span class="hlFld-ContribAuthor ">Paola  Mercuri</span>, <span class="hlFld-ContribAuthor ">Carine  Bebrone</span>, <span class="hlFld-ContribAuthor ">Georges  Feller</span>, <span class="hlFld-ContribAuthor ">Alice  Legru</span>, <span class="hlFld-ContribAuthor ">Giulia  Cerboni</span>, <span class="hlFld-ContribAuthor ">Silvia  Tanfoni</span>, <span class="hlFld-ContribAuthor ">Damien  Baud</span>, <span class="hlFld-ContribAuthor ">Giuliano  Cutolo</span>, <span class="hlFld-ContribAuthor ">Benoît  Bestgen</span>, <span class="hlFld-ContribAuthor ">Giulia  Chelini</span>, <span class="hlFld-ContribAuthor ">Federica  Verdirosa</span>, <span class="hlFld-ContribAuthor ">Filomena  Sannio</span>, <span class="hlFld-ContribAuthor ">Cecilia  Pozzi</span>, <span class="hlFld-ContribAuthor ">Manuela  Benvenuti</span>, <span class="hlFld-ContribAuthor ">Karolina  Kwapien</span>, <span class="hlFld-ContribAuthor ">Marina  Fischer</span>, <span class="hlFld-ContribAuthor ">Katja  Becker</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Frère</span>, <span class="hlFld-ContribAuthor ">Stefano  Mangani</span>, <span class="hlFld-ContribAuthor ">Nohad  Gresh</span>, <span class="hlFld-ContribAuthor ">Dorothée  Berthomieu</span>, <span class="hlFld-ContribAuthor ">Moreno  Galleni</span>, <span class="hlFld-ContribAuthor ">Jean-Denis  Docquier</span>, <span class="hlFld-ContribAuthor ">Jean-François  Hernandez</span>. </span><span class="cited-content_cbyCitation_article-title">4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112720. <a href="https://doi.org/10.1016/j.ejmech.2020.112720" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112720%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Amino-1%25252C2%25252C4-triazole-3-thione-derived%252BSchiff%252Bbases%252Bas%252Bmetallo-%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DGavara%26aufirst%3DLaurent%26date%3D2020%26volume%3D208%26spage%3D112720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matteo  Bassetti</span>, <span class="hlFld-ContribAuthor ">Vincenzo Di  Pilato</span>, <span class="hlFld-ContribAuthor ">Tommaso  Giani</span>, <span class="hlFld-ContribAuthor ">Antonio  Vena</span>, <span class="hlFld-ContribAuthor ">Gian Maria  Rossolini</span>, <span class="hlFld-ContribAuthor ">Anna  Marchese</span>, <span class="hlFld-ContribAuthor ">Daniele  R Giacobbe</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of severe infections due to metallo-β-lactamases-producing Gram-negative bacteria. </span><span class="cited-content_cbyCitation_journal-name">Future Microbiology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (15)
                                     , 1489-1505. <a href="https://doi.org/10.2217/fmb-2020-0210" title="DOI URL">https://doi.org/10.2217/fmb-2020-0210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fmb-2020-0210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffmb-2020-0210%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Microbiology%26atitle%3DTreatment%252Bof%252Bsevere%252Binfections%252Bdue%252Bto%252Bmetallo-%2525CE%2525B2-lactamases-producing%252BGram-negative%252Bbacteria%26aulast%3DBassetti%26aufirst%3DMatteo%26date%3D2020%26volume%3D15%26issue%3D15%26spage%3D1489%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan P. A.  Hinkes</span>, <span class="hlFld-ContribAuthor ">Severin  Kämmerer</span>, <span class="hlFld-ContribAuthor ">Christian D. P.  Klein</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-oriented synthesis of peptide-boronic acids by a versatile building-block approach. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (36)
                                     , 9898-9903. <a href="https://doi.org/10.1039/D0SC03999C" title="DOI URL">https://doi.org/10.1039/D0SC03999C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC03999C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC03999C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDiversity-oriented%252Bsynthesis%252Bof%252Bpeptide-boronic%252Bacids%252Bby%252Ba%252Bversatile%252Bbuilding-block%252Bapproach%26aulast%3DHinkes%26aufirst%3DStefan%2BP.%2BA.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D36%26spage%3D9898%26epage%3D9903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Orville A.  Pemberton</span>, <span class="hlFld-ContribAuthor ">Ruslan  Tsivkovski</span>, <span class="hlFld-ContribAuthor ">Maxim  Totrov</span>, <span class="hlFld-ContribAuthor ">Olga  Lomovskaya</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis and Binding Kinetics of Vaborbactam in Class A β-Lactamase Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (10)
                                     <a href="https://doi.org/10.1128/AAC.00398-20" title="DOI URL">https://doi.org/10.1128/AAC.00398-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00398-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00398-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DStructural%252BBasis%252Band%252BBinding%252BKinetics%252Bof%252BVaborbactam%252Bin%252BClass%252BA%252B%2525CE%2525B2-Lactamase%252BInhibition%26aulast%3DPemberton%26aufirst%3DOrville%2BA.%26date%3D2020%26volume%3D64%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu‐Hang  Yan</span>, <span class="hlFld-ContribAuthor ">Gen  Li</span>, <span class="hlFld-ContribAuthor ">Guo‐Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Principles and current strategies targeting metallo‐β‐lactamase mediated antibacterial resistance. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (5)
                                     , 1558-1592. <a href="https://doi.org/10.1002/med.21665" title="DOI URL">https://doi.org/10.1002/med.21665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21665%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DPrinciples%252Band%252Bcurrent%252Bstrategies%252Btargeting%252Bmetallo%2525E2%252580%252590%2525CE%2525B2%2525E2%252580%252590lactamase%252Bmediated%252Bantibacterial%252Bresistance%26aulast%3DYan%26aufirst%3DYu%25E2%2580%2590Hang%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D5%26spage%3D1558%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caitlyn A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Zishuo  Cheng</span>, <span class="hlFld-ContribAuthor ">Kundi  Yang</span>, <span class="hlFld-ContribAuthor ">Elle  Hellwarth</span>, <span class="hlFld-ContribAuthor ">Cole J.  Yurkiewicz</span>, <span class="hlFld-ContribAuthor ">Faith M.  Baxter</span>, <span class="hlFld-ContribAuthor ">Sarah A.  Fullington</span>, <span class="hlFld-ContribAuthor ">Spencer A.  Klinsky</span>, <span class="hlFld-ContribAuthor ">Jen L.  Otto</span>, <span class="hlFld-ContribAuthor ">Allie Y.  Chen</span>, <span class="hlFld-ContribAuthor ">Seth M.  Cohen</span>, <span class="hlFld-ContribAuthor ">Michael W.  Crowder</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the mechanisms of inhibition for various inhibitors of metallo-β-lactamases VIM-2 and NDM-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>210 </em>, 111123. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111123" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111123%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DProbing%252Bthe%252Bmechanisms%252Bof%252Binhibition%252Bfor%252Bvarious%252Binhibitors%252Bof%252Bmetallo-%2525CE%2525B2-lactamases%252BVIM-2%252Band%252BNDM-1%26aulast%3DThomas%26aufirst%3DCaitlyn%2BA.%26date%3D2020%26volume%3D210%26spage%3D111123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Hang  Yan</span>, <span class="hlFld-ContribAuthor ">Jian  Chen</span>, <span class="hlFld-ContribAuthor ">Zhen  Zhan</span>, <span class="hlFld-ContribAuthor ">Zhu-Jun  Yu</span>, <span class="hlFld-ContribAuthor ">Gen  Li</span>, <span class="hlFld-ContribAuthor ">Li  Guo</span>, <span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Wu</span>, <span class="hlFld-ContribAuthor ">Yongxiang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of mercaptopropanamide-substituted aryl tetrazoles as new broad-spectrum metallo-β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (52)
                                     , 31377-31384. <a href="https://doi.org/10.1039/D0RA06405J" title="DOI URL">https://doi.org/10.1039/D0RA06405J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA06405J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA06405J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Bof%252Bmercaptopropanamide-substituted%252Baryl%252Btetrazoles%252Bas%252Bnew%252Bbroad-spectrum%252Bmetallo-%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DYan%26aufirst%3DYu-Hang%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D52%26spage%3D31377%26epage%3D31384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Gavara</span>, <span class="hlFld-ContribAuthor ">Federica  Verdirosa</span>, <span class="hlFld-ContribAuthor ">Alice  Legru</span>, <span class="hlFld-ContribAuthor ">Paola Sandra  Mercuri</span>, <span class="hlFld-ContribAuthor ">Lionel  Nauton</span>, <span class="hlFld-ContribAuthor ">Laurent  Sevaille</span>, <span class="hlFld-ContribAuthor ">Georges  Feller</span>, <span class="hlFld-ContribAuthor ">Dorothée  Berthomieu</span>, <span class="hlFld-ContribAuthor ">Filomena  Sannio</span>, <span class="hlFld-ContribAuthor ">Francesca  Marcoccia</span>, <span class="hlFld-ContribAuthor ">Silvia  Tanfoni</span>, <span class="hlFld-ContribAuthor ">Filomena  De Luca</span>, <span class="hlFld-ContribAuthor ">Nohad  Gresh</span>, <span class="hlFld-ContribAuthor ">Moreno  Galleni</span>, <span class="hlFld-ContribAuthor ">Jean-Denis  Docquier</span>, <span class="hlFld-ContribAuthor ">Jean-François  Hernandez</span>. </span><span class="cited-content_cbyCitation_article-title">4-(N-Alkyl- and -Acyl-amino)-1,2,4-triazole-3-thione Analogs as Metallo-β-Lactamase Inhibitors: Impact of 4-Linker on Potency and Spectrum of Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (8)
                                     , 1094. <a href="https://doi.org/10.3390/biom10081094" title="DOI URL">https://doi.org/10.3390/biom10081094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10081094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10081094%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3D4-%252528N-Alkyl-%252Band%252B-Acyl-amino%252529-1%25252C2%25252C4-triazole-3-thione%252BAnalogs%252Bas%252BMetallo-%2525CE%2525B2-Lactamase%252BInhibitors%25253A%252BImpact%252Bof%252B4-Linker%252Bon%252BPotency%252Band%252BSpectrum%252Bof%252BInhibition%26aulast%3DGavara%26aufirst%3DLaurent%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D8%26spage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivakumar S.  Jalde</span>, <span class="hlFld-ContribAuthor ">Hyun Kyung  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the development of β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Microbiology</span><span> <strong>2020,</strong> <em>58 </em>
                                    (8)
                                     , 633-647. <a href="https://doi.org/10.1007/s12275-020-0285-z" title="DOI URL">https://doi.org/10.1007/s12275-020-0285-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12275-020-0285-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12275-020-0285-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Microbiology%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252B%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DJalde%26aufirst%3DShivakumar%2BS.%26date%3D2020%26date%3D2020%26volume%3D58%26issue%3D8%26spage%3D633%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allie Y.  Chen</span>, <span class="hlFld-ContribAuthor ">Caitlyn A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Pei W.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kundi  Yang</span>, <span class="hlFld-ContribAuthor ">Zishuo  Cheng</span>, <span class="hlFld-ContribAuthor ">Walter  Fast</span>, <span class="hlFld-ContribAuthor ">Michael W.  Crowder</span>, <span class="hlFld-ContribAuthor ">Seth M.  Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Iminodiacetic Acid as a Novel Metal‐Binding Pharmacophore for New Delhi Metallo‐β‐lactamase Inhibitor Development. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (14)
                                     , 1272-1282. <a href="https://doi.org/10.1002/cmdc.202000123" title="DOI URL">https://doi.org/10.1002/cmdc.202000123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000123%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DIminodiacetic%252BAcid%252Bas%252Ba%252BNovel%252BMetal%2525E2%252580%252590Binding%252BPharmacophore%252Bfor%252BNew%252BDelhi%252BMetallo%2525E2%252580%252590%2525CE%2525B2%2525E2%252580%252590lactamase%252BInhibitor%252BDevelopment%26aulast%3DChen%26aufirst%3DAllie%2BY.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D14%26spage%3D1272%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nakita  Reddy</span>, <span class="hlFld-ContribAuthor ">Mbongeni  Shungube</span>, <span class="hlFld-ContribAuthor ">Per I  Arvidsson</span>, <span class="hlFld-ContribAuthor ">Sooraj  Baijnath</span>, <span class="hlFld-ContribAuthor ">Hendrik G  Kruger</span>, <span class="hlFld-ContribAuthor ">Thavendran  Govender</span>, <span class="hlFld-ContribAuthor ">Tricia  Naicker</span>. </span><span class="cited-content_cbyCitation_article-title">A 2018–2019 patent review of metallo beta-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (7)
                                     , 541-555. <a href="https://doi.org/10.1080/13543776.2020.1767070" title="DOI URL">https://doi.org/10.1080/13543776.2020.1767070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1767070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1767070%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252B2018%2525E2%252580%2525932019%252Bpatent%252Breview%252Bof%252Bmetallo%252Bbeta-lactamase%252Binhibitors%26aulast%3DReddy%26aufirst%3DNakita%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D7%26spage%3D541%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen Bin  Jin</span>, <span class="hlFld-ContribAuthor ">Chen  Xu</span>, <span class="hlFld-ContribAuthor ">Qipeng  Cheung</span>, <span class="hlFld-ContribAuthor ">Wei  Gao</span>, <span class="hlFld-ContribAuthor ">Ping  Zeng</span>, <span class="hlFld-ContribAuthor ">Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Edward W.C.  Chan</span>, <span class="hlFld-ContribAuthor ">Yun-Chung  Leung</span>, <span class="hlFld-ContribAuthor ">Tak Hang  Chan</span>, <span class="hlFld-ContribAuthor ">Kwok-Yin  Wong</span>, <span class="hlFld-ContribAuthor ">Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Kin-Fai  Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteric investigation of ebselen: Synthesis and in vitro characterization of 1,2-benzisothiazol-3(2H)-one derivatives as potent New Delhi metallo-β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>100 </em>, 103873. <a href="https://doi.org/10.1016/j.bioorg.2020.103873" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103873%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DBioisosteric%252Binvestigation%252Bof%252Bebselen%25253A%252BSynthesis%252Band%252Bin%252Bvitro%252Bcharacterization%252Bof%252B1%25252C2-benzisothiazol-3%2525282H%252529-one%252Bderivatives%252Bas%252Bpotent%252BNew%252BDelhi%252Bmetallo-%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DJin%26aufirst%3DWen%2BBin%26date%3D2020%26volume%3D100%26spage%3D103873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojuan  Wang</span>, <span class="hlFld-ContribAuthor ">Chunjiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanwei  Wang</span>, <span class="hlFld-ContribAuthor ">Xinyue  Liang</span>, <span class="hlFld-ContribAuthor ">Feifei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yawei  Zhang</span>, <span class="hlFld-ContribAuthor ">Han  Meng</span>, <span class="hlFld-ContribAuthor ">Hongbin  Chen</span>, <span class="hlFld-ContribAuthor ">Shuguang  Li</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Henan  Li</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China. </span><span class="cited-content_cbyCitation_journal-name">Journal of Antimicrobial Chemotherapy</span><span> <strong>2020,</strong> <em>75 </em>
                                    (7)
                                     , 1850-1858. <a href="https://doi.org/10.1093/jac/dkaa053" title="DOI URL">https://doi.org/10.1093/jac/dkaa053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jac/dkaa053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjac%2Fdkaa053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Antimicrobial%2520Chemotherapy%26atitle%3DIn%252Bvitro%252Bactivity%252Bof%252Bthe%252Bnovel%252B%2525CE%2525B2-lactamase%252Binhibitor%252Btaniborbactam%252B%252528VNRX-5133%252529%25252C%252Bin%252Bcombination%252Bwith%252Bcefepime%252Bor%252Bmeropenem%25252C%252Bagainst%252BMDR%252BGram-negative%252Bbacterial%252Bisolates%252Bfrom%252BChina%26aulast%3DWang%26aufirst%3DXiaojuan%26date%3D2020%26date%3D2020%26volume%3D75%26issue%3D7%26spage%3D1850%26epage%3D1858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark S.  Butler</span>, <span class="hlFld-ContribAuthor ">David L.  Paterson</span>. </span><span class="cited-content_cbyCitation_article-title">Antibiotics in the clinical pipeline in October 2019. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Antibiotics</span><span> <strong>2020,</strong> <em>73 </em>
                                    (6)
                                     , 329-364. <a href="https://doi.org/10.1038/s41429-020-0291-8" title="DOI URL">https://doi.org/10.1038/s41429-020-0291-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41429-020-0291-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41429-020-0291-8%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Antibiotics%26atitle%3DAntibiotics%252Bin%252Bthe%252Bclinical%252Bpipeline%252Bin%252BOctober%252B2019%26aulast%3DButler%26aufirst%3DMark%2BS.%26date%3D2020%26date%3D2020%26volume%3D73%26issue%3D6%26spage%3D329%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonela R.  Palacios</span>, <span class="hlFld-ContribAuthor ">María-Agustina  Rossi</span>, <span class="hlFld-ContribAuthor ">Graciela S.  Mahler</span>, <span class="hlFld-ContribAuthor ">Alejandro J.  Vila</span>. </span><span class="cited-content_cbyCitation_article-title">Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (6)
                                     , 854. <a href="https://doi.org/10.3390/biom10060854" title="DOI URL">https://doi.org/10.3390/biom10060854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10060854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10060854%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DMetallo-%2525CE%2525B2-Lactamase%252BInhibitors%252BInspired%252Bon%252BSnapshots%252Bfrom%252Bthe%252BCatalytic%252BMechanism%26aulast%3DPalacios%26aufirst%3DAntonela%2BR.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D6%26spage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pauline A.  Lang</span>, <span class="hlFld-ContribAuthor ">Anete  Parkova</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Leissing</span>, <span class="hlFld-ContribAuthor ">Karina  Calvopiña</span>, <span class="hlFld-ContribAuthor ">Ricky  Cain</span>, <span class="hlFld-ContribAuthor ">Alen  Krajnc</span>, <span class="hlFld-ContribAuthor ">Tharindi D.  Panduwawala</span>, <span class="hlFld-ContribAuthor ">Jules  Philippe</span>, <span class="hlFld-ContribAuthor ">Colin W. G.  Fishwick</span>, <span class="hlFld-ContribAuthor ">Peteris  Trapencieris</span>, <span class="hlFld-ContribAuthor ">Malcolm G. P.  Page</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schofield</span>, <span class="hlFld-ContribAuthor ">Jürgen  Brem</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (6)
                                     , 899. <a href="https://doi.org/10.3390/biom10060899" title="DOI URL">https://doi.org/10.3390/biom10060899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10060899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10060899%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DBicyclic%252BBoronates%252Bas%252BPotent%252BInhibitors%252Bof%252BAmpC%25252C%252Bthe%252BClass%252BC%252B%2525CE%2525B2-Lactamase%252Bfrom%252BEscherichia%252Bcoli%26aulast%3DLang%26aufirst%3DPauline%2BA.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D6%26spage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chris S.  Thomas</span>, <span class="hlFld-ContribAuthor ">Doug R.  Braun</span>, <span class="hlFld-ContribAuthor ">Jose Luis  Olmos</span>, <span class="hlFld-ContribAuthor ">Scott R.  Rajski</span>, <span class="hlFld-ContribAuthor ">George N.  Phillips</span>, <span class="hlFld-ContribAuthor ">David  Andes</span>, <span class="hlFld-ContribAuthor ">Tim S.  Bugni</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridine-2,6-Dithiocarboxylic Acid and Its Metal Complexes: New Inhibitors of New Delhi Metallo -Lactamase-1. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2020,</strong> <em>18 </em>
                                    (6)
                                     , 295. <a href="https://doi.org/10.3390/md18060295" title="DOI URL">https://doi.org/10.3390/md18060295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md18060295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd18060295%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DPyridine-2%25252C6-Dithiocarboxylic%252BAcid%252Band%252BIts%252BMetal%252BComplexes%25253A%252BNew%252BInhibitors%252Bof%252BNew%252BDelhi%252BMetallo%252B-Lactamase-1%26aulast%3DThomas%26aufirst%3DChris%2BS.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D6%26spage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna N.  Tevyashova</span>. </span><span class="cited-content_cbyCitation_article-title">Oxaborine Derivatives: Synthesis and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (6)
                                     , 715-718. <a href="https://doi.org/10.1007/s10593-020-02720-6" title="DOI URL">https://doi.org/10.1007/s10593-020-02720-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02720-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02720-6%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DOxaborine%252BDerivatives%25253A%252BSynthesis%252Band%252BTherapeutic%252BPotential%26aulast%3DTevyashova%26aufirst%3DAnna%2BN.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D6%26spage%3D715%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruslan  Tsivkovski</span>, <span class="hlFld-ContribAuthor ">Maxim  Totrov</span>, <span class="hlFld-ContribAuthor ">Olga  Lomovskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.00130-20" title="DOI URL">https://doi.org/10.1128/AAC.00130-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00130-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00130-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DBiochemical%252BCharacterization%252Bof%252BQPX7728%25252C%252Ba%252BNew%252BUltrabroad-Spectrum%252BBeta-Lactamase%252BInhibitor%252Bof%252BSerine%252Band%252BMetallo-Beta-Lactamases%26aulast%3DTsivkovski%26aufirst%3DRuslan%26date%3D2020%26volume%3D64%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huifang  Guo</span>, <span class="hlFld-ContribAuthor ">Kai  Cheng</span>, <span class="hlFld-ContribAuthor ">Yan  Gao</span>, <span class="hlFld-ContribAuthor ">Weiqi  Bai</span>, <span class="hlFld-ContribAuthor ">Cai  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Conggang  Li</span>, <span class="hlFld-ContribAuthor ">Zhuorong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A novel potent metal-binding NDM-1 inhibitor was identified by fragment virtual, SPR and NMR screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (9)
                                     , 115437. <a href="https://doi.org/10.1016/j.bmc.2020.115437" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115437%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnovel%252Bpotent%252Bmetal-binding%252BNDM-1%252Binhibitor%252Bwas%252Bidentified%252Bby%252Bfragment%252Bvirtual%25252C%252BSPR%252Band%252BNMR%252Bscreening%26aulast%3DGuo%26aufirst%3DHuifang%26date%3D2020%26volume%3D28%26issue%3D9%26spage%3D115437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ursula  Theuretzbacher</span>, <span class="hlFld-ContribAuthor ">Karen  Bush</span>, <span class="hlFld-ContribAuthor ">Stephan  Harbarth</span>, <span class="hlFld-ContribAuthor ">Mical  Paul</span>, <span class="hlFld-ContribAuthor ">John H.  Rex</span>, <span class="hlFld-ContribAuthor ">Evelina  Tacconelli</span>, <span class="hlFld-ContribAuthor ">Guy E.  Thwaites</span>. </span><span class="cited-content_cbyCitation_article-title">Critical analysis of antibacterial agents in clinical development. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Microbiology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (5)
                                     , 286-298. <a href="https://doi.org/10.1038/s41579-020-0340-0" title="DOI URL">https://doi.org/10.1038/s41579-020-0340-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41579-020-0340-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41579-020-0340-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Microbiology%26atitle%3DCritical%252Banalysis%252Bof%252Bantibacterial%252Bagents%252Bin%252Bclinical%252Bdevelopment%26aulast%3DTheuretzbacher%26aufirst%3DUrsula%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D5%26spage%3D286%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott T.  Lefurgy</span>, <span class="hlFld-ContribAuthor ">Emilia  Caselli</span>, <span class="hlFld-ContribAuthor ">Magdalena A.  Taracila</span>, <span class="hlFld-ContribAuthor ">Vladimir N.  Malashkevich</span>, <span class="hlFld-ContribAuthor ">Beena  Biju</span>, <span class="hlFld-ContribAuthor ">Krisztina M.  Papp-Wallace</span>, <span class="hlFld-ContribAuthor ">Jeffrey B.  Bonanno</span>, <span class="hlFld-ContribAuthor ">Fabio  Prati</span>, <span class="hlFld-ContribAuthor ">Steven C.  Almo</span>, <span class="hlFld-ContribAuthor ">Robert A.  Bonomo</span>. </span><span class="cited-content_cbyCitation_article-title">Structures of FOX-4 Cephamycinase in Complex with Transition-State Analog Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (5)
                                     , 671. <a href="https://doi.org/10.3390/biom10050671" title="DOI URL">https://doi.org/10.3390/biom10050671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10050671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10050671%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DStructures%252Bof%252BFOX-4%252BCephamycinase%252Bin%252BComplex%252Bwith%252BTransition-State%252BAnalog%252BInhibitors%26aulast%3DLefurgy%26aufirst%3DScott%2BT.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D5%26spage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Soledad  Ramirez</span>, <span class="hlFld-ContribAuthor ">Robert A.  Bonomo</span>, <span class="hlFld-ContribAuthor ">Marcelo E.  Tolmasky</span>. </span><span class="cited-content_cbyCitation_article-title">Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (5)
                                     , 720. <a href="https://doi.org/10.3390/biom10050720" title="DOI URL">https://doi.org/10.3390/biom10050720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10050720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10050720%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DCarbapenemases%25253A%252BTransforming%252BAcinetobacter%252Bbaumannii%252Binto%252Ba%252BYet%252BMore%252BDangerous%252BMenace%26aulast%3DRamirez%26aufirst%3DMaria%2BSoledad%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D5%26spage%3D720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine L.  Tooke</span>, <span class="hlFld-ContribAuthor ">Philip  Hinchliffe</span>, <span class="hlFld-ContribAuthor ">Alen  Krajnc</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Mulholland</span>, <span class="hlFld-ContribAuthor ">Jürgen  Brem</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schofield</span>, <span class="hlFld-ContribAuthor ">James  Spencer</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibition. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 491-496. <a href="https://doi.org/10.1039/C9MD00557A" title="DOI URL">https://doi.org/10.1039/C9MD00557A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00557A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00557A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DCyclic%252Bboronates%252Bas%252Bversatile%252Bscaffolds%252Bfor%252BKPC-2%252B%2525CE%2525B2-lactamase%252Binhibition%26aulast%3DTooke%26aufirst%3DCatherine%2BL.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D4%26spage%3D491%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-ichi  Wachino</span>, <span class="hlFld-ContribAuthor ">Wanchun  Jin</span>, <span class="hlFld-ContribAuthor ">Kouji  Kimura</span>, <span class="hlFld-ContribAuthor ">Hiromasa  Kurosaki</span>, <span class="hlFld-ContribAuthor ">Ayato  Sato</span>, <span class="hlFld-ContribAuthor ">Yoshichika  Arakawa</span>, . </span><span class="cited-content_cbyCitation_article-title">Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance. </span><span class="cited-content_cbyCitation_journal-name">mBio</span><span> <strong>2020,</strong> <em>11 </em>
                                    (2)
                                     <a href="https://doi.org/10.1128/mBio.03144-19" title="DOI URL">https://doi.org/10.1128/mBio.03144-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mBio.03144-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmBio.03144-19%26sid%3Dliteratum%253Aachs%26jtitle%3DmBio%26atitle%3DSulfamoyl%252BHeteroarylcarboxylic%252BAcids%252Bas%252BPromising%252BMetallo-%2525CE%2525B2-Lactamase%252BInhibitors%252Bfor%252BControlling%252BBacterial%252BCarbapenem%252BResistance%26aulast%3DWachino%26aufirst%3DJun-ichi%26date%3D2020%26volume%3D11%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenbo  Ming</span>, <span class="hlFld-ContribAuthor ">Xiaocui  Liu</span>, <span class="hlFld-ContribAuthor ">Alexandra  Friedrich</span>, <span class="hlFld-ContribAuthor ">Johannes  Krebs</span>, <span class="hlFld-ContribAuthor ">Yudha P.  Budiman</span>, <span class="hlFld-ContribAuthor ">Mingming  Huang</span>, <span class="hlFld-ContribAuthor ">Todd B.  Marder</span>. </span><span class="cited-content_cbyCitation_article-title">Concise synthesis of α-amino cyclic boronates
              via
              multicomponent coupling of salicylaldehydes, amines, and B
              2
              (OH)
              4. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (7)
                                     , 2184-2190. <a href="https://doi.org/10.1039/D0GC00346H" title="DOI URL">https://doi.org/10.1039/D0GC00346H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0GC00346H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0GC00346H%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DConcise%252Bsynthesis%252Bof%252B%2525CE%2525B1-amino%252Bcyclic%252Bboronates%252Bvia%252Bmulticomponent%252Bcoupling%252Bof%252Bsalicylaldehydes%25252C%252Bamines%25252C%252Band%252BB%252B2%252B%252528OH%252529%252B4%26aulast%3DMing%26aufirst%3DWenbo%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D7%26spage%3D2184%26epage%3D2190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasunari  Otsuka</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2020,</strong> <em>68 </em>
                                    (3)
                                     , 182-190. <a href="https://doi.org/10.1248/cpb.c19-00842" title="DOI URL">https://doi.org/10.1248/cpb.c19-00842</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c19-00842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c19-00842%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DPotent%252BAntibiotics%252BActive%252Bagainst%252BMultidrug-Resistant%252BGram-Negative%252BBacteria%26aulast%3DOtsuka%26aufirst%3DYasunari%26date%3D2020%26volume%3D68%26issue%3D3%26spage%3D182%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zishuo  Cheng</span>, <span class="hlFld-ContribAuthor ">Caitlyn A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Adam R.  Joyner</span>, <span class="hlFld-ContribAuthor ">Robert L.  Kimble</span>, <span class="hlFld-ContribAuthor ">Aidan M.  Sturgill</span>, <span class="hlFld-ContribAuthor ">Nhu-Y  Tran</span>, <span class="hlFld-ContribAuthor ">Maya R.  Vulcan</span>, <span class="hlFld-ContribAuthor ">Spencer A.  Klinsky</span>, <span class="hlFld-ContribAuthor ">Diego J.  Orea</span>, <span class="hlFld-ContribAuthor ">Cody R.  Platt</span>, <span class="hlFld-ContribAuthor ">Fanpu  Cao</span>, <span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Qilin  Yang</span>, <span class="hlFld-ContribAuthor ">Cole J.  Yurkiewicz</span>, <span class="hlFld-ContribAuthor ">Walter  Fast</span>, <span class="hlFld-ContribAuthor ">Michael W.  Crowder</span>. </span><span class="cited-content_cbyCitation_article-title">MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo-β-Lactamase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3)
                                     , 459. <a href="https://doi.org/10.3390/biom10030459" title="DOI URL">https://doi.org/10.3390/biom10030459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10030459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10030459%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DMBLinhibitors.com%25252C%252Ba%252BWebsite%252BResource%252BOffering%252BInformation%252Band%252BExpertise%252Bfor%252Bthe%252BContinued%252BDevelopment%252Bof%252BMetallo-%2525CE%2525B2-Lactamase%252BInhibitors%26aulast%3DCheng%26aufirst%3DZishuo%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D3%26spage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pasquale  Linciano</span>, <span class="hlFld-ContribAuthor ">Eleonora  Gianquinto</span>, <span class="hlFld-ContribAuthor ">Martina  Montanari</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Maso</span>, <span class="hlFld-ContribAuthor ">Pierangelo  Bellio</span>, <span class="hlFld-ContribAuthor ">Esmeralda  Cebrián-Sastre</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Celenza</span>, <span class="hlFld-ContribAuthor ">Jesús  Blázquez</span>, <span class="hlFld-ContribAuthor ">Laura  Cendron</span>, <span class="hlFld-ContribAuthor ">Francesca  Spyrakis</span>, <span class="hlFld-ContribAuthor ">Donatella  Tondi</span>. </span><span class="cited-content_cbyCitation_article-title">4-Amino-1,2,4-triazole-3-thione as a Promising Scaffold for the Inhibition of Serine and Metallo-β-Lactamases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (3)
                                     , 52. <a href="https://doi.org/10.3390/ph13030052" title="DOI URL">https://doi.org/10.3390/ph13030052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13030052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13030052%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3D4-Amino-1%25252C2%25252C4-triazole-3-thione%252Bas%252Ba%252BPromising%252BScaffold%252Bfor%252Bthe%252BInhibition%252Bof%252BSerine%252Band%252BMetallo-%2525CE%2525B2-Lactamases%26aulast%3DLinciano%26aufirst%3DPasquale%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D3%26spage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Yuan</span>, <span class="hlFld-ContribAuthor ">Jie  Yan</span>, <span class="hlFld-ContribAuthor ">Chen  Song</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Huiling  Su</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Lijiao  Wang</span>, <span class="hlFld-ContribAuthor ">Zhouyu  Wang</span>, <span class="hlFld-ContribAuthor ">Shan  Qian</span>, <span class="hlFld-ContribAuthor ">Lingling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of [1,2,4]Triazole Derivatives as New Metallo-β-Lactamase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 56. <a href="https://doi.org/10.3390/molecules25010056" title="DOI URL">https://doi.org/10.3390/molecules25010056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25010056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25010056%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252B%25255B1%25252C2%25252C4%25255DTriazole%252BDerivatives%252Bas%252BNew%252BMetallo-%2525CE%2525B2-Lactamase%252BInhibitors%26aulast%3DYuan%26aufirst%3DChen%26date%3D2020%26date%3D2019%26volume%3D25%26issue%3D1%26spage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhang</span>, <span class="hlFld-ContribAuthor ">Faheem</span>, <span class="hlFld-ContribAuthor ">Dang</span>, <span class="hlFld-ContribAuthor ">Morris</span>, <span class="hlFld-ContribAuthor ">Kumar</span>, <span class="hlFld-ContribAuthor ">Oelschlaeger</span>. </span><span class="cited-content_cbyCitation_article-title">Mutation S115T in IMP-Type Metallo-β-Lactamases Compensates for Decreased Expression Levels Caused by Mutation S119G. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (11)
                                     , 724. <a href="https://doi.org/10.3390/biom9110724" title="DOI URL">https://doi.org/10.3390/biom9110724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9110724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9110724%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DMutation%252BS115T%252Bin%252BIMP-Type%252BMetallo-%2525CE%2525B2-Lactamases%252BCompensates%252Bfor%252BDecreased%252BExpression%252BLevels%252BCaused%252Bby%252BMutation%252BS119G%26aulast%3DZhang%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D11%26spage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. β-Lactam antibacterials, β-lactamase inhibitors in clinical use, outline mechanisms for serine- and metallo-β-lactamase (SBL and MBL) catalysis, and bicyclic boronates in research and development. (A) Major classes of β-lactam antibiotics and SBL inhibitors currently in clinical use, including the clinically approved “monocyclic” boron-containing inhibitor vaborbactam (which has little MBL activity<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>); mode of action of (B) SBLs and (C) MBLs, exemplified by hydrolysis of a carbapenem. Note that the hydrolyzed carbapenem products can be produced in different tautomeric forms. (D) Note that the ability of boronate inhibitors (e.g., VNRX-5133) to interchange between sp<sup>2</sup> and sp<sup>3</sup> forms can enable them to mimic both substrates (sp<sup>2</sup> carbonyl) and the first tetrahedral intermediate (sp<sup>3</sup>). Selected examples of bicyclic boronates from research and development are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthesis and NMR analysis of VNRX-5133. (A) Reagents and conditions: (a) oxalyl chloride, cat. DMF, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt), 90 min and then 2-methylpropan-2-ol, 40 °C, 18 h; (b) <i>N</i>-bromosuccinimide, benzoyl peroxide, CCl<sub>4</sub>, reflux, UV, 5 h; (c) bis[(+)-pinanediolato]diboron, Pd(dppf)Cl<sub>2</sub>, KOAc, 1,4-dioxane, 95 °C, 16 h; (d) CH<sub>2</sub>Cl<sub>2</sub>, tetrahydrofuran (THF), <i>n</i>-BuLi, −100 °C, 45 min and then 4 in THF, ZnCl<sub>2</sub>, −95 °C to rt, overnight; (e) lithium bis(trimethylsilyl)amide, THF, −100 °C to −78 °C, 2 h; (f) MeOH, THF, −10 °C to rt, 1 h; (g) K<sub>2</sub>CO<sub>3</sub>, 1:1 CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, rt, 1 h and then 2-(boc-amino)ethyl bromide, benzyltriethylammonium chloride, reflux, 18 h; (h) di-<i>tert</i>-butyl dicarbonate, <i>N</i>,<i>N</i>-diisopropylethylamine, reflux, 16 h; (i) LiOH·H<sub>2</sub>O, 1:2:1 THF/EtOH/H<sub>2</sub>O, rt, 5 h; (j) 11, triethylamine, PyBOP and then crude 7, rt, 75 min; (k) BCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 1 h. (B) <sup>1</sup>H NMR (600 MHz) of high-performance liquid chromatography (HPLC)-purified VNRX-5133 in D<sub>2</sub>O.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural basis of serine- and metallo-β-lactamase inhibition by VNRX-5133. (A) View from a crystal structure of VNRX-5133 complexed with NDM-1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RMF">6RMF</a>) in chain A showing the major observed bicyclic form (yellow). (B) View from a crystal structure of VNRX-5133 complexed with NDM-1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RMF">6RMF</a>) in chain B showing the tricyclic form (magenta). (C) An overlay of bicyclic (60%, yellow) and tricyclic (40%, magenta) forms of VNRX-5133 in chains A or B of NDM-1 and 2mFo-DFc electron density for the tricyclic inhibitor form in chain B (contoured to 3σ, gray mesh). (D) Proposed mechanism for formation of the unexpected tricyclic VNRX-5133 complex. Enz-Nu = Enz-(ZnII)<sub>n</sub>-OH (MBL) or Enz-Ser-OH (SBL). (E) Binding mode of VNRX-5133 to the OXA-10 SBL (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RTN">6RTN</a>). (F) Comparison of the binding modes of VNRX-5133 in complex with OXA-10 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RTN">6RTN</a>) in chain A (pale blue) and chain B (pale yellow); omit electron density for the bicyclic form in chain A (contoured at 3σ, gray mesh).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/medium/jm9b00911_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlays of reported bicyclic boronate structures and VNRX-5133 in MBLs, SBLs, and a PBP reveal different side-chain orientations. Views from NDM-1:VNRX-5133 (yellow, bicyclic form, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RFM">6RFM</a>), VIM-2:CB2 (teal, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQC">5FQC</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), BcII:CB2 (pale green, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQB">5FQB</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), AmpC:CB1 (orange, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6I30">6I30</a><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>), PBP-2:CB2 (gray, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J8X">5J8X</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), OXA-10:VNRX-5133 (pale blue, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RTN">6RTN</a>), OXA-10:CB1 (brown, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQ9">5FQ9</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), and CTX-M-15:CB1 (wheat, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T66">5T66</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>). Note that although the crystallographically observed orientations of the acylamino side chains vary, the binding modes of cyclic ring systems and their carboxylate are conserved, including for VNRX-5133. The acylamino side chains adopt two broad orientations, reflecting binding to SBLs (U-shaped). The VNRX-5133 acylamino side chain adopts clearly different conformations in the bicyclic inhibitor forms in both OXA-10 and NDM-1 structures (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Although care should be taken in assuming that the crystallographically observed binding modes accurately reflect the solution behavior, the structural observations imply that the optimized VNRX-5133 side chain can enable potent inhibition of different β-lactamase classes, by adopting different binding modes. Structural analyses of the cyclic boronates bound to MBLs and SBLs reveal that the acylamino side chain adopts two types of orientations (at least in the crystalline state), reflecting binding to SBLs or MBLs. These observations imply that there is likely further scope for side chain optimization, including with respect to extending the scope and potency of MBL inhibition and obtaining more potent (bi/tri)cyclic boronate-based PBP inhibitors. Importantly, comparison of the OXA-10 and NDM-1 structures with those observed for other structurally related compounds, i.e., CB1/CB2 (which differ from VNRX-5133 only in their C-3 acylamino side chains) when complexed with SBLs (OXA-10,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> CTX-M-15,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> AmpC<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>), MBLs (NDM-1,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> VIM-2,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> BcII<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), and a PBP (PBP-5<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), reveal conservation in the binding mode of the bicyclic boronate core (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Even allowing for the observed tricycle formation with NDM-1, similar conformations are observed across all Ambler classes of β-lactamases as well as with a PBP (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Superimposition of structures of OXA-10:<b>VNRX-5133</b> and NDM-1:<b>VNRX-5133</b> with analogous structures of the respective enzymes with “intermediate” complexes derived from substrates (e.g., hydrolyzed benzylpenicillin) reveals the binding modes adopted by VNRX-5133/related inhibitors overlap with those adopted by hydrolyzed β-lactams (Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv" class="ext-link">Figures S1 and S2B</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00911/20190926-01/images/large/jm9b00911_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00911&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munita, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, C. A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Antibiotic Resistance</span>. <i>Microbiol. Spectr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">42</span> <span class="refDoi"> DOI: 10.1128/microbiolspec.VMBF-0016-2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2Fmicrobiolspec.VMBF-0016-2015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&author=J.+M.+Munitaauthor=C.+A.+Arias&title=Mechanisms+of+Antibiotic+Resistance&doi=10.1128%2Fmicrobiolspec.VMBF-0016-2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2Fmicrobiolspec.VMBF-0016-2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fmicrobiolspec.VMBF-0016-2015%26sid%3Dliteratum%253Aachs%26aulast%3DMunita%26aufirst%3DJ.%2BM.%26aulast%3DArias%26aufirst%3DC.%2BA.%26atitle%3DMechanisms%2520of%2520Antibiotic%2520Resistance%26jtitle%3DMicrobiol.%2520Spectr.%26date%3D2016%26volume%3D4%26doi%3D10.1128%2Fmicrobiolspec.VMBF-0016-2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majiduddin, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Materon, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T. G.</span></span> <span> </span><span class="NLM_article-title">Molecular analysis of beta-lactamase structure and function</span>. <i>Int. J. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1078/1438-4221-00198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1078%2F1438-4221-00198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=12195735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVCqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2002&pages=127-137&author=F.+K.+Majiduddinauthor=I.+C.+Materonauthor=T.+G.+Palzkill&title=Molecular+analysis+of+beta-lactamase+structure+and+function&doi=10.1078%2F1438-4221-00198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular analysis of beta-lactamase structure and function</span></div><div class="casAuthors">Majiduddin, Fahd K.; Materon, Isabel C.; Palzkill, Timothy G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-137</span>CODEN:
                <span class="NLM_cas:coden">IMEMFV</span>;
        ISSN:<span class="NLM_cas:issn">1438-4221</span>.
    
            (<span class="NLM_cas:orgname">Urban & Fischer Verlag GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review with 83 refs.  The extensive and sometimes irresponsible use of β-lactam antibiotics in clin. and agricultural settings has contributed to the emergence and widespread dissemination of antibiotic-resistant bacteria.  Bacteria have evolved 3 strategies to escape the activity of β-lactam antibiotics: (1) alteration of the target site (e.g., penicillin-binding proteins), (2) redn. of drug permeation across the bacterial membrane (e.g., efflux pumps) and (3) prodn. of β-lactamases.  The β-lactamases inactivate β-lactam antibiotics by hydrolyzing the peptide bond of the characteristic 4-membered β-lactam ring, thus rendering the antibiotic ineffective.  The inactivation of the antibiotic provides resistance to the bacterium.  Currently, there are >300 β-lactamases described for which numerous kinetic, structural, computational, and mutagenesis studies have been performed.  Here, the authors discuss recent work performed on the 4 different classes (A, B, C, and D) of β-lactamases.  These investigative advances further expand the knowledge of these complex enzymes, and hopefully, will provide addnl. tools to develop new inhibitors and antibiotics based on structural and rational designs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Pw6I_rH_V7Vg90H21EOLACvtfcHk0lh0ul_OMrwlLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVCqurw%253D&md5=f8e4bd8e364a6924de9be9f4bdf49895</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1078%2F1438-4221-00198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1078%252F1438-4221-00198%26sid%3Dliteratum%253Aachs%26aulast%3DMajiduddin%26aufirst%3DF.%2BK.%26aulast%3DMateron%26aufirst%3DI.%2BC.%26aulast%3DPalzkill%26aufirst%3DT.%2BG.%26atitle%3DMolecular%2520analysis%2520of%2520beta-lactamase%2520structure%2520and%2520function%26jtitle%3DInt.%2520J.%2520Med.%2520Microbiol.%26date%3D2002%26volume%3D292%26spage%3D127%26epage%3D137%26doi%3D10.1078%2F1438-4221-00198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leigh, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradnock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marriner, J. M.</span></span> <span> </span><span class="NLM_article-title">Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1093/jac/7.3.229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fjac%2F7.3.229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=6974165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A280%3ADyaL38%252FgslGktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1981&pages=229-236&author=D.+A.+Leighauthor=K.+Bradnockauthor=J.+M.+Marriner&title=Augmentin+%28amoxycillin+and+clavulanic+acid%29+therapy+in+complicated+infections+due+to+beta-lactamase+producing+bacteria&doi=10.1093%2Fjac%2F7.3.229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria</span></div><div class="casAuthors">Leigh D A; Bradnock K; Marriner J M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of antimicrobial chemotherapy</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-36</span>
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSq6_Rz7rzPpPlX7E30qdzfW6udTcc2ebZGmQdBjLBWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL38%252FgslGktw%253D%253D&md5=e1fd25853e4509fbc4859b5fbe33b96d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F7.3.229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F7.3.229%26sid%3Dliteratum%253Aachs%26aulast%3DLeigh%26aufirst%3DD.%2BA.%26aulast%3DBradnock%26aufirst%3DK.%26aulast%3DMarriner%26aufirst%3DJ.%2BM.%26atitle%3DAugmentin%2520%2528amoxycillin%2520and%2520clavulanic%2520acid%2529%2520therapy%2520in%2520complicated%2520infections%2520due%2520to%2520beta-lactamase%2520producing%2520bacteria%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1981%26volume%3D7%26spage%3D229%26epage%3D236%26doi%3D10.1093%2Fjac%2F7.3.229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reading, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, M.</span></span> <span> </span><span class="NLM_article-title">Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">852</span>– <span class="NLM_lpage">857</span>, <span class="refDoi"> DOI: 10.1128/AAC.11.5.852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.11.5.852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=879738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaE2sXks1GjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1977&pages=852-857&author=C.+Readingauthor=M.+Cole&title=Clavulanic+acid%3A+a+beta-lactamase-inhiting+beta-lactam+from+Streptomyces+clavuligerus&doi=10.1128%2FAAC.11.5.852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Clavulanic acid:  a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus</span></div><div class="casAuthors">Reading, C.; Cole, M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">852-7</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">A novel β-lactamase inhibitor has been isolated from S. clavuligerus ATCC 27064 and given the name clavulanic acid (I).  Conditions for the cultivation of the organism and detection and isolation of I are described.  This compd. resembles the nucleus of a penicillin but differs in having no acylamino side chain, having O instead of S, and contg. a β-hydroxyethylidine substituent in the oxazolidine ring.  I is a potent inhibitor of many β-lactamases, including those found in Escherichia coli (plasmid mediated), Klebsiella aerogenes, Proteus mirabilis, and Staphylococcus aureus, the inhibition being of a progressive type.  The cephalosporinase type of β-lactamase found in Pseudomonas aeruginosa and Enterobacter cloacae P99 and the chromosomally mediated β-lactamase of E. coli are less well inhibited.  The min. inhibitory concns. of ampicillin and cephaloridine against β-lactamase-producing, penicillin-resistant strains of S. aureus, K. aerogenes, P. mirabilis, and E. coli are considerably reduced by the addn. of low concns. of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ573qlu2SG7Vg90H21EOLACvtfcHk0li3HPBqMCBq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXks1GjtLw%253D&md5=f418af59b52360c0ffe187922c0ef99d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1128%2FAAC.11.5.852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.11.5.852%26sid%3Dliteratum%253Aachs%26aulast%3DReading%26aufirst%3DC.%26aulast%3DCole%26aufirst%3DM.%26atitle%3DClavulanic%2520acid%253A%2520a%2520beta-lactamase-inhiting%2520beta-lactam%2520from%2520Streptomyces%2520clavuligerus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1977%26volume%3D11%26spage%3D852%26epage%3D857%26doi%3D10.1128%2FAAC.11.5.852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nahata, M. C.</span></span> <span> </span><span class="NLM_article-title">Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination</span>. <i>Drug Intell. Clin. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1177/106002808802200702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1177%2F106002808802200702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=3046887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaL1cXltVeqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1988&pages=534-541&author=J.+M.+Bensonauthor=M.+C.+Nahata&title=Sulbactam%2Fampicillin%2C+a+new+beta-lactamase+inhibitor%2Fbeta-lactam+antibiotic+combination&doi=10.1177%2F106002808802200702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination</span></div><div class="casAuthors">Benson, John M.; Nahata, Milap C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Intelligence & Clinical Pharmacy</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">534-41</span>CODEN:
                <span class="NLM_cas:coden">DICPBB</span>;
        ISSN:<span class="NLM_cas:issn">0012-6578</span>.
    </div><div class="casAbstract">A review with 62 refs.  Chem. and stability, mechanism of action, antibacterial spectrum, pharmacokinetics, clin. trials, and cost are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jCNXJQcIELVg90H21EOLACvtfcHk0li3HPBqMCBq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVeqsbo%253D&md5=c9783303eb3b65ac887db0cec13f5831</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1177%2F106002808802200702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F106002808802200702%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DJ.%2BM.%26aulast%3DNahata%26aufirst%3DM.%2BC.%26atitle%3DSulbactam%252Fampicillin%252C%2520a%2520new%2520beta-lactamase%2520inhibitor%252Fbeta-lactam%2520antibiotic%2520combination%26jtitle%3DDrug%2520Intell.%2520Clin.%2520Pharm.%26date%3D1988%26volume%3D22%26spage%3D534%26epage%3D541%26doi%3D10.1177%2F106002808802200702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitzis, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acar, J. F.</span></span> <span> </span><span class="NLM_article-title">Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">955</span>– <span class="NLM_lpage">957</span>, <span class="refDoi"> DOI: 10.1128/AAC.29.5.955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.29.5.955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=3015011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaL28XktVensL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=955-957&author=L.+Gutmannauthor=M.+D.+Kitzisauthor=S.+Yamabeauthor=J.+F.+Acar&title=Comparative+evaluation+of+a+new+beta-lactamase+inhibitor%2C+YTR+830%2C+combined+with+different+beta-lactam+antibiotics+against+bacteria+harboring+known+beta-lactamases&doi=10.1128%2FAAC.29.5.955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative evaluation of a new β-lactamase inhibitor, YTR 830, combined with different β-lactam antibiotics against bacteria harboring known β-lactamases</span></div><div class="casAuthors">Gutmann, L.; Kitzis, M. D.; Yamabe, S.; Acar, J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">955-7</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">YTR 830, a new β-lactamase inhibitor, combined with amoxicillin or carbenicillin, showed a synergistic effect similar to that obsd. with clavulanic acid, and generally better than that with sulbactam, against strains harboring chromosome-encoded penicillinases and broad-spectrum β-lactamases or plasmid-detd. β-lactamases.  With ampicillin, YTR 830 showed the best synergistic activity of the inhibitors against Proteus morganii, Citrobacter freundii, and Enterobacter cloacae and their mutants with a depressed chromosome-encoded cephalosporinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogTChUBoARS7Vg90H21EOLACvtfcHk0li3HPBqMCBq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktVensL8%253D&md5=82dd2faab2a9f4c5eec1c500f09e9c66</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2FAAC.29.5.955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.29.5.955%26sid%3Dliteratum%253Aachs%26aulast%3DGutmann%26aufirst%3DL.%26aulast%3DKitzis%26aufirst%3DM.%2BD.%26aulast%3DYamabe%26aufirst%3DS.%26aulast%3DAcar%26aufirst%3DJ.%2BF.%26atitle%3DComparative%2520evaluation%2520of%2520a%2520new%2520beta-lactamase%2520inhibitor%252C%2520YTR%2520830%252C%2520combined%2520with%2520different%2520beta-lactam%2520antibiotics%2520against%2520bacteria%2520harboring%2520known%2520beta-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1986%26volume%3D29%26spage%3D955%26epage%3D957%26doi%3D10.1128%2FAAC.29.5.955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endimiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Carbapenems: past, present, and future</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4943</span>– <span class="NLM_lpage">4960</span>, <span class="refDoi"> DOI: 10.1128/AAC.00296-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.00296-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=21859938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSru7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=4943-4960&author=K.+M.+Papp-Wallaceauthor=A.+Endimianiauthor=M.+A.+Taracilaauthor=R.+A.+Bonomo&title=Carbapenems%3A+past%2C+present%2C+and+future&doi=10.1128%2FAAC.00296-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenems: past, present, and future</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.; Endimiani, Andrea; Taracila, Magdalena A.; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4943-4960</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  In this review, we summarize the current "state of the art" of carbapenem antibiotics and their role in our antimicrobial armamentarium.  Among the β-lactams currently available, carbapenems are unique because they are relatively resistant to hydrolysis by most β-lactamases, in some cases act as "slow substrates" or inhibitors of β-lactamases, and still target penicillin binding proteins.  This "value-added feature" of inhibiting β-lactamases serves as a major rationale for expansion of this class of β-lactams.  We describe the initial discovery and development of the carbapenem family of β-lactams.  Of the early carbapenems evaluated, thienamycin demonstrated the greatest antimicrobial activity and became the parent compd. for all subsequent carbapenems.  To date, more than 80 compds. with mostly improved antimicrobial properties, compared to those of thienamycin, are described in the literature.  We also highlight important features of the carbapenems that are presently in clin. use: imipenem-cilastatin, meropenem, ertapenem, doripenem, panipenem-betamipron, and biapenem.  In closing, we emphasize some major challenges and urge the medicinal chemist to continue development of these versatile and potent compds., as they have served us well for more than 3 decades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Y-IuobRax7Vg90H21EOLACvtfcHk0liA-muB0djy2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSru7rJ&md5=5104ffe81fe097b4ae11a5c6a8fc7fb0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FAAC.00296-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00296-11%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DEndimiani%26aufirst%3DA.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DCarbapenems%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D4943%26epage%3D4960%26doi%3D10.1128%2FAAC.00296-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, P. A.</span></span> <span> </span><span class="NLM_article-title">Interplay between beta-lactamases and new beta-lactamase inhibitors</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1038/s41579-019-0159-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1038%2Fs41579-019-0159-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=30837684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmsV2it78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=295-306&author=K.+Bushauthor=P.+A.+Bradford&title=Interplay+between+beta-lactamases+and+new+beta-lactamase+inhibitors&doi=10.1038%2Fs41579-019-0159-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Interplay between β-lactamases and new β-lactamase inhibitors</span></div><div class="casAuthors">Bush, Karen; Bradford, Patricia A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">295-306</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Resistance to β-lactam antibiotics in Gram-neg. bacteria is commonly assocd. with prodn. of β-lactamases, including extended-spectrum β-lactamases (ESBLs) and carbapenemases belonging to different mol. classes: those with a catalytically active serine and those with at least one active-site Zn2+ to facilitate hydrolysis.  To counteract the hydrolytic activity of these enzymes, combinations of a β-lactam with a β-lactamase inhibitor (BLI) have been clin. successful.  However, some β-lactam-BLI combinations have lost their effectiveness against prevalent Gram-neg. pathogens that produce ESBLs, carbapenemases or multiple β-lactamases in the same organism.  In this Review, descriptions are provided for medically relevant β-lactamase families and various BLI combinations that have been developed or are under development.  Recently approved inhibitor combinations include the inhibitors avibactam and vaborbactam of the diazabicyclooctanone and boronic acid inhibitor classes, resp., as new scaffolds for future inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXtftw0FH0DbVg90H21EOLACvtfcHk0liA-muB0djy2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmsV2it78%253D&md5=a34fa17f62c7e7ff86b3c82960d7b465</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41579-019-0159-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41579-019-0159-8%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DK.%26aulast%3DBradford%26aufirst%3DP.%2BA.%26atitle%3DInterplay%2520between%2520beta-lactamases%2520and%2520new%2520beta-lactamase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2019%26volume%3D17%26spage%3D295%26epage%3D306%26doi%3D10.1038%2Fs41579-019-0159-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span> <span> </span><span class="NLM_article-title">Metallo-beta-lactamase structure and function</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1277</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2012.06796.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1111%2Fj.1749-6632.2012.06796.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=23163348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1277&publication_year=2013&pages=91-104&author=T.+Palzkill&title=Metallo-beta-lactamase+structure+and+function&doi=10.1111%2Fj.1749-6632.2012.06796.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Metallo-β-lactamase structure and function</span></div><div class="casAuthors">Palzkill, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1277</span>
        (<span class="NLM_cas:issue">Antimicrobial Therapeutics Reviews</span>),
    <span class="NLM_cas:pages">91-104</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Lactam antibiotics are the most commonly used antibacterial agents and growing resistance to these drugs is a concern.  Metallo-β-lactamases are a diverse set of enzymes that catalyze the hydrolysis of a broad range of β-lactam drugs including carbapenems.  This diversity is reflected in the observation that the enzyme mechanisms differ based on whether one or two zincs are bound in the active site that, in turn, is dependent on the subclass of β-lactamase.  The dissemination of the genes encoding these enzymes among Gram-neg. bacteria has made them an important cause of resistance.  In addn., there are currently no clin. available inhibitors to block metallo-β-lactamase action.  This review summarizes the numerous studies that have yielded insights into the structure, function, and mechanism of action of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKW_XazIQODLVg90H21EOLACvtfcHk0liA-muB0djy2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCgtb4%253D&md5=ceb4276f35d73e361e2c2fe27015ab8e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2012.06796.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2012.06796.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalzkill%26aufirst%3DT.%26atitle%3DMetallo-beta-lactamase%2520structure%2520and%2520function%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2013%26volume%3D1277%26spage%3D91%26epage%3D104%26doi%3D10.1111%2Fj.1749-6632.2012.06796.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span> <span> </span><span class="NLM_article-title">Emerging carbapenemases: a global perspective</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">S8</span>– <span class="NLM_lpage">S14</span>, <span class="refDoi"> DOI: 10.1016/S0924-8579(10)70004-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2FS0924-8579%2810%2970004-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=21129630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFant7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=S8-S14&author=T.+R.+Walsh&title=Emerging+carbapenemases%3A+a+global+perspective&doi=10.1016%2FS0924-8579%2810%2970004-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging carbapenemases: a global perspective</span></div><div class="casAuthors">Walsh, Timothy R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S8-S14</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The celestial rise in antibiotic resistance among Gram-neg. bacteria has challenged both the scientific and pharmaceutical sectors.  The hallmark of this general increase is the unbridled dissemination of carbapenem resistance genes, namely KPC, OXA and metallo-β-lactamase variants.  In particular, the media attention given to the NDM-1 metallo-β-lactamase has highlighted the global consequences of human behavior on spreading antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppOj-JqmWB2rVg90H21EOLACvtfcHk0ljI6_mKEvIHaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFant7%252FL&md5=82ca57681fcb369b0d30868e2c15fa41</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0924-8579%2810%2970004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-8579%252810%252970004-2%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26atitle%3DEmerging%2520carbapenemases%253A%2520a%2520global%2520perspective%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2010%26volume%3D36%26spage%3DS8%26epage%3DS14%26doi%3D10.1016%2FS0924-8579%2810%2970004-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenitsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagace-Wiens, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denisuik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. P.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlowsky, J. A.</span></span> <span> </span><span class="NLM_article-title">Ceftazidime-avibactam: a novel cephalosporin/beta-lactamase inhibitor combination</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1007/s40265-013-0013-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1007%2Fs40265-013-0013-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=23371303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWms7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=159-177&author=G.+G.+Zhanelauthor=C.+D.+Lawsonauthor=H.+Adamauthor=F.+Schweizerauthor=S.+Zelenitskyauthor=P.+R.+Lagace-Wiensauthor=A.+Denisuikauthor=E.+Rubinsteinauthor=A.+S.+Ginauthor=D.+J.+Hobanauthor=J.+P.+Lynchauthor=J.+A.+Karlowsky&title=Ceftazidime-avibactam%3A+a+novel+cephalosporin%2Fbeta-lactamase+inhibitor+combination&doi=10.1007%2Fs40265-013-0013-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination</span></div><div class="casAuthors">Zhanel, George G.; Lawson, Christopher D.; Adam, Heather; Schweizer, Frank; Zelenitsky, Sheryl; Lagace-Wiens, Philippe R. S.; Denisuik, Andrew; Rubinstein, Ethan; Gin, Alfred S.; Hoban, Daryl J.; Lynch, Joseph P., 3rd; Karlowsky, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-177</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and some Ambler class D enzymes.  This review summarizes the existing data published for ceftazidime-avibactam, including relevant chem., mechanisms of action and resistance, microbiol., pharmacokinetics, pharmacodynamics, and efficacy and safety data from animal and human trials.  Although not a β-lactam, the chem. structure of avibactam closely resembles portions of the cephem bicyclic ring system, and avibactam has been shown to bond covalently to β-lactamases.  Very little is known about the potential for avibactam to select for resistance.  The addn. of avibactam greatly (4-1024-fold min. inhibitory concn. [MIC] redn.) improves the activity of ceftazidime vs. most species of Enterobacteriaceae depending on the presence or absence of β-lactamase enzyme(s).  Against Pseudomonas aeruginosa, the addn. of avibactam also improves the activity of ceftazidime (∼fourfold MIC redn.).  Limited data suggest that the addn. of avibactam does not improve the activity of ceftazidime vs. Acinetobacter species or most anaerobic bacteria (exceptions: Bacteroides fragilis, Clostridium perfringens, Prevotella spp. and Porphyromonas spp.).  The pharmacokinetics of avibactam follow a two-compartment model and do not appear to be altered by the co-administration of ceftazidime.  The max. plasma drug concn. (Cmax) and area under the plasma concn.-time curve (AUC) of avibactam increase linearly with doses ranging from 50 mg to 2,000 mg.  The mean vol. of distribution and half-life of 22 L (∼0.3 L/kg) and ∼2 h, resp., are similar to ceftazidime.  Like ceftazidime, avibactam is primarily renally excreted, and clearance correlates with creatinine clearance.  Pharmacodynamic data suggest that ceftazidime-avibactam is rapidly bactericidal vs. β-lactamase-producing Gram-neg. bacilli that are not inhibited by ceftazidime alone.  Clin. trials to date have reported that ceftazidime-avibactam is as effective as std. carbapenem therapy in complicated intra-abdominal infection and complicated urinary tract infection, including infection caused by cephalosporin-resistant Gram-neg. isolates.  The safety and tolerability of ceftazidime-avibactam has been reported in three phase I pharmacokinetic studies and two phase II clin. studies.  Ceftazidime-avibactam appears to be well tolerated in healthy subjects and hospitalized patients, with few serious drug-related treatment-emergent adverse events reported to date.  In conclusion, avibactam serves to broaden the spectrum of ceftazidime vs. ss-lactamase-producing Gram-neg. bacilli.  The exact roles for ceftazidime-avibactam will be defined by efficacy and safety data from further clin. trials.  Potential future roles for ceftazidime-avibactam include the treatment of suspected or documented infections caused by resistant Gram-neg.-bacilli producing extended-spectrum ss-lactamase (ESBL), Klebsiella pneumoniae carbapenemases (KPCs) and/or AmpC ss-lactamases.  In addn., ceftazidime-avibactam may be used in combination (with metronidazole) for suspected polymicrobial infections.  Finally, the increased activity of ceftazidime-avibactam vs. P. aeruginosa may be of clin. benefit in patients with suspected or documented P. aeruginosa infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe6FoMOMncBbVg90H21EOLACvtfcHk0ljI6_mKEvIHaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWms7zO&md5=29776a4dd902a5e75f1971270fa545a5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs40265-013-0013-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-013-0013-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DLawson%26aufirst%3DC.%2BD.%26aulast%3DAdam%26aufirst%3DH.%26aulast%3DSchweizer%26aufirst%3DF.%26aulast%3DZelenitsky%26aufirst%3DS.%26aulast%3DLagace-Wiens%26aufirst%3DP.%2BR.%26aulast%3DDenisuik%26aufirst%3DA.%26aulast%3DRubinstein%26aufirst%3DE.%26aulast%3DGin%26aufirst%3DA.%2BS.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BP.%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26atitle%3DCeftazidime-avibactam%253A%2520a%2520novel%2520cephalosporin%252Fbeta-lactamase%2520inhibitor%2520combination%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26spage%3D159%26epage%3D177%26doi%3D10.1007%2Fs40265-013-0013-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehmann, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkup, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S. L.</span></span> <span> </span><span class="NLM_article-title">Avibactam is a covalent, reversible, non-beta-lactam beta-lactamase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">11663</span>– <span class="NLM_lpage">11668</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205073109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1073%2Fpnas.1205073109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=22753474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ciu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=11663-11668&author=D.+E.+Ehmannauthor=H.+Jahicauthor=P.+L.+Rossauthor=R.+F.+Guauthor=J.+Huauthor=G.+Kernauthor=G.+K.+Walkupauthor=S.+L.+Fisher&title=Avibactam+is+a+covalent%2C+reversible%2C+non-beta-lactam+beta-lactamase+inhibitor&doi=10.1073%2Fpnas.1205073109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor</span></div><div class="casAuthors">Ehmann, David E.; Jahic, Haris; Ross, Philip L.; Gu, Rong-Fang; Hu, Jun; Kern, Gunther; Walkup, Grant K.; Fisher, Stewart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">11663-11668, S11663/1-S11663/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Avibactam is a β-lactamase inhibitor that is in clin. development, combined with P-lactam partners, for the treatment of bacterial infections comprising Gram-neg. organisms.  Avibactam is a structural class of inhibitor that does not contain a β-lactam core but maintains the capacity to covalently acylate its β-lactamase targets.  Using the TEM-1 enzyme, we characterized avibactam inhibition by measuring the on-rate for acylation and the off-rate for deacylation.  The deacylation off-rate was 0.045 min-1, which allowed investigation of the deacylation route from TEM-1.  Using NMR and MS, we showed that deacylation proceeds through regeneration of intact avibactam and not hydrolysis.  Other than TEM-1, four addnl. clin. relevant β-lactamases were shown to release intact avibactam after being acylated.  We showed that avibactam is a covalent, slowly reversible inhibitor, which is a unique mechanism of inhibition among β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDBeJlngFA5LVg90H21EOLACvtfcHk0ljI6_mKEvIHaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ciu73K&md5=4da3c333df0a1eeb6ab84cabd65ab8ec</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205073109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205073109%26sid%3Dliteratum%253Aachs%26aulast%3DEhmann%26aufirst%3DD.%2BE.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DRoss%26aufirst%3DP.%2BL.%26aulast%3DGu%26aufirst%3DR.%2BF.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DKern%26aufirst%3DG.%26aulast%3DWalkup%26aufirst%3DG.%2BK.%26aulast%3DFisher%26aufirst%3DS.%2BL.%26atitle%3DAvibactam%2520is%2520a%2520covalent%252C%2520reversible%252C%2520non-beta-lactam%2520beta-lactamase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D11663%26epage%3D11668%26doi%3D10.1073%2Fpnas.1205073109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damblon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smargiasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercuri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frère, J.-M.</span></span> <span> </span><span class="NLM_article-title">Interaction of Avibactam with Class B Metallo-β-Lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5655</span>– <span class="NLM_lpage">5662</span>, <span class="refDoi"> DOI: 10.1128/AAC.00897-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.00897-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=27401561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=5655-5662&author=M.+I.+Abboudauthor=C.+Damblonauthor=J.+Bremauthor=N.+Smargiassoauthor=P.+Mercuriauthor=B.+Gilbertauthor=A.+M.+Rydzikauthor=T.+D.+W.+Claridgeauthor=C.+J.+Schofieldauthor=J.-M.+Fr%C3%A8re&title=Interaction+of+Avibactam+with+Class+B+Metallo-%CE%B2-Lactamases&doi=10.1128%2FAAC.00897-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of Avibactam with class B metallo-β-lactamases</span></div><div class="casAuthors">Abboud, Martine I.; Damblon, Christian; Brem, Jurgen; Smargiasso, Nicolas; Mercuri, Paola; Gilbert, Bernard; Rydzik, Anna M.; Claridge, Timothy D. W.; Schofield, Christopher J.; Frere, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5655-5662</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-Lactamases are the most important mechanisms of resistance to the β-lactam antibacterials.  There are two mechanistic classes of β-lactamases: the serine β-lactamases (SBLs) and the zinc-dependent metallo-β-lactamases (MBLs).  Avibactam, the first clin. useful non-β-lactam β-lactamase inhibitor, is a broad-spectrum SBL inhibitor, which is used in combination with a cephalosporin antibiotic (ceftazidime).  There are multiple reports on the interaction of avibactam with SBLs but few such studies with MBLs.  We report biochem. and biophys. studies on the binding and reactivity of avibactam with representatives from all 3 MBL subfamilies (B1, B2, and B3).  Avibactam has only limited or no activity vs. MBL-mediated resistance in pathogens.  Avibactam does not inhibit MBLs and binds only weakly to most of the MBLs tested; in some cases, avibactam undergoes slow hydrolysis of one of its urea N-CO bonds followed by loss of CO2, in a process different from that obsd. with the SBLs studied.  The results suggest that while the evolution of MBLs that more efficiently catalyze avibactam hydrolysis should be anticipated, pursuing the development of dual-action SBL and MBL inhibitors based on the diazabicyclooctane core of avibactam may be productive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSoutDc696brVg90H21EOLACvtfcHk0lj9Og72BeMS2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKkt74%253D&md5=e789376f6e1f32c28b2b26f3ed89e926</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FAAC.00897-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00897-16%26sid%3Dliteratum%253Aachs%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DDamblon%26aufirst%3DC.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSmargiasso%26aufirst%3DN.%26aulast%3DMercuri%26aufirst%3DP.%26aulast%3DGilbert%26aufirst%3DB.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DFr%25C3%25A8re%26aufirst%3DJ.-M.%26atitle%3DInteraction%2520of%2520Avibactam%2520with%2520Class%2520B%2520Metallo-%25CE%25B2-Lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D5655%26epage%3D5662%26doi%3D10.1128%2FAAC.00897-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e01224</span>– <span class="NLM_lpage">e01217</span>, <span class="refDoi"> DOI: 10.1128/AAC.01224-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.01224-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28971873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1CrtbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01224-e01217&author=C.+T.+Lohansauthor=J.+Bremauthor=C.+J.+Schofield&title=New+Delhi+Metallo-%CE%B2-Lactamase+1+Catalyzes+Avibactam+and+Aztreonam+Hydrolysis&doi=10.1128%2FAAC.01224-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis</span></div><div class="casAuthors">Lohans, Christopher T.; Brem, Juergen; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e01224-17/1-e01224-17/3</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpxK2A1fuBLVg90H21EOLACvtfcHk0lj9Og72BeMS2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1CrtbnO&md5=9ea98051adda394c81a86a8ee6851c99</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.01224-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01224-17%26sid%3Dliteratum%253Aachs%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DNew%2520Delhi%2520Metallo-%25CE%25B2-Lactamase%25201%2520Catalyzes%2520Avibactam%2520and%2520Aztreonam%2520Hydrolysis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01224%26epage%3De01217%26doi%3D10.1128%2FAAC.01224-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gareth, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvopiña, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widlake, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowson, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Profiling Interactions of Vaborbactam with Metallo-β-Lactamases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1981</span>– <span class="NLM_lpage">1984</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.05.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.bmcl.2019.05.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=31171422" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1981-1984&author=W.+Garethauthor=R.+C.+Langleyauthor=J.+M.+Tyrrellauthor=P.+Hinchliffeauthor=K.+Calvopi%C3%B1aauthor=C.+Tookeauthor=E.+Widlakeauthor=C.+G.+Dowsonauthor=J.+Spencerauthor=T.+R.+Walshauthor=C.+J.+Schofieldauthor=J.+Brem&title=Profiling+Interactions+of+Vaborbactam+with+Metallo-%CE%B2-Lactamases&doi=10.1016%2Fj.bmcl.2019.05.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.05.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.05.031%26sid%3Dliteratum%253Aachs%26aulast%3DGareth%26aufirst%3DW.%26aulast%3DLangley%26aufirst%3DR.%2BC.%26aulast%3DTyrrell%26aufirst%3DJ.%2BM.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DCalvopi%25C3%25B1a%26aufirst%3DK.%26aulast%3DTooke%26aufirst%3DC.%26aulast%3DWidlake%26aufirst%3DE.%26aulast%3DDowson%26aufirst%3DC.%2BG.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DProfiling%2520Interactions%2520of%2520Vaborbactam%2520with%2520Metallo-%25CE%25B2-Lactamases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D1981%26epage%3D1984%26doi%3D10.1016%2Fj.bmcl.2019.05.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Field-Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, F. E.</span></span> <span> </span><span class="NLM_article-title">Bortezomib (Velcade trade mark) in the Treatment of Multiple Myeloma</span>. <i>Ther. Clin. Risk Manage.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.2147/tcrm.2006.2.3.271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.2147%2Ftcrm.2006.2.3.271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=18360602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWltb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=271-279&author=A.+Field-Smithauthor=G.+J.+Morganauthor=F.+E.+Davies&title=Bortezomib+%28Velcade+trade+mark%29+in+the+Treatment+of+Multiple+Myeloma&doi=10.2147%2Ftcrm.2006.2.3.271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bortezomib (Velcade) in the treatment of multiple myeloma</span></div><div class="casAuthors">Field-Smith, Antonia; Morgan, Gareth J.; Davies, Faith E.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-279</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1176-6336</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  The introduction of bortezomib, a novel first-in-class proteasome inhibitor, has been a major break through in the treatment of multiple myeloma.  It is currently approved for the treatment of myeloma in the relapsed setting post transplant or as a second line treatment in patients unsuitable for transplantation.  In pre-clin. studies bortezomib showed a no. of different anti-myeloma effects including disruption of the cell cycle and induction of apoptosis, alteration of the bone marrow microenvironment and inhibition of nuclear factor kappa B (NFκB).  Due to its novel mechanism of action, bortezomib has been shown to induce responses in previously refractory patients (including those with poor risk cytogenetics), and results in an increased progression free and overall survival in relapsed patients when compared with dexamethasone treatment alone.  It is well tolerated and can be administered in the outpatient setting with manageable toxicities.  Peripheral neuropathy is the most common dose limiting toxicity and thrombocytopenia can generally be managed with platelet transfusions without reducing or omitting doses.  Bortezomib shows a synergistic effect in combination with dexamethasone and also sensitizes myeloma cells to the effects of other chemotherapeutic agents with major response rates of over 50% being shown in the relapsed setting.  Initial data from ongoing trials in front line therapy are encouraging with response rates of 80%-90% when bortezomib is given in combination with other agents and importantly, the ability to mobilize peripheral blood stem cells is not impaired.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-VhbO5d60LVg90H21EOLACvtfcHk0lj9Og72BeMS2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWltb7L&md5=a146395a750aaa853913d3014f03979a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2147%2Ftcrm.2006.2.3.271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Ftcrm.2006.2.3.271%26sid%3Dliteratum%253Aachs%26aulast%3DField-Smith%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DG.%2BJ.%26aulast%3DDavies%26aufirst%3DF.%2BE.%26atitle%3DBortezomib%2520%2528Velcade%2520trade%2520mark%2529%2520in%2520the%2520Treatment%2520of%2520Multiple%2520Myeloma%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manage.%26date%3D2006%26volume%3D2%26spage%3D271%26epage%3D279%26doi%3D10.2147%2Ftcrm.2006.2.3.271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focia, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span> <span> </span><span class="NLM_article-title">Nanomolar inhibitors of AmpC beta-lactamase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1021/ja0288338</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0288338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslOntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=685-695&author=F.+Morandiauthor=E.+Caselliauthor=S.+Morandiauthor=P.+J.+Fociaauthor=J.+Blazquezauthor=B.+K.+Shoichetauthor=F.+Prati&title=Nanomolar+inhibitors+of+AmpC+beta-lactamase&doi=10.1021%2Fja0288338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomolar Inhibitors of AmpC β-Lactamase</span></div><div class="casAuthors">Morandi, Federica; Caselli, Emilia; Morandi, Stefania; Focia, Pamela J.; Blazquez, Jesus; Shoichet, Brian K.; Prati, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">685-695</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and the cephalosporins.  In an effort to combat these enzymes, a combination of stereoselective org. synthesis, enzymol., microbiol., and X-ray crystallog. was used to design and evaluate new carboxyphenyl-glycylboronic acid transition-state analog inhibitors of the class C β-lactamase AmpC.  The new compds. improve inhibition by over 2 orders of magnitude compared to analogous glycylboronic acids, with Ki values as low as 1 nM.  On the basis of the differential binding of different analogs, the introduced carboxylate alone contributes about 2.1 kcal/mol in affinity.  This carboxylate corresponds to the ubiquitous C3(4)' carboxylate of β-lactams, and this energy represents the first thermodn. measurement of the importance of this group in mol. recognition by class C β-lactamases.  The structures of AmpC in complex with two of these inhibitors were detd. by X-ray crystallog. at 1.72 and 1.83 Å resoln.  These structures suggest a structural basis for the high affinity of the new compds. and provide templates for further design.  The highest affinity inhibitor was 5 orders of magnitude more selective for AmpC than for characteristic serine proteases, such as chymotrypsin.  This inhibitor reversed the resistance of clin. pathogens to the third generation cephalosporin ceftazidime; it may serve as a lead compd. for drug discovery to combat bacterial resistance to β-lactam antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR7LDmSNwdM7Vg90H21EOLACvtfcHk0lg4nrlCSX6Y2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslOntL4%253D&md5=308c88cbf5e16934025866276a6ae8e7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja0288338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0288338%26sid%3Dliteratum%253Aachs%26aulast%3DMorandi%26aufirst%3DF.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DMorandi%26aufirst%3DS.%26aulast%3DFocia%26aufirst%3DP.%2BJ.%26aulast%3DBlazquez%26aufirst%3DJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DPrati%26aufirst%3DF.%26atitle%3DNanomolar%2520inhibitors%2520of%2520AmpC%2520beta-lactamase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D685%26epage%3D695%26doi%3D10.1021%2Fja0288338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, R. A.</span></span> <span> </span><span class="NLM_article-title">Exploring the potential of boronic acids as inhibitors of OXA-24/40 beta-lactamase</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1002/pro.3100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1002%2Fpro.3100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=27997706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=515-526&author=J.+P.+Wernerauthor=J.+M.+Mitchellauthor=M.+A.+Taracilaauthor=R.+A.+Bonomoauthor=R.+A.+Powers&title=Exploring+the+potential+of+boronic+acids+as+inhibitors+of+OXA-24%2F40+beta-lactamase&doi=10.1002%2Fpro.3100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase</span></div><div class="casAuthors">Werner, Josephine P.; Mitchell, Joshua M.; Taracila, Magdalena A.; Bonomo, Robert A.; Powers, Rachel A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-526</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">β-Lactam antibiotics are crucial to the management of bacterial infections in the medical community.  Due to overuse and misuse, clin. significant bacteria are now resistant to many com. available antibiotics.  The most widespread resistance mechanism to β-lactams is the expression of β-lactamase enzymes.  To overcome β-lactamase mediated resistance, inhibitors were designed to inactivate these enzymes.  However, current inhibitors (clavulanic acid, tazobactam, and sulbactam) for β-lactamases also contain the characteristic β-lactam ring, making them susceptible to resistance mechanisms employed by bacteria.  This presents a crit. need for novel, non-β-lactam inhibitors that can circumvent these resistance mechanisms.  The carbapenem-hydrolyzing class D β-lactamases (CHDLs) are of particular concern, given that they efficiently hydrolyze potent carbapenem antibiotics.  Unfortunately, these enzymes are not inhibited by clin. available β-lactamase inhibitors, nor are they effectively inhibited by the newest, non-β-lactam inhibitor, avibactam.  Boronic acids are known transition state analog inhibitors of class A and C β-lactamases, and are not extensively characterized as inhibitors of class D β-lactamases.  Importantly, boronic acids provide a novel way to potentially inhibit class D β-lactamases.  Sixteen boronic acids were selected and tested for inhibition of the CHDL OXA-24/40.  Several compds. were identified as effective inhibitors of OXA-24/40, with Ki values as low as 5 μM.  The X-ray crystal structures of OXA-24/40 in complex with BA3, BA4, BA8, and BA16 were detd. and revealed the importance of interactions with hydrophobic residues Tyr112 and Trp115.  These boronic acids serve as progenitors in optimization efforts of a novel series of inhibitors for class D β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphGKFNJYCrO7Vg90H21EOLACvtfcHk0lg4nrlCSX6Y2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kisrg%253D&md5=73c4063f4a06e5cf8bd8262e17b6e611</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fpro.3100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3100%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DJ.%2BP.%26aulast%3DMitchell%26aufirst%3DJ.%2BM.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DPowers%26aufirst%3DR.%2BA.%26atitle%3DExploring%2520the%2520potential%2520of%2520boronic%2520acids%2520as%2520inhibitors%2520of%2520OXA-24%252F40%2520beta-lactamase%26jtitle%3DProtein%2520Sci.%26date%3D2017%26volume%3D26%26spage%3D515%26epage%3D526%26doi%3D10.1002%2Fpro.3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spellberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Boronic Acid Transition State Inhibitors Active against KPC and Other Class A beta-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1128/AAC.02641-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.02641-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=26729496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2mtL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1751-1759&author=L.+J.+Rojasauthor=M.+A.+Taracilaauthor=K.+M.+Papp-Wallaceauthor=C.+R.+Bethelauthor=E.+Caselliauthor=C.+Romagnoliauthor=M.+L.+Winklerauthor=B.+Spellbergauthor=F.+Pratiauthor=R.+A.+Bonomo&title=Boronic+Acid+Transition+State+Inhibitors+Active+against+KPC+and+Other+Class+A+beta-Lactamases%3A+Structure-Activity+Relationships+as+a+Guide+to+Inhibitor+Design&doi=10.1128%2FAAC.02641-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic acid transition state inhibitors active against KPC and other class A β-lactamases: structure-activity relationships as a guide to inhibitor design</span></div><div class="casAuthors">Rojas, Laura J.; Taracila, Magdalena A.; Papp-Wallace, Krisztina M.; Bethel, Christopher R.; Caselli, Emilia; Romagnoli, Chiara; Winkler, Marisa L.; Spellberg, Brad; Prati, Fabio; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1751-1759</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Boronic acid transition state inhibitors (BATSIs) are competitive, reversible β-lactamase inhibitors (BLIs).  In this study, a series of BATSIs with selectively modified regions (R1, R2, and amide group) were strategically designed and tested against representative class A β-lactamases of Klebsiella pneumoniae, KPC-2 and SHV-1.  Firstly, the R1 group of compds. 1a to 1c and 2a to 2e mimicked the side chain of cephalothin, whereas for compds. 3a to 3c, 4a, and 4b, the thiophene ring was replaced by a Ph, typical of benzylpenicillin.  Secondly, variations in the R2 groups which included substituted aryl side chains (compds. 1a, 1b, 1c, 3a, 3b, and 3c) and triazole groups (compds. 2a to 2e) were chosen to mimic the thiazolidine and dihydrothiazine ring of penicillins and cephalosporins, resp.  Thirdly, the amide backbone of the BATSI, which corresponds to the amide at C-6 or C-7 of β-lactams, was also changed to the following bioisosteric groups: urea (compd. 3b), thiourea (compd. 3c), and sulfonamide (compds. 4a and 4b).  Among the compds. that inhibited KPC-2 and SHV-1 β-lactamases, nine possessed 50% inhibitory concns. (IC50s) of ≤ 600 nM.  The most active compds. contained the thiopheneacetyl group at R1 and for the chiral BATSIs, a carboxy- or hydroxy-substituted aryl group at R2.  The most active sulfonamido deriv., compd. 4b, lacked an R2 group.  Compd. 2b (S02030) was the most active, with acylation rates (k2/K) of 1.2 ± 0.2 ± 104 M-1 s-1 for KPC-2 and 4.7 ± 0.6 × 103 M-1 s-1 for SHV-1, and demonstrated antimicrobial activity against Escherichia coli DH10B carrying blaSHV variants and blaKPC-2 or blaKPC-2 and against clin. strains of Klebsiella pneumoniae and E. coli producing different class A β-lactamase genes.  At most, MICs decreased from 16 to 0.5 mg/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHumxGp1lHkrVg90H21EOLACvtfcHk0lg4nrlCSX6Y2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2mtL3O&md5=490342c29e85e45e3bd1875eff15c583</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.02641-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02641-15%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DL.%2BJ.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DWinkler%26aufirst%3DM.%2BL.%26aulast%3DSpellberg%26aufirst%3DB.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DBoronic%2520Acid%2520Transition%2520State%2520Inhibitors%2520Active%2520against%2520KPC%2520and%2520Other%2520Class%2520A%2520beta-Lactamases%253A%2520Structure-Activity%2520Relationships%2520as%2520a%2520Guide%2520to%2520Inhibitor%2520Design%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D1751%26epage%3D1759%26doi%3D10.1128%2FAAC.02641-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. B.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1038/nsb0896-688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1038%2Fnsb0896-688" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=688-695&author=N.+C.+Strynadkaauthor=R.+Martinauthor=S.+E.+Jensenauthor=M.+Goldauthor=J.+B.+Jones&title=Structure-based+design+of+a+potent+transition+state+analogue+for+TEM-1+beta-lactamase&doi=10.1038%2Fnsb0896-688"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnsb0896-688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb0896-688%26sid%3Dliteratum%253Aachs%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DS.%2BE.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DJ.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520a%2520potent%2520transition%2520state%2520analogue%2520for%2520TEM-1%2520beta-lactamase%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D3%26spage%3D688%26epage%3D695%26doi%3D10.1038%2Fnsb0896-688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ness, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paetzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span> <span> </span><span class="NLM_article-title">Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">5312</span>– <span class="NLM_lpage">5321</span>, <span class="refDoi"> DOI: 10.1021/bi992505b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi992505b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVelsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=5312-5321&author=S.+Nessauthor=R.+Martinauthor=A.+M.+Kindlerauthor=M.+Paetzelauthor=M.+Goldauthor=S.+E.+Jensenauthor=J.+B.+Jonesauthor=N.+C.+Strynadka&title=Structure-based+design+guides+the+improved+efficacy+of+deacylation+transition+state+analogue+inhibitors+of+TEM-1+beta-Lactamase&doi=10.1021%2Fbi992505b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design Guides the Improved Efficacy of Deacylation Transition State Analogue Inhibitors of TEM-1 β-Lactamase</span></div><div class="casAuthors">Ness, Steven; Martin, Richard; Kindler, Alois M.; Paetzel, Mark; Gold, Marvin; Jensen, Susan E.; Jones, J. Bryan; Strynadka, Natalie C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5312-5321</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition state analog boronic acid inhibitors mimicking the structures and interactions of good penicillin substrates for the TEM-1 β-lactamase of Escherichia coli were designed using graphic analyses based on the enzyme's 1.7 Å crystallog. structure.  The synthesis of two of these transition state analogs, (1R)-1-phenylacetamido-2-(3-carboxyphenyl)ethylboronic acid (1) and (1R)-1-acetamido-2-(3-carboxy-2-hydroxyphenyl)ethylboronic acid (2), is reported.  Kinetic measurements show that, as designed, compds. 1 and 2 are highly effective deacylation transition state analog inhibitors of TEM-1 β-lactamase, with inhibition consts. of 5.9 and 13 nM, resp.  These values identify them as among the most potent competitive inhibitors yet reported for a β-lactamase.  The best inhibitor of the current series was (1R)-1-phenylacetamido-2-(3-carboxyphenyl)ethylboronic acid (1, KI = 5.9 nM), which resembles most closely the best known substrate of TEM-1, benzylpenicillin (penicillin G).  The high-resoln. crystallog. structures of these two inhibitors covalently bound to TEM-1 are also described.  In addn. to verifying the design features, these two structures show interesting and unanticipated changes in the active site area, including strong hydrogen bond formation, water displacement, and rearrangement of side chains.  The structures provide new insights into the further design of this potent class of β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-aQSFfZl_R7Vg90H21EOLACvtfcHk0ljzQoGn-SuM4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVelsr8%253D&md5=441c78891c1860f80e29660283299961</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi992505b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi992505b%26sid%3Dliteratum%253Aachs%26aulast%3DNess%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DKindler%26aufirst%3DA.%2BM.%26aulast%3DPaetzel%26aufirst%3DM.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DS.%2BE.%26aulast%3DJones%26aufirst%3DJ.%2BB.%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26atitle%3DStructure-based%2520design%2520guides%2520the%2520improved%2520efficacy%2520of%2520deacylation%2520transition%2520state%2520analogue%2520inhibitors%2520of%2520TEM-1%2520beta-Lactamase%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26spage%3D5312%26epage%3D5321%26doi%3D10.1021%2Fbi992505b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudin, A. K.</span></span> <span> </span><span class="NLM_article-title">The versatility of boron in biological target engagement</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1038/nchem.2814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1038%2Fnchem.2814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28754930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Gku7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=731-742&author=D.+B.+Diazauthor=A.+K.+Yudin&title=The+versatility+of+boron+in+biological+target+engagement&doi=10.1038%2Fnchem.2814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The versatility of boron in biological target engagement</span></div><div class="casAuthors">Diaz, Diego B.; Yudin, Andrei K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">731-742</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Boron-contg. mols. have been extensively used for the purposes of chem. sensing, biol. probe development, and drug discovery.  Due to boron's empty p orbital, it can coordinate to heteroatoms such as oxygen and nitrogen.  This reversible covalent mode of interaction has led to the use of boron as bait for nucleophilic residues in disease-assocd. proteins, culminating in the approval of new therapeutics that work by covalent mechanisms.  Our anal. of a wide range of covalent inhibitors with electrophilic groups suggests that boron is a unique electrophile in its chameleonic ability to engage protein targets.  Here, we review boron's interactions with a range of protein side-chain residues and reveal that boron's properties are nuanced and arise from its uncommon coordination preferences.  These mechanistic and structural insights should serve as a guide for the development of selective boron-based bioactive mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYy4b-paw5prVg90H21EOLACvtfcHk0ljzQoGn-SuM4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Gku7bF&md5=cf5669d184a5badc7101aa2e3d1f2500</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2814%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DD.%2BB.%26aulast%3DYudin%26aufirst%3DA.%2BK.%26atitle%3DThe%2520versatility%2520of%2520boron%2520in%2520biological%2520target%2520engagement%26jtitle%3DNat.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D731%26epage%3D742%26doi%3D10.1038%2Fnchem.2814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krajnc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduwawala, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Will morphing boron-based inhibitors beat the beta-lactamases?</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2019.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.cbpa.2019.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=31004962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXns1yrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2019&pages=101-110&author=A.+Krajncauthor=P.+A.+Langauthor=T.+D.+Panduwawalaauthor=J.+Bremauthor=C.+J.+Schofield&title=Will+morphing+boron-based+inhibitors+beat+the+beta-lactamases%3F&doi=10.1016%2Fj.cbpa.2019.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Will morphing boron-based inhibitors beat the β-lactamases?</span></div><div class="casAuthors">Krajnc, Alen; Lang, Pauline A.; Panduwawala, Tharindi D.; Brem, Jurgen; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The β-lactams remain the most important antibacterials, but their use is increasingly compromised by resistance, importantly by β-lactamases.  Although β-lactam and non-β-lactam inhibitors forming stable acyl-enzyme complexes with nucleophilic serine β-lactamases (SBLs) are widely used, these are increasingly susceptible to evolved SBLs and do not inhibit metallo-β-lactamases (MBLs).  Boronic acids and boronate esters, esp. cyclic ones, can potently inhibit both SBLs and MBLs.  Vaborbactam, a monocyclic boronate, is approved for clin. use, but its β-lactamase coverage is limited.  Bicyclic boronates rapidly react with SBLs and MBLs forming stable enzyme-inhibitor complexes that mimic the common anionic high-energy tetrahedral intermediates in SBL/MBL catalysis, as revealed by crystallog.  The ability of boronic acids to 'morph' between sp2 and sp3 hybridization states may help enable potent inhibition.  There is limited structure-activity relationship information on the (bi)cyclic boronate inhibitors compared to β-lactams, hence scope for creativity towards new boron-based β-lactamase inhibitors/antibacterials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYQIvXncI3a7Vg90H21EOLACvtfcHk0ljzQoGn-SuM4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXns1yrt7k%253D&md5=7e703c747a254766bda580563fb42a7f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2019.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2019.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DKrajnc%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DP.%2BA.%26aulast%3DPanduwawala%26aufirst%3DT.%2BD.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DWill%2520morphing%2520boron-based%2520inhibitors%2520beat%2520the%2520beta-lactamases%253F%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D50%26spage%3D101%26epage%3D110%26doi%3D10.1016%2Fj.cbpa.2019.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsivkovski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potts, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abendroth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loutit, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, M. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Cyclic Boronic Acid beta-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3682</span>– <span class="NLM_lpage">3692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3682-3692&author=S.+J.+Heckerauthor=K.+R.+Reddyauthor=M.+Totrovauthor=G.+C.+Hirstauthor=O.+Lomovskayaauthor=D.+C.+Griffithauthor=P.+Kingauthor=R.+Tsivkovskiauthor=D.+Sunauthor=M.+Sabetauthor=Z.+Taraziauthor=M.+C.+Cliftonauthor=K.+Atkinsauthor=A.+Raymondauthor=K.+T.+Pottsauthor=J.+Abendrothauthor=S.+H.+Boyerauthor=J.+S.+Loutitauthor=E.+E.+Morganauthor=S.+Dursoauthor=M.+N.+Dudley&title=Discovery+of+a+Cyclic+Boronic+Acid+beta-Lactamase+Inhibitor+%28RPX7009%29+with+Utility+vs+Class+A+Serine+Carbapenemases&doi=10.1021%2Facs.jmedchem.5b00127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases</span></div><div class="casAuthors">Hecker, Scott J.; Reddy, K. Raja; Totrov, Maxim; Hirst, Gavin C.; Lomovskaya, Olga; Griffith, David C.; King, Paula; Tsivkovski, Ruslan; Sun, Dongxu; Sabet, Mojgan; Tarazi, Ziad; Clifton, Matthew C.; Atkins, Kateri; Raymond, Amy; Potts, Kristy T.; Abendroth, Jan; Boyer, Serge H.; Loutit, Jeffrey S.; Morgan, Elizabeth E.; Durso, Stephanie; Dudley, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3682-3692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The increasing dissemination of carbapenemases in Gram-neg. bacteria has threatened the clin. usefulness of the β-lactam class of antimicrobials.  A program was initiated to discover a new series of serine β-lactamase inhibitors contg. a boronic acid pharmacophore, with the goal of finding a potent inhibitor of serine carbapenemase enzymes that are currently compromising the utility of the carbapenem class of antibacterials.  Potential lead structures were screened in silico by modeling into the active sites of key serine β-lactamases.  Promising candidate mols. were synthesized and evaluated in biochem. and whole-cell assays.  Inhibitors were identified with potent inhibition of serine carbapenemases, particularly the Klebsiella pneumoniae carbapenemase (KPC), with no inhibition of mammalian serine proteases.  Studies in vitro and in vivo show that RPX7009 (9f) is a broad-spectrum inhibitor, notably restoring the activity of carbapenems against KPC-producing strains.  Combined with a carbapenem, 9f is a promising product for the treatment of multidrug resistant Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpE5YX_dRNLVg90H21EOLACvtfcHk0lgT7kbBpke5nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2gs7g%253D&md5=965fbf2b42f2e1b38eccc3b23dfa374f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00127%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DGriffith%26aufirst%3DD.%2BC.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DTsivkovski%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DSabet%26aufirst%3DM.%26aulast%3DTarazi%26aufirst%3DZ.%26aulast%3DClifton%26aufirst%3DM.%2BC.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DRaymond%26aufirst%3DA.%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DBoyer%26aufirst%3DS.%2BH.%26aulast%3DLoutit%26aufirst%3DJ.%2BS.%26aulast%3DMorgan%26aufirst%3DE.%2BE.%26aulast%3DDurso%26aufirst%3DS.%26aulast%3DDudley%26aufirst%3DM.%2BN.%26atitle%3DDiscovery%2520of%2520a%2520Cyclic%2520Boronic%2520Acid%2520beta-Lactamase%2520Inhibitor%2520%2528RPX7009%2529%2520with%2520Utility%2520vs%2520Class%2520A%2520Serine%2520Carbapenemases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3682%26epage%3D3692%26doi%3D10.1021%2Facs.jmedchem.5b00127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhillon, S.</span></span> <span> </span><span class="NLM_article-title">Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1270</span>, <span class="refDoi"> DOI: 10.1007/s40265-018-0966-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1007%2Fs40265-018-0966-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=30128699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGjt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=1259-1270&author=S.+Dhillon&title=Meropenem%2FVaborbactam%3A+A+Review+in+Complicated+Urinary+Tract+Infections&doi=10.1007%2Fs40265-018-0966-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections</span></div><div class="casAuthors">Dhillon, Sohita</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1259-1270</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  The global threat of the spread of carbapenem resistance in Enterobacteriaceae has led to the search for new antibacterials.  I.v. meropenem/vaborbactam (Vabomere) is the first carbapenem/β-lactamase inhibitor combination approved in the USA for use in patients with complicated urinary tract infections (cUTIs), including pyelonephritis.  Vaborbactam is a potent inhibitor of class A serine carbapenemases, which, when combined with the antibacterial meropenem, restores the activity of meropenem against β-lactamase producing Enterobacteriaceae, particularly Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae.  In the phase 3, noninferiority TANGO I trial in patients with cUTIs, i.v. meropenem/vaborbactam was noninferior to i.v. piperacillin/tazobactam for overall success (composite of clin. cure and microbial eradication; FDA primary endpoint) and microbial eradication (EMA primary endpoint).  Meropenem/vaborbactam was generally well tolerated, with a tolerability profile generally similar to that of piperacillin/tazobactam.  TANGO I did not assess the efficacy of meropenem/vaborbactam for the treatment of infections caused by carbapenem-resistant Enterobacteriaceae and meropenem/vaborbactam is currently not indicated for these patients.  Available evidence indicates that meropenem/vaborbactam is a useful treatment option for patients with cUTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfbl_iY8DrWrVg90H21EOLACvtfcHk0lgT7kbBpke5nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGjt7vE&md5=61025d2c50c93af20f96fc70cbf60a32</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs40265-018-0966-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-018-0966-7%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26atitle%3DMeropenem%252FVaborbactam%253A%2520A%2520Review%2520in%2520Complicated%2520Urinary%2520Tract%2520Infections%26jtitle%3DDrugs%26date%3D2018%26volume%3D78%26spage%3D1259%26epage%3D1270%26doi%3D10.1007%2Fs40265-018-0966-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio-Aparicio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsivkovski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, M. N.</span></span> <span> </span><span class="NLM_article-title">Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e01443</span>– <span class="NLM_lpage">e01417</span>, <span class="refDoi"> DOI: 10.1128/AAC.01443-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.01443-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28848018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsl2jur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01443-e01417&author=O.+Lomovskayaauthor=D.+Sunauthor=D.+Rubio-Aparicioauthor=K.+Nelsonauthor=R.+Tsivkovskiauthor=D.+C.+Griffithauthor=M.+N.+Dudley&title=Vaborbactam%3A+Spectrum+of+Beta-Lactamase+Inhibition+and+Impact+of+Resistance+Mechanisms+on+Activity+in+Enterobacteriaceae&doi=10.1128%2FAAC.01443-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Vaborbactam: spectrum of beta- lactamase inhibition and impact of resistance mechanisms on activity in Enterobacteriaceae</span></div><div class="casAuthors">Lomovskaya, Olga; Sun, Dongxu; Rubio-Aparicio, Debora; Nelson, Kirk; Tsivkovski, Ruslan; Griffith, David C.; Dudley, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e01443-17/1-e01443-17/15</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Vaborbactam (formerly RPX7009) is a new beta-lactamase inhibitor based on a cyclic boronic acid pharmacophore.  The spectrum of beta-lactamase inhibition by vaborbactam and the impact of bacterial efflux and permeability on its activity were detd. using a panel of strains with beta-lactamases cloned from various classes and a panel of Klebsiella pneumoniae carbapenemase 3 (KPC-3)-producing isogenic strains with various combinations of efflux and porin mutations.  Vaborbactam is a potent inhibitor of class A carbapenemases, such as KPC, as well as an inhibitor of other class A (CTX-M, SHV, TEM) and class C (P99, MIR, FOX) beta-lactamases.  Vaborbactam does not inhibit class D or class B carbapenemases.  When combined with meropenem, vaborbactam had the highest potency compared to the potencies of vaborbactam in combination with other antibiotics against strains producing the KPC beta-lactamase.  Consistent with broad-spectrum beta-lactamase inhibition, vaborbactam reduced the meropenem MICs for engineered isogenic strains of K. pneumoniae with increased meropenem MICs due to a combination of extended-spectrum beta-lactamase prodn., class C betalactamase prodn., and reduced permeability due to porin mutations.  Vaborbactam crosses the outer membrane of K. pneumoniae using both OmpK35 and OmpK36, but OmpK36 is the preferred porin.  Efflux by the multidrug resistance efflux pump AcrAB-TolC had a minimal impact on vaborbactam activity.  Investigation of the vaborbactam concn. necessary for restoration of meropenem potency showed that vaborbactam at 8 g/mL results in meropenem MICs of ≤ 2 g/mL in the most resistant engineered strains contg. multiple mutations.  Vaborbactam is a highly active betalactamase inhibitor that restores the activity of meropenem and other beta-lactam antibiotics in beta-lactamase-producing bacteria, particularly KPC-producing carbapenemresistant Enterobacteriaceae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxqM5yJaqrZ7Vg90H21EOLACvtfcHk0lgT7kbBpke5nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsl2jur4%253D&md5=657d37b1378a7d2d9ba9f829e73e8221</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.01443-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01443-17%26sid%3Dliteratum%253Aachs%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DRubio-Aparicio%26aufirst%3DD.%26aulast%3DNelson%26aufirst%3DK.%26aulast%3DTsivkovski%26aufirst%3DR.%26aulast%3DGriffith%26aufirst%3DD.%2BC.%26aulast%3DDudley%26aufirst%3DM.%2BN.%26atitle%3DVaborbactam%253A%2520Spectrum%2520of%2520Beta-Lactamase%2520Inhibition%2520and%2520Impact%2520of%2520Resistance%2520Mechanisms%2520on%2520Activity%2520in%2520Enterobacteriaceae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01443%26epage%3De01417%26doi%3D10.1128%2FAAC.01443-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Castellanos, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">12406</span> <span class="refDoi"> DOI: 10.1038/ncomms12406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1038%2Fncomms12406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=27499424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaks7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=J.+Bremauthor=R.+Cainauthor=S.+Cahillauthor=M.+A.+McDonoughauthor=I.+J.+Cliftonauthor=J.-C.+Jim%C3%A9nez-Castellanosauthor=M.+B.+Avisonauthor=J.+Spencerauthor=C.+W.+G.+Fishwickauthor=C.+J.+Schofield&title=Structural+basis+of+metallo-%CE%B2-lactamase%2C+serine-%CE%B2-lactamase+and+penicillin-binding+protein+inhibition+by+cyclic+boronates&doi=10.1038%2Fncomms12406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates</span></div><div class="casAuthors">Brem, Jurgen; Cain, Ricky; Cahill, Samuel; McDonough, Michael A.; Clifton, Ian J.; Jimenez-Castellanos, Juan-Carlos; Avison, Matthew B.; Spencer, James; Fishwick, Colin W. G.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12406</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Lactamases enable resistance to almost all β-lactam antibiotics.  Pioneering work revealed that acyclic boronic acids can act as 'transition state analog' inhibitors of nucleophilic serine enzymes, including serine-β-lactamases.  Here we report biochem. and biophys. analyses revealing that cyclic boronates potently inhibit both nucleophilic serine and zinc-dependent β-lactamases by a mechanism involving mimicking of the common tetrahedral intermediate.  Cyclic boronates also potently inhibit the non-essential penicillin-binding protein PBP 5 by the same mechanism of action.  The results open the way for development of dual action inhibitors effective against both serine- and metallo-β-lactamases, and which could also have antimicrobial activity through inhibition of PBPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod70NVhmwa-7Vg90H21EOLACvtfcHk0lj0zU4AQ0lepQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaks7fM&md5=ec35f6a2ffbfe52b9046821526658492</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fncomms12406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12406%26sid%3Dliteratum%253Aachs%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DCahill%26aufirst%3DS.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DJim%25C3%25A9nez-Castellanos%26aufirst%3DJ.-C.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520metallo-%25CE%25B2-lactamase%252C%2520serine-%25CE%25B2-lactamase%2520and%2520penicillin-binding%2520protein%2520inhibition%2520by%2520cyclic%2520boronates%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fncomms12406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oswin, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Cyclic Boronates Inhibit All Classes of β-Lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e02260</span>– <span class="NLM_lpage">e02216</span>, <span class="refDoi"> DOI: 10.1128/AAC.02260-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.02260-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28115348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFeksbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e02260-e02216&author=S.+T.+Cahillauthor=R.+Cainauthor=D.+Y.+Wangauthor=C.+T.+Lohansauthor=D.+W.+Warehamauthor=H.+P.+Oswinauthor=J.+Mohammedauthor=J.+Spencerauthor=C.+W.+G.+Fishwickauthor=M.+A.+McDonoughauthor=C.+J.+Schofieldauthor=J.+Brem&title=Cyclic+Boronates+Inhibit+All+Classes+of+%CE%B2-Lactamases&doi=10.1128%2FAAC.02260-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic boronates inhibit all classes of β-lactamases</span></div><div class="casAuthors">Cahill, Samuel T.; Cain, Ricky; Wang, David Y.; Lohans, Christopher T.; Wareham, David W.; Oswin, Henry P.; Mohammed, Jabril; Spencer, James; Fishwick, Colin W. G.; McDonough, Michael A.; Schofield, Christopher J.; Brem, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e02260-16/1-e02260-16/13</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-Lactamase-mediated resistance is a growing threat to the continued use of β-lactam antibiotics.  The use of the β-lactam-based serine-β-lactamase (SBL) inhibitors clavulanic acid, sulbactam, and tazobactam and, more recently, the non-β-lactam inhibitor avibactam has extended the utility of β-lactams against bacterial infections demonstrating resistance via these enzymes.  These mols. are, however, ineffective against the metallo-β-lactamases (MBLs), which catalyze their hydrolysis.  To date, there are no clin. available metallo-β-lactamase inhibitors.  Coprodn. of MBLs and SBLs in resistant infections is thus of major clin. concern.  The development of "dual-action" inhibitors, targeting both SBLs and MBLs, is of interest, but this is considered difficult to achieve due to the structural and mechanistic differences between the two enzyme classes.  We recently reported evidence that cyclic boronates can inhibit both serine- and metallo-β-lactamases.  Here we report that cyclic boronates are able to inhibit all four classes of β-lactamase, including the class A extended spectrum β-lactamase CTX-M-15, the class C enzyme AmpC from Pseudomonas aeruginosa, and class D OXA enzymes with carbapenem-hydrolyzing capabilities.  We demonstrate that cyclic boronates can potentiate the use of β-lactams against Gram-neg. clin. isolates expressing a variety of β-lactamases.  Comparison of a crystal structure of a CTX-M-15:cyclic boronate complex with structures of cyclic boronates complexed with other β-lactamases reveals remarkable conservation of the small-mol. binding mode, supporting our proposal that these mols. work by mimicking the common tetrahedral anionic intermediate present in both serine- and metallo-β-lactamase catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUZbpAmThEjrVg90H21EOLACvtfcHk0lj0zU4AQ0lepQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFeksbnE&md5=829de86b71e9f23c0b131f3b95b7869c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FAAC.02260-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02260-16%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DS.%2BT.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DD.%2BY.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DOswin%26aufirst%3DH.%2BP.%26aulast%3DMohammed%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DCyclic%2520Boronates%2520Inhibit%2520All%2520Classes%2520of%2520%25CE%25B2-Lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De02260%26epage%3De02216%26doi%3D10.1128%2FAAC.02260-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navratilova, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvopina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Studies on the inhibition of AmpC and other beta-lactamases by cyclic boronates</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2019.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.bbagen.2019.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=30738906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivFSqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2019&pages=742-748&author=S.+T.+Cahillauthor=J.+M.+Tyrrellauthor=I.+H.+Navratilovaauthor=K.+Calvopinaauthor=S.+W.+Robinsonauthor=C.+T.+Lohansauthor=M.+A.+McDonoughauthor=R.+Cainauthor=C.+W.+G.+Fishwickauthor=M.+B.+Avisonauthor=T.+R.+Walshauthor=C.+J.+Schofieldauthor=J.+Brem&title=Studies+on+the+inhibition+of+AmpC+and+other+beta-lactamases+by+cyclic+boronates&doi=10.1016%2Fj.bbagen.2019.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates</span></div><div class="casAuthors">Cahill, Samuel T.; Tyrrell, Jonathan M.; Navratilova, Iva Hopkins; Calvopina, Karina; Robinson, Sean W.; Lohans, Christopher T.; McDonough, Michael A.; Cain, Ricky; Fishwick, Colin W. G.; Avison, Matthew B.; Walsh, Timothy R.; Schofield, Christopher J.; Brem, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">742-748</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The β-lactam antibiotics represent the most successful drug class for treatment of bacterial infections.  Resistance to them, importantly via prodn. of β-lactamases, which collectively are able to hydrolyze all classes of β-lactams, threatens their continued widespread use.  Bicyclic boronates show potential as broad spectrum inhibitors of the mechanistically distinct serine- (SBL) and metallo- (MBL) β-lactamase families.  Using biophys. methods, including crystallog. anal., we have investigated the binding mode of bicyclic boronates to clin. important β-lactamases.  Induction expts. and agar-based MIC screening against MDR-Enterobacteriaceae (n = 132) were used to evaluate induction properties and the in vitro efficacy of a bicyclic boronate in combination with meropenem.  Crystallog. anal. of a bicyclic boronate in complex with AmpC from Pseudomonas aeruginosa reveals it binds to form a tetrahedral boronate species.  Microbiol. studies on the clin. coverage (in combination with meropenem) and induction of β-lactamases by bicyclic boronates further support the promise of such compds. as broad spectrum β-lactamase inhibitors.  Together with reported studies on the structural basis of their inhibition of class A, B and D β-lactamases, biophys. studies, including crystallog. anal., support the proposal that bicyclic boronates mimic tetrahedral intermediates common to SBL and MBL catalysis.  Bicyclic boronates are a new generation of broad spectrum inhibitors of both SBLs and MBLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphrtl6rzz_pbVg90H21EOLACvtfcHk0lj0zU4AQ0lepQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivFSqsbo%253D&md5=2437a9feb705e3e7d2390b11a611e611</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2019.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DS.%2BT.%26aulast%3DTyrrell%26aufirst%3DJ.%2BM.%26aulast%3DNavratilova%26aufirst%3DI.%2BH.%26aulast%3DCalvopina%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DStudies%2520on%2520the%2520inhibition%2520of%2520AmpC%2520and%2520other%2520beta-lactamases%2520by%2520cyclic%2520boronates%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2019%26volume%3D1863%26spage%3D742%26epage%3D748%26doi%3D10.1016%2Fj.bbagen.2019.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span></span> <span> </span><span class="NLM_article-title">Beta-Lactamase Inhibitors</span>. WO Patent <span class="NLM_patent">WO 2014/089365 A1</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Burns%2C+C.+J.%3B+Daigle%2C+D.%3B+Liu%2C+B.%3B+McGarry%2C+D.%3B+Pevear%2C+D.+C.%3B+Trout%2C+R.+E.+L.+Beta-Lactamase+Inhibitors.+WO+Patent+WO+2014%2F089365+A1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-Lactamase%2520Inhibitors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mushtaq, S.</span>; <span class="NLM_string-name">Vickers, A.</span>; <span class="NLM_string-name">Woodford, N.</span>; <span class="NLM_string-name">Livermore, D. M.</span></span> <i>Potentiation of cefepime by the boronate VNRX-5133 versus gram-negative bacteria with known β-lactamases</i>; <span class="NLM_publisher-name">European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid</span>: <span class="NLM_publisher-loc">Spain</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Mushtaq&author=A.+Vickers&author=N.+Woodford&author=D.+M.+Livermore&title=Potentiation+of+cefepime+by+the+boronate+VNRX-5133+versus+gram-negative+bacteria+with+known+%CE%B2-lactamases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMushtaq%26aufirst%3DS.%26btitle%3DPotentiation%2520of%2520cefepime%2520by%2520the%2520boronate%2520VNRX-5133%2520versus%2520gram-negative%2520bacteria%2520with%2520known%2520%25CE%25B2-lactamases%26pub%3DEuropean%2520Congress%2520of%2520Clinical%2520Microbiology%2520and%2520Infectious%2520Diseases%2520%2528ECCMID%2529%2520in%2520Madrid%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackel Meredith, D. S.</span></span> <i>Antimicrobial Activity of Cefepime in Combination with VNRX-5133 Against a Global 2018 Surveillance Collection of Clinical Isolates</i>; <span class="NLM_publisher-name">European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam</span>: <span class="NLM_publisher-loc">The Netherlands</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=D.+S.+Hackel+Meredith&title=Antimicrobial+Activity+of+Cefepime+in+Combination+with+VNRX-5133+Against+a+Global+2018+Surveillance+Collection+of+Clinical+Isolates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHackel%2BMeredith%26aufirst%3DD.%2BS.%26btitle%3DAntimicrobial%2520Activity%2520of%2520Cefepime%2520in%2520Combination%2520with%2520VNRX-5133%2520Against%2520a%2520Global%25202018%2520Surveillance%2520Collection%2520of%2520Clinical%2520Isolates%26pub%3DEuropean%2520Congress%2520of%2520Clinical%2520Microbiology%2520and%2520Infectious%2520Diseases%2520%2528ECCMID%2529%2520in%2520Amsterdam%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamrick, J. C.</span>; <span class="NLM_string-name">Chatwin, C. L.</span>; <span class="NLM_string-name">John, K. J.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Xerri, L.</span></span> <i>The Ability of Broad-spectrum β-Lactamase Inhibitor Vnrx-5133 to Restore Bactericidal Activity of Cefepime in Enterobacteriaceae and P. aeruginosa-Expressing Ambler Class A, B, C and D Enzymes is Demonstrated Using Time-Kill Kinetics</i>; <span class="NLM_publisher-name">European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid</span>: <span class="NLM_publisher-loc">Spain</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+C.+Hamrick&author=C.+L.+Chatwin&author=K.+J.+John&author=D.+C.+Pevear&author=C.+J.+Burns&author=L.+Xerri&title=The+Ability+of+Broad-spectrum+%CE%B2-Lactamase+Inhibitor+Vnrx-5133+to+Restore+Bactericidal+Activity+of+Cefepime+in+Enterobacteriaceae+and+P.+aeruginosa-Expressing+Ambler+Class+A%2C+B%2C+C+and+D+Enzymes+is+Demonstrated+Using+Time-Kill+Kinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHamrick%26aufirst%3DJ.%2BC.%26btitle%3DThe%2520Ability%2520of%2520Broad-spectrum%2520%25CE%25B2-Lactamase%2520Inhibitor%2520Vnrx-5133%2520to%2520Restore%2520Bactericidal%2520Activity%2520of%2520Cefepime%2520in%2520Enterobacteriaceae%2520and%2520P.%2520aeruginosa-Expressing%2520Ambler%2520Class%2520A%252C%2520B%252C%2520C%2520and%2520D%2520Enzymes%2520is%2520Demonstrated%2520Using%2520Time-Kill%2520Kinetics%26pub%3DEuropean%2520Congress%2520of%2520Clinical%2520Microbiology%2520and%2520Infectious%2520Diseases%2520%2528ECCMID%2529%2520in%2520Madrid%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, D. S.</span></span> <span> </span><span class="NLM_article-title">Boronic esters in asymmetric synthesis</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">10009</span>– <span class="NLM_lpage">10023</span>, <span class="refDoi"> DOI: 10.1021/jo4013942</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo4013942" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=10009-10023&author=D.+S.+Matteson&title=Boronic+esters+in+asymmetric+synthesis&doi=10.1021%2Fjo4013942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic Esters in Asymmetric Synthesis</span></div><div class="casAuthors">Matteson, Donald S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10009-10023</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review discusses the work of Professor Donald Matteson and his research group in the enantioselective synthesis of α-substituted boronic acid esters and their derivs. using the diastereoselective insertion of lithiated dihalomethanes into nonracemic boronates and subsequent substitution reactions as the key steps; the use of the method in the synthesis of insect pheromones and α-amino boronic acid amino acid analogs are discussed.  The use of nonracemic diol auxiliaries for enantioselective boronate ester synthesis, particularly pinanediols, is discussed and the advantages and limitations of the discussed methods for boronate ester synthesis are delineated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppRJ5y69-SqbVg90H21EOLACvtfcHk0lhCW4vVKgJ_kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsr7K&md5=b81acd35a955663e4be806cf65bbbd6c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo4013942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo4013942%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26atitle%3DBoronic%2520esters%2520in%2520asymmetric%2520synthesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26spage%3D10009%26epage%3D10023%26doi%3D10.1021%2Fjo4013942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span> <span> </span><span class="NLM_article-title">Homologation of Boronic Esters to Alpha-Chloro Boronic Esters</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1529</span>– <span class="NLM_lpage">1535</span>, <span class="refDoi"> DOI: 10.1021/om50005a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om50005a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaL3sXlslGrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1983&pages=1529-1535&author=D.+S.+Mattesonauthor=D.+Majumdar&title=Homologation+of+Boronic+Esters+to+Alpha-Chloro+Boronic+Esters&doi=10.1021%2Fom50005a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Homologation of boronic esters to α-chloro boronic esters</span></div><div class="casAuthors">Matteson, Donald S.; Majumdar, Debesh</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1529-35</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    </div><div class="casAbstract">The homologation of boronic esters (I, R = primary, secondary, or tertiary alkyl, cycloalkyl, alkenyl, allyl, aryl, or benzyl, and functional substituents in R may include α-benzyloxy, β or remote carbalkoxy, or a remote ketal substituent; R1 = H or Me) with (dichloromethyl)lithium to form α-chloro boronic esters II has been found to be a highly efficient process.  The homologation failed in the presence of an α-phenylthio or an α-boronic ester substituent.  The α-chloro boronic esters readily undergo nucleophilic replacement of chloride with a variety of reagents, including thiophenolate, benzyl oxide, an ester enolate, or alkyl groups from Grignard or lithium reagents.  Either 100% C-alkylation or a majority of O-alkylation and Cope rearrangement could be obtained when tert-Bu lithioacetate reacted with pinacol 3-chloro-1-propene-3-boronate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAlGjGhBVPhrVg90H21EOLACvtfcHk0lhCW4vVKgJ_kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslGrtrw%253D&md5=585036c9e7af21592e9fd9ffaffcf71e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fom50005a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom50005a008%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DMajumdar%26aufirst%3DD.%26atitle%3DHomologation%2520of%2520Boronic%2520Esters%2520to%2520Alpha-Chloro%2520Boronic%2520Esters%26jtitle%3DOrganometallics%26date%3D1983%26volume%3D2%26spage%3D1529%26epage%3D1535%26doi%3D10.1021%2Fom50005a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, R.</span></span> <span> </span><span class="NLM_article-title">Directed Chiral Synthesis with Pinanediol Boronic Esters</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">7590</span>– <span class="NLM_lpage">7591</span>, <span class="refDoi"> DOI: 10.1021/ja00545a046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00545a046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaL3MXjtV2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=7590-7591&author=D.+S.+Mattesonauthor=R.+Ray&title=Directed+Chiral+Synthesis+with+Pinanediol+Boronic+Esters&doi=10.1021%2Fja00545a046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Directed chiral synthesis with pinanediol boronic esters</span></div><div class="casAuthors">Matteson, Donald S.; Ray, Rahul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7590-1</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Homologation of boronic esters of (+)-I with LiCHCl2 gave S-α-chloroalkaneboronic esters with high stereoselectivity.  Thus, homologation of II (R = Ph) to S-II (R = PhCHCl) which was treated with MeMgBr to give S-II (R = PhCHMe) which was oxidized to give 93.7% pure S-PhCHMeOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryK2_djJ6WQLVg90H21EOLACvtfcHk0lhCW4vVKgJ_kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXjtV2nsg%253D%253D&md5=e91984e6c035eeadec90335d4401426c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja00545a046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00545a046%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DRay%26aufirst%3DR.%26atitle%3DDirected%2520Chiral%2520Synthesis%2520with%2520Pinanediol%2520Boronic%2520Esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26spage%3D7590%26epage%3D7591%26doi%3D10.1021%2Fja00545a046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coste, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le-Nguyen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, B.</span></span> <span> </span><span class="NLM_article-title">PyBOP: A new peptide coupling reagent devoid of toxic by-product</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)94371-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2FS0040-4039%2800%2994371-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaK3cXkslyqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1990&pages=205-208&author=J.+Costeauthor=D.+Le-Nguyenauthor=B.+Castro&title=PyBOP%3A+A+new+peptide+coupling+reagent+devoid+of+toxic+by-product&doi=10.1016%2FS0040-4039%2800%2994371-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">PyBOP:  a new peptide coupling reagent devoid of toxic byproduct</span></div><div class="casAuthors">Coste, J.; Le-Nguyen, D.; Castro, B.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-8</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The title compd., benzotriazolyloxytris(pyrrolidine)phosphonium hexafluorophosphate (I, R = pyrrolidino), an analog of BOP (I, R = NMe2), is the only analog exhibiting equiv. properties in peptide bond formation.  It can be used instead of BOP for the sake of safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq9vtgwdipVLVg90H21EOLACvtfcHk0ljOZhwrSZpAaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslyqtro%253D&md5=41bcec259d56a4a598f56cc778fa57ea</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2994371-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252994371-5%26sid%3Dliteratum%253Aachs%26aulast%3DCoste%26aufirst%3DJ.%26aulast%3DLe-Nguyen%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DB.%26atitle%3DPyBOP%253A%2520A%2520new%2520peptide%2520coupling%2520reagent%2520devoid%2520of%2520toxic%2520by-product%26jtitle%3DTetrahedron%2520Lett.%26date%3D1990%26volume%3D31%26spage%3D205%26epage%3D208%26doi%3D10.1016%2FS0040-4039%2800%2994371-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Berkel, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salimraj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Assay platform for clinically relevant metallo-beta-lactamases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6945</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1021/jm400769b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400769b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2qsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6945-6953&author=S.+S.+van%0ABerkelauthor=J.+Bremauthor=A.+M.+Rydzikauthor=R.+Salimrajauthor=R.+Cainauthor=A.+Vermaauthor=R.+J.+Owensauthor=C.+W.+Fishwickauthor=J.+Spencerauthor=C.+J.+Schofield&title=Assay+platform+for+clinically+relevant+metallo-beta-lactamases&doi=10.1021%2Fjm400769b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Assay Platform for Clinically Relevant Metallo-β-lactamases</span></div><div class="casAuthors">van Berkel, Sander S.; Brem, Jurgen; Rydzik, Anna M.; Salimraj, Ramya; Cain, Ricky; Verma, Anil; Owens, Raymond J.; Fishwick, Colin W. G.; Spencer, James; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6945-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metallo-β-lactamases (MBLs) are a growing threat to the use of almost all clin. used β-lactam antibiotics.  The identification of broad-spectrum MBL inhibitors is hampered by the lack of a suitable screening platform, consisting of appropriate substrates and a set of clin. relevant MBLs.  We report procedures for the prepn. of a set of clin. relevant metallo-β-lactamases (i.e., NDM-1 (New Delhi MBL), IMP-1 (Imipenemase), SPM-1 (Sao Paulo MBL), and VIM-2 (Verona integron-encoded MBL)) and the identification of suitable fluorogenic substrates (umbelliferone-derived cephalosporins).  The fluorogenic substrates were compared to chromogenic substrates (CENTA, nitrocefin, and imipenem), showing improved sensitivity and kinetic parameters.  The efficiency of the fluorogenic substrates was exemplified by inhibitor screening, identifying 4-chloroisoquinolinols as potential pan MBL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeR_KCHkVUErVg90H21EOLACvtfcHk0ljOZhwrSZpAaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2qsL3M&md5=033f9dbfc850699c9c319a4db0d2046d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm400769b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400769b%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBerkel%26aufirst%3DS.%2BS.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DSalimraj%26aufirst%3DR.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DOwens%26aufirst%3DR.%2BJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DAssay%2520platform%2520for%2520clinically%2520relevant%2520metallo-beta-lactamases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6945%26epage%3D6953%26doi%3D10.1021%2Fjm400769b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamrick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatwin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurepina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiswirth, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clancy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pevear, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xerri, L.</span></span> <span> </span><span class="NLM_article-title">1370. Cefepime/VNRX-5133 Broad-Spectrum Activity Is Maintained Against Emerging KPC- and PDC-Variants in Multidrug-Resistant <i>K. pneumoniae</i> and <i>P. aeruginosa</i></span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S419</span>– <span class="NLM_lpage">S420</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fofid%2Fofy210.1201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S419-S420&author=D.+Daigleauthor=J.+Hamrickauthor=C.+Chatwinauthor=N.+Kurepinaauthor=B.+N.+Kreiswirthauthor=R.+K.+Shieldsauthor=A.+Oliverauthor=C.+J.+Clancyauthor=M.-H.+Nguyenauthor=D.+Pevearauthor=L.+Xerri&title=1370.+Cefepime%2FVNRX-5133+Broad-Spectrum+Activity+Is+Maintained+Against+Emerging+KPC-+and+PDC-Variants+in+Multidrug-Resistant+K.+pneumoniae+and+P.+aeruginosa&doi=10.1093%2Fofid%2Fofy210.1201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1201%26sid%3Dliteratum%253Aachs%26aulast%3DDaigle%26aufirst%3DD.%26aulast%3DHamrick%26aufirst%3DJ.%26aulast%3DChatwin%26aufirst%3DC.%26aulast%3DKurepina%26aufirst%3DN.%26aulast%3DKreiswirth%26aufirst%3DB.%2BN.%26aulast%3DShields%26aufirst%3DR.%2BK.%26aulast%3DOliver%26aufirst%3DA.%26aulast%3DClancy%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DM.-H.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DXerri%26aufirst%3DL.%26atitle%3D1370.%2520Cefepime%252FVNRX-5133%2520Broad-Spectrum%2520Activity%2520Is%2520Maintained%2520Against%2520Emerging%2520KPC-%2520and%2520PDC-Variants%2520in%2520Multidrug-Resistant%2520K.%2520pneumoniae%2520and%2520P.%2520aeruginosa%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3DS419%26epage%3DS420%26doi%3D10.1093%2Fofid%2Fofy210.1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
den Akker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Exploring Additional Dimensions of Complexity in Inhibitor Design for Serine β-Lactamases: Mechanistic and Intra- and Inter-molecular Chemistry Approaches</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.00622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.3389%2Ffmicb.2018.00622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=29403456" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-622&author=F.+van%0Aden+Akkerauthor=R.+A.+Bonomo&title=Exploring+Additional+Dimensions+of+Complexity+in+Inhibitor+Design+for+Serine+%CE%B2-Lactamases%3A+Mechanistic+and+Intra-+and+Inter-molecular+Chemistry+Approaches&doi=10.3389%2Ffmicb.2018.00622"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.00622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.00622%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bden%2BAkker%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DExploring%2520Additional%2520Dimensions%2520of%2520Complexity%2520in%2520Inhibitor%2520Design%2520for%2520Serine%2520%25CE%25B2-Lactamases%253A%2520Mechanistic%2520and%2520Intra-%2520and%2520Inter-molecular%2520Chemistry%2520Approaches%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D1%26epage%3D622%26doi%3D10.3389%2Ffmicb.2018.00622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calvopiña, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heesom, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span> <span> </span><span class="NLM_article-title">Structural/mechanistic insights into the efficacy of nonclassical beta-lactamase inhibitors against extensively drug resistant <i>Stenotrophomonas maltophilia</i> clinical isolates</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1111/mmi.13831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1111%2Fmmi.13831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=28876489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFehsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2017&pages=492-504&author=K.+Calvopi%C3%B1aauthor=P.+Hinchliffeauthor=J.+Bremauthor=K.+J.+Heesomauthor=S.+Johnsonauthor=R.+Cainauthor=C.+T.+Lohansauthor=C.+W.+G.+Fishwickauthor=C.+J.+Schofieldauthor=J.+Spencerauthor=M.+B.+Avison&title=Structural%2Fmechanistic+insights+into+the+efficacy+of+nonclassical+beta-lactamase+inhibitors+against+extensively+drug+resistant+Stenotrophomonas+maltophilia+clinical+isolates&doi=10.1111%2Fmmi.13831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates</span></div><div class="casAuthors">Calvopina, Karina; Hinchliffe, Philip; Brem, Juergen; Heesom, Kate J.; Johnson, Samar; Cain, Ricky; Lohans, Christopher T.; Fishwick, Colin W. G.; Schofield, Christopher J.; Spencer, James; Avison, Matthew B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-504</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Clavulanic acid and avibactam are clin. deployed serine β-lactamase inhibitors, important as a defense against antibacterial resistance.  Bicyclic boronates are recently discovered inhibitors of serine and some metallo β-lactamases.  Here, we show that avibactam and a bicyclic boronate inhibit L2 (serine β-lactamase) but not L1 (metallo β-lactamase) from the extensively drug resistant human pathogen Stenotrophomonas maltophilia.  X-ray crystallog. revealed that both inhibitors bind L2 by covalent attachment to the nucleophilic serine.  Both inhibitors reverse ceftazidime resistance in S. maltophilia because, unlike clavulanic acid, they do not induce L1 prodn.  Ceftazidime/inhibitor resistant mutants hyperproduce L1, but retain aztreonam/inhibitor susceptibility because aztreonam is not an L1 substrate.  Importantly, avibactam, but not the bicyclic boronate is deactivated by L1 at a low rate; the utility of avibactam might be compromised by mutations that increase this deactivation rate.  These data rationalize the obsd. clin. efficacy of ceftazidime/avibactam plus aztreonam as combination therapy for S. maltophilia infections and confirm that aztreonam-like β-lactams plus nonclassical β-lactamase inhibitors, particularly avibactam-like and bicyclic boronate compds., have potential for treating infections caused by this most intractable of drug resistant pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWDFZtxpcUELVg90H21EOLACvtfcHk0ljGurUrHO2x0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFehsL%252FP&md5=743df6eec7685626581123465d8d6079</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fmmi.13831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmmi.13831%26sid%3Dliteratum%253Aachs%26aulast%3DCalvopi%25C3%25B1a%26aufirst%3DK.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DHeesom%26aufirst%3DK.%2BJ.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26atitle%3DStructural%252Fmechanistic%2520insights%2520into%2520the%2520efficacy%2520of%2520nonclassical%2520beta-lactamase%2520inhibitors%2520against%2520extensively%2520drug%2520resistant%2520Stenotrophomonas%2520maltophilia%2520clinical%2520isolates%26jtitle%3DMol.%2520Microbiol.%26date%3D2017%26volume%3D106%26spage%3D492%26epage%3D504%26doi%3D10.1111%2Fmmi.13831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Observations on the Deprotection of Pinanediol and Pinacol Boronate Esters via Fluorinated Intermediates</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1021/jo901930v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo901930v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFKgurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=468-471&author=S.+R.+Inglisauthor=E.+C.+Y.+Woonauthor=A.+L.+Thompsonauthor=C.+J.+Schofield&title=Observations+on+the+Deprotection+of+Pinanediol+and+Pinacol+Boronate+Esters+via+Fluorinated+Intermediates&doi=10.1021%2Fjo901930v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Observations on the Deprotection of Pinanediol and Pinacol Boronate Esters via Fluorinated Intermediates</span></div><div class="casAuthors">Inglis, Steven R.; Woon, Esther C. Y.; Thompson, Amber L.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">468-471</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methods for the deprotection of pinanediol and pinacol esters of various boronic acids via fluoroborane intermediates were evaluated.  Treatment of the boronate esters with potassium hydrogen difluoride normally gives trifluoroborate salts; in the case of α-amido alkyl or o-amido Ph boronate esters, aq. workup gives difluoroboranes.  Procedures for transformation of both trifluoroborates and difluoroboranes to free boronic acids are described, involving either aq. ammonia or TMSCl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSWOgebPm18LVg90H21EOLACvtfcHk0ljGurUrHO2x0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFKgurjO&md5=4a294b48b07c81df789591989058be17</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo901930v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901930v%26sid%3Dliteratum%253Aachs%26aulast%3DInglis%26aufirst%3DS.%2BR.%26aulast%3DWoon%26aufirst%3DE.%2BC.%2BY.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DObservations%2520on%2520the%2520Deprotection%2520of%2520Pinanediol%2520and%2520Pinacol%2520Boronate%2520Esters%2520via%2520Fluorinated%2520Intermediates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D468%26epage%3D471%26doi%3D10.1021%2Fjo901930v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Q.</span></span> <span> </span><span class="NLM_article-title">Active-Site Conformational Fluctuations Promote the Enzymatic Activity of NDM-1</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">e01579</span>– <span class="NLM_lpage">e01518</span>, <span class="refDoi"> DOI: 10.1128/AAC.01579-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1128%2FAAC.01579-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=30150473" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=e01579-e01518&author=H.+Zhangauthor=G.+Maauthor=Y.+Zhuauthor=L.+Zengauthor=A.+Ahmadauthor=C.+Wangauthor=B.+Pangauthor=H.+Fangauthor=L.+Zhaoauthor=Q.+Hao&title=Active-Site+Conformational+Fluctuations+Promote+the+Enzymatic+Activity+of+NDM-1&doi=10.1128%2FAAC.01579-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FAAC.01579-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01579-18%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DPang%26aufirst%3DB.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DQ.%26atitle%3DActive-Site%2520Conformational%2520Fluctuations%2520Promote%2520the%2520Enzymatic%2520Activity%2520of%2520NDM-1%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26spage%3De01579%26epage%3De01518%26doi%3D10.1128%2FAAC.01579-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ullah, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of the L1 metallo-β-lactamase from <i>Stenotrophomonas maltophilia</i> at 1.7 å resolution11 Edited by K. Nagai</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1998.2148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1006%2Fjmbi.1998.2148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=9811546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFOqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1998&pages=125-136&author=J.+H.+Ullahauthor=T.+R.+Walshauthor=I.+A.+Taylorauthor=D.+C.+Emeryauthor=C.+S.+Vermaauthor=S.+J.+Gamblinauthor=J.+Spencer&title=The+crystal+structure+of+the+L1+metallo-%CE%B2-lactamase+from+Stenotrophomonas+maltophilia+at+1.7+%C3%A5+resolution11+Edited+by+K.+Nagai&doi=10.1006%2Fjmbi.1998.2148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 Å resolution</span></div><div class="casAuthors">Ullah, J. H.; Walsh, T. R.; Taylor, I. A.; Emery, D. C.; Verma, C. S.; Gamblin, S. J.; Spencer, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-136</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The structure of metallo-β-lactamase L1 from the opportunistic pathogen, S. maltophilia, was detd. at 1.7 Å resoln. by the multi-wavelength anomalous dispersion (MAD) approach exploiting both the intrinsic binuclear Zn center and incorporated selenomethionine residues.  L1 is unique among all known β-lactamases in that it exists as a tetramer.  The protein was found to exhibit the αβ/βα fold found only in the metallo-β-lactamases and displayed several unique features not previously obsd. in these enzymes.  These included a disulfide bridge and 2 substantially elongated loops connected to the active site of the enzyme.  Two closely spaced Zn2+ ions are bound at the active site with tetrahedral (Zn1) and trigonal bipyramidal (Zn2) coordination, resp.; these were bridged by a water mol. which it was proposed acts as the nucleophile in the hydrolytic reaction.  Ligation of the 2nd Zn2+ ion involved both residues and geometry which had not been previously obsd. in the metallo-β-lactamases.  Simulated binding of the substrates, ampicillin, ceftazidime, and imipenem, suggested that the substrate is able to bind to the enzyme in a variety of different conformations whose common features are direct interactions of the β-lactam carbonyl O and N atoms with the Zn2+ ions and of the β-lactam carboxylate with Ser-187.  Here, the authors describe a catalytic mechanism whose principal features are a nucleophilic attack of the bridging water on the β-lactam carbonyl C atom, electrostatic stabilization of a neg. charged tetrahedral transition state, and protonation of the β-lactam N atom by a 2nd water mol. coordinated by Zn2.  Further, the authors propose that direct metal-substrate interactions provide a substantial contribution to substrate binding and that this may explain the lack of specificity which is a feature of this class of enzyme.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ9BHl5xZ3bbVg90H21EOLACvtfcHk0ljGurUrHO2x0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFOqtLY%253D&md5=d4d86e30cb7f6e8cac5efd46b7d3c7a3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2148%26sid%3Dliteratum%253Aachs%26aulast%3DUllah%26aufirst%3DJ.%2BH.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DTaylor%26aufirst%3DI.%2BA.%26aulast%3DEmery%26aufirst%3DD.%2BC.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26aulast%3DSpencer%26aufirst%3DJ.%26atitle%3DThe%2520crystal%2520structure%2520of%2520the%2520L1%2520metallo-%25CE%25B2-lactamase%2520from%2520Stenotrophomonas%2520maltophilia%2520at%25201.7%2520%25C3%25A5%2520resolution11%2520Edited%2520by%2520K.%2520Nagai%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D284%26spage%3D125%26epage%3D136%26doi%3D10.1006%2Fjmbi.1998.2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yapp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aik, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristensen, J. B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, O. N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walport, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinnes, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagg, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krojer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppermann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klose, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span> <span> </span><span class="NLM_article-title">5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3110</span>– <span class="NLM_lpage">3117</span>, <span class="refDoi"> DOI: 10.1039/c3sc51122g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1039%2Fc3sc51122g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=26682036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVehs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=3110-3117&author=R.+J.+Hopkinsonauthor=A.+Tumberauthor=C.+Yappauthor=R.+Chowdhuryauthor=W.+Aikauthor=K.+H.+Cheauthor=X.+S.+Liauthor=J.+B.+L.+Kristensenauthor=O.+N.+F.+Kingauthor=M.+C.+Chanauthor=K.+K.+Yeohauthor=H.+Choiauthor=L.+J.+Walportauthor=C.+C.+Thinnesauthor=J.+T.+Bushauthor=C.+Lejeuneauthor=A.+M.+Rydzikauthor=N.+R.+Roseauthor=E.+A.+Baggauthor=M.+A.+McDonoughauthor=T.+Krojerauthor=W.+W.+Yueauthor=S.+S.+Ngauthor=L.+Olsenauthor=P.+E.+Brennanauthor=U.+Oppermannauthor=S.+Muller-Knappauthor=R.+J.+Kloseauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofieldauthor=A.+Kawamura&title=5-Carboxy-8-hydroxyquinoline+is+a+Broad+Spectrum+2-Oxoglutarate+Oxygenase+Inhibitor+which+Causes+Iron+Translocation&doi=10.1039%2Fc3sc51122g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation</span></div><div class="casAuthors">Hopkinson, Richard J.; Tumber, Anthony; Yapp, Clarence; Chowdhury, Rasheduzzaman; Aik, WeiShen; Che, Ka Hing; Li, Xuan Shirley; Kristensen, Jan B. L.; King, Oliver N. F.; Chan, Mun Chiang; Yeoh, Kar Kheng; Choi, Hwanho; Walport, Louise J.; Thinnes, Cyrille C.; Bush, Jacob T.; Lejeune, Clarisse; Rydzik, Anna M.; Rose, Nathan R.; Bagg, Eleanor A.; McDonough, Michael A.; Krojer, Tobias J.; Yue, Wyatt W.; Ng, Stanley S.; Olsen, Lars; Brennan, Paul E.; Oppermann, Udo; Mueller, Susanne; Klose, Robert J.; Ratcliffe, Peter J.; Schofield, Christopher J.; Kawamura, Akane</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3110-3117</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">2-Oxoglutarate and iron dependent oxygenases are therapeutic targets for human diseases.  Using a representative 2OG oxygenase panel, the authors compare the inhibitory activities of 5-carboxy-8-hydroxyquinoline (IOX1) and 4-carboxy-8-hydroxyquinoline (4C8HQ) with that of two other commonly used 2OG oxygenase inhibitors, N-oxalylglycine (NOG) and 2,4-pyridinedicarboxylic acid (2,4-PDCA).  IOX1 has a broad spectrum of activity, as demonstrated by the inhibition of transcription factor hydroxylases, representatives of all 2OG dependent histone demethylase subfamilies, nucleic acid demethylases and γ-butyrobetaine hydroxylase.  Cellular assays show that, unlike NOG and 2,4-PDCA, IOX1 is active against both cytosolic and nuclear 2OG oxygenases without ester derivatization.  Unexpectedly, crystallog. studies on these oxygenases demonstrate that IOX1, but not 4C8HQ, can cause translocation of the active site metal, revealing a rare example of protein ligand-induced metal movement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_NBtJvNEBOLVg90H21EOLACvtfcHk0lgeEZ9kZ2-P5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVehs73L&md5=506fb4e75971c57a7a968f4d37805856</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc3sc51122g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc51122g%26sid%3Dliteratum%253Aachs%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DAik%26aufirst%3DW.%26aulast%3DChe%26aufirst%3DK.%2BH.%26aulast%3DLi%26aufirst%3DX.%2BS.%26aulast%3DKristensen%26aufirst%3DJ.%2BB.%2BL.%26aulast%3DKing%26aufirst%3DO.%2BN.%2BF.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DYeoh%26aufirst%3DK.%2BK.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DWalport%26aufirst%3DL.%2BJ.%26aulast%3DThinnes%26aufirst%3DC.%2BC.%26aulast%3DBush%26aufirst%3DJ.%2BT.%26aulast%3DLejeune%26aufirst%3DC.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DRose%26aufirst%3DN.%2BR.%26aulast%3DBagg%26aufirst%3DE.%2BA.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DKrojer%26aufirst%3DT.%26aulast%3DYue%26aufirst%3DW.%2BW.%26aulast%3DNg%26aufirst%3DS.%2BS.%26aulast%3DOlsen%26aufirst%3DL.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DOppermann%26aufirst%3DU.%26aulast%3DMuller-Knapp%26aufirst%3DS.%26aulast%3DKlose%26aufirst%3DR.%2BJ.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DKawamura%26aufirst%3DA.%26atitle%3D5-Carboxy-8-hydroxyquinoline%2520is%2520a%2520Broad%2520Spectrum%25202-Oxoglutarate%2520Oxygenase%2520Inhibitor%2520which%2520Causes%2520Iron%2520Translocation%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D3110%26epage%3D3117%26doi%3D10.1039%2Fc3sc51122g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tierney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, G.</span></span> <span> </span><span class="NLM_article-title">X-ray absorption spectroscopy of dinuclear metallohydrolases</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1263</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2014.07.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.bpj.2014.07.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=25229134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVaktLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2014&pages=1263-1272&author=D.+L.+Tierneyauthor=G.+Schenk&title=X-ray+absorption+spectroscopy+of+dinuclear+metallohydrolases&doi=10.1016%2Fj.bpj.2014.07.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">X-Ray Absorption Spectroscopy of Dinuclear Metallohydrolases</span></div><div class="casAuthors">Tierney, David L.; Schenk, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1263-1272</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  In this mini-review, the authors briefly discuss the phys. origin of x-ray absorption spectroscopy (XAS) before illustrating its application using dinuclear metallohydrolases as exemplary systems.  The systems the authors have selected for illustrative purposes present a challenging problem for XAS, one that is ideal to demonstrate the potential of this methodol. for structure/function studies of metalloenzymes in general.  When the metal ion is redox active, XAS provides a sensitive measure of oxidn.-state-dependent differences.  When the metal ion is zinc, XAS is the only spectroscopic method that will provide easily accessible structural information in soln.  In the case of heterodimetallic sites, XAS has the unique ability to interrogate each metal site independently in the same sample.  One of the strongest advantages of XAS is its ability to examine metal ion site structures with crystallog. precision, without the need for a crystal.  This is key for studying flexible metal ion sites, such as those described in the selected examples, because it allows one to monitor structural changes that occur during substrate turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ8NlOsjmFqbVg90H21EOLACvtfcHk0lgeEZ9kZ2-P5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVaktLzO&md5=1d757c5c02bca7ed786a680489d5d531</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2014.07.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2014.07.066%26sid%3Dliteratum%253Aachs%26aulast%3DTierney%26aufirst%3DD.%2BL.%26aulast%3DSchenk%26aufirst%3DG.%26atitle%3DX-ray%2520absorption%2520spectroscopy%2520of%2520dinuclear%2520metallohydrolases%26jtitle%3DBiophys.%2520J.%26date%3D2014%26volume%3D107%26spage%3D1263%26epage%3D1272%26doi%3D10.1016%2Fj.bpj.2014.07.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aitha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Adbul-Wahid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tierney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowder, M. W.</span></span> <span> </span><span class="NLM_article-title">Probing substrate binding to the metal binding sites in metallo-β-lactamase L1 during catalysis</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1039/C5MD00358J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1039%2FC5MD00358J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=27087914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=194-201&author=M.+Aithaauthor=S.+Al-Adbul-Wahidauthor=D.+L.+Tierneyauthor=M.+W.+Crowder&title=Probing+substrate+binding+to+the+metal+binding+sites+in+metallo-%CE%B2-lactamase+L1+during+catalysis&doi=10.1039%2FC5MD00358J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Probing substrate binding to the metal binding sites in metallo-β-lactamase L1 during catalysis</span></div><div class="casAuthors">Aitha, Mahesh; Al-Adbul-Wahid, Sameer; Tierney, David L.; Crowder, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-201</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Metal ions in metallo-β-lactamases (MBLs) play a major role in catalysis.  In this study we investigated the role of the metal ions in the Zn1 and Zn2 sites of MBL L1 during catalysis.  A ZnCo (with Zn(II) in the invariant Zn1 site and Co(II) in the Zn2 site) analog of MBL L1 was prepd. by using a biol. incorporation method.  Extended X-ray absorption fine structure (EXAFS) spectroscopic studies were used to confirm that the ZnCo analog was prepd.  To study the roles of the Zn(II) and Co(II) ions during catalysis, rapid freeze quench (RFQ)-EXAFS studies were used to probe the reaction of the ZnCo-L1 analog with chromacef when quenched at 10 ms, 50 ms, and 100 ms.  The L1-product complex was also analyzed with EXAFS spectroscopy.  The data show that the Zn-Co distance is 3.49 Å in the resting enzyme and that this distance increases by 0.3 Å in the sample that was quenched at 10 ms.  The av. Zn-Co distance decreases at the other time points until reaching a distance of 3.58 Å in the L1-product complex.  The data also show that a Co-S interaction is present in the 100 ms quenched sample and in the L1-product complex, which suggests that there is a significant rearrangement of product in the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-9sdbFv4vt7Vg90H21EOLACvtfcHk0lgeEZ9kZ2-P5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCrsA%253D%253D&md5=1b8ec3da5f9d539a9db8b5a2784e3963</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1039%2FC5MD00358J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00358J%26sid%3Dliteratum%253Aachs%26aulast%3DAitha%26aufirst%3DM.%26aulast%3DAl-Adbul-Wahid%26aufirst%3DS.%26aulast%3DTierney%26aufirst%3DD.%2BL.%26aulast%3DCrowder%26aufirst%3DM.%2BW.%26atitle%3DProbing%2520substrate%2520binding%2520to%2520the%2520metal%2520binding%2520sites%2520in%2520metallo-%25CE%25B2-lactamase%2520L1%2520during%2520catalysis%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26spage%3D194%26epage%3D201%26doi%3D10.1039%2FC5MD00358J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojica, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinati, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llarrull, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, A. J.</span></span> <span> </span><span class="NLM_article-title">Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=544-554&author=M.+M.+Gonzalezauthor=M.+Kosmopoulouauthor=M.+F.+Mojicaauthor=V.+Castilloauthor=P.+Hinchliffeauthor=I.+Pettinatiauthor=J.+Bremauthor=C.+J.+Schofieldauthor=G.+Mahlerauthor=R.+A.+Bonomoauthor=L.+I.+Llarrullauthor=J.+Spencerauthor=A.+J.+Vila&title=Bisthiazolidines%3A+A+Substrate-Mimicking+Scaffold+as+an+Inhibitor+of+the+NDM-1+Carbapenemase&doi=10.1021%2Facsinfecdis.5b00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase</span></div><div class="casAuthors">Gonzalez, Mariano M.; Kosmopoulou, Magda; Mojica, Maria F.; Castillo, Valerie; Hinchliffe, Philip; Pettinati, Ilaria; Brem, Jurgen; Schofield, Christopher J.; Mahler, Graciela; Bonomo, Robert A.; Llarrull, Leticia I.; Spencer, James; Vila, Alejandro J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">544-554</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pathogenic Gram-neg. bacteria resistant to almost all β-lactam antibiotics are a major public health threat.  Zn(II)-dependent or metallo-β-lactamases (MBLs) produced by these bacteria inactivate most β-lactam antibiotics, including the carbapenems, which are "last line therapies" for life-threatening Gram-neg. infections.  NDM-1 is a carbapenemase belonging to the MBL family that is rapidly spreading worldwide.  Regrettably, inhibitors of MBLs are not yet developed.  Here the authors present the bisthiazolidine (BTZ) scaffold as a structure with some features of β-lactam substrates, which can be modified with metal-binding groups to target the MBL active site.  Inspired by known interactions of MBLs with β-lactams, the authors designed four BTZs that behave as in vitro NDM-1 inhibitors with Ki values in the low micromolar range (from 7±1 to 19±3 μM).  NMR spectroscopy demonstrated that they inhibit hydrolysis of imipenem in NDM-1-producing Escherichia coli.  In vitro time kill cell-based assays against a variety of bacterial strains harboring blaNDM-1 including Acinetobacter baumannii show that the compds. restore the antibacterial activity of imipenem.  A crystal structure of the most potent heterocycle (L-CS319) in complex with NDM-1 at 1.9 Å resoln. identified both structural determinants for inhibitor binding and opportunities for further improvements in potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokg8f_hU7BV7Vg90H21EOLACvtfcHk0litWbL7kXqarg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLbI&md5=3a13478a79bee2dddfad2137406d54a0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00046%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DM.%2BM.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DMojica%26aufirst%3DM.%2BF.%26aulast%3DCastillo%26aufirst%3DV.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DPettinati%26aufirst%3DI.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DMahler%26aufirst%3DG.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DVila%26aufirst%3DA.%2BJ.%26atitle%3DBisthiazolidines%253A%2520A%2520Substrate-Mimicking%2520Scaffold%2520as%2520an%2520Inhibitor%2520of%2520the%2520NDM-1%2520Carbapenemase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D544%26epage%3D554%26doi%3D10.1021%2Facsinfecdis.5b00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebrone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galleni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frère, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dideberg, O.</span></span> <span> </span><span class="NLM_article-title">A Metallo-β-lactamase Enzyme in Action: Crystal Structures of the Monozinc Carbapenemase CphA and its Complex with Biapenem</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.10.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1016%2Fj.jmb.2004.10.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=15588826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A280%3ADC%252BD2cnhvVWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2005&pages=785-795&author=G.+Garauauthor=C.+Bebroneauthor=C.+Anneauthor=M.+Galleniauthor=J.-M.+Fr%C3%A8reauthor=O.+Dideberg&title=A+Metallo-%CE%B2-lactamase+Enzyme+in+Action%3A+Crystal+Structures+of+the+Monozinc+Carbapenemase+CphA+and+its+Complex+with+Biapenem&doi=10.1016%2Fj.jmb.2004.10.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem</span></div><div class="casAuthors">Garau Gianpiero; Bebrone Carine; Anne Christine; Galleni Moreno; Frere Jean-Marie; Dideberg Otto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">785-95</span>
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">One strategy developed by bacteria to resist the action of beta-lactam antibiotics is the expression of metallo-beta-lactamases.  CphA from Aeromonas hydrophila is a member of a clinically important subclass of metallo-beta-lactamases that have only one zinc ion in their active site and for which no structure is available.  The crystal structures of wild-type CphA and its N220G mutant show the structural features of the active site of this enzyme, which is modeled specifically for carbapenem hydrolysis.  The structure of CphA after reaction with a carbapenem substrate, biapenem, reveals that the enzyme traps a reaction intermediate in the active site.  These three X-ray structures have allowed us to propose how the enzyme recognizes carbapenems and suggest a mechanistic pathway for hydrolysis of the beta-lactam.  This will be relevant for the design of metallo-beta-lactamase inhibitors as well as of antibiotics that escape their hydrolytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1dmDxal0dc7BItaL1WaVAfW6udTcc2ebrbfRh3PixXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnhvVWksA%253D%253D&md5=74925de6f500b9fbbe0c015fda324ff3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.10.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.10.070%26sid%3Dliteratum%253Aachs%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DBebrone%26aufirst%3DC.%26aulast%3DAnne%26aufirst%3DC.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DFr%25C3%25A8re%26aufirst%3DJ.-M.%26aulast%3DDideberg%26aufirst%3DO.%26atitle%3DA%2520Metallo-%25CE%25B2-lactamase%2520Enzyme%2520in%2520Action%253A%2520Crystal%2520Structures%2520of%2520the%2520Monozinc%2520Carbapenemase%2520CphA%2520and%2520its%2520Complex%2520with%2520Biapenem%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D345%26spage%3D785%26epage%3D795%26doi%3D10.1016%2Fj.jmb.2004.10.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span> <span> </span><span class="NLM_article-title">QM/MM Studies of Monozinc β-Lactamase CphA Suggest That the Crystal Structure of an Enzyme–Intermediate Complex Represents a Minor Pathway</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">17986</span>– <span class="NLM_lpage">17988</span>, <span class="refDoi"> DOI: 10.1021/ja104241g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja104241g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFaktrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=17986-17988&author=S.+Wuauthor=D.+Xuauthor=H.+Guo&title=QM%2FMM+Studies+of+Monozinc+%CE%B2-Lactamase+CphA+Suggest+That+the+Crystal+Structure+of+an+Enzyme%E2%80%93Intermediate+Complex+Represents+a+Minor+Pathway&doi=10.1021%2Fja104241g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">QM/MM Studies of Monozinc β-Lactamase CphA Suggest That the Crystal Structure of an Enzyme-Intermediate Complex Represents a Minor Pathway</span></div><div class="casAuthors">Wu, Shanshan; Xu, Dingguo; Guo, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17986-17988</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">QM/MM studies of the hydrolysis of a β-lactam antibiotic mol. (biapenem) catalyzed by a monozinc β-lactamase (CphA) have revealed the complete reaction mechanism and shown that an exptl. detd. enzyme-intermediate complex is a stable intermediate or product in a minor pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-R71w52XjPrVg90H21EOLACvtfcHk0litWbL7kXqarg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFaktrfE&md5=adcdd55e04872574168228abe60d5f4a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fja104241g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja104241g%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DH.%26atitle%3DQM%252FMM%2520Studies%2520of%2520Monozinc%2520%25CE%25B2-Lactamase%2520CphA%2520Suggest%2520That%2520the%2520Crystal%2520Structure%2520of%2520an%2520Enzyme%25E2%2580%2593Intermediate%2520Complex%2520Represents%2520a%2520Minor%2520Pathway%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D17986%26epage%3D17988%26doi%3D10.1021%2Fja104241g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vercheval, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauvois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Paolo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauvage, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matagne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frère, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galleni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerff, F.</span></span> <span> </span><span class="NLM_article-title">Three factors that modulate the activity of class D β-lactamases and interfere with the post-translational carboxylation of Lys70</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>432</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1042/BJ20101122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1042%2FBJ20101122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=21108605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOkt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2010&pages=495-506&author=L.+Verchevalauthor=C.+Bauvoisauthor=A.+di+Paoloauthor=F.+Borelauthor=J.-L.+Ferrerauthor=E.+Sauvageauthor=A.+Matagneauthor=J.-M.+Fr%C3%A8reauthor=P.+Charlierauthor=M.+Galleniauthor=F.+Kerff&title=Three+factors+that+modulate+the+activity+of+class+D+%CE%B2-lactamases+and+interfere+with+the+post-translational+carboxylation+of+Lys70&doi=10.1042%2FBJ20101122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Three factors that modulate the activity of class D β-lactamases and interfere with the post-translational carboxylation of Lys70</span></div><div class="casAuthors">Vercheval, Lionel; Bauvois, Cedric; di Paolo, Alexandre; Borel, Franck; Ferrer, Jean-Luc; Sauvage, Eric; Matagne, Andre; Frere, Jean-Marie; Charlier, Paulette; Galleni, Moreno; Kerff, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-504</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The activity of class D β-lactamases is dependent on Lys70 carboxylation in the active site.  Structural, kinetic and affinity studies show that this post-translational modification can be affected by the presence of a poor substrate such as moxalactam but also by the V117T substitution.  Val117 is a strictly conserved hydrophobic residue located in the active site.  In addn., inhibition of class D β-lactamases by chloride ions is due to a competition between the side chain carboxylate of the modified Lys70 and chloride ions.  Detn. of the individual kinetic consts. shows that the deacylation of the acyl-enzyme is the rate-limiting step for the wild-type OXA-10 β-lactamase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0FjX7OsuI7Vg90H21EOLACvtfcHk0lh5GEvQdIbpFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOkt73K&md5=9c771536c8e0e7f38427e7736ecfd234</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2FBJ20101122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20101122%26sid%3Dliteratum%253Aachs%26aulast%3DVercheval%26aufirst%3DL.%26aulast%3DBauvois%26aufirst%3DC.%26aulast%3Ddi%2BPaolo%26aufirst%3DA.%26aulast%3DBorel%26aufirst%3DF.%26aulast%3DFerrer%26aufirst%3DJ.-L.%26aulast%3DSauvage%26aufirst%3DE.%26aulast%3DMatagne%26aufirst%3DA.%26aulast%3DFr%25C3%25A8re%26aufirst%3DJ.-M.%26aulast%3DCharlier%26aufirst%3DP.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DKerff%26aufirst%3DF.%26atitle%3DThree%2520factors%2520that%2520modulate%2520the%2520activity%2520of%2520class%2520D%2520%25CE%25B2-lactamases%2520and%2520interfere%2520with%2520the%2520post-translational%2520carboxylation%2520of%2520Lys70%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D432%26spage%3D495%26epage%3D506%26doi%3D10.1042%2FBJ20101122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdelraouf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuhussain, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, D. P.</span></span> <span> </span><span class="NLM_article-title">1405. Efficacy of the Human-Simulated Regimen (HSR) of Cefepime (FEP)/VNRX-5133 Combination Against Serine β-Lactamase-Producing Gram-negative Bacteria in the Neutropenic Murine Thigh Infection Model</span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S432</span>– <span class="NLM_lpage">S433</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fofid%2Fofy210.1236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S432-S433&author=K.+Abdelraoufauthor=S.+A.+Abuhussainauthor=D.+P.+Nicolau&title=1405.+Efficacy+of+the+Human-Simulated+Regimen+%28HSR%29+of+Cefepime+%28FEP%29%2FVNRX-5133+Combination+Against+Serine+%CE%B2-Lactamase-Producing+Gram-negative+Bacteria+in+the+Neutropenic+Murine+Thigh+Infection+Model&doi=10.1093%2Fofid%2Fofy210.1236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1236%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelraouf%26aufirst%3DK.%26aulast%3DAbuhussain%26aufirst%3DS.%2BA.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26atitle%3D1405.%2520Efficacy%2520of%2520the%2520Human-Simulated%2520Regimen%2520%2528HSR%2529%2520of%2520Cefepime%2520%2528FEP%2529%252FVNRX-5133%2520Combination%2520Against%2520Serine%2520%25CE%25B2-Lactamase-Producing%2520Gram-negative%2520Bacteria%2520in%2520the%2520Neutropenic%2520Murine%2520Thigh%2520Infection%2520Model%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3DS432%26epage%3DS433%26doi%3D10.1093%2Fofid%2Fofy210.1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geibel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkel, T.</span></span> <span> </span><span class="NLM_article-title">1401. A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single and Repeat Doses of VNRX-5133 in Healthy Subjects</span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S431</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fofid%2Fofy210.1232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S431&author=B.+Geibelauthor=J.+Dowellauthor=D.+Dickersonauthor=T.+Henkel&title=1401.+A+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Study+of+the+Safety+and+Pharmacokinetics+of+Single+and+Repeat+Doses+of+VNRX-5133+in+Healthy+Subjects&doi=10.1093%2Fofid%2Fofy210.1232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1232%26sid%3Dliteratum%253Aachs%26aulast%3DGeibel%26aufirst%3DB.%26aulast%3DDowell%26aufirst%3DJ.%26aulast%3DDickerson%26aufirst%3DD.%26aulast%3DHenkel%26aufirst%3DT.%26atitle%3D1401.%2520A%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Study%2520of%2520the%2520Safety%2520and%2520Pharmacokinetics%2520of%2520Single%2520and%2520Repeat%2520Doses%2520of%2520VNRX-5133%2520in%2520Healthy%2520Subjects%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3DS431%26doi%3D10.1093%2Fofid%2Fofy210.1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahm, D.</span></span> <span> </span><span class="NLM_article-title">1360. Antimicrobial Activity of Cefepime in Combination with VNRX-5133 Against a Global Collection of Enterobacteriaceae Including Resistant Phenotypes</span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S416</span>– <span class="NLM_lpage">S417</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1093%2Fofid%2Fofy210.1191" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S416-S417&author=M.+Hackelauthor=D.+Sahm&title=1360.+Antimicrobial+Activity+of+Cefepime+in+Combination+with+VNRX-5133+Against+a+Global+Collection+of+Enterobacteriaceae+Including+Resistant+Phenotypes&doi=10.1093%2Fofid%2Fofy210.1191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1191%26sid%3Dliteratum%253Aachs%26aulast%3DHackel%26aufirst%3DM.%26aulast%3DSahm%26aufirst%3DD.%26atitle%3D1360.%2520Antimicrobial%2520Activity%2520of%2520Cefepime%2520in%2520Combination%2520with%2520VNRX-5133%2520Against%2520a%2520Global%2520Collection%2520of%2520Enterobacteriaceae%2520Including%2520Resistant%2520Phenotypes%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3DS416%26epage%3DS417%26doi%3D10.1093%2Fofid%2Fofy210.1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Dynamic combinatorial chemistry employing boronic acids/boronate esters leads to potent oxygenase inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6672</span>– <span class="NLM_lpage">6675</span>, <span class="refDoi"> DOI: 10.1002/anie.201202000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1002%2Fanie.201202000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1WjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=6672-6675&author=M.+Demetriadesauthor=I.+K.+Leungauthor=R.+Chowdhuryauthor=M.+C.+Chanauthor=M.+A.+McDonoughauthor=K.+K.+Yeohauthor=Y.+M.+Tianauthor=T.+D.+Claridgeauthor=P.+J.+Ratcliffeauthor=E.+C.+Woonauthor=C.+J.+Schofield&title=Dynamic+combinatorial+chemistry+employing+boronic+acids%2Fboronate+esters+leads+to+potent+oxygenase+inhibitors&doi=10.1002%2Fanie.201202000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Combinatorial Chemistry Employing Boronic Acids/Boronate Esters Leads to Potent Oxygenase Inhibitors</span></div><div class="casAuthors">Demetriades, Marina; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Chan, Mun Chiang; McDonough, Michael A.; Yeoh, Kar Kheng; Tian, Ya-Min; Claridge, Timothy D. W.; Ratcliffe, Peter J.; Woon, Esther C. Y.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6672-6675, S6672/1-S6672/53</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The reversible reaction of boronic acids with alcs. to form boronate esters, coupled to protein mass spectrometry analyses, was used to discover potent oxygenase inhibitors.  This dynamic combinatorial mass spectrometry technique could potentially be applied to the identification of other protein inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0EBYJgddCLVg90H21EOLACvtfcHk0lh5GEvQdIbpFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1WjtL0%253D&md5=1e6b2d573dec343072822882f9cccaef</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fanie.201202000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201202000%26sid%3Dliteratum%253Aachs%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DYeoh%26aufirst%3DK.%2BK.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DWoon%26aufirst%3DE.%2BC.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DDynamic%2520combinatorial%2520chemistry%2520employing%2520boronic%2520acids%252Fboronate%2520esters%2520leads%2520to%2520potent%2520oxygenase%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D6672%26epage%3D6675%26doi%3D10.1002%2Fanie.201202000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zervosen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frere, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joris, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luxen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauvage, E.</span></span> <span> </span><span class="NLM_article-title">Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">10839</span>– <span class="NLM_lpage">10848</span>, <span class="refDoi"> DOI: 10.1021/ja200696y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja200696y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFKhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=10839-10848&author=A.+Zervosenauthor=R.+Hermanauthor=F.+Kerffauthor=A.+Hermanauthor=A.+Bouillezauthor=F.+Pratiauthor=R.+F.+Prattauthor=J.+M.+Frereauthor=B.+Jorisauthor=A.+Luxenauthor=P.+Charlierauthor=E.+Sauvage&title=Unexpected+tricovalent+binding+mode+of+boronic+acids+within+the+active+site+of+a+penicillin-binding+protein&doi=10.1021%2Fja200696y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected Tricovalent Binding Mode of Boronic Acids within the Active Site of a Penicillin-Binding Protein</span></div><div class="casAuthors">Zervosen, Astrid; Herman, Raphael; Kerff, Frederic; Herman, Alexandre; Bouillez, Andre; Prati, Fabio; Pratt, R. F.; Frere, Jean-Marie; Joris, Bernard; Luxen, Andre; Charlier, Paulette; Sauvage, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10839-10848</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Boronic acids bearing appropriate side chains are good inhibitors of serine amidohydrolases.  The boron usually adopts a tetrahedral conformation, bound to the nucleophilic serine of the active site and mimicking the transition state of the enzymic reaction.  We have solved the structures of complexes of a penicillin-binding protein (PBP), the DD-peptidase from Actinomadura sp. R39, with four amidomethylboronic acids (2,6-dimethoxybenzamidomethylboronic acid, phenylacetamidomethylboronic acid, 2-chlorobenzamidomethylboronic acid, and 2-nitrobenzamidomethylboronic acid) and the pinacol ester derived from phenylacetamidomethylboronic acid.  We found that in each case, the boron forms a tricovalent adduct with the Oγ from Ser49 and Ser298, and the terminal amine group of Lys410, three key residues involved in the catalytic mechanism of penicillin-binding proteins.  This represents the first tricovalent enzyme-inhibitor adducts obsd. by crystallog.  In two of the five R39-boronate structures, the boronic acid is found as a tricovalent adduct in two monomers of the asym. unit and as a monocovalent adduct with the active serine in the two remaining monomers of the asym. unit.  Formation of the tricovalent complex from a classical monocovalent complex may involve rotation around the Ser49 Cα-Cβ bond to place the boron in a position to interact with Ser298 and Lys410, and a twisting of the side-chain amide such that its carbonyl oxygen is able to hydrogen bond to the oxyanion hole NH of Thr413.  Biphasic kinetics were obsd. in three of the five cases, and details of the reaction between R39 and 2,6-dimethoxybenzamidomethylboronic acid were studied.  Observation of biphasic kinetics was not, however, thought to be correlated with formation of tricovalent complexes, assuming that the latter do form in soln.  On the basis of the crystallog. and kinetic results, a reaction scheme for this unexpected inhibition by boronic acids is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2ewm48mQ5fLVg90H21EOLACvtfcHk0lisIixvfJG-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFKhsr0%253D&md5=847cbfcb9458d610240b34d01a99a261</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja200696y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja200696y%26sid%3Dliteratum%253Aachs%26aulast%3DZervosen%26aufirst%3DA.%26aulast%3DHerman%26aufirst%3DR.%26aulast%3DKerff%26aufirst%3DF.%26aulast%3DHerman%26aufirst%3DA.%26aulast%3DBouillez%26aufirst%3DA.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26aulast%3DFrere%26aufirst%3DJ.%2BM.%26aulast%3DJoris%26aufirst%3DB.%26aulast%3DLuxen%26aufirst%3DA.%26aulast%3DCharlier%26aufirst%3DP.%26aulast%3DSauvage%26aufirst%3DE.%26atitle%3DUnexpected%2520tricovalent%2520binding%2520mode%2520of%2520boronic%2520acids%2520within%2520the%2520active%2520site%2520of%2520a%2520penicillin-binding%2520protein%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D10839%26epage%3D10848%26doi%3D10.1021%2Fja200696y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wayne, P. A.</span></span> <i>Performance Standards for Antimicrobial Susceptibility Testing</i>, <span class="NLM_edition">27</span>th ed.; <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+A.+Wayne&title=Performance+Standards+for+Antimicrobial+Susceptibility+Testing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWayne%26aufirst%3DP.%2BA.%26btitle%3DPerformance%2520Standards%2520for%2520Antimicrobial%2520Susceptibility%2520Testing%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of New Delhi metallo-beta-lactamase reveals molecular basis for antibiotic resistance</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1484</span>– <span class="NLM_lpage">1491</span>, <span class="refDoi"> DOI: 10.1002/pro.697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1002%2Fpro.697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=21774017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaksL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1484-1491&author=D.+Kingauthor=N.+Strynadka&title=Crystal+structure+of+New+Delhi+metallo-beta-lactamase+reveals+molecular+basis+for+antibiotic+resistance&doi=10.1002%2Fpro.697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance</span></div><div class="casAuthors">King, Dustin; Strynadka, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1484-1491</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">β-Lactams are the most commonly prescribed class of antibiotics and have had an enormous impact on human health.  Thus, it is disquieting that New Delhi metallo-β-lactamase-1 (NDM-1) can confer Enterobacteriaceae with nearly complete resistance to all β-lactam antibiotics including carbapenams.  Here, the authors detd. the crystal structure of Klebsiella pneumoniae apo-NDM-1 to 2.1-Å resoln.  From the structure, it was revealed that NDM-1 had an expansive active site with a unique electrostatic profile, which the authors propose leads to a broader substrate specificity.  In addn., NDM-1 underwent important conformational changes upon substrate binding.  These changes have not been previously obsd. in metallo-β-lactamases and may have a direct influence on substrate recognition and catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrajfR8I0jnVbVg90H21EOLACvtfcHk0lisIixvfJG-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaksL3O&md5=0f82182108d813855421d7a651095c8a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fpro.697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.697%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DD.%26aulast%3DStrynadka%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520New%2520Delhi%2520metallo-beta-lactamase%2520reveals%2520molecular%2520basis%2520for%2520antibiotic%2520resistance%26jtitle%3DProtein%2520Sci.%26date%3D2011%26volume%3D20%26spage%3D1484%26epage%3D1491%26doi%3D10.1002%2Fpro.697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span> <span> </span><span class="NLM_article-title">PHENIX: building new software for automated crystallographic structure determination</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1954</span>, <span class="refDoi"> DOI: 10.1107/S0907444902016657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1107%2FS0907444902016657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=12393927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1948-1954&author=P.+D.+Adamsauthor=R.+W.+Grosse-Kunstleveauthor=L.-W.+Hungauthor=T.+R.+Ioergerauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+J.+Readauthor=J.+C.+Sacchettiniauthor=N.+K.+Sauterauthor=T.+C.+Terwilliger&title=PHENIX%3A+building+new+software+for+automated+crystallographic+structure+determination&doi=10.1107%2FS0907444902016657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: building new software for automated crystallographic structure determination</span></div><div class="casAuthors">Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li Wei; Ioerger, Thomas R.; McCoy, Airlie J.; Moriarty, Nigel W.; Read, Randy J.; Sacchettini, James C.; Sauter, Nicholas K.; Terwilliger, Thomas C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">D58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1954</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">Structural genomics seeks to rapidly expand the no. of protein structures to ext. the max. amt. of information from genomic sequence databases.  The advent of several large-scale projects worldwide leads to many new challenges in the field of crystallog. macromol. structure detn.  A novel software package, called PHENIX (Python-based Hierarchical Environment for Integrated Xtallog.), is therefore being developed.  This new software will provide the necessary algorithms to proceed from reduced intensity data to a refined mol. model and to facilitate structure soln. for both the novice and expert crystallographer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtuUfHXPmCbVg90H21EOLACvtfcHk0lisIixvfJG-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D&md5=9a3b66e1f7d064183f7a9ce108cb4e5e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1107%2FS0907444902016657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444902016657%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26atitle%3DPHENIX%253A%2520building%2520new%2520software%2520for%2520automated%2520crystallographic%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2002%26volume%3D58%26spage%3D1948%26epage%3D1954%26doi%3D10.1107%2FS0907444902016657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lisIixvfJG-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RMF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RMF','PDB','6RMF'); return false;">PDB: 6RMF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RTN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RTN','PDB','6RTN'); return false;">PDB: 6RTN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZGZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZGZ','PDB','5ZGZ'); return false;">PDB: 5ZGZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZGE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZGE','PDB','5ZGE'); return false;">PDB: 5ZGE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQ9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQ9','PDB','5FQ9'); return false;">PDB: 5FQ9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RFM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RFM','PDB','6RFM'); return false;">PDB: 6RFM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQC','PDB','5FQC'); return false;">PDB: 5FQC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FQB','PDB','5FQB'); return false;">PDB: 5FQB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6I30" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6I30','PDB','6I30'); return false;">PDB: 6I30</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J8X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J8X','PDB','5J8X'); return false;">PDB: 5J8X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T66" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T66','PDB','5T66'); return false;">PDB: 5T66</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SPU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SPU','PDB','3SPU'); return false;">PDB: 3SPU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00911">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_60731"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00911">10.1021/acs.jmedchem.9b00911</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings for VNRX-5133 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv">CSV</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS spectra of all synthesized compounds; LC–MS spectrum of VNRX-5133; data from time dependence experiments; error analysis for reported inhibition values and processing and refinement statistics (including Molprobity validation reports) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_001.csv">jm9b00911_si_001.csv (0.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00911/suppl_file/jm9b00911_si_002.pdf">jm9b00911_si_002.pdf (2.26 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 6RMF (NDM-1:<b>VNRX-5133</b>) and 6RTN (OXA-10:<b>VNRX-5133</b>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00911" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00911" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994a182f6924c7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
